,tumor_code,tumor_sample_id,normal_sample_id,in_published_paper,withdrawn.disqualified,specimen.aliquout_id_protein_normal,specimen.aliquout_id_protein_tumor,specimen.aliquout_id_RNA_Tumor,specimen.aliquout_id_RNA_Normal,specimen.aliquout_id_DNA_Blood,specimen.aliquout_id_DNA_Tumor,specimen.aliquout_id_DNA_Normal,is_gtex,Age,Sex,Race,Ethnicity,Inferred.Ancestry.based.on.Genomic.data,Participant.Country,consent.case_stopped,baseline.tumor_site,baseline.tumor_site_other,baseline.tumor_laterality,baseline.tumor_focality,baseline.tumor_size_cm,baseline.histologic_type,cptac_path.histologic_grade,baseline.tumor_necrosis,baseline.margin_status,baseline.ajcc_tnm_cancer_staging_edition_used,baseline.pathologic_staging_primary_tumor_pt,baseline.pathologic_staging_regional_lymph_nodes_pn,baseline.number_of_lymph_nodes_examined,baseline.number_of_lymph_nodes_positive_for_tumor_by_he_staining,baseline.clinical_staging_distant_metastasis_cm,baseline.pathologic_staging_distant_metastasis_pm,baseline.specify_distant_metastasis_documented_sites,baseline.residual_tumor,baseline.tumor_stage_pathological,baseline.ancillary_studies_immunohistochemistry_type_and_result,baseline.ancillary_studies_other_testing_type_and_result,baseline.number_of_lymph_nodes_positive_for_tumor_by_ihc_staining,medical_history.height_at_time_of_surgery_cm,medical_history.weight_at_time_of_surgery_kg,medical_history.bmi,medical_history.history_of_cancer,medical_history.alcohol_consumption,medical_history.tobacco_smoking_history,medical_history.number_of_pack_years_smoked,medical_history.was_the_participant_exposed_to_secondhand_smoke,medical_history.exposure_to_secondhand_smoke_in_household_during_participants_childhood,medical_history.exposure_to_secondhand_smoke_in_participants_current_household,medical_history.number_of_years_participant_has_consumed_more_than_2_drinks_per_day_for_men_and_more_than_1_drink_per_day_for_women,cancer_history.cancer_type,cancer_history.history_of_any_treatment,cancer_history.medical_record_documentation_of_this_history_of_cancer_and_treatment,medications.medication_name_vitamins_supplements,medications.history_source,procurement.tumor_tissue_collection_frozen_with_oct,follow.up.vital_status_at_date_of_last_contact,follow.up.number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_last_contact,follow.up.number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_death,follow.up.cause_of_death,follow.up.number_of_days_from_date_of_collection_to_date_of_last_contact,follow.up.number_of_days_from_date_of_collection_to_date_of_death,follow.up.adjuvant_post.operative_radiation_therapy,follow.up.adjuvant_post.operative_pharmaceutical_therapy,follow.up.adjuvant_post.operative_immunological_therapy,follow.up.tumor_status_at_date_of_last_contact_or_death,follow.up.measure_of_success_of_outcome_at_the_completion_of_initial_first_course_treatment,follow.up.measure_of_success_of_outcome_at_date_of_last_contact_or_death,follow.up.new_tumor_after_initial_treatment,follow.up.number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_new_tumor_event_after_initial_treatment,follow.up.type_of_new_tumor,follow.up.site_of_new_tumor,follow.up.other_site_of_new_tumor,follow.up.diagnostic_evidence_of_recurrence_or_relapse,follow.up.additional_surgery_for_new_tumor_loco.regional,follow.up.additional_surgery_for_new_tumor_metastasis,follow.up.residual_tumor_after_surgery_for_new_tumor,follow.up.additional_treatment_radiation_therapy_for_new_tumor,follow.up.additional_treatment_pharmaceutical_therapy_for_new_tumor,follow.up.additional_treatment_immuno_for_new_tumor,follow.up.number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_additional_surgery_for_new_tumor_event_loco.regional,follow.up.number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_additional_surgery_for_new_tumor_event_metastasis,Recurrence.free.survival..days,Recurrence.free.survival.from.collection..days,Recurrence.status..1..yes..0..no.,Overall.survival..days,Survival.status..1..dead..0..alive.,Time.between.collection.and.diagnosis..days,Diagnosis.delay..days,age_num,binned_OS,binned_age
CPT001846,BR,,,FALSE,disqualified,,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
CPT000814,BR,,,FALSE,disqualified,,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
11BR047,BR,11BR047-T,,TRUE,,,81116212-b7e6-454b-9579-105cf3,ef52c640-13a9-4855-9ce2-0be77a_D7_1,,0bfd3ae8-d275-4dab-9360-d1df30_D1_1,ef52c640-13a9-4855-9ce2-0be77a_D6_1,,FALSE,59,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,5,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,369,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,369,0,NA,NA,59,High or alive at last follow-up,50-60
11BR043,BR,11BR043-T,,TRUE,,,6d34d499-167e-42aa-9790-316fca_D2,6d34d499-167e-42aa-9790-316fca_D7_1,,a1338e3d-598a-45b5-838f-9b6206_D1_1,6d34d499-167e-42aa-9790-316fca_D6_1,,FALSE,36,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1,10,2,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,374,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,374,0,NA,NA,36,High or alive at last follow-up,<50
11BR049,BR,11BR049-T,,TRUE,,,2e700669-85b0-43fa-a9c7-3eaf5a_D2,2e700669-85b0-43fa-a9c7-3eaf5a_D1,,ad85fadf-31b7-44f3-b6ea-73c55d_D1,2e700669-85b0-43fa-a9c7-3eaf5a_D6,,FALSE,45,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,6,6,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,379,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,379,0,NA,NA,45,High or alive at last follow-up,<50
11BR023,BR,11BR023-T,,TRUE,,,0a80d3c4-0758-447a-958c-ea868c,079b5600-6afc-4785-bb22-48cfab_D7_1,,70ee4720-f4dc-4b91-a6aa-c0efd9_D1_1,079b5600-6afc-4785-bb22-48cfab_D6_1,,FALSE,58,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,398,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,398,0,NA,NA,58,High or alive at last follow-up,50-60
18BR010,BR,18BR010-T,,TRUE,,,0bb9d596-774e-452b-9c89-a6643c_D2,0bb9d596-774e-452b-9c89-a6643c_D7_1,,feab8720-9694-4679-917f-f1287c_D1_1,0bb9d596-774e-452b-9c89-a6643c_D6_1,,FALSE,41,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,7,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,410,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,410,0,NA,NA,41,High or alive at last follow-up,<50
06BR003,BR,06BR003-T,,TRUE,,,31b13596-554e-452f-91a4-7e67a8_D2,"['31b13596-554e-452f-91a4-7e67a8_D7', 'not run']",,"['31da4db6-8404-43f0-995d-ebc10b_D1', 'not run']","['31b13596-554e-452f-91a4-7e67a8_D6', 'not run']",,FALSE,75,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,13,0,,MX,,,Stage II,,,Not Performed,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,323,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,323,0,NA,NA,75,High or alive at last follow-up,>70
11BR074,BR,11BR074-T,,TRUE,,,3367406e-d39c-4641-a3e7-44e1f3,12ce8313-6c54-4bee-a996-1aa7f8_D7,,93f961e1-fe4c-4dfc-8cbe-1dff31_D1_1,12ce8313-6c54-4bee-a996-1aa7f8_D6_1,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2,10,10,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,367,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,367,0,NA,NA,66,High or alive at last follow-up,60-70
18BR017,BR,18BR017-T,,TRUE,,,392b8aa4-9f99-4250-b693-326260_D2,392b8aa4-9f99-4250-b693-326260_D7_1,,f49705bd-129b-4bfe-a944-a7eb51_D1_1,392b8aa4-9f99-4250-b693-326260_D6_1,,FALSE,72,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T1,N0,8,0,,M0,,,Stage I,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,445,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,445,0,NA,NA,72,High or alive at last follow-up,>70
01BR017,BR,01BR017-T,,TRUE,,,09659708-7747-4d59-a3b9-e221e0_D2,09659708-7747-4d59-a3b9-e221e0_D7,,b76c68fc-2403-4e79-ad46-4ae336_D1,09659708-7747-4d59-a3b9-e221e0_D6,,FALSE,45,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T3,N1,,,,MX,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,413,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,413,0,NA,NA,45,High or alive at last follow-up,<50
06BR006,BR,06BR006-T,,TRUE,,,3799eeb5-c966-4059-a78f-ace269_D2,3799eeb5-c966-4059-a78f-ace269_D7,,7e168c2a-f22a-44d9-ac7d-1a4c42_D1,3799eeb5-c966-4059-a78f-ace269_D6,,FALSE,51,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Reported/ Unknown,,Not Performed,Not Performed,,,,Not Performed,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,137,NA,,NA,NA,No,Yes,,Distant met recurrence/progression,,,Yes,NA,Distant Metastasis,Liver,,,Not Reported/ Unknown,,,No,Not Reported/ Unknown,,NA,NA,NA,NA,1,137,0,NA,NA,51,High or alive at last follow-up,50-60
09BR005,BR,09BR005-T,,TRUE,,,150c2086-1815-40d2-bc5d-8eeb48_D2,8dc13656-a9c0-4b99-b02d-650893_D7_1,,fb2f019d-a181-4939-916a-5dccbd_D1_1,150c2086-1815-40d2-bc5d-8eeb48_D6_1,,FALSE,38,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1a,13,3,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,337,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,337,0,NA,NA,38,High or alive at last follow-up,<50
11BR017,BR,11BR017-T,,TRUE,,,241ecd0e-89bd-4d3a-81b3-55a250,241c8dec-b317-4794-8cc2-07c14c_D7_1,,e324df92-19fa-41f1-bf90-638803_D1,241c8dec-b317-4794-8cc2-07c14c_D6_1,,FALSE,74,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,9,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,221,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,221,1,NA,NA,74,Low,>70
01BR015,BR,01BR015-T,,TRUE,,,42cc89e1-a896-4f57-b8d9-e7fe56_D2,42cc89e1-a896-4f57-b8d9-e7fe56_D7,,f99563c8-f45c-4508-a41c-620e7c_D1,42cc89e1-a896-4f57-b8d9-e7fe56_D6,,FALSE,35,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N1,,,,M0,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,347,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,347,0,NA,NA,35,High or alive at last follow-up,<50
11BR025,BR,11BR025-T,,TRUE,,,1740224c-32d1-4c9f-98c6-653363,8d7fc1ef-a0ac-44bb-8381-1444a0_D7_1,,af148751-8390-4acc-8ef9-8cb829_D1_1,8d7fc1ef-a0ac-44bb-8381-1444a0_D6_1,,FALSE,77,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,,,,M0,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,393,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,393,0,NA,NA,77,High or alive at last follow-up,>70
01BR001,BR,01BR001-T,,TRUE,,,17d55745-4ab3-4a80-a182-af938b_D2,17d55745-4ab3-4a80-a182-af938b_D7,,60439729-0ee4-431a-a8db-3325a2_D1,17d55745-4ab3-4a80-a182-af938b_D6,,FALSE,55,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N1c,,,,M0,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,421,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,421,0,NA,NA,55,High or alive at last follow-up,50-60
11BR031,BR,11BR031-T,,TRUE,,,3fdf0dbe-e05c-465f-8bed-4a92dd_D2,3fdf0dbe-e05c-465f-8bed-4a92dd_D7,,567b7b28-c132-4d78-a181-e2d340_D1_1,3fdf0dbe-e05c-465f-8bed-4a92dd_D6_1,,FALSE,50,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,11,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,370,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,370,0,NA,NA,50,High or alive at last follow-up,<50
01BR032,BR,01BR032-T,,TRUE,,,e5e1306b-719e-4c3e-b85b-fd1231_D2,e5e1306b-719e-4c3e-b85b-fd1231_D7_1,,67ebb699-4493-40ac-8aa2-2e7852_D1_1,e5e1306b-719e-4c3e-b85b-fd1231_D6_1,,FALSE,46,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T4,N0,,,,M0,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,363,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,363,0,NA,NA,46,High or alive at last follow-up,<50
05BR045,BR,05BR045-T,,TRUE,,,92862537-5f30-47db-a3e2-cc9d0c_D2,92862537-5f30-47db-a3e2-cc9d0c_D7_1,,4e998bbe-c506-4778-b321-135dae_D1_1,92862537-5f30-47db-a3e2-cc9d0c_D6_1,,FALSE,60,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,2,0,,MX,,,Stage II,,,Not Performed,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,60,,50-60
11BR053,BR,11BR053-T,,TRUE,,,fb526979-ee2d-4edf-b41d-01074f_D2,28be2eb2-1c1c-4799-b5af-e4b447_D7_1,,a5ecd1b1-8075-4d46-9a4f-18b8b1_D1_1,28be2eb2-1c1c-4799-b5af-e4b447_D6_1,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,371,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,371,0,NA,NA,61,High or alive at last follow-up,60-70
01BR027,BR,01BR027-T,,TRUE,,,64ee175f-f3ce-446e-bbf4-9b6fa8_D1,1990853a-0e82-40b3-a025-91cdc1_D7,,71f40378-962e-4a4b-b0de-6ec414_D1,1990853a-0e82-40b3-a025-91cdc1_D6,,FALSE,80,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N1,,,,MX,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,351,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,351,0,NA,NA,80,High or alive at last follow-up,>70
14BR008,BR,14BR008-T,,TRUE,,,ca14c6dd-2069-4bc5-b1f2-6f2297_D2,99df02e0-56b3-4b00-80b7-ea58ce_D7,,5d7892a4-966e-44e4-b4d1-83173f_D1_1,99df02e0-56b3-4b00-80b7-ea58ce_D6,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3,N2a,11,9,,MX,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,505,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,505,0,NA,NA,66,High or alive at last follow-up,60-70
18BR002,BR,18BR002-T,,TRUE,,,fe591474-99d7-44d3-be73-c3b8ed_D2,fe591474-99d7-44d3-be73-c3b8ed_D7_1,,bfcfa737-bf42-4249-b016-7d5ce1_D1_1,fe591474-99d7-44d3-be73-c3b8ed_D6_1,,FALSE,64,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,7,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,431,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,431,0,NA,NA,64,High or alive at last follow-up,60-70
03BR013,BR,03BR013-T,,TRUE,,,01f203fd-e664-4d78-bea0-7c40cf_D2,d0dd0347-9b0f-46fe-8d62-bf17f3_D7,,24c38c22-1518-40bf-9f39-043d7d_D1_1,01f203fd-e664-4d78-bea0-7c40cf_D6_1,,FALSE,52,Female,Unknown,Unknown,Ad_Mixed_American,,No,,,,,NA,IDC and DCIS,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0(i-),2,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,355,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,0,NA,NA,52,High or alive at last follow-up,50-60
11BR032,BR,11BR032-T,,TRUE,,,314de592-f356-4801-8ace-278173_D2,314de592-f356-4801-8ace-278173_D7_1,,560627f2-6763-475a-8c1d-009ef9_D1_1,314de592-f356-4801-8ace-278173_D6_1,,FALSE,49,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,13,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,369,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,369,0,NA,NA,49,High or alive at last follow-up,<50
21BR010,BR,21BR010-T,,TRUE,,,68ef4aa9-00b0-4528-8828-4d3e43_D2,68ef4aa9-00b0-4528-8828-4d3e43_D7_1,,22bb2418-f3a9-4a2e-aceb-5f2c02_D1_1,68ef4aa9-00b0-4528-8828-4d3e43_D6_1,,FALSE,71,Female,White,Hispanic or Latino,Ad_Mixed_American,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N1a,8,1,,MX,,,Stage II,,,Not Applicable,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,327,NA,,NA,NA,No,No,,Not Reported / Unknown,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,327,0,NA,NA,71,High or alive at last follow-up,>70
03BR004,BR,03BR004-T,,TRUE,,,4683de9c-49ca-4ddd-9d1a-be8121_D2,4683de9c-49ca-4ddd-9d1a-be8121_D7,,195a74d7-12c8-498d-9b63-c67177_D1,4683de9c-49ca-4ddd-9d1a-be8121_D6,,FALSE,88,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1mi,1,1,,MX,,,Stage II,,,1,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,358,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,358,0,NA,NA,88,High or alive at last follow-up,>70
11BR003,BR,11BR003-T,,TRUE,,,2dc74c29-2e89-4600-80bf-1e3637_D2,"['2dc74c29-2e89-4600-80bf-1e3637_D7', 'not run']",,"['df724f1a-ea3d-4a56-bef5-aa0307_D1', 'not run']","['2dc74c29-2e89-4600-80bf-1e3637_D6', 'not run']",,FALSE,53,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,394,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,394,0,NA,NA,53,High or alive at last follow-up,50-60
11BR028,BR,11BR028-T,,TRUE,,,885fe794-a98e-4f81-a284-ac4bb8,3b177fd6-e7d2-4312-bec7-4a253d_D7_1,,82887429-6fff-4bb0-8664-ce4d22_D1_1,3b177fd6-e7d2-4312-bec7-4a253d_D6_1,,FALSE,55,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,380,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,380,0,NA,NA,55,High or alive at last follow-up,50-60
18BR004,BR,18BR004-T,,TRUE,,,b292e992-0611-4254-872f-af8275_D2,b292e992-0611-4254-872f-af8275_D7_1,,f2d0d540-c092-4404-9ce2-bd5e15_D1_1,b292e992-0611-4254-872f-af8275_D6_1,,FALSE,76,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Infiltrating Ductal and Mucinous Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,426,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,426,0,NA,NA,76,High or alive at last follow-up,>70
20BR005,BR,20BR005-T,,TRUE,,,2f398497-d53e-4838-8006-d60f3e_D2,2f398497-d53e-4838-8006-d60f3e_D7_1,,36b40856-2603-4e84-a7a1-e12e6f_D1_1,2f398497-d53e-4838-8006-d60f3e_D6_1,,FALSE,47,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N1,4,1,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,357,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,357,0,NA,NA,47,High or alive at last follow-up,<50
11BR073,BR,11BR073-T,,TRUE,,,1664b920-5e60-4e3b-9aab-fe121c,5d27516f-58d7-4155-80b4-4c7f39_D7_1,,ba46cb26-65c0-4c5d-95de-ef7d41_D1_1,5d27516f-58d7-4155-80b4-4c7f39_D6_1,,FALSE,64,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2,10,6,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,64,High or alive at last follow-up,60-70
11BR009,BR,11BR009-T,,TRUE,,,3324361b-df55-4e53-a2ef-4f8df2_D2,3324361b-df55-4e53-a2ef-4f8df2_D7,,af5441ab-b2ad-4a62-9973-6b3f9c_D1,3324361b-df55-4e53-a2ef-4f8df2_D6,,FALSE,44,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N3b,11,4,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,406,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,406,0,NA,NA,44,High or alive at last follow-up,<50
18BR019,BR,18BR019-T,,TRUE,,,0edcba67-0714-4b04-b433-77834e_D2,0edcba67-0714-4b04-b433-77834e_D7_1,,89b91c31-8d75-42cb-bb72-a97657_D1_1,0edcba67-0714-4b04-b433-77834e_D6_1,,FALSE,68,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2a,N2,16,7,,M0,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,437,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,437,0,NA,NA,68,High or alive at last follow-up,60-70
20BR001,BR,20BR001-T,,TRUE,,,358296ad-e2a7-40cd-849e-8590fd_D2,358296ad-e2a7-40cd-849e-8590fd_D8_1,,cee1c3f1-6fab-4d2c-9982-27406d_D1_1,358296ad-e2a7-40cd-849e-8590fd_D6_1,,FALSE,82,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N0,1,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,87,NA,,NA,NA,Yes,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,87,0,NA,NA,82,High or alive at last follow-up,>70
09BR007,BR,09BR007-T,,TRUE,,,6cb5d29a-9437-430d-b91c-57ee3d_D2,6cb5d29a-9437-430d-b91c-57ee3d_D7_1,,a86ecd9a-10fd-4eed-b246-12d587_D1_1,6cb5d29a-9437-430d-b91c-57ee3d_D6_1,,FALSE,77,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,8,6,,MX,,,Stage III,,,Not Applicable,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,329,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,329,0,NA,NA,77,High or alive at last follow-up,>70
11BR020,BR,11BR020-T,,TRUE,,,428de0d4-7f84-4075-bae1-352af6,94176301-9658-4151-9110-5139de_D7_1,,04bb91d9-92af-4fe1-b02a-9972ac_D1_1,94176301-9658-4151-9110-5139de_D6_1,,FALSE,37,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,367,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,367,0,NA,NA,37,High or alive at last follow-up,<50
20BR002,BR,20BR002-T,,TRUE,,,abee08ca-606d-4e2a-a2e6-24780f_D2,9462caa5-13e8-4997-a4f7-294f16_D7,,ea2fbf6a-45bc-445b-9bd1-341311_D1_1,9462caa5-13e8-4997-a4f7-294f16_D6_1,,FALSE,95,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,NX,,,,MX,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,9,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,9,0,NA,NA,95,High or alive at last follow-up,>70
11BR019,BR,11BR019-T,,TRUE,,,8dd1d8be-dc7e-44f5-9f44-77ecf0_D2,8dd1d8be-dc7e-44f5-9f44-77ecf0_D7_1,,0819e79c-6e11-4c5a-826b-6a3de0_D1_1,8dd1d8be-dc7e-44f5-9f44-77ecf0_D6_1,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Infiltrating Ductal and Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,377,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,377,0,NA,NA,61,High or alive at last follow-up,60-70
20BR008,BR,20BR008-T,,TRUE,,,acf022b3-7f01-43b3-ac14-86f97d,b87e7f88-a1f2-425a-8cff-8ae4b9_D7,,393ad6ef-250a-493c-8c41-e47504_D1_1,b87e7f88-a1f2-425a-8cff-8ae4b9_D6_1,,FALSE,71,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,invasive ductal carcinoma with extensive high-grade DCIS with comedonecrosis and features of papillary carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T4b,N2,30,6,,MX,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,347,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,347,0,NA,NA,71,High or alive at last follow-up,>70
01BR033,BR,01BR033-T,,TRUE,,,c646b902-e1e0-4e3e-a4c5-daca71_D2,3329b802-e49f-4494-b645-868a25_D7,,0ab89209-3cf4-4082-a5d8-684c84_D1_1,3329b802-e49f-4494-b645-868a25_D6_1,,FALSE,40,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T3,N2,,,,M0,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,351,NA,,NA,NA,Yes,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,351,0,NA,NA,40,High or alive at last follow-up,<50
11BR022,BR,11BR022-T,,TRUE,,,da3d7876-ca79-4f21-a00e-27e6b6_D2,da3d7876-ca79-4f21-a00e-27e6b6_D7_1,,19a415b6-f700-44ae-b704-348eda_D1_1,da3d7876-ca79-4f21-a00e-27e6b6_D6_1,,FALSE,48,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,13,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,13,0,NA,NA,48,High or alive at last follow-up,<50
11BR013,BR,11BR013-T,,TRUE,,,faadb553-9437-42cb-b469-498d67_D2,faadb553-9437-42cb-b469-498d67_D7_1,,51de6425-8c2f-486c-8073-2d60fa_D1_1,faadb553-9437-42cb-b469-498d67_D6_1,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,378,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,378,0,NA,NA,70,High or alive at last follow-up,60-70
03BR010,BR,03BR010-T,,TRUE,,,49f55bd6-a89a-4d18-b732-139c3d_D2,49f55bd6-a89a-4d18-b732-139c3d_D7,,04fa7dba-53a4-4696-94e4-75efc5_D1,49f55bd6-a89a-4d18-b732-139c3d_D6,,FALSE,78,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,4,0,,MX,,,Stage II,,,0,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year",,,NA,,,,,,No,,,,,Living,357,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,357,0,NA,NA,78,High or alive at last follow-up,>70
20BR007,BR,20BR007-T,,TRUE,,,33adae13-5dbd-4530-a5d5-3763e4,547f521a-5851-426c-a125-d9d82c_D7_1,,58f39d9c-9c17-4268-a206-564f83_D1_1,547f521a-5851-426c-a125-d9d82c_D6_1,,FALSE,55,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N0,2,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,357,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,357,0,NA,NA,55,High or alive at last follow-up,50-60
11BR030,BR,11BR030-T,,TRUE,,,4749ba99-d3b8-4ae3-b6f6-458bc7,63a05d68-f0f7-42d9-a45f-df0f7e_D7_1,,2e1881a6-2228-4f07-883c-e25c6a_D1_1,63a05d68-f0f7-42d9-a45f-df0f7e_D6_1,,FALSE,50,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,377,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,377,0,NA,NA,50,High or alive at last follow-up,<50
18BR007,BR,18BR007-T,,TRUE,,,1ae5772a-ba49-4c00-b890-7513d0_D2,1ae5772a-ba49-4c00-b890-7513d0_D7,,1389064d-3882-462c-ab2d-407775_D1_1,1ae5772a-ba49-4c00-b890-7513d0_D6_1,,FALSE,64,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,431,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,431,0,NA,NA,64,High or alive at last follow-up,60-70
11BR050,BR,11BR050-T,,TRUE,,,d8a5467b-549b-48ed-9ae5-c9c39d_D2,d8a5467b-549b-48ed-9ae5-c9c39d_D11,,d5298917-e497-4c47-a604-645708_D1_1,d8a5467b-549b-48ed-9ae5-c9c39d_D6_1,,FALSE,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Mucinous Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,8,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,386,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,386,0,NA,NA,54,High or alive at last follow-up,50-60
05BR001,BR,05BR001-T,,TRUE,,,55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2,55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D7,,90128f2d-2a4c-4514-bcc8-e39be7_D1,55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D6,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1a,12,1,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,363,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,363,0,NA,NA,70,High or alive at last follow-up,60-70
11BR014,BR,11BR014-T,,TRUE,,,ddc680ad-63cf-4807-b535-9ccc88_D2,ddc680ad-63cf-4807-b535-9ccc88_D7_1,,5da4ac87-0990-419c-88c1-acd047_D1_1,ddc680ad-63cf-4807-b535-9ccc88_D6_1,,FALSE,39,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,8,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,408,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,408,0,NA,NA,39,High or alive at last follow-up,<50
22BR005,BR,22BR005-T,,TRUE,,,12110cb8-8da4-4461-ac1a-1af490_D2,12110cb8-8da4-4461-ac1a-1af490_D7_1,,7604cab5-d108-4fbd-8bc7-2bee52_D1_1,12110cb8-8da4-4461-ac1a-1af490_D6_1,,FALSE,46,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Mixed ductal and lobular features,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1a,15,2,,M0,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,348,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,348,0,NA,NA,46,High or alive at last follow-up,<50
11BR010,BR,11BR010-T,,TRUE,,,436db08d-c316-44b5-b0de-62617d_D2,436db08d-c316-44b5-b0de-62617d_D7_1,,b6c9faff-5782-45d1-895c-3e9cf5_D1_1,436db08d-c316-44b5-b0de-62617d_D6_1,,FALSE,35,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1,8,1,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,394,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,394,0,NA,NA,35,High or alive at last follow-up,<50
01BR031,BR,01BR031-T,,TRUE,,,96c52a27-3d9a-49e7-8ae8-a71e7c_D2,96c52a27-3d9a-49e7-8ae8-a71e7c_D7_1,,107c4d84-cd05-487c-a3aa-bbe849_D1_1,96c52a27-3d9a-49e7-8ae8-a71e7c_D6_1,,FALSE,61,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T3,N3,,,,M1,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,363,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,363,0,NA,NA,61,High or alive at last follow-up,60-70
11BR011,BR,11BR011-T,,TRUE,,,bc9fe67f-c4a2-43ba-87bd-438bda_D2,bc9fe67f-c4a2-43ba-87bd-438bda_D7_1,,85252bdd-206b-486f-b12a-705fcb_D1_1,bc9fe67f-c4a2-43ba-87bd-438bda_D6_1,,FALSE,71,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,6,4,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,402,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,402,0,NA,NA,71,High or alive at last follow-up,>70
03BR005,BR,03BR005-T,,TRUE,,,96c95de1-514b-44a5-b487-dc390b_D2,96c95de1-514b-44a5-b487-dc390b_D7,,b66903d8-088e-496e-97b7-348a9e_D1,96c95de1-514b-44a5-b487-dc390b_D6,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,2,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,304,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,304,0,NA,NA,61,High or alive at last follow-up,60-70
18BR003,BR,18BR003-T,,TRUE,,,e3d45dc6-66ef-4e0b-9d96-1b5db5,436297af-feb7-4754-96b7-c5bfb5_D7_1,,a0935138-0a31-4b38-a750-2914be_D1_1,436297af-feb7-4754-96b7-c5bfb5_D6_1,,FALSE,65,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,426,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,426,0,NA,NA,65,High or alive at last follow-up,60-70
11BR024,BR,11BR024-T,,TRUE,,,53723086-8858-4395-93d7-0baa68,9efd41a5-3db1-445b-accb-040c2b_D7_1,,e2366c0d-43f0-4761-9b7b-7a94ac_D1_1,9efd41a5-3db1-445b-accb-040c2b_D6_1,,FALSE,80,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,,,,M0,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,393,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,393,0,NA,NA,80,High or alive at last follow-up,>70
05BR016,BR,05BR016-T,,TRUE,,,3f957017-d081-45f4-b458-ec3f8d_D2,3f957017-d081-45f4-b458-ec3f8d_D7,,7a087328-9980-4488-ac9b-ba9550_D1,3f957017-d081-45f4-b458-ec3f8d_D6,,FALSE,78,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1a,14,2,,MX,,,Stage II,,,2,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,308,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,308,0,NA,NA,78,High or alive at last follow-up,>70
01BR030,BR,01BR030-T,,TRUE,,,1f5a9aad-61a1-4a64-a9b0-38cd2b_D2,1f5a9aad-61a1-4a64-a9b0-38cd2b_D7_1,,a2b1c102-3c96-4e75-bd12-e6b33f_D1_1,1f5a9aad-61a1-4a64-a9b0-38cd2b_D6_1,,FALSE,84,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T3,N1a,13,2,,MX,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,389,NA,,NA,NA,No,Yes,,Loco-regional recurrence/progression,,,No,NA,,,,,Not Applicable,,,Not Applicable,Not Applicable,,NA,NA,NA,NA,0,389,0,NA,NA,84,High or alive at last follow-up,>70
01BR018,BR,01BR018-T,,TRUE,,,d154d194-2b08-46d4-a199-84cfb8_D8,d154d194-2b08-46d4-a199-84cfb8_D7,,f0359550-c332-466b-badd-310292_D1,d154d194-2b08-46d4-a199-84cfb8_D6,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T3,N1,,,,M0,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,384,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,NA,NA,66,High or alive at last follow-up,60-70
05BR042,BR,05BR042-T,,TRUE,,,8ab1a564-9a18-43bf-aee3-7fceb0_D2,8ab1a564-9a18-43bf-aee3-7fceb0_D7_1,,9c427144-07ba-4190-bbe4-ec7faf_D1_1,8ab1a564-9a18-43bf-aee3-7fceb0_D6,,FALSE,40,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N1mi,4,2,,MX,,,Stage II,,,Not Performed,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,40,,<50
11BR054,BR,11BR054-T,,TRUE,,,b10c7b72-1d44-4668-a637-a536b2_D2,b10c7b72-1d44-4668-a637-a536b2_D7_1,,4c811274-4185-4b8b-93dd-93dbaf_D1_1,b10c7b72-1d44-4668-a637-a536b2_D6_1,,FALSE,84,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,376,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,376,0,NA,NA,84,High or alive at last follow-up,>70
05BR044,BR,05BR044-T,,TRUE,,,d01714eb-22bf-4ad7-95d9-f95bdf_D2,d01714eb-22bf-4ad7-95d9-f95bdf_D7_1,,ccd93955-378a-48ae-8ed2-07ee76_D1_1,d01714eb-22bf-4ad7-95d9-f95bdf_D6,,FALSE,62,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N1a,2,1,,MX,,,Stage II,,,Not Performed,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,62,,60-70
11BR006,BR,11BR006-T,,TRUE,,,3208e021-1dae-42fd-bd36-0f3c3d,4798bb9d-7100-43aa-b615-85897d_D7_1,,f2cf56e9-6d6d-4e29-8222-212720_D1_1,4798bb9d-7100-43aa-b615-85897d_D6_1,,FALSE,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,4,0,,M0,,,Stage II,,,Not Applicable,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,405,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,405,0,NA,NA,54,High or alive at last follow-up,50-60
14BR005,BR,14BR005-T,,TRUE,,,2386c36d-8d5d-4fd4-bbfa-39cc8d_D2,2386c36d-8d5d-4fd4-bbfa-39cc8d_D7_1,,c28e911d-87c7-4998-b36a-f4cee1_D1_1,2386c36d-8d5d-4fd4-bbfa-39cc8d_D6_1,,FALSE,78,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0(i-),4,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,517,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,517,0,NA,NA,78,High or alive at last follow-up,>70
11BR044,BR,11BR044-T,,TRUE,,,d92a2942-dba6-4fff-b0d0-0566fb_D2,75adceb5-eea5-4cb1-864e-876a8f_D7_1,,fd55a60e-fa4f-4e4e-a2b8-6273b9_D1_1,d92a2942-dba6-4fff-b0d0-0566fb_D6_1,,FALSE,48,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,7,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,382,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,382,0,NA,NA,48,High or alive at last follow-up,<50
11BR016,BR,11BR016-T,,TRUE,,,a7d58d61-5049-488f-9d0a-0a4411_D2,a7d58d61-5049-488f-9d0a-0a4411_D7_1,,97a6122a-7d33-49bb-96fb-4ab468_D1_1,a7d58d61-5049-488f-9d0a-0a4411_D6_1,,FALSE,30,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,388,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,388,0,NA,NA,30,High or alive at last follow-up,<50
11BR055,BR,11BR055-T,,TRUE,,,4533a2d6-e850-43f3-9c44-621c07_D2,4533a2d6-e850-43f3-9c44-621c07_D7_1,,284b7f89-0dfe-4333-b05e-988a60_D1_1,4533a2d6-e850-43f3-9c44-621c07_D6_1,,FALSE,56,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,13,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,13,0,NA,NA,56,High or alive at last follow-up,50-60
06BR005,BR,06BR005-T,,TRUE,,,25db2586-55b0-4456-9bba-c24e06_D2,25db2586-55b0-4456-9bba-c24e06_D7,,8d94b162-fa3a-4856-8c84-078f65_D1,25db2586-55b0-4456-9bba-c24e06_D6,,FALSE,58,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T1c,N1a,12,3,,MX,,,Stage II,,,Not Performed,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,320,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,320,0,NA,NA,58,High or alive at last follow-up,50-60
11BR042,BR,11BR042-T,,TRUE,,,a176fcc2-97b5-45c3-a0f3-3b2e41_D2,a176fcc2-97b5-45c3-a0f3-3b2e41_D7_1,,6e370163-4c31-4b23-be51-8d5c66_D1_1,a176fcc2-97b5-45c3-a0f3-3b2e41_D6_1,,FALSE,71,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,374,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,374,0,NA,NA,71,High or alive at last follow-up,>70
11BR018,BR,11BR018-T,,TRUE,,,855256a7-e41e-4158-b02f-ba61a9_D2,855256a7-e41e-4158-b02f-ba61a9_D7,,ba088f32-97f7-446a-9b7b-a804d2_D1_1,855256a7-e41e-4158-b02f-ba61a9_D6_1,,FALSE,54,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,7,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,377,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,377,0,NA,NA,54,High or alive at last follow-up,50-60
05BR009,BR,05BR009-T,,TRUE,,,48d1b543-dbf6-4594-b34a-d0e30a_D2,48d1b543-dbf6-4594-b34a-d0e30a_D7,,a1e9c072-ec07-4215-bfc3-5a65eb_D1,48d1b543-dbf6-4594-b34a-d0e30a_D6,,FALSE,64,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3,N3a,31,15,,MX,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,323,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,323,0,NA,NA,64,High or alive at last follow-up,60-70
01BR025,BR,01BR025-T,,TRUE,,,d6d42051-ad8e-4fb2-8cfc-829353_D2,d6d42051-ad8e-4fb2-8cfc-829353_D7,,110009db-7606-406d-a9f8-1aa86c_D1,d6d42051-ad8e-4fb2-8cfc-829353_D6,,FALSE,62,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Positive (+),,T3,N1a,15,1,,M0,,,Stage III,,,Not Applicable,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,601,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,601,0,NA,NA,62,High or alive at last follow-up,60-70
11BR015,BR,11BR015-T,,TRUE,,,6c660b6b-bfda-47b0-9499-160d49,cab796c6-0129-43cf-bd27-7da395_D7_1,,4a92b6da-eff2-46b8-b17e-97a19c_D1,cab796c6-0129-43cf-bd27-7da395_D6_1,,FALSE,60,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,5,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,386,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,386,0,NA,NA,60,High or alive at last follow-up,50-60
11BR040,BR,11BR040-T,,TRUE,,,d7b05dce-4362-4e8f-a77a-07dd74_D2,d7b05dce-4362-4e8f-a77a-07dd74_D7_1,,4c5dd3bd-ff23-4f6e-9f10-82a33b_D1_1,d7b05dce-4362-4e8f-a77a-07dd74_D6_1,,FALSE,67,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2,12,0,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,377,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,377,0,NA,NA,67,High or alive at last follow-up,60-70
11BR004,BR,11BR004-T,,TRUE,,,48de7e82-4cba-423c-9e39-89ac6b_D2,f33d08f0-f15c-4f34-90ba-7cbe75_D7_1,,0be767d3-9827-4d4f-9f76-208353_D1_1,48de7e82-4cba-423c-9e39-89ac6b_D6_1,,FALSE,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,8,0,,M0,,,Stage II,,,Not Applicable,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,405,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,405,0,NA,NA,54,High or alive at last follow-up,50-60
11BR057,BR,11BR057-T,,FALSE,,,8886aaca-adcf-4416-920a-794bf0_D2,,,,,,FALSE,51,Female,Asian,Not Hispanic or Latino,,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,8,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,371,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,371,0,NA,NA,51,High or alive at last follow-up,50-60
01BR043,BR,01BR043-T,,TRUE,,,c4015b28-269b-4dc4-8b2e-1b83f7_D2,c4015b28-269b-4dc4-8b2e-1b83f7_D7_1,,99a3ae40-47ba-43af-a290-19619b_D1_1,c4015b28-269b-4dc4-8b2e-1b83f7_D6,,FALSE,59,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Other (specify),"GX Grading is not applicable, cannot be assessed or not specified",,,,TX,N1,,,,M0,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,59,,50-60
05BR003,BR,05BR003-T,,TRUE,,,ffc76bfb-61f6-4492-a782-c23321_D2,ffc76bfb-61f6-4492-a782-c23321_D7,,e18f4e63-342f-4b53-9236-e1b4e3_D1,ffc76bfb-61f6-4492-a782-c23321_D6,,FALSE,37,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3,N0(i-),3,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,406,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,406,0,NA,NA,37,High or alive at last follow-up,<50
05BR029,BR,05BR029-T,,TRUE,,,7ac27de9-0932-4ff5-aab8-29c527,1dbc76a2-76bf-44fb-8663-923093_D7_1,,de477850-d854-4df8-8a84-67224c_D1_1,d0ce3c06-9c4c-41bd-b583-9254b0_D6_1,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,4,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,342,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,342,0,NA,NA,61,High or alive at last follow-up,60-70
05BR043,BR,05BR043-T,,TRUE,,,6eaf19bf-dd93-4b0b-93c5-e2bca3_D2,6eaf19bf-dd93-4b0b-93c5-e2bca3_D7,,fab8a1c5-c592-47cd-9d32-54bf14_D1_1,6eaf19bf-dd93-4b0b-93c5-e2bca3_D6,,FALSE,50,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N1a,3,1,,MX,,,Stage II,,,Not Performed,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,50,,<50
05BR026,BR,05BR026-T,,TRUE,,,d1e36453-8d78-4247-8c3c-3b2a6f_D2,d1e36453-8d78-4247-8c3c-3b2a6f_D7_1,,a361c808-b55e-451f-be99-1fb391_D1_1,d1e36453-8d78-4247-8c3c-3b2a6f_D6_1,,FALSE,71,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0(i-),2,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,377,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,377,0,NA,NA,71,High or alive at last follow-up,>70
11BR056,BR,11BR056-T,,TRUE,,,e45c73a8-da96-4269-a039-d43942_D2,e45c73a8-da96-4269-a039-d43942_D7_1,,0c693667-415a-4f86-b2fc-c16973_D1_1,e45c73a8-da96-4269-a039-d43942_D6_1,,FALSE,52,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1,9,1,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,367,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,367,0,NA,NA,52,High or alive at last follow-up,50-60
11BR038,BR,11BR038-T,,TRUE,,,4e766d9f-ede3-4311-bf09-b1f9ba_D2,4e766d9f-ede3-4311-bf09-b1f9ba_D7,,6386a31e-1ecc-4229-9f0d-e09e01_D1_1,4e766d9f-ede3-4311-bf09-b1f9ba_D6_1,,FALSE,47,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,7,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,385,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,385,0,NA,NA,47,High or alive at last follow-up,<50
11BR036,BR,11BR036-T,,TRUE,,,45b99ac4-0859-4a3d-8b1e-ce5590_D2,45b99ac4-0859-4a3d-8b1e-ce5590_D11_1,,1069702b-d6f0-40db-837f-b006fe_D1_1,45b99ac4-0859-4a3d-8b1e-ce5590_D6_1,,FALSE,51,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,9,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,51,High or alive at last follow-up,50-60
18BR009,BR,18BR009-T,,TRUE,,,5c9ee07a-ca8f-49bf-9c03-2dc513_D2,5c9ee07a-ca8f-49bf-9c03-2dc513_D7_1,,a4e97f71-27e2-44ed-9f3a-76a987_D1_1,5c9ee07a-ca8f-49bf-9c03-2dc513_D6_1,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,417,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,417,0,NA,NA,63,High or alive at last follow-up,60-70
18BR006,BR,18BR006-T,,TRUE,,,bebb15ad-03f1-4773-b3d4-2f78e3_D2,bebb15ad-03f1-4773-b3d4-2f78e3_D7,,a2e6e27a-79d3-47dd-b9b5-a16ee0_D1_1,bebb15ad-03f1-4773-b3d4-2f78e3_D6_1,,FALSE,62,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,419,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,419,0,NA,NA,62,High or alive at last follow-up,60-70
22BR006,BR,22BR006-T,,TRUE,,,a2637649-1fa1-4c20-a19d-5d5f11_D2,cdcc4b54-fcf8-4667-a686-9abda4_D7_1,,4d08772f-7a24-4de1-b997-60dd02_D1_1,cdcc4b54-fcf8-4667-a686-9abda4_D6_1,,FALSE,55,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3,N1,17,2,,M0,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,282,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,282,1,NA,NA,55,Low,50-60
11BR072,BR,11BR072-T,,TRUE,,,59318d66-8b88-45b2-9b97-90e9a7_D2,59318d66-8b88-45b2-9b97-90e9a7_D7_1,,faa5e826-30db-411b-8f90-240c1f_D1_1,59318d66-8b88-45b2-9b97-90e9a7_D6_1,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N3a,10,10,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,369,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,369,0,NA,NA,70,High or alive at last follow-up,60-70
11BR027,BR,11BR027-T,,TRUE,,,413d7d87-7b86-4b76-af93-8e8136_D2,413d7d87-7b86-4b76-af93-8e8136_D7_1,,288bd0e2-6850-4950-a89c-a2a8ab_D1_1,413d7d87-7b86-4b76-af93-8e8136_D6,,FALSE,76,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,385,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,385,0,NA,NA,76,High or alive at last follow-up,>70
01BR040,BR,01BR040-T,,TRUE,,,4a25e3da-2226-4e23-a595-c11709_D2,4a25e3da-2226-4e23-a595-c11709_D7_1,,079a67ab-c81a-4fcb-a976-2d2fb6_D1_1,4a25e3da-2226-4e23-a595-c11709_D6_1,,FALSE,40,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N1,,,,Not Reported/ Unknown,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,40,,<50
11BR059,BR,11BR059-T,,TRUE,,,fc0aa1e4-c1d8-43ed-a5cd-038f61_D2,fc0aa1e4-c1d8-43ed-a5cd-038f61_D7_1,,b8534837-c177-4fcd-9778-dd7844_D1_1,fc0aa1e4-c1d8-43ed-a5cd-038f61_D6_1,,FALSE,45,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,7,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,382,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,382,0,NA,NA,45,High or alive at last follow-up,<50
11BR051,BR,11BR051-T,,TRUE,,,56b488cf-a189-47a8-b4e2-d976eb_D2,d5187303-080a-4cec-b069-e06b6b_D7_1,,6b0937e4-0b78-4c0b-90ba-32fcf5_D1_1,56b488cf-a189-47a8-b4e2-d976eb_D6_1,,FALSE,65,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N2a,10,9,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,379,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,379,0,NA,NA,65,High or alive at last follow-up,60-70
05BR038,BR,05BR038-T,,TRUE,,,942e63bd-84d6-4227-b3de-03e182_D2,b27211b5-7ee1-4e3a-af73-e227b1_D7,,532b795c-c9cf-463e-85c5-32dfbe_D1,942e63bd-84d6-4227-b3de-03e182_D6,,FALSE,52,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T1c,N0,1,0,,M0,,,Stage I,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,195,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,195,0,NA,NA,52,High or alive at last follow-up,50-60
11BR060,BR,11BR060-T,,TRUE,,,97cc4d46-cf80-41f1-b99c-bc4829_D2,97cc4d46-cf80-41f1-b99c-bc4829_D7_1,,23d5da6f-7593-4652-8db6-07372e_D1_1,97cc4d46-cf80-41f1-b99c-bc4829_D6_1,,FALSE,52,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1,11,1,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,385,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,385,0,NA,NA,52,High or alive at last follow-up,50-60
09BR004,BR,09BR004-T,,TRUE,,,cfc121b5-9562-4a6d-b792-3cd6d5_D2,cfc121b5-9562-4a6d-b792-3cd6d5_D7_1,,f111f400-5751-40ea-82b5-3ca0c8_D1_1,cfc121b5-9562-4a6d-b792-3cd6d5_D6_1,,FALSE,75,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0(i-),11,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Unknown,NA,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Tumor free,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,357,NA,NA,NA,75,Low,>70
11BR075,BR,11BR075-T,,TRUE,,,5504c643-4a9c-4ec4-ab07-bebdaf_D2,5504c643-4a9c-4ec4-ab07-bebdaf_D7,,b6af20fa-c744-44ac-ab44-e3b62c_D1,5504c643-4a9c-4ec4-ab07-bebdaf_D6,,FALSE,79,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3,N2,10,5,,M0,,,Stage III,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,362,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,362,0,NA,NA,79,High or alive at last follow-up,>70
03BR002,BR,03BR002-T,,TRUE,,,ca576d30-be91-4bf5-a31d-80f7eb_D2,ca576d30-be91-4bf5-a31d-80f7eb_D7,,14cb26cf-0eec-4140-8db2-b18ce6_D1,ca576d30-be91-4bf5-a31d-80f7eb_D6,,FALSE,60,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3,N1a,17,1,,MX,,,Stage III,,,2,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,365,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,365,0,NA,NA,60,High or alive at last follow-up,50-60
11BR078,BR,11BR078-T,,FALSE,,,8c9232b9-bd06-4474-8236-70dd8a_D2,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
16BR012,BR,16BR012-T,,TRUE,,,7557b796-f11c-4077-a1af-b249c8_D2,7557b796-f11c-4077-a1af-b249c8_D7_1,,c7c982b6-8d9a-474d-82ba-81e59d_D1_1,7557b796-f11c-4077-a1af-b249c8_D6_1,,FALSE,47,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N3c,11,7,,M0,,,Stage III,,,Not Performed,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,478,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,478,0,NA,NA,47,High or alive at last follow-up,<50
06BR014,BR,06BR014-T,,TRUE,,,b2d62dca-3741-4d59-92b8-bdcfed_D2,b2d62dca-3741-4d59-92b8-bdcfed_D7_1,,865b5360-f603-4418-9c9f-c182e9_D1_1,b2d62dca-3741-4d59-92b8-bdcfed_D6,,FALSE,51,Female,Unknown,Hispanic or Latino,African,,No,,,,,NA,Other (specify),"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1a,3,1,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,357,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,357,0,NA,NA,51,High or alive at last follow-up,50-60
11BR076,BR,11BR076-T,,FALSE,,,5a9e89e9-4ac6-4c2f-b05e-c956ba_D2,,,,,,FALSE,52,Female,White,Not Hispanic or Latino,,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,378,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,378,0,NA,NA,52,High or alive at last follow-up,50-60
18BR016,BR,18BR016-T,,TRUE,,,3bbf4310-6a83-4d3b-8772-a5dbb6_D2,3bbf4310-6a83-4d3b-8772-a5dbb6_D7_1,,4720de03-4a0e-4574-99c2-7fd6dc_D1_1,3bbf4310-6a83-4d3b-8772-a5dbb6_D6_1,,FALSE,73,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T1,N0,17,0,,M0,,,Stage I,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,449,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,449,0,NA,NA,73,High or alive at last follow-up,>70
05BR005,BR,05BR005-T,,TRUE,,,6838157f-361d-4e95-b933-35bd46_D2,c6e0280a-f739-474e-9bcd-821221_D7,,e7e44e0d-7412-4d26-814b-ff0d45_D1,6838157f-361d-4e95-b933-35bd46_D6,,FALSE,50,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T1c,N0,4,0,,M0,,,Stage I,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,528,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,528,0,NA,NA,50,High or alive at last follow-up,<50
13BR009,BR,13BR009-T,,TRUE,,,878c2524-208e-40b2-8089-ceb820_D2,878c2524-208e-40b2-8089-ceb820_D7_1,,d6aff277-c3bf-4977-bb41-64debf_D1_1,878c2524-208e-40b2-8089-ceb820_D6,,FALSE,75,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,23,Not Reported/ Unknown,,M0,,,Stage III,,,3,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,75,,>70
11BR080,BR,11BR080-T,,TRUE,,,e2c7113f-957f-4088-b57d-55d2f2_D2,2ddefa4f-77aa-416f-93f3-904e07_D7,,7cfd025a-e4e5-48ac-b44b-56a114_D1,2ddefa4f-77aa-416f-93f3-904e07_D6,,FALSE,68,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N1,10,2,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,377,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,377,0,NA,NA,68,High or alive at last follow-up,60-70
01BR042,BR,01BR042-T,,TRUE,,,4df35993-eab6-4289-822c-d77da9_D2,4df35993-eab6-4289-822c-d77da9_D7_1,,6be03918-b249-48b1-a447-a1a64b_D1_1,4df35993-eab6-4289-822c-d77da9_D6_1,,FALSE,58,Female,Black or African American,Unknown,African,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,NX,,,,MX,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,58,,50-60
15BR003,BR,15BR003-T,,TRUE,,,433c2eb6-560f-4387-93af-6c2e1a_D2,433c2eb6-560f-4387-93af-6c2e1a_D7,,3de9a97b-ec2d-4778-b7cd-f52fb2_D1_1,433c2eb6-560f-4387-93af-6c2e1a_D6_1,,FALSE,74,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T1c,N1a,4,1,,M0,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,344,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,344,0,NA,NA,74,High or alive at last follow-up,>70
14BR014,BR,14BR014-T,,TRUE,,,d1034660-11ce-4e38-9ad0-8b9b72_D2,d1034660-11ce-4e38-9ad0-8b9b72_D8_1,,15f928a5-e824-477a-9882-0f1029_D1_1,d1034660-11ce-4e38-9ad0-8b9b72_D6,,FALSE,59,Female,White,Unknown,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0(i+),3,0,,MX,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,448,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,448,0,NA,NA,59,High or alive at last follow-up,50-60
11BR058,BR,11BR058-T,,TRUE,,,80a970f7-7b36-4450-aff8-0b55dc_D2,80a970f7-7b36-4450-aff8-0b55dc_D7_1,,425542b5-a675-4283-8480-ff386a_D1_1,80a970f7-7b36-4450-aff8-0b55dc_D6_1,,FALSE,65,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,8,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,378,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,378,0,NA,NA,65,High or alive at last follow-up,60-70
11BR012,BR,11BR012-T,,TRUE,,,98225215-ff21-4893-8b6d-d9b7e7_D2,98225215-ff21-4893-8b6d-d9b7e7_D7_1,,5e62d006-cf7f-45e4-8b14-fcb7a0_D1_1,98225215-ff21-4893-8b6d-d9b7e7_D6_1,,FALSE,77,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,10,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,42,NA,,NA,NA,,,,Tumor free,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,42,0,NA,NA,77,High or alive at last follow-up,>70
01BR009,BR,01BR009-T,,TRUE,,,0ecabbfa-8095-4875-acdb-051582_D1,,,,,,FALSE,64,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,64,,60-70
01BR008,BR,01BR008-T,,TRUE,,,cfa2809f-5468-4457-870c-467c39_D1,,,,,,FALSE,48,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,48,,<50
21BR001,BR,21BR001-T,,TRUE,,,1fb9fca2-cf63-41f2-9381-d9108c,,,,,,FALSE,86,Female,White,Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,86,,>70
21BR002,BR,21BR002-T,,TRUE,,,32944ee6-428e-44fc-97d6-22665e,,,,,,FALSE,86,Female,White,Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,86,,>70
01BR026,BR,01BR026-T,,TRUE,,,884659ef-cce7-4b4a-b28b-0e1f49,,,,,,FALSE,48,Female,White,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,48,,<50
05BR004,BR,05BR004-T,,TRUE,,,71e07184-b085-4d3d-aabf-6e1420_D1,,,,,,FALSE,46,Female,White,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,46,,<50
03BR006,BR,03BR006-T,,TRUE,,,071be0fb-b7fd-4165-b3c5-348352,,,,,,FALSE,42,Female,White,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,42,,<50
01BR023,BR,01BR023-T,,TRUE,,,c875a9a4-035f-425a-9348-26129c_D1,,,,,,FALSE,52,Female,White,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,52,,50-60
01BR020,BR,01BR020-T,,TRUE,,,3fd68501-514a-4a30-9ce1-2fca26_D1,,,,,,FALSE,45,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,45,,<50
20BR006,BR,20BR006-T,,TRUE,,,3f52e236-1daa-4aa0-9a77-e3d043_D2,3f52e236-1daa-4aa0-9a77-e3d043_D7_1,,ac6a7d2b-c376-49ca-8fc6-4b1e94_D1_1,3f52e236-1daa-4aa0-9a77-e3d043_D6_1,,FALSE,65,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Negative (-),,T2,N1a,7,1,,MX,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,327,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,327,0,NA,NA,65,High or alive at last follow-up,60-70
09BR001,BR,09BR001-T,,TRUE,,,20506075-36a7-4754-8e5e-628918,,,,,,FALSE,61,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,61,,60-70
03BR011,BR,03BR011-T,,TRUE,,,60c8c914-f53d-4f72-a1ce-5fb803,,,,,,FALSE,71,Female,White,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year",,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,71,,>70
01BR010,BR,01BR010-T,,TRUE,,,26ecef2d-fcf3-4b85-9647-5e5d29_D1,,,,,,FALSE,65,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,65,,60-70
604,BR,,,FALSE,,,,CPT000814-0008,,CPT000820-0002,CPT000814-0010,,FALSE,41,Female,Black or African American,Unknown,African,,No,,,,,NA,Triple Negative,"GX Grading is not applicable, cannot be assessed or not specified",,,,2,0,1,0,,0,,,Stage II,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,41,,<50
1488,BR,,,FALSE,,,,CPT000815-0008,,CPT000821-0002,CPT000815-0010,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
100002921,BR,,,FALSE,,,,CPT000816-0008,,CPT000822-0002,CPT000816-0010,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
100003304,BR,,,FALSE,,,,CPT000817-0008,,CPT000823-0002,CPT000817-0010,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
100004012,BR,,,FALSE,,,,CPT000818-0008,,CPT000824-0002,CPT000818-0012,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
100004028,BR,,,FALSE,,,,CPT000819-0008,,CPT000825-0002,CPT000819-0010,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
01BR044,BR,,,FALSE,,,,CPT001846-0009,,CPT001849-0002,CPT001846-0011,,FALSE,84,Female,white,unknown,European,,No,,,,,NA,"other, specify","GX Grading is not applicable, cannot be assessed or not specified",,,,T4b , N0 ,17,0,,,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,84,,>70
03BR012,BR,,,FALSE,,,,2d8514b6-c01a-4166-a0c1-bc7012_D7,,52a53fb4-2433-4e65-a5c6-169abe_D1_1,2d8514b6-c01a-4166-a0c1-bc7012_D6_1,,FALSE,46,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3,N1a,6,3,,MX,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,390,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,390,0,NA,NA,46,High or alive at last follow-up,<50
05BR031,BR,,,FALSE,,,,4cab24a5-70d4-4364-a2be-da0d99_D7,,0b9c8570-2765-42db-9ad7-696943_D1_1,4cab24a5-70d4-4364-a2be-da0d99_D6_1,,FALSE,46,Female,White,Not Hispanic or Latino,European,,No,,,,,NA,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T3a,N1a,1,1,,M0,,,Stage III,,,0,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,319,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,319,0,NA,NA,46,High or alive at last follow-up,<50
05BR051,BR,,,FALSE,,,,CPT000415-0013,,CPT000409-0002,CPT000415-0015,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
05BR052,BR,,,FALSE,,,,CPT000424-0009,,CPT000419-0002,CPT000424-0011,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
05BR055,BR,,,FALSE,,,,CPT000400-0009,,CPT000404-0002,CPT000400-0013,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
05BR058,BR,,,FALSE,,,,CPT000432-0009,,CPT000428-0002,CPT000432-0011,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
11BR069,BR,,,FALSE,,,,07c4bb93-a373-4748-a2c7-5806cb_D7_1,,ea97a4cf-4acb-47f5-b19f-1e8d4a_D1,07c4bb93-a373-4748-a2c7-5806cb_D6_1,,FALSE,65,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,NA,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,Not Applicable,,T2,N0,5,0,,M0,,,Stage II,,,Not Reported/ Unknown,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,387,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,387,0,NA,NA,65,High or alive at last follow-up,60-70
18BR008,BR,,,FALSE,,,,88ad3f0f-96ac-4a60-a687-d55adf_D7_1,,not run,not run,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-01287,CCRCC,C3L-01287-T,C3L-01287-N,TRUE,,CPT0079430001,CPT0079410003,"['CPT0079420009', 'CPT0079410006', 'CPT007940 0003', 'CPT0079400009', 'CPT007942 0003']",CPT0079430006,CPT0080130002,CPT0079410009,CPT0079430009,FALSE,60,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,10.5,Clear cell renal cell carcinoma,G4 Undifferentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM1,pM1,Left Lung Nodule ,R0:No residual tumor,Stage IV,,,IHC staining not done,178,80,25.31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Duloxetine|Atorvastatin,Medical Record|Medical Record,No,Deceased,630,633,Main malignancy,NA,633,Yes,Yes,Yes,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,633,1,0,NA,60,High or alive at last follow-up,50-60
C3L-00561,CCRCC,C3L-00561-T,C3L-00561-N,TRUE,,CPT0023360001,CPT0023350003,['CPT0023350009'],CPT0023360006,CPT0024550002,CPT0023350006,CPT0023360009,FALSE,50,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,10,Clear cell renal cell carcinoma,G4 Undifferentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3b,pN0,29,0,cM0,Staging Incomplete,Not applicable,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,185,94,27.47,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Lispinopril|Lopressor|Tambocor,Medical Record|Medical Record|Medical Record,No,Living,1796,NA,,1796,NA,No,No,No,With Tumor,Not Applicable,Persistent Disease,Yes,368,Distant Metastasis,Lung,,,,No,,No,Yes,No,NA,NA,368,368,1,1796,0,0,NA,50,High or alive at last follow-up,<50
C3L-01603,CCRCC,C3L-01603-T,C3L-01603-N,TRUE,,CPT0087050003,CPT0087040003,"['CPT0087030006', 'CPT0087020006', 'CPT0087040006']",CPT0087050006,CPT0087460001,CPT0087040009,CPT0087050009,FALSE,63,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage I,,,0,173,128,42.77,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",36,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1765,NA,,1771,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1765,0,6,NA,63,High or alive at last follow-up,60-70
C3N-01524,CCRCC,C3N-01524-T,C3N-01524-N,TRUE,,CPT0077320001,CPT0077310003,"['CPT0077300006', 'CPT0077310006', 'CPT0077290006']",CPT0077320006,CPT0077410002,CPT0077310009,CPT0077320009,FALSE,61,Male,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,8,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,0,cM0,Staging Incomplete,No.,R0:No residual tumor,Stage II,CD10 - positive; Vimentin - positive; EMA - positive; RCC - positive;,,IHC staining not done,182,94,28.38,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,694,NA,,700,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,694,0,6,NA,61,High or alive at last follow-up,60-70
C3L-00359,CCRCC,C3L-00359-T,,TRUE,,,CPT0002270011,['CPT0002270005'],,CPT0004370002,CPT0002270008,,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,3,non-Clear Cell renal cell carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable ,R0:No residual tumor,Stage I,,,IHC staining not done,165,117,42.92,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,64.5,Exposure to secondhand smoke history not available,,,,,,,Metoprolol Succinate-XL|Duloxetine|Pregabalin|Albuterol|Methylphenidate ER|Lisinopril|Hydrocodone-acetaminophen|Calcium Carb-Cholecalciferol|Loratadine|Melatonin|Docusate Sodium|Naproxen|Alprazolam|Midrin|Allopurinol|Levothyroxine|Magnesium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1779,1779,Main malignancy,NA,1779,No,No,No,With Tumor,Not Applicable,Persistent Disease,Yes,1402,,,,,No,No,,No,Yes,No,NA,NA,1402,1402,1,1779,1,0,NA,73,High or alive at last follow-up,>70
C3N-00834,CCRCC,C3N-00834-T,C3N-00834-N,TRUE,,CPT0078840001,CPT0078830003,['CPT0078830006'],CPT0078840006,CPT0078870002,CPT0078830009,CPT0078840009,FALSE,65,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,5,Clear cell renal cell carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,173,90,30,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",20,Exposure to secondhand smoke history not available,,,,,,,Tritace (ramiprilum)|Bisocard (bisoprololi)|IPP (pantoprazolum)|Diuver (torasemidum)|Amlozek (amlodipinum)|Atoris (atorvastatinum)|clexane (enoxaparinum),Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,No,Living,1755,NA,,1769,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1755,0,14,NA,65,High or alive at last follow-up,60-70
C3N-01214,CCRCC,C3N-01214-T,C3N-01214-N,TRUE,,CPT0075570001,CPT0075560003,"['CPT0075560009', 'CPT0075550005', 'CPT0075540016']",CPT0075570006,CPT0075620002,CPT0075560006,CPT0075570009,FALSE,60,Male,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,8.4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,5,0,cM0,Staging Incomplete,No.,R0:No residual tumor,Stage II,CD10 - positive; RCC - positive; Vimentin - positive; EMA - positive;,,IHC staining not done,191,78,21.38,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,41,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,653,NA,,659,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,653,0,6,NA,60,High or alive at last follow-up,50-60
C3N-01261,CCRCC,C3N-01261-T,C3N-01261-N,TRUE,,CPT0077500001,CPT0077490003,"['CPT0077490006', 'CPT0077480006', 'CPT0077470006']",CPT0077500006,CPT0077590002,CPT0077490009,CPT0077500009,FALSE,67,Male,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,5.2,Clear cell renal cell carcinoma,G1 Well differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,cM0,Staging Incomplete,No.,R0:No residual tumor,Stage I,CD10 - positve; Vimentin - positive; EMA - positive; AE1/AE3 - positive;,,IHC staining not done,167,67,24.02,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,680,NA,,683,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,680,0,3,NA,67,High or alive at last follow-up,60-70
C3L-00917,CCRCC,C3L-00917-T,C3L-00917-N,TRUE,,CPT0023710001,CPT0023690003,['CPT0023690009'],CPT0023710006,CPT0024600002,CPT0023690006,CPT0023710009,FALSE,37,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,,Left Kidney,Unifocal,3,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,185,156,45.37,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Humira,Medical Record,No,Living,1783,NA,,1783,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1783,0,0,NA,37,High or alive at last follow-up,<50
C3L-00607,CCRCC,C3L-00607-T,C3L-00607-N,TRUE,,CPT0025060001,CPT0025050003,['CPT0025050006'],CPT0025060006,CPT0029400002,CPT0025050009,['CPT0025060009'],FALSE,66,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Multifocal,7.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage III,,,IHC staining not done,171,112,37.96,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Novolog Flexpen (Insulin)|Lasix,Medical Record|Medical Record,No,Deceased,781,781,Main malignancy,NA,781,No,No,No,With Tumor,Complete Remission,,Yes,377,,,,,No,Yes,,No,Yes,No,NA,377,377,377,1,781,1,0,NA,66,High or alive at last follow-up,60-70
C3L-01861,CCRCC,C3L-01861-T,C3L-01861-N,TRUE,,CPT0092310003,CPT0092290003,"['CPT0092280006', 'CPT0092300006', 'CPT0092290005']",CPT0092310006,CPT0093770002,CPT0092290008,CPT0092310009,FALSE,57,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,3.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,,,IHC staining not done,173,86,28.63,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",0.5,Exposure to secondhand smoke history not available,,,,Basal cell carcinoma of skin,Unknown,No,Lipitor|Freestyle Lite strip|Novolog Flexpen|Toujeo Solostar|Hyzaar|glucophage|prilosec|BD Ultra fine |Revatio,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1761,NA,,1761,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1761,0,0,NA,57,High or alive at last follow-up,50-60
C3N-00194,CCRCC,C3N-00194-T,C3N-00194-N,TRUE,,CPT0014130001,CPT0014160003,"['CPT0014180018', 'CPT0014160009', 'CPT0014150013']",CPT0014130006,CPT0015040002,CPT0014160006,CPT0014130009,FALSE,51,Female,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,12,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,165,73,26.96,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,17.5,Exposure to secondhand smoke history not available,,,,,,,NORCO|ibprofen,Medical Record|Medical Record,No,Living,208,NA,,209,NA,No,Yes,Unknown,With Tumor,Persistent Disease,,Yes,115,,,,,No,No,,No,Yes,No,NA,NA,115,116,1,208,0,1,NA,51,High or alive at last follow-up,50-60
C3L-00010,CCRCC,C3L-00010-T,C3L-00010-N,TRUE,,CPT0001230001,CPT0001220008,CPT0001220164,CPT0001230006,CPT0000060163,CPT0001220165,"['CPT0001230014', 'CPT0001230009']",FALSE,30,Male,White,Not Hispanic or Latino,Ad_Mixed_American,United States,No,,,Left Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,2,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,Stage I,,,0,177,107,34.15,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,10,Exposure to secondhand smoke history not available,,,,,,,Tramadol|Esomeprazole |Rivaroxaban,Medical Record|Medical Record|Medical Record,No,Living,896,NA,,896,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,896,0,0,NA,30,High or alive at last follow-up,<50
C3L-01352,CCRCC,C3L-01352-T,,TRUE,,,CPT0071150004,['CPT0071150007'],,CPT0071980002,CPT0071150010,,FALSE,76,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,,Right Kidney,Unifocal,3.4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,0,163,71,26.95,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Acetaminophen|Calcitrate/Vita D|Cholecalciferol Vitamin D3|Hydrochlorothiazide|Hydroxychloroquine Sulfate|Latanoprost|Losartan|Multivitamins w/ minerals and iron|Omeprzaole|Refresh Ophthalmic Solution|Sertraline HCL|Simvastatin|Sulfasalazine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,233,NA,,233,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,233,0,0,NA,76,High or alive at last follow-up,>70
C3N-01646,CCRCC,C3N-01646-T,C3N-01646-N,TRUE,,CPT0088500001,CPT0088480003,['CPT0088480006'],CPT0088500006,CPT0088540001,CPT0088480009,"['CPT0088500014', 'CPT0088500009']",FALSE,69,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,10,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,170,75,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,9.6,No or minimal exposure to secondhand smoke,,,,,,,trazodone|pregabalin|fluvoxamini|torasemidum|fenofibratum|Rosuvastatinum|Humulin N|Humalog|clexane (enoxaparinum),Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,No,Living,1470,NA,,1478,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1470,0,8,NA,69,High or alive at last follow-up,60-70
C3N-00495,CCRCC,C3N-00495-T,C3N-00495-N,TRUE,,CPT0078530001,CPT0078510003,['CPT0078510006'],CPT0078530006,CPT0078570002,CPT0078510009,CPT0078530009,FALSE,67,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,170,48,16,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",1.5,Exposure to secondhand smoke history not available,,,,,,,Diuresin (indapamidum)|lokren (betaxololi)|Axtil (ramiprilum)|penester (finasteridum)|Apo-Doxan (doxazosini),Self Report|Self Report|Self Report|Self Report|Self Report,No,Living,1779,NA,,1786,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1779,0,7,NA,67,High or alive at last follow-up,60-70
C3L-01281,CCRCC,C3L-01281-T,C3L-01281-N,TRUE,,CPT0079510001,CPT0079480003,['CPT0079480006'],CPT0079510006,CPT0080150002,CPT0079480009,CPT0079510009,FALSE,66,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Multifocal,11.5,Clear cell renal cell carcinoma,G4 Undifferentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM1,pM1,Right 8th Rib,R0:No residual tumor,Stage IV,,,IHC staining not done,168,98,34.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,Budesonide-Formoterol Fumarate|Albuterol|Hydrocodone-acetaminophen,Medical Record|Medical Record|Medical Record,No,Living,1779,NA,,1779,NA,No,No,Yes,With Tumor,Unknown,Persistent Disease,Yes,876,,,,,No,No,,Unknown,Unknown,Unknown,NA,NA,876,876,1,1779,0,0,NA,66,High or alive at last follow-up,60-70
C3N-00831,CCRCC,C3N-00831-T,C3N-00831-N,TRUE,,CPT0089040001,CPT0089020003,['CPT0089020006'],CPT0089040006,CPT0089080002,CPT0089020009,CPT0089040009,FALSE,52,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,0,cM1,Staging Incomplete,lungs,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,186,107,30,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Glucophage (metformini),Self Report,No,Deceased,374,452,Main malignancy,NA,463,No,Yes,No,With Tumor,Persistent Disease,,Yes,35,,,,,No,No,,No,Yes,No,NA,NA,35,46,1,452,1,11,NA,52,High or alive at last follow-up,50-60
C3L-00791,CCRCC,C3L-00791-T,C3L-00791-N,TRUE,,CPT0026420001,CPT0026410003,['CPT0026410006'],,CPT0029500002,CPT0026410009,,FALSE,76,Male,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN1,1,1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,"The neoplastic cells are positive for pancytokeratin, carbonic anhydrase IX (CA-IX), CD10 and vimentin (patchy); and negative for parvalbumin. CK7; cytokeratin 7 shows focal staining",,1,173,88,29.49,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Multivutamins,Medical Record,No,Living,708,NA,,708,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,708,0,0,NA,76,High or alive at last follow-up,>70
C3L-00369,CCRCC,C3L-00369-T,C3L-00369-N,TRUE,,CPT0006530001,CPT0006440003,"['CPT0006470008', 'CPT0006440006', 'CPT0006520006']",CPT0006530006,CPT0002660002,CPT0006440009,"['CPT0006530009', 'CPT0006530014']",FALSE,89,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,12.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage III,,,IHC staining not done,175,84,27.35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Tramadol|Psyllium|Levothyroxine|Hydrochlorothiazide|Lactulose|Polyethylene glycol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,91,91,Main malignancy,NA,91,No,No,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,91,1,0,NA,89,Low,>70
C3L-00183,CCRCC,C3L-00183-T,C3L-00183-N,TRUE,,CPT0066430001,CPT0066470004,CPT0066470007,,CPT0070990002,CPT0066470010,,FALSE,33,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,,Right Kidney,Unifocal,6,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,Stage III,,,IHC staining not done,157,90,36.39,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,0.8,Exposure to secondhand smoke history not available,,,,,,,albuteral,Medical Record,No,Living,227,NA,,227,NA,No,No,No,Unknown,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,227,0,0,NA,33,High or alive at last follow-up,<50
C3N-01180,CCRCC,C3N-01180-T,,TRUE,,,CPT0088970003,['CPT0088970006'],,CPT0089010002,CPT0088970009,,FALSE,51,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,5,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,180,80,24,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,19,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1815,NA,,1824,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1815,0,9,NA,51,High or alive at last follow-up,50-60
C3N-00168,CCRCC,C3N-00168-T,C3N-00168-N,TRUE,,CPT0020020001,CPT0019990003,"['CPT0019990006', 'CPT0019980006', 'CPT0020000006', 'CPT0020010006']",CPT0020020006,CPT0020920002,CPT0019990009,CPT0020020009,FALSE,47,Male,Unknown,Unknown,East_Asian,Vietnam,No,,,Left Kidney,Unifocal,4,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,0,0,cM0,Staging Incomplete,Unknown,R0:No residual tumor,Stage I,,,IHC staining not done,168,53,18.78,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5,No or minimal exposure to secondhand smoke,,,20,,,,,,No,Living,826,NA,,828,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,826,0,2,NA,47,High or alive at last follow-up,<50
C3L-00097,CCRCC,C3L-00097-T,C3L-00097-N,TRUE,,CPT0000790001,CPT0000780007,CPT0000780008,CPT0000790006,CPT0003920002,CPT0000780005,['CPT0000790009'],FALSE,59,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Multifocal,3.7,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,Stage I,,,IHC staining not done,175,113,36.81,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",22,Exposure to secondhand smoke history not available,,,,,,,Ciprofloxacin|Metronidazole,Medical Record|Medical Record,No,Living,1735,NA,,1735,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1735,0,0,NA,59,High or alive at last follow-up,50-60
C3L-00004,CCRCC,C3L-00004-T,C3L-00004-N,TRUE,,CPT0001550001,CPT0001540009,CPT0001540164,CPT0001550006,CPT0000140163,CPT0001540165,"['CPT0001550009', 'CPT0001550013']",FALSE,72,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,12,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,Stage III,,,IHC staining not done,170,66,22.8,No,Lifelong non-drinker,Current reformed smoker within past 15 years,44,Exposure to secondhand smoke history not available,,,,,,,zocor|colace|glycolax|rivaroxaban|tylenol|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,384,NA,,384,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,0,NA,72,High or alive at last follow-up,>70
C3N-00953,CCRCC,C3N-00953-T,C3N-00953-N,TRUE,,CPT0065450001,CPT0065430003,"['CPT0065440006', 'CPT0065430006', 'CPT0065220006']",,CPT0070680002,CPT0065430009,,FALSE,41,Male,Asian,Not Hispanic or Latino,South_Asian,United States,No,,,Left Kidney,Unifocal,8,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,185,77,22.43,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1785,NA,,1785,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1785,0,0,NA,41,High or alive at last follow-up,<50
C3N-00150,CCRCC,C3N-00150-T,C3N-00150-N,TRUE,,CPT0066520001,CPT0066480003,"['CPT0066510012', 'CPT0066480006', 'CPT0066490006', 'CPT0066500006']",CPT0066520006,CPT0071650002,CPT0066480009,CPT0066520009,FALSE,55,Female,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,12,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,0,cM1,Staging Incomplete,Brain,R0:No residual tumor,Stage IV,,,IHC staining not done,168,52,18.42,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,-7,NA,,0,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,7,7,55,High or alive at last follow-up,50-60
C3L-00583,CCRCC,C3L-00583-T,C3L-00583-N,TRUE,,CPT0019160001,CPT0019130003,"['CPT0019130009', 'CPT0019140006', 'CPT0019150006']",CPT0019160006,CPT0019900002,CPT0019130006,['CPT0019160009'],FALSE,55,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,,Right Kidney,Multifocal,4,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,162,99,37.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Albuterol sulfate|Ferrous Sulfate|Protonix|Qvar|Sulfasalazine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,301,NA,,301,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,301,0,0,NA,55,High or alive at last follow-up,50-60
C3N-00244,CCRCC,C3N-00244-T,C3N-00244-N,TRUE,,CPT0014350001,CPT0014370004,['CPT0014370010'],CPT0014350006,CPT0015060002,CPT0014370007,CPT0014350009,FALSE,46,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,175,136,44.3,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,acetaminophen|gabapentin|silodosin,Medical Record|Medical Record|Medical Record,No,Living,728,NA,,675,NA,No,No,No,Tumor Free,Not Applicable,,Yes,525,,,,,No,No,,Unknown,Unknown,Unknown,NA,NA,525,472,1,728,0,-53,NA,46,High or alive at last follow-up,<50
C3N-01178,CCRCC,C3N-01178-T,C3N-01178-N,TRUE,,CPT0079000001,CPT0078990003,['CPT0078990006'],CPT0079000006,CPT0079040002,CPT0078990009,CPT0079000009,FALSE,58,Female,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,7,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,173,75,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,5,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1703,NA,,1716,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1703,0,13,NA,58,High or alive at last follow-up,50-60
C3L-00088,CCRCC,C3L-00088-T,C3L-00088-N,TRUE,,CPT0000890001,CPT0000870016,CPT0000870008,CPT0000890006,CPT0003890002,CPT0000870012,"['CPT0000890009', 'CPT0000890014']",FALSE,72,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,Stage III,,,IHC staining not done,178,104,32.82,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",52,Exposure to secondhand smoke history not available,,,,,,,Apixaban|Asa 81mg|Carvedilol|Digoxin|Anasteride|Lantus Solostar|Lisinopril|Melatonin|Quetlapine|Simvastatin|Tamsulosin|Victoza,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,687,694,Unknown,NA,694,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,694,1,0,NA,72,High or alive at last follow-up,>70
C3L-00814,CCRCC,C3L-00814-T,C3L-00814-N,TRUE,,CPT0065820001,CPT0065810003,['CPT0065810006'],CPT0065820006,CPT0067690002,CPT0065810009,CPT0065820009,FALSE,83,Male,Unknown,Unknown,European,United States,No,,,Left Kidney,Unifocal,3,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,0,178,97,30.56,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,lisinopril-hydrochlorothiazide ,Medical Record,No,Living,15,NA,,15,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,15,0,0,NA,83,High or alive at last follow-up,>70
C3L-00908,CCRCC,C3L-00908-T,C3L-00908-N,TRUE,,CPT0086370003,CPT0086360003,"['CPT0086360006', 'CPT0086350009']",CPT0086370006,CPT0087380001,"['CPT0086360009', 'CPT0086350006']",CPT0086370009,FALSE,60,Female,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,10.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage II,,,0,163,74,27.85,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",3,Exposure to secondhand smoke history not available,,,,,,,tylenol|albuterol|glucosamine-chondroit|multiple vitamins,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1785,NA,,1795,NA,No,No,No,With Tumor,Not Applicable,Persistent Disease,Yes,1105,Distant Metastasis,Other,Lumbar spine ,,,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,1517,1105,1115,1,1785,0,10,NA,60,High or alive at last follow-up,50-60
C3L-01885,CCRCC,C3L-01885-T,C3L-01885-N,TRUE,,CPT0092800003,CPT0092790003,CPT0092790006,CPT0092800006,CPT0093830002,CPT0092790009,"['CPT0092800009', 'CPT0092800013']",FALSE,67,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,3.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,,,IHC staining not done,175,108,35.27,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",37.5,Exposure to secondhand smoke history not available,,,,Renal Cancer|Prostate Cancer,Surgery|Surgery,Yes|Yes,Uloric |paroxetine|simvastatin|METOPROLOL & DIET MANAGE PROD PO|Toprol XL ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,342,NA,,342,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,342,0,0,NA,67,High or alive at last follow-up,60-70
C3L-00026,CCRCC,C3L-00026-T,C3L-00026-N,TRUE,,CPT0001510001,CPT0001500009,CPT0001500164,CPT0001510006,CPT0000130163,CPT0001500005,"['CPT0001510009', 'CPT0001510014']",FALSE,65,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,2,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,Staging Incomplete,Not Applicable,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,163,75,28.23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Citracal|Cyproheptadine HCL|Levothyroxine Sodium|Omeprazole|Valacyclovir|Zomig,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1769,NA,,1769,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1769,0,0,NA,65,High or alive at last follow-up,60-70
C3L-00447,CCRCC,C3L-00447-T,C3L-00447-N,TRUE,,CPT0006950001,CPT0006900003,"['CPT0006900006', 'CPT0006910006', 'CPT0006860006']",CPT0006950006,CPT0002760002,CPT0006900009,"['CPT0006950014', 'CPT0006950009']",FALSE,35,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,180,118,36.57,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,15,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,671,NA,,671,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,671,0,0,NA,35,High or alive at last follow-up,<50
C3L-00416,CCRCC,C3L-00416-T,C3L-00416-N,TRUE,,CPT0010120001,CPT0010110003,['CPT0010110009'],CPT0010120006,CPT0019870002,CPT0010110006,CPT0010120009,FALSE,62,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,6,Clear cell renal cell carcinoma,G4 Undifferentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage III,,,IHC staining not done,175,98,32,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,96,Exposure to secondhand smoke history not available,,,Unknown,,,,norvasc|asa|coreg|lasix|celexa|lopid|catapres|imdur|praxachol|Lantus solotar|trazodone|ferrous sulfate |humalog,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,608,NA,,608,NA,No,No,No,Tumor Free,Not Applicable,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,608,0,0,NA,62,High or alive at last follow-up,60-70
C3N-00246,CCRCC,C3N-00246-T,C3N-00246-N,TRUE,,CPT0025610001,CPT0025580004,['CPT0025580007'],,CPT0028450002,CPT0025580010,,FALSE,44,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,3.1,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,175,141,45.77,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Valium,Medical Record,No,Living,2006,NA,,1982,NA,No,No,No,With Tumor,Complete Remission,Persistent Disease,Yes,1890,Distant Metastasis,Other,Retroperitoneum,,,Yes,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,1956,1890,1866,1,2006,0,-24,NA,44,High or alive at last follow-up,<50
C3N-00148,CCRCC,C3N-00148-T,C3N-00148-N,TRUE,,CPT0081620001,CPT0081600003,"['CPT0081600009', 'CPT008159 0004', 'CPT0081590006', 'CPT008160 0004', 'CPT008161 0004', 'CPT008158 0004', 'CPT0081610006', 'CPT0081580006']",CPT0081620006,CPT0081700002,CPT0081600006,CPT0081620009,FALSE,52,Male,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,,0,178,90,28.41,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,-9,NA,,0,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,9,9,52,High or alive at last follow-up,50-60
C3L-00096,CCRCC,C3L-00096-T,C3L-00096-N,TRUE,,CPT0001190001,CPT0001180009,CPT0001180164,CPT0001190006,CPT0000050163,CPT0001180005,"['CPT0001190015', 'CPT0001190009']",FALSE,52,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Multifocal,12.3,Clear cell renal cell carcinoma,G4 Undifferentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,1,0,cM1,pM1,"Pelvic bone, liver, lung, brain",R0:No residual tumor,Stage IV,,,IHC staining not done,185,94,27.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Lisinopril|Glimepiride|Metformin|cyclobenzaprine|Atorvastatin|Asa 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,68,71,Unknown,NA,71,Yes,Yes,No,With Tumor,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,71,1,0,NA,52,Low,50-60
C3N-00646,CCRCC,C3N-00646-T,C3N-00646-N,TRUE,,CPT0082010001,CPT0081990003,"['CPT0082000006', 'CPT0081980005', 'CPT0081970006', 'CPT0081990009']",CPT0082010006,CPT0082030002,CPT0081990006,CPT0082010009,FALSE,57,Female,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,3.2,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,Staging Incomplete,None specified,R0:No residual tumor,Stage I,,,IHC staining not done,172,82,27.72,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,-6,NA,,0,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,6,6,57,High or alive at last follow-up,50-60
C3L-00765,CCRCC,C3L-00765-T,,TRUE,,,CPT0015910003,['CPT0015910008'],,CPT0018310001,CPT0015910006,,FALSE,61,Female,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,5.6,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,160,56,21.96,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,10,Exposure to secondhand smoke history not available,,,,,,,Omeprazole,Medical Record,No,Living,1414,NA,,1414,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1414,0,0,NA,61,High or alive at last follow-up,60-70
C3L-01836,CCRCC,C3L-01836-T,C3L-01836-N,TRUE,,CPT0086890003,CPT0086870003,"['CPT0086860006', 'CPT0086870006', 'CPT0086880006']",CPT0086890006,CPT0087440002,CPT0086870009,CPT0086890009,FALSE,47,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,4.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage I,,,0,172,87,29.41,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,aspirin|fenofibrate|inderal|protonix,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1122,NA,,1128,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1122,0,6,NA,47,High or alive at last follow-up,<50
C3L-00902,CCRCC,C3L-00902-T,C3L-00902-N,TRUE,,CPT0063330001,CPT0063320003,['CPT0063320005'],CPT0063330006,CPT0065240002,['CPT0063320009'],CPT0063330009,FALSE,69,Female,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,5,Clear cell renal cell carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,Stage I,,,IHC staining not done,170,57,19.72,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",3.8,Exposure to secondhand smoke history not available,,,,Left Breast Cancer|Left Breast Cancer,"Radiation,Surgery,Chemotherapy|Radiation,Surgery,Chemotherapy",Yes|Yes,Alendronate|Gabapentin|Hydroxychloroquine|Leflunomide|Risedronate|Calcium Citrate-Vitamin D|Cholecalciferol|Multi Vitamin|Amlodipine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1791,NA,,1791,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1791,0,0,NA,69,High or alive at last follow-up,60-70
C3N-01175,CCRCC,C3N-01175-T,C3N-01175-N,TRUE,,CPT0078670001,CPT0078660003,['CPT0078660006'],CPT0078670006,CPT0078700002,CPT0078660009,CPT0078670009,FALSE,60,Female,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,3,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,164,39,14,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,bisoprolol,Self-reported and Medical Record,No,Living,1714,NA,,1730,NA,No,No,No,Tumor Free,Not Applicable,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1714,0,16,NA,60,High or alive at last follow-up,50-60
C3L-00011,CCRCC,C3L-00011-T,C3L-00011-N,TRUE,,CPT0001350001,CPT0001340003,CPT0001340164,CPT0001350006,CPT0000090163,CPT0001340005,"['CPT0001350009', 'CPT0001350014']",FALSE,63,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,12,Clear cell renal cell carcinoma,G4 Undifferentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM1,pM1,Right Patella ,R1:Microscopic residual tumor,Stage IV,,,IHC staining not done,180,89,27.47,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Metastatic Renal Cell Carcinoma to Rt Patella,Surgery,Yes,Aspirin|Calcium Carb-Cholecalciferol|Diphenhydramine-APAP|Escitalopram Oxalate|Ibandronate Sodium|Levothyroxine Sodium|Multi Vitamin|Naproxen Sodium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,229,241,Main malignancy,NA,241,No,Yes,Yes,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,241,1,0,NA,63,Low,60-70
C3N-00177,CCRCC,C3N-00177-T,C3N-00177-N,TRUE,,CPT0020130001,CPT0020120003,"['CPT0020110006', 'CPT0020120006', 'CPT0020100006']",CPT0020130006,CPT0020940002,CPT0020120009,CPT0020130009,FALSE,52,Male,Unknown,Unknown,East_Asian,Vietnam,No,,,Left Kidney,Unifocal,7,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,0,0,cM0,Staging Incomplete,Not known,R0:No residual tumor,Stage III,,,IHC staining not done,173,72,24.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,841,NA,,843,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,841,0,2,NA,52,High or alive at last follow-up,50-60
C3N-01200,CCRCC,C3N-01200-T,C3N-01200-N,TRUE,,CPT0075170001,CPT0075130003,"['CPT0075130006', 'CPT0075150009', 'CPT0075120009', 'CPT0075160009', 'CPT0075140009']",CPT0075170006,CPT0075240001,CPT0075130009,CPT0075170009,FALSE,56,Female,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,16,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN0,8,0,cM1,Staging Incomplete,"Liver, lung.",R0:No residual tumor,Stage IV,CD10 - positive; EMA - positive; Vimentin - positive; AE1/AE3 - positive;,,IHC staining not done,172,78,26.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,47,47,Main malignancy,NA,56,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,47,1,9,NA,56,Low,50-60
C3N-01176,CCRCC,C3N-01176-T,C3N-01176-N,TRUE,,CPT0078940001,CPT0078930003,['CPT0078930006'],CPT0078940006,CPT0078970002,CPT0078930009,CPT0078940009,FALSE,71,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Multifocal,6.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM1,Staging Incomplete,lungs,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,175,91,29,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Symlosin SR (tamsulosini)|Tezeo (telmisartanum)|Amlopin (amlodipinum)|Ipres long (indapamidum)|Zocor (simvastatinum)|betaloc (metorpolol),Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,Living,1710,NA,,1724,NA,No,No,No,With Tumor,Persistent Disease,Persistent Disease,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1710,0,14,NA,71,High or alive at last follow-up,>70
C3N-01808,CCRCC,C3N-01808-T,C3N-01808-N,TRUE,,CPT0089480003,CPT0089460004,CPT0089460006,CPT0089480006,CPT0091340002,CPT0089460009,"['CPT0089480009', 'CPT0089480013']",FALSE,47,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,5.8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,183,96,28.75,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,778,NA,,778,NA,Unknown,Unknown,Unknown,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,778,0,0,NA,47,High or alive at last follow-up,<50
C3L-00103,CCRCC,C3L-00103-T,C3L-00103-N,TRUE,,CPT0000660001,CPT0000640003,"['CPT0000630009', 'CPT0000640005', 'CPT0000650008']",CPT0000660006,CPT0003850002,CPT0000640008,"['CPT0000660009', 'CPT0000660014']",FALSE,56,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,11,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b,pN0,6,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,Stage III,,,IHC staining not done,180,93,28.7,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,17.5,Exposure to secondhand smoke history not available,,,,,,,Lisinopril ,Medical Report,No,Deceased,1659,1659,Main malignancy,NA,1659,No,No,No,With Tumor,Not Applicable,Patient Deceased,Yes,833,,,,,No,No,,No,Yes,No,NA,NA,833,833,1,1659,1,0,NA,56,High or alive at last follow-up,50-60
C3N-01649,CCRCC,C3N-01649-T,C3N-01649-N,TRUE,,CPT0088640003,CPT0088630003,CPT0088630006,CPT0088640006,CPT0088680009,CPT0088630009,CPT0088640009,FALSE,51,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM1,No pathologic evidence of distant metastasis,liver,R0:No residual tumor,Stage III,,,IHC staining not done,173,105,35,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,46.5,Exposure to secondhand smoke history not available,,,5,,,,Methyldopum|nitrendypinum|torasemidum|metoprolol|candesartan,Self Report|Self Report|Self Report|Self Report|Self Report,No,Living,1421,NA,,1430,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1421,0,9,NA,51,High or alive at last follow-up,50-60
C3N-00149,CCRCC,C3N-00149-T,C3N-00149-N,TRUE,,CPT0084590001,CPT0084560003,"['CPT008458 0004', 'CPT0084560009', 'CPT008457 0004', 'CPT008456 0004', 'CPT0084580006', 'CPT0084570006']",CPT0084590006,CPT0085310002,CPT0084560006,CPT0084590009,FALSE,68,Female,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,12,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN0,0,0,cM0,Staging Incomplete,None known,R0:No residual tumor,Stage IV,,,IHC staining not done,162,71,27.05,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,-8,NA,,0,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,8,8,68,High or alive at last follow-up,60-70
C3L-00581,CCRCC,C3L-00581-T,C3L-00581-N,TRUE,,CPT0007470001,CPT0007320003,"['CPT0007410006', 'CPT0007320006', 'CPT0007330006']",CPT0007470006,CPT0002780002,CPT0007320009,['CPT0007470009'],FALSE,52,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,13,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage II,,,IHC staining not done,168,95,33.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,1230,1230,Main malignancy,NA,1230,No,No,No,With Tumor,Not Applicable,,Yes,389,Distant Metastasis,"Lung, Bone",,,No,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,411,389,389,1,1230,1,0,NA,52,High or alive at last follow-up,50-60
C3L-00817,CCRCC,C3L-00817-T,,TRUE,,,CPT0065870003,['CPT0065870006'],,CPT0067710002,CPT0065870009,,FALSE,80,Male,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,1.2,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,175,104,33.96,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,amLODIPine (NORVASC|carvedilol (COREG|glimepiride (AMARYL|hydrochlorothiazide (MICROZIDE|isosorbide mononitrate (IMDUR) ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1365,NA,,1365,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1365,0,0,NA,80,High or alive at last follow-up,>70
C3L-01313,CCRCC,C3L-01313-T,C3L-01313-N,TRUE,,CPT0086830003,CPT0086820003,CPT0086820006,CPT0086830006,CPT0087430002,CPT0086820009,CPT0086830009,FALSE,63,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,9,Clear cell renal cell carcinoma,G4 Undifferentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage III,,,0,165,80,29.38,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",19,Exposure to secondhand smoke history not available,,,,,,,Blood Glucose test|lancets|metformin HCI|omeprazole|metoprolol |zofran|norco|baby aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1229,1229,Main malignancy,NA,1234,No,No,No,With Tumor,Not Applicable,Patient Deceased,Yes,456,Distant Metastasis,Other,thoracic and lumbar spine,,No,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,469,456,461,1,1229,1,5,NA,63,High or alive at last follow-up,60-70
C3N-00573,CCRCC,C3N-00573-T,C3N-00573-N,TRUE,,CPT0069010001,CPT0069000003,"['CPT0068970006', 'CPT0068990006', 'CPT0068980006', 'CPT0069000009']",CPT0069010006,CPT0069090002,CPT0069000006,CPT0069010009,FALSE,61,Male,Unknown,Unknown,East_Asian,Vietnam,No,,,Left Kidney,Unifocal,11,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,0,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,,,IHC staining not done,165,60,22.04,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,6,NA,,7,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,6,0,1,NA,61,High or alive at last follow-up,60-70
C3L-00360,CCRCC,C3L-00360-T,C3L-00360-N,TRUE,,CPT0002370001,CPT0002350011,['CPT0002350005'],CPT0002370006,CPT0004380002,CPT0002350008,"['CPT0002370009', 'CPT0002370014']",FALSE,72,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,3.7,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,Stage II,,,IHC staining not done,177,122,38.94,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40,Exposure to secondhand smoke history not available,,,,,,,Amlodipine|Aspirin|Calcium + D PO|Centrum Silver Adult |Docqlace |Hydrocodone-acetaminophen|Ferrous Gluconate (Iron)|Lisinopril |Metformin|Naproxen DR|Niacin ER|Omeprazole |Atorvastatin ,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,Living,1780,NA,,1780,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1780,0,0,NA,72,High or alive at last follow-up,>70
C3L-01302,CCRCC,C3L-01302-T,C3L-01302-N,TRUE,,CPT0063640001,CPT0063630003,['CPT0063630008'],CPT0063640006,CPT0065290002,CPT0063630006,['CPT0063640009'],FALSE,71,Female,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,8.5,Clear cell renal cell carcinoma,G4 Undifferentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,22,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage III,,,IHC staining not done,165,98,36,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Imodium A-D|methotrexate|folic acid|xarelto|prilosec|Calan|Zyrtec|mobic,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,53,55,Unknown,NA,55,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,55,1,0,NA,71,Low,>70
C3N-01361,CCRCC,C3N-01361-T,C3N-01361-N,TRUE,,CPT0088780001,CPT0088760003,['CPT0088760006'],CPT0088780006,CPT0088820002,CPT0088760009,CPT0088780009,FALSE,48,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,180,128,39,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Tolura (telmisartanum)|Dilzem (diltiazemi)|Tertensif SR (indapamidum),Self Report|Self Report|Self Report,No,Living,1811,NA,,1819,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1811,0,8,NA,48,High or alive at last follow-up,<50
C3N-01651,CCRCC,C3N-01651-T,C3N-01651-N,TRUE,,CPT0088710001,CPT0088690003,['CPT0088690006'],CPT0088710006,CPT0088750002,CPT0088690009,CPT0088710009,FALSE,58,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Multifocal,10,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,172,75,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,fraxiparine,Medical Record,No,Living,1420,NA,,1428,NA,No,No,No,With Tumor,Complete Remission,Persistent Disease,Yes,354,,,,,No,No,,No,No,No,NA,NA,354,362,1,1420,0,8,NA,58,High or alive at last follow-up,50-60
C3L-00907,CCRCC,C3L-00907-T,C3L-00907-N,TRUE,,CPT0064400001,CPT0064370003,"['CPT0064390006', 'CPT0064370009', 'CPT0064380006']",CPT0064400006,CPT0065420002,CPT0064370006,CPT0064400009,FALSE,55,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,4.8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,178,150,47.25,Yes,Lifelong non-drinker,Current reformed smoker within past 15 years,27,Exposure to secondhand smoke history not available,,,,melanoma,Surgery,Yes,protonix|metformin|cozaar|amaryl|lipitor|coreg|norco|aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1791,NA,,1795,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1791,0,4,NA,55,High or alive at last follow-up,50-60
C3L-00448,CCRCC,C3L-00448-T,C3L-00448-N,TRUE,,CPT0010170001,CPT0010160003,['CPT0010160009'],CPT0010170006,CPT0019880002,CPT0010160006,CPT0010170009,FALSE,66,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,1.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,Staging Incomplete,Not Applicable,R0:No residual tumor,Stage I,,,IHC staining not done,185,90,26.18,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",30,Exposure to secondhand smoke history not available,,,,,,,Apixaban|Metoprolol Succinate|Atorvastatin|Carbamazepine|Primidone|Lisinopril|Fluticasone|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1758,NA,,1758,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,Yes,779,New Primary Tumor,Other,Prostate,,,,,No,No,No,NA,NA,779,779,1,1758,0,0,NA,66,High or alive at last follow-up,60-70
C3L-01286,CCRCC,C3L-01286-T,C3L-01286-N,TRUE,,CPT0086970003,CPT0086950003,"['CPT0086950006', 'CPT0086960006', 'CPT0086940006']",CPT0086970006,CPT0087450002,CPT0086950009,CPT0086970009,FALSE,58,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,6,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage III,,,IHC staining not done,185,158,46.17,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,apresoline|Diovan|kenalog 0.1%|Insulin pen needle |novolog|tresiba Flextouch|Norvasc|Lasix |Silvadene 1% cream|lipitor|coreg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1028,1028,Main malignancy,NA,1028,No,No,No,With Tumor,Not Applicable,,Yes,594,,,,,No,No,,No,No,Yes,NA,NA,594,594,1,1028,1,0,NA,58,High or alive at last follow-up,50-60
C3L-01607,CCRCC,C3L-01607-T,C3L-01607-N,TRUE,,CPT0092190003,CPT0092160003,"['CPT0092160006', 'CPT0092170006', 'CPT0092180013']",CPT0092190006,CPT0093750002,CPT0092160009,"['CPT0092190013', 'CPT0092190009']",FALSE,83,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage III,,,IHC staining not done,178,87,27.52,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1794,NA,,1794,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1794,0,0,NA,83,High or alive at last follow-up,>70
C3N-01179,CCRCC,C3N-01179-T,C3N-01179-N,TRUE,,CPT0088920001,CPT0088900003,['CPT0088900006'],CPT0088920006,CPT0088960002,CPT0088900009,CPT0088920009,FALSE,72,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Multifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,164,72,26,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,70.5,Exposure to secondhand smoke history not available,,,,,,,Co-Prestarium (amlodipinum + perindoprilum)|Noliprel (indapamidum + perindoprilum)|Acard (Acidum acetylsalicylicum)|Zahron (rosuvastatinum)|clexane (enoxaparinum),Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,No,Living,1816,NA,,1824,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1816,0,8,NA,72,High or alive at last follow-up,>70
C3L-00606,CCRCC,C3L-00606-T,C3L-00606-N,TRUE,,CPT0079300001,CPT0079270003,"['CPT0079290006', 'CPT0079270006', 'CPT007927 0004', 'CPT0079280006', 'CPT007928 0004', 'CPT007929 0004']",CPT0079300006,CPT0080110002,CPT0079270009,['CPT0079300009'],FALSE,75,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,7,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,5,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage III,,,IHC staining not done,158,105,42.33,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",15,Exposure to secondhand smoke history not available,,,,,,,Amlodipine-benazepril|Atenolol|Furosemide|Simvastatin|Tramadol|Aspirin|Cranberry PO|Cholecalciferol|Potassium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1045,1045,Main malignancy,NA,1045,No,No,No,With Tumor,Not Applicable,,Yes,780,Distant Metastasis,Bone,,,No,No,,No,No,Yes,NA,NA,780,780,1,1045,1,0,NA,75,High or alive at last follow-up,>70
C3N-01648,CCRCC,C3N-01648-T,C3N-01648-N,TRUE,,CPT0088570001,CPT0088550004,['CPT0088550007'],CPT0088570006,CPT0088610002,CPT0088550010,CPT0088570009,FALSE,69,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Multifocal,7.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,176,87,28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,29.3,Exposure to secondhand smoke history not available,,,,,,,Ramipril|Bisoprolol,Self-reported and Medical Record|Self-reported and Medical Record,No,Living,1417,NA,,1431,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1417,0,14,NA,69,High or alive at last follow-up,60-70
C3N-00242,CCRCC,C3N-00242-T,C3N-00242-N,TRUE,,CPT0014470001,CPT0014450004,['CPT0014450010'],CPT0014470006,CPT0015070002,['CPT0014450007'],CPT0014470009,FALSE,69,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,3.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,in Oncocytoma of kidney: CD117 (C-Kit): Diffusely positive ; CK7: Rare positivity (<5%) in oncocytoma,,IHC staining not done,193,146,39.2,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",30,Exposure to secondhand smoke history not available,,,,,,,atorvastatin|diltiazem HCI|glimeperide|metfomin|metoprolol|nitroglycerin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1793,NA,,1793,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1793,0,0,NA,69,High or alive at last follow-up,60-70
C3L-00418,CCRCC,C3L-00418-T,C3L-00418-N,TRUE,,CPT0006730001,CPT0006630003,"['CPT0006630006', 'CPT0006670006', 'CPT0006640006']",CPT0006730006,CPT0002730002,CPT0006630009,"['CPT0006730014', 'CPT0006730009']",FALSE,56,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,8.7,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,Stage III,,,IHC staining not done,168,169,59.88,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Norco|Iron|multvitamin|Nifedical|vitamin C,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1714,NA,,1714,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1714,0,0,NA,56,High or alive at last follow-up,50-60
C3N-00577,CCRCC,C3N-00577-T,C3N-00577-N,TRUE,,CPT0069190001,CPT0069160003,"['CPT0069180006', 'CPT0069170006', 'CPT0069150006', 'CPT0069160009']",CPT0069190006,CPT0069270002,CPT0069160006,CPT0069190009,FALSE,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,,,Left Kidney,Unifocal,14,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,4,4,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage IV,,,IHC staining not done,163,58,21.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,397,NA,,397,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,397,0,0,NA,72,High or alive at last follow-up,>70
C3L-01882,CCRCC,C3L-01882-T,C3L-01882-N,TRUE,,CPT0092740003,CPT0092730003,CPT0092730006,CPT0092740006,CPT0093820002,CPT0092730009,"['CPT0092740013', 'CPT0092740009']",FALSE,48,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,2.2,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,1,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,Stage I,,,IHC staining not done,170,141,48.79,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,35,Exposure to secondhand smoke history not available,,,,,,,Aspirin|Atorvastatin|Carvedilol|NovolognFlex Pen|Insulin Detemir|Rivaroxaban|Nitroglycerin|lisinopril |Pepcid complete oral tablet |Ester-C500 oral tablet,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,350,NA,,350,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,350,0,0,NA,48,High or alive at last follow-up,<50
C3N-00733,CCRCC,C3N-00733-T,C3N-00733-N,TRUE,,CPT0025920001,CPT0025880003,"['CPT0025880006', 'CPT0025900006', 'CPT0025890009']",CPT0025920006,CPT0028480002,CPT0025880009,CPT0025920009,FALSE,56,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,8.6,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage III,Vimentin: Positive; C-kit: Negative; Cytokeratin 7: Negative,,IHC staining not done,177,87,27.77,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,calcium|multiple vitamin|omeprazole,Medical Record|Medical Record|Medical Record,No,Living,1464,NA,,1464,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1464,0,0,NA,56,High or alive at last follow-up,50-60
C3L-00910,CCRCC,C3L-00910-T,C3L-00910-N,TRUE,,CPT0007870001,CPT0007860003,['CPT0007860006'],CPT0007870006,CPT0002930002,CPT0007860009,CPT0007870009,FALSE,75,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,152,84,36.36,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",25,Exposure to secondhand smoke history not available,,,,,,,Microzide|Lopressor|Advair Diskus|valtrex,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1797,NA,,1797,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1797,0,0,NA,75,High or alive at last follow-up,>70
C3L-00079,CCRCC,C3L-00079-T,C3L-00079-N,TRUE,,CPT0001270001,CPT0001260009,CPT0001260164,CPT0001270006,CPT0000070163,CPT0001260005,"['CPT0001270009', 'CPT0001270014']",FALSE,49,Male,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,14,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN1,1,1,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage III,,,IHC staining not done,175,116,37.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,miralax|Norco|ibuprofen,Medical Record|Medical Record|Medical Record,No,Deceased,245,274,Main malignancy,NA,274,Yes,Yes,Yes,With Tumor,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,274,1,0,NA,49,Low,<50
C3N-01522,CCRCC,C3N-01522-T,C3N-01522-N,TRUE,,CPT0077140001,CPT0077110003,"['CPT0077130006', 'CPT0077120006', 'CPT0077110006']",CPT0077140006,CPT0077230002,['CPT0077110009'],CPT0077140009,FALSE,80,Male,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,10,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage I,CD10 - positive; EMA - positive; Vimentin - positive; RCC - patchy positive;,,IHC staining not done,171,90,30.78,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,692,NA,,697,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,692,0,5,NA,80,High or alive at last follow-up,>70
C3N-01220,CCRCC,C3N-01220-T,C3N-01220-N,TRUE,,CPT0076350001,CPT0076330003,"['CPT0076320014', 'CPT0076340009', 'CPT0076330008']",CPT0076350006,CPT0076400002,CPT0076330006,CPT0076350009,FALSE,51,Male,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,6.8,Clear cell renal cell carcinoma,G4 Undifferentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM1,Staging Incomplete,No,R0:No residual tumor,Stage IV,CK7 - negative; EMA - positive; Vimentin - positive; CD10 - patchy positive;,,IHC staining not done,183,80,23.89,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,31,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,633,633,Main malignancy,NA,642,No,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,633,1,9,NA,51,High or alive at last follow-up,50-60
C3L-01283,CCRCC,C3L-01283-T,,TRUE,,,CPT0079380003,['CPT0079380006'],,CPT0080120001,CPT0079380009,,FALSE,37,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,,Left Kidney,Unifocal,2.4,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,180,100,30.86,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,norco|Aleve|colace|Metaxalone|Mult. vitamins,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,735,NA,,735,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,735,0,0,NA,37,High or alive at last follow-up,<50
C3L-00813,CCRCC,C3L-00813-T,,TRUE,,,CPT0015810003,CPT0015810009,,CPT0018370002,CPT0015810013,,FALSE,61,Male,White,Unknown,European,United States,No,,,Left Kidney,Unifocal,4,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,175,60,19.49,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,5,NA,,5,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,5,0,0,NA,61,High or alive at last follow-up,60-70
C3L-01560,CCRCC,C3L-01560-T,,TRUE,,,CPT0086030003,CPT0086030006,,CPT0086720001,CPT0086030009,,FALSE,54,Female,White,Unknown,European,United States,No,,,Left Kidney,Unifocal,1.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,"The malignant cells are positive for pancytokeratin, vimentin, carbonic anhydrase 9 (CA-9), CD10, renal cell carcinoma antigen (RCC) (patchy) and PAX8. The neoplastic cells are negative for CK7",,IHC staining not done,160,98,38.08,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,amLODIPine (NORVASC) |carvedilol (COREG) |losartan-hydrochlorothiazide (HYZAAR) ,Medical Record|Medical Record|Medical Record,No,Living,250,NA,,250,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,250,0,0,NA,54,High or alive at last follow-up,50-60
C3L-01557,CCRCC,C3L-01557-T,,TRUE,,,CPT0085670003,CPT0085670006,,CPT0086610002,CPT0085670009,,FALSE,51,Male,Black or African American,Unknown,African,United States,No,,,Right Kidney,Unifocal,9.6,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,3,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,"positive for pankeratin, PAX8, CA-9, CD10, Renal Cell Carcinoma Antigen, and Vimentin and negative for CK7","PERSONALIZED CANCER MUTATION PANEL (PCMP);VHL mutation POSITIVE (p.?[splice], c.341-2A>G",IHC staining not done,157,120,48.46,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,329,NA,,329,NA,No,No,Unknown,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,329,0,0,NA,51,High or alive at last follow-up,50-60
C3L-00799,CCRCC,C3L-00799-T,,TRUE,,,CPT0025230003,['CPT0025230006'],,CPT0029440002,CPT0025230009,,FALSE,41,Male,White,Not Hispanic or Latino,European,United States,No,,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,177,111,35.66,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,495,NA,,495,NA,No,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,495,0,0,NA,41,High or alive at last follow-up,<50
C3L-00796,CCRCC,C3L-00796-T,,TRUE,,,CPT0065750003,CPT0065750006,,CPT0067670002,CPT0065750009,,FALSE,67,Male,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,188,109,30.81,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,47,Exposure to secondhand smoke history not available,,,48,,,,hydrochlorothiazide-lisinopril ,Medical Record,No,Living,333,NA,,333,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,333,0,0,NA,67,High or alive at last follow-up,60-70
C3L-00792,CCRCC,C3L-00792-T,,TRUE,,,CPT0015730003,['CPT0015730009'],,CPT0018270002,CPT0015730006,,FALSE,>=90,Female,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,8.7,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,0,170,86,29.6,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Simvastatin|Metoprolol|Insulin (Novolog) ,Medical Record|Medical Record|Medical Record,No,Living,1419,NA,,1419,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1419,0,0,NA,90,High or alive at last follow-up,>70
C3N-00832,CCRCC,C3N-00832-T,,TRUE,,,CPT0078800003,['CPT0078800006'],,CPT0078820002,CPT0078800009,,FALSE,79,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,4.5,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,164,63,23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Apo-tamis (tamsulosini)|Apo-Fina (finasteridum),Self Report|Self Report,No,Living,1770,NA,,1778,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,Yes,299,New Primary Tumor,Other,Prostate,,,,,Yes,No,No,NA,NA,299,307,1,1770,0,8,NA,79,High or alive at last follow-up,>70
C3L-01288,CCRCC,C3L-01288-T,,TRUE,,,CPT0079230003,['CPT0079230006'],,CPT0080100002,CPT0079230009,,FALSE,70,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,2.8,Clear cell renal cell carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,160,101,39.45,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,52,Exposure to secondhand smoke history not available,,,,,,,"Prednisone|Flexeril|Zantac|Lidoderm|Amlactin|Norco|Neurontin|Desyrel|Mult Vitamin for women 50+|Vitamin B 12|OS-CAL calcium carbonate|Imodium|Macrodantin|Lantus Solostar |Atarax|Prinzide zestoretic|Nystatin Topical Powder|Lasix|Effexor|K-Dru, Klorcon|glucose blood VI test strips |Vitamin D",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1800,NA,,1800,NA,No,No,No,With Tumor,Not Applicable,Persistent Disease,Yes,1416,Locoregional Recurrence,Other,lesion in the anterior right renal cortex ,,No,,,No,No,No,NA,NA,1416,1416,1,1800,0,0,NA,70,High or alive at last follow-up,60-70
C3L-00766,CCRCC,C3L-00766-T,,TRUE,,,CPT0025170003,['CPT0025170006'],,CPT0029430002,CPT0025170009,,FALSE,57,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,2.8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,156,167,68.59,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Albuterol|Fenofibrate|Omeprazole,Medical Record|Medical Record|Medical Record,No,Living,266,NA,,266,NA,No,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,266,0,0,NA,57,High or alive at last follow-up,50-60
C3L-00610,CCRCC,C3L-00610-T,,TRUE,,,CPT0025110003,['CPT0025110006'],,CPT0029410002,CPT0025110009,,FALSE,57,Female,White,Not Hispanic or Latino,European,United States,No,,,Right Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,160,104,40.74,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Metoprolol|Atorvastatin,Medical Record|Medical Record,No,Living,1472,NA,,1472,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1472,0,0,NA,57,High or alive at last follow-up,50-60
C3L-00800,CCRCC,C3L-00800-T,,TRUE,,,CPT0025290003,['CPT0025290006'],,CPT0029460002,CPT0025290009,,FALSE,41,Male,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,"positive for CD10, CA9 and CK7",,IHC staining not done,180,94,29.01,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,344,NA,,344,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,344,0,0,NA,41,High or alive at last follow-up,<50
C3N-00154,CCRCC,C3N-00154-T,,TRUE,,,CPT0081880003,['CPT0081880009'],,CPT0085300002,CPT0081880006,,FALSE,68,Male,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,8,Clear cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,0,cM0,Staging Incomplete,,R0:No residual tumor,Stage II,,,IHC staining not done,182,93,28.08,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,-7,NA,,0,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,7,7,68,High or alive at last follow-up,60-70
C3N-01213,CCRCC,C3N-01213-T,,TRUE,,,CPT0075720003,['CPT0075720006'],,CPT0075800002,CPT0075720009,,FALSE,68,Male,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,8.3,Clear cell renal cell carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage III,CD10 - positive; RCC - positive; Vimentin - positive; EMA - positive;,,IHC staining not done,168,64,22.68,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,654,NA,,658,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,654,0,4,NA,68,High or alive at last follow-up,60-70
C3L-01553,CCRCC,C3L-01553-T,,TRUE,,,CPT0065930003,['CPT0065930006'],,CPT0067730002,CPT0065930009,,FALSE,59,Male,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,1.9,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,"positive for CA-9, CD10 and focal staining for CK7",,IHC staining not done,185,159,46.17,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Levothyroxine (SYNTHROID)|Metformin (GLUCOPHAGE)|losartan-hydrochlorothiazide (HYZAAR) ,Medical Record|Medical Record|Medical Record,No,Living,384,NA,,384,NA,No,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,0,NA,59,High or alive at last follow-up,50-60
C3L-00812,CCRCC,C3L-00812-T,,TRUE,,,CPT0025350003,['CPT0025350006'],,CPT0029480002,CPT0025350009,,FALSE,74,Male,White,Unknown,European,United States,No,,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,164,73,27.04,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Amlodipine,Medical Record,No,Living,8,NA,,8,NA,Unknown,Unknown,Unknown,Unknown,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,8,0,0,NA,74,High or alive at last follow-up,>70
C3L-00790,CCRCC,C3L-00790-T,,TRUE,,,CPT0065690003,['CPT0065690006'],,CPT0067650002,CPT0065690009,,FALSE,44,Male,White,Unknown,European,United States,No,,,Right Kidney,Unifocal,7,Clear cell renal cell carcinoma,G2 Moderately differentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,,,IHC staining not done,170,113,38.99,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,10,,,,amLODIPine-benazepril (LOTREL|hydroCHLOROthiazide (HYDRODIURIL|sitaGLIPtin (JANUVIA|XIGDUO XR |Metformin (GLUCOPHAGE),Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,441,NA,,441,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,441,0,0,NA,44,High or alive at last follow-up,<50
C3N-00313,CCRCC,C3N-00313-T,,TRUE,,,CPT0011410003,['CPT0011410006'],,CPT0012040002,CPT0011410009,,FALSE,31,Female,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,4.5,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,158,56,22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,clexane,Self-reported and Medical Record,Yes,Living,1869,NA,,1888,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,Yes,1803,New Primary Tumor,Other,right breast,,,,,No,No,No,NA,NA,1803,1822,1,1869,0,19,NA,31,High or alive at last follow-up,<50
C3N-00852,CCRCC,C3N-00852-T,C3N-00852-N,TRUE,,CPT0024680001,CPT0024670003,"['CPT0024650009', 'CPT0024670006', 'CPT0024660009']",CPT0024680013,CPT0024740002,CPT0024670009,CPT0024680009,FALSE,62,Male,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,13.6,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage III,CD10 - positive; EMA - positive; Vimentin - focally positive;,,IHC staining not done,179,92,28.71,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,620,NA,,628,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,620,0,8,NA,62,High or alive at last follow-up,60-70
C3N-00437,CCRCC,C3N-00437-T,C3N-00437-N,TRUE,,CPT0012570003,CPT0012550003,"['CPT0012550006', 'CPT0012560008', 'CPT0012540009']",,CPT0012620002,CPT0012550008,CPT0012570009,FALSE,69,Female,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,6,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,156,92,37,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,0.3,Exposure to secondhand smoke history not available,,,,Clear Cell Renal Carcinoma,Surgery,Yes,letrox|Theovent (teofilin)|Zafiron|Gensulin M50|Tritace|Nebilenin|Poltram Combo|Prazol|Atrox|clexane,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,Yes,Deceased,1637,1637,Unknown,NA,1644,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1637,1,7,NA,69,High or alive at last follow-up,60-70
C3N-00320,CCRCC,C3N-00320-T,C3N-00320-N,TRUE,,CPT0013790003,CPT0012370003,"['CPT0012390006', 'CPT0012380006', 'CPT0012370006', 'CPT0012360006']",,CPT0012530002,CPT0012370009,['CPT0013790009'],FALSE,67,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,170,94,32,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40,Exposure to secondhand smoke history not available,,,,,,,Bisocard|Gisartan (Hydrochlorothiazide + Telmisartan)|Polocard|clexane|Tulip (atorvastatin)|Amlopin|Milurit|Euthyrox,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,Yes,Living,1849,NA,,1856,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1849,0,7,NA,67,High or alive at last follow-up,60-70
C3N-00492,CCRCC,C3N-00492-T,C3N-00492-N,TRUE,,CPT0012770003,CPT0079180003,['CPT0079180006'],,CPT0012820002,CPT0079180009,CPT0012770009,FALSE,49,Female,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,11,non-Clear Cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,170,76,26,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,,Yes,,,,,Euthyrox (levothyroxine)|Fostex (beclomethasone + formoterolum),Self Report|Self Report,Yes,Living,1792,NA,,1801,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1792,0,9,NA,49,High or alive at last follow-up,<50
C3N-00305,CCRCC,C3N-00305-T,,TRUE,,,CPT0011240003,CPT0011240005,,CPT0011270002,CPT0011240009,,FALSE,60,Female,Unknown,Unknown,European,Poland,No,,,Left Kidney,Multifocal,1,Clear cell renal cell carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,164,52,19,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,38,Exposure to secondhand smoke history not available,,,,,,,acard|Bisoprolol|pantoprazole,Self Report|Self Report|Self Report,Yes,Living,1913,NA,,1920,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,Yes,199,,,,,Yes,No,,Yes,Yes,No,213,NA,199,206,1,1913,0,7,NA,60,High or alive at last follow-up,50-60
C3N-00491,CCRCC,C3N-00491-T,C3N-00491-N,TRUE,,CPT0012640003,CPT0012670003,CPT0012670009,CPT0012640006,CPT0012730002,CPT0012670006,CPT0012640009,FALSE,54,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,cM1,Staging Incomplete,left femur,RX:Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,176,95,30,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Vivace (ramipril)|tulip  (atorvastatin)|betaloc (metorpolol),Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Deceased,77,99,Unknown,NA,112,No,No,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,99,1,13,NA,54,Low,50-60
C3N-00314,CCRCC,C3N-00314-T,C3N-00314-N,TRUE,,CPT0012090003,CPT0012080003,"['CPT0012070016', 'CPT0012080006', 'CPT0012060009', 'CPT0012050005']",CPT0012090013,CPT0012150002,"['CPT0012070011', 'CPT0012080009']",['CPT0012090009'],FALSE,78,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,4.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,175,96,31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,50,No or minimal exposure to secondhand smoke,,,,,,,clexane|Tulip (atorvastatin)|Tolura (telmisartan)|Bisoprolol,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Deceased,62,126,Unknown,NA,140,No,Yes,No,With Tumor,Persistent Disease,,Yes,1,,,,,No,Unknown,,No,No,No,NA,NA,1,15,1,126,1,14,NA,78,Low,>70
C3N-00435,CCRCC,C3N-00435-T,C3N-00435-N,TRUE,,CPT0018250001,CPT0017850003,['CPT0017850006'],CPT0018250006,CPT0022960002,CPT0017850009,CPT0018250009,FALSE,72,Male,Unknown,Unknown,European,Ukraine,No,,,Right Kidney,Unifocal,10.5,non-Clear Cell renal cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,12,cM0,Staging Incomplete,No,R0:No residual tumor,Stage III,CD10 - focal positivity; EMA - positive; Vimentin - focal positivity; S100 - positive,,IHC staining not done,170,78,26.99,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,7,NA,,14,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,7,0,7,NA,72,High or alive at last follow-up,>70
C3N-00317,CCRCC,C3N-00317-T,C3N-00317-N,TRUE,,CPT0012290003,CPT0012280003,"['CPT0012280006', 'CPT0012260009']",,CPT0012350002,CPT0012280009,CPT0012290009,FALSE,74,Female,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,168,65,23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,clexane|insulin|perindopril|metoprolol,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Living,1133,NA,,1143,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1133,0,10,NA,74,High or alive at last follow-up,>70
C3N-00315,CCRCC,C3N-00315-T,,TRUE,,,CPT0012180003,['CPT0012180006'],,CPT0012240002,CPT0012180009,,FALSE,68,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,7,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,164,77,28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Apo_tamis (tamsulosin)|Apo_Fina (finastyrid)|clexane,Self Report|Self Report|Self-reported and Medical Record,Yes,Living,1861,NA,,1870,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1861,0,9,NA,68,High or alive at last follow-up,60-70
C3N-00380,CCRCC,C3N-00380-T,,TRUE,,,CPT0021240003,['CPT0021240006'],,CPT0021300002,CPT0021240009,,FALSE,57,Female,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,4.1,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage I,S-100 (4C4.9) – Negative; CD 10(56C6) – Negative; Vimentin (Vim3B4)- Positive; Epithelial Membrane Antigen (EMA) (E29) – Positive,,IHC staining not done,172,138,46,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,662,NA,,670,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,662,0,8,NA,57,High or alive at last follow-up,50-60
C3N-00310,CCRCC,C3N-00310-T,C3N-00310-N,TRUE,,CPT0009020003,CPT0009000003,"['CPT0009000009', 'CPT0008980013', 'CPT0009010006', 'CPT0008990006']",CPT0009020006,CPT0009030002,CPT0009000006,CPT0009020009,FALSE,84,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,172,84,28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",1,No or minimal exposure to secondhand smoke,,,,,,,Hyplafin (finasterid)|TamisPras (tamsulosine)|Axtil (ramipril)|clexane,Self Report|Self Report|Self Report|Self-reported and Medical Record,Yes,Deceased,1623,1623,Other reasons,NA,1637,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1623,1,14,NA,84,High or alive at last follow-up,>70
C3N-00390,CCRCC,C3N-00390-T,C3N-00390-N,TRUE,,CPT0017450001,CPT0017410003,"['CPT0017410006', 'CPT0017380009', 'CPT0017420009', 'CPT0017440009']",CPT0017450006,CPT0017650002,CPT0017410009,CPT0017450009,FALSE,58,Male,Unknown,Unknown,European,Ukraine,No,,,Left Kidney,Unifocal,14.1,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,cM1,Staging Incomplete,Liver.,R0:No residual tumor,Stage IV,CD10 - positive; EMA - positive; Vimentin - positive; S100 - positive;,,IHC staining not done,176,90,29.05,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,687,NA,,693,NA,No,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,687,0,6,NA,58,High or alive at last follow-up,50-60
C3N-00312,CCRCC,C3N-00312-T,C3N-00312-N,TRUE,,CPT0009080003,CPT0009060003,"['CPT0009050006', 'CPT0009040006', 'CPT0009060009', 'CPT0009070006']",,CPT0009090002,CPT0009060006,CPT0009080009,FALSE,68,Male,Unknown,Unknown,European,Poland,No,,,Right Kidney,Unifocal,4,Clear cell renal cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,173,92,30,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,clexane|Sintrom (acenokumarol),Self-reported and Medical Record|Self Report,Yes,Living,1888,NA,,1898,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,Yes,236,,,,,Yes,No,,No,No,No,247,NA,236,246,1,1888,0,10,NA,68,High or alive at last follow-up,60-70
C3N-00494,CCRCC,C3N-00494-T,C3N-00494-N,TRUE,,CPT0012920003,CPT0012900004,"['CPT0012910009', 'CPT0012900007', 'CPT0012880009']",CPT0012920013,CPT0012980002,CPT0012900010,['CPT0012920009'],FALSE,66,Male,Unknown,Unknown,European,Poland,No,,,Left Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,165,94,34,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,84,Exposure to secondhand smoke history not available,,,,,,,Carvedilol|Insulin|Allopurinol|Ramipril|Doxazosin|Rosuvastatin|Clopidogrel|clexane,Self Report|Self-reported and Medical Record|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,Yes,Living,1786,NA,,1793,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1786,0,7,NA,66,High or alive at last follow-up,60-70
11CO037,CO,11CO037-T,11CO037-N,TRUE,,853ecf90-71e6-4156-a56f-a34b65_D2,1563ef63-d2e6-406f-adc1-255949_D3,1563ef63-d2e6-406f-adc1-255949_D7_1,,38fe94db-051d-408f-abe8-7e87c2_D1_1,1563ef63-d2e6-406f-adc1-255949_D6,,FALSE,52,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,10,2,,M0,,R0,Stage III,,,999,155,40,NA,No,,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,52,High or alive at last follow-up,50-60
11CO051,CO,11CO051-T,11CO051-N,TRUE,,b3696374-c6c0-49dd-833e-596e26_D2,f6b1079b-9d67-4c63-b3d0-d562b5_D2,f2a13f8d-b129-4567-beae-049b15_D7_1,,07245471-6673-4b5c-a88e-ee5904_D1_1,f2a13f8d-b129-4567-beae-049b15_D6_1,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,164,80,NA,No,,,NA,,,,,,No,,,,,Living,417,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,417,0,NA,NA,61,High or alive at last follow-up,60-70
01CO008,CO,01CO008-T,01CO008-N,TRUE,,5347d2ce-df0c-4d81-a3e2-22db11_D2,8cc7e656-0152-4359-8566-0581c3,9452572f-e3ec-4063-a82e-43ac90_D7,,0c1f2419-4b8a-42f7-a369-a5b438_D1,9452572f-e3ec-4063-a82e-43ac90_D6,,FALSE,54,Female,Black or African American,Not Hispanic or Latino,African,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,21,0,,M0,,R0,Stage II,,,0,175,88.4,NA,No,,,NA,,,,,,No,,,,,Living,369,NA,,NA,NA,No,No,,With tumor,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,369,0,NA,NA,54,High or alive at last follow-up,50-60
22CO006,CO,22CO006-T,22CO006-N,TRUE,,1c070992-647b-4173-a481-904c4d_D2,e1cd3d70-132b-452f-ba10-026721_D2,4d86cf19-8d5b-46b5-ab4c-ace0b2_D7_1,,3487b5c2-1dce-4e1c-bb84-30e8f2_D1_1,4d86cf19-8d5b-46b5-ab4c-ace0b2_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N2b,25,24,,M0,,R0,Stage III,,,0,178,68,NA,No,,,NA,,,,,,No,,,,,Living,334,NA,,NA,NA,Not Reported/ Unknown,Yes,,With tumor,,,Yes,NA,Both Locoregional and Distant Metastasis,Liver,,,No,,,Not Applicable,Yes,,NA,NA,NA,NA,1,334,0,NA,NA,57,High or alive at last follow-up,50-60
05CO002,CO,05CO002-T,05CO002-N,TRUE,,cc271b3d-ed33-481f-9d23-15f2f6_D2,f635496c-0046-4ecd-89bc-7a4f33_D2,159c49fd-40ff-4616-b6b6-be21a6_D7,,d271597e-f19c-4c55-b9dd-1a251a_D1,159c49fd-40ff-4616-b6b6-be21a6_D6,,FALSE,,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N1a,17,1,,MX,,R0,Stage III,,,0,167,82.73,NA,No,,,NA,,,,,,No,,,,,Living,350,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,350,0,NA,NA,NA,High or alive at last follow-up,
11CO036,CO,11CO036-T,11CO036-N,TRUE,,41a04113-2061-4923-bca5-da586c_D2,21cab01c-e968-42cc-9651-1e53c0_D3,21cab01c-e968-42cc-9651-1e53c0_D7_1,,8ffc3824-36ef-464a-a1e4-9e0e50_D1_1,21cab01c-e968-42cc-9651-1e53c0_D6_1,,FALSE,36,Male,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,9,1,,M0,,R0,Stage III,,,Not Reported/ Unknown,166,55,NA,No,,,NA,,,,,,No,,,,,Living,367,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,367,0,NA,NA,36,High or alive at last follow-up,<50
20CO006,CO,20CO006-T,20CO006-N,TRUE,,9a6879b1-4f78-4ac6-9fca-dad049_D2,bd67de01-ad7d-431a-9ad6-4dd5a1,,,,,,FALSE,58,Male,White,Not Hispanic or Latino,,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,38,1,,M1,,R0,Stage IV,,,Not Performed,188,123,NA,No,,,NA,,,,,,No,,,,,Living,309,NA,,NA,NA,No,Yes,,With tumor,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,309,0,NA,NA,58,High or alive at last follow-up,50-60
01CO019,CO,01CO019-T,01CO019-N,TRUE,,7784e2e5-c0e1-4b85-8cc1-7faac8_D2,573048dd-2502-40e0-8e8c-c41bb8_D3,573048dd-2502-40e0-8e8c-c41bb8_D7_1,,6e1e0cf0-0af1-4561-b8f4-056fcb_D1_1,573048dd-2502-40e0-8e8c-c41bb8_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N2a,12,4,,MX,,R0,Stage III,,,0,165,83.97,NA,No,,,NA,,,,,,No,,,,,Living,357,NA,,NA,NA,No,Yes,,With tumor,,,Yes,NA,Distant Metastasis,Liver,,,No,,,No,Yes,,NA,NA,NA,NA,1,357,0,NA,NA,63,High or alive at last follow-up,60-70
09CO005,CO,09CO005-T,09CO005-N,TRUE,,e3c012aa-51c2-42b0-a478-bd620f_D2,ec9afcc4-ccf7-4226-b0e8-d6897d_D3,ec9afcc4-ccf7-4226-b0e8-d6897d_D7,,04a00ed3-7f0c-4ddf-9de5-ec7916_D1,ec9afcc4-ccf7-4226-b0e8-d6897d_D6,,FALSE,69,Female,White,Not Hispanic or Latino,African,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,19,Not Reported/ Unknown,,M0,,R0,Stage III,,,1,157,63.2,NA,No,,,NA,,,,,,No,,,,,Living,293,NA,,NA,NA,No,No,,Unknown tumor status,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,293,0,NA,NA,69,High or alive at last follow-up,60-70
05CO035,CO,05CO035-T,05CO035-N,TRUE,,e070ff10-058b-4733-93ab-bdd702_D2,dfdf03a6-c324-4d8c-a909-ea7345_D2,1312a0e0-5025-433e-9670-0595bb_D7_1,,c69ba610-1bdb-41b6-8369-a83016_D1_1,1312a0e0-5025-433e-9670-0595bb_D6,,FALSE,64,Female,Black or African American,Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,28,0,,MX,,R0,Stage II,,,0,157,154.4,NA,No,,,NA,,,,,,No,,,,,Living,360,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,360,0,NA,NA,64,High or alive at last follow-up,60-70
05CO053,CO,05CO053-T,05CO053-N,TRUE,,cd3a9d59-bf13-48f3-ae97-bdbca4_D2,66b829db-1cdd-460d-b2f3-0e9ca9_D3,66b829db-1cdd-460d-b2f3-0e9ca9_D7_1,,acefec8a-32a0-4686-a421-6d12d5_D1_1,66b829db-1cdd-460d-b2f3-0e9ca9_D6_1,,FALSE,51,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,48,2,,MX,,R0,Stage II,,,0,178,118,NA,No,,,NA,,,,,,No,,,,,Living,363,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,363,0,NA,NA,51,High or alive at last follow-up,50-60
20CO001,CO,20CO001-T,20CO001-N,TRUE,,5c70e654-583c-4dd3-ad42-0d9b39_D2,b2400046-1d25-429d-a821-6040a6,d8345fa1-f692-4025-bc82-bfaec6_D7,,04143d60-42b0-477d-9e44-6ab225_D1,d8345fa1-f692-4025-bc82-bfaec6_D6,,FALSE,53,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,16,2,,MX,,R0,Stage III,,,Not Performed,165,46,NA,No,,,NA,,,,,,No,,,,,Living,353,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,353,0,NA,NA,53,High or alive at last follow-up,50-60
05CO045,CO,05CO045-T,05CO045-N,TRUE,,bda3787a-1397-4716-bb17-4992a8_D2,92c1ebb5-ac1d-4bf5-a14f-516e1d_D3,92c1ebb5-ac1d-4bf5-a14f-516e1d_D7_1,,8d0e2230-208e-43d7-8048-73d6d6_D1_1,92c1ebb5-ac1d-4bf5-a14f-516e1d_D6_1,,FALSE,75,Female,White,Unknown,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,29,2,,MX,,R0,Stage III,,,0,150,80,NA,No,,,NA,,,,,,No,,,,,Living,354,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,354,0,NA,NA,75,High or alive at last follow-up,>70
15CO001,CO,15CO001-T,15CO001-N,TRUE,,a243b765-61ab-4aa6-88e1-226896_D2,cd89ffbb-574a-4052-bd9a-00c890_D2,c2db7236-990c-42b6-9ffb-2ad150_D7_1,,7e71d580-cbc5-4ced-938a-a2d9b9_D1_1,c2db7236-990c-42b6-9ffb-2ad150_D6,,FALSE,57,Female,Asian,Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,16,1,,MX,,RX,Stage III,,,999,139,39,NA,No,,,NA,,,,,,No,,,,,Living,353,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,353,0,NA,NA,57,High or alive at last follow-up,50-60
05CO044,CO,05CO044-T,05CO044-N,TRUE,,d8805fa4-30f9-4417-907e-fdc50c_D2,8af80ae9-2088-4124-91fb-8d6c17_D3,8af80ae9-2088-4124-91fb-8d6c17_D7,,eb4fbb4e-3f5f-4f33-a7ac-be0306_D1_1,8af80ae9-2088-4124-91fb-8d6c17_D6_1,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N0,15,0,,MX,,R0,Stage II,,,0,157,72,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,365,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,365,0,NA,NA,70,High or alive at last follow-up,60-70
11CO053,CO,11CO053-T,11CO053-N,TRUE,,d80408d6-598d-4411-ab34-eb2545_D2,092c5a37-325b-4181-b230-2d8fff_D2,ecf1ca92-c8b7-470f-baf4-81cf73_D7_1,,5bf39865-182c-4c82-90e4-a7ea59_D1_1,ecf1ca92-c8b7-470f-baf4-81cf73_D6_1,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,155,90,NA,No,,,NA,,,,,,No,,,,,Living,411,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,411,0,NA,NA,63,High or alive at last follow-up,60-70
11CO019,CO,11CO019-T,11CO019-N,TRUE,,325b5314-6f3c-4d79-9b36-4e7ded_D2,722378ea-d1a7-4cfc-aca5-ba45f9_D8,722378ea-d1a7-4cfc-aca5-ba45f9_D7_1,,7303fb7b-e7a6-4753-be4d-1e3d29_D1_1,722378ea-d1a7-4cfc-aca5-ba45f9_D6,,FALSE,74,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,5,3,,M0,,R0,Stage III,,,Not Reported/ Unknown,163,62,NA,No,,,NA,,,,,,No,,,,,Living,373,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,373,0,NA,NA,74,High or alive at last follow-up,>70
20CO007,CO,20CO007-T,20CO007-N,TRUE,,5de06adb-e00d-4114-8d76-04bd30_D2,0065bfd9-e1b9-43a8-9379-9658ba_D3,0065bfd9-e1b9-43a8-9379-9658ba_D7_1,,46c880d8-2352-43b5-84cc-acc87c_D1_1,0065bfd9-e1b9-43a8-9379-9658ba_D6_1,,FALSE,54,Male,Black or African American,Not Hispanic or Latino,African,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,61,0,,MX,,R0,Stage II,,,Not Performed,170,108,NA,No,,,NA,,,,,,No,,,,,Living,279,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,279,0,NA,NA,54,High or alive at last follow-up,50-60
05CO041,CO,05CO041-T,05CO041-N,TRUE,,3a17283c-a0f4-4514-956b-080d11_D2,b4dd4a04-5eda-43dd-8298-215b07_D3,b4dd4a04-5eda-43dd-8298-215b07_D7_1,,693ff8e7-2929-4caa-bbcf-6b0016_D1_1,b4dd4a04-5eda-43dd-8298-215b07_D6_1,,FALSE,78,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,24,0,,MX,,R0,Stage II,,,0,162,66.5,NA,No,,,NA,,,,,,No,,,,,Living,362,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,362,0,NA,NA,78,High or alive at last follow-up,>70
11CO042,CO,11CO042-T,11CO042-N,TRUE,,43bc845e-d22e-4c10-b3e8-bc54e6_D2,2167c594-c33f-4795-b95b-69bd07_D2,4b68d71e-48b4-45ba-a041-9d6aa0_D7_1,,163f4ce9-bec0-48bc-9899-033cb7_D1_1,4b68d71e-48b4-45ba-a041-9d6aa0_D6,,FALSE,70,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,163,65,NA,No,,,NA,,,,,,No,,,,,Living,375,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,375,0,NA,NA,70,High or alive at last follow-up,60-70
05CO033,CO,05CO033-T,05CO033-N,TRUE,,a5c8bf1d-776c-406f-82a3-2d9ce6_D2,2f8b02e4-1848-4abc-a95e-dd9eb5_D3,2f8b02e4-1848-4abc-a95e-dd9eb5_D7,,2db0e2fa-e434-4751-924f-c55ad3_D1,2f8b02e4-1848-4abc-a95e-dd9eb5_D6,,FALSE,61,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N2a,19,4,,MX,,R0,Stage III,,,0,187,86,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,337,NA,,NA,NA,No,Yes,,With tumor,,,Yes,NA,Distant Metastasis,Liver,,,Yes,,R0,No,No,,NA,NA,NA,NA,1,337,0,NA,NA,61,High or alive at last follow-up,60-70
11CO008,CO,11CO008-T,11CO008-N,TRUE,,e74089a9-f78c-4ffe-8174-aef71b_D2,98742d96-cc2f-43f0-9de2-bc7afe_D3,98742d96-cc2f-43f0-9de2-bc7afe_D7_1,,012baf0d-2c53-4409-91ec-2c7998_D1_1,de439530-464e-481b-91ab-0685b9_D6,,FALSE,67,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1,4,2,,M0,,R0,Stage III,,,Not Reported/ Unknown,152,40,NA,No,,,NA,,,,,,No,,,,,Living,384,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,NA,NA,67,High or alive at last follow-up,60-70
09CO008,CO,09CO008-T,09CO008-N,TRUE,,154115ac-2ec2-439d-b55e-0464ee_D2,aa0f5b40-3290-4255-8f4d-f45d4e_D3,aa0f5b40-3290-4255-8f4d-f45d4e_D7,,02345909-96ed-4f40-a623-7b95be_D1,aa0f5b40-3290-4255-8f4d-f45d4e_D6,,FALSE,53,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,19,Not Reported/ Unknown,,MX,,RX,Stage III,,,1,160,64.41,NA,No,,,NA,,,,,,No,,,,,Living,343,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,343,0,NA,NA,53,High or alive at last follow-up,50-60
11CO033,CO,11CO033-T,11CO033-N,TRUE,,348f6009-e1be-44d2-a093-9ca844_D2,8960a27e-69d8-4ec8-a795-c6cf8a_D3,8960a27e-69d8-4ec8-a795-c6cf8a_D7_1,,d14ecda4-00aa-463e-b6a9-a8a255_D1_1,8960a27e-69d8-4ec8-a795-c6cf8a_D6,,FALSE,54,Male,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,10,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,167,46,NA,No,,,NA,,,,,,No,,,,,Living,385,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,385,0,NA,NA,54,High or alive at last follow-up,50-60
05CO039,CO,05CO039-T,05CO039-N,TRUE,,694e8df1-d9ee-473b-bec1-4f9237_D2,66b57abc-0d49-46bb-a390-0e11a9_D2,c952715e-35ca-4e18-ad6f-dd4e39_D7_1,,38dbebd9-e1ba-475d-bc18-1e3506_D1_1,c952715e-35ca-4e18-ad6f-dd4e39_D6_1,,FALSE,73,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N0,20,0,,MX,,R0,Stage II,,,0,180,135,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,214,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,214,1,NA,NA,73,Low,>70
11CO020,CO,11CO020-T,11CO020-N,TRUE,,377cdd37-d1bd-4042-997e-478a0f_D2,321fb3b2-ebb6-4ea5-b737-081264_D2,52d61ab1-5781-4b47-8e88-37c2ea_D7_1,,0318bcea-2ea7-471a-9f42-5f5ccd_D1_1,52d61ab1-5781-4b47-8e88-37c2ea_D6,,FALSE,55,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,5,3,,M0,,R0,Stage III,,,Not Reported/ Unknown,183,100,NA,No,,,NA,,,,,,No,,,,,Living,370,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,370,0,NA,NA,55,High or alive at last follow-up,50-60
21CO007,CO,21CO007-T,21CO007-N,TRUE,,efee6bb9-69dd-46c2-85b3-b55962_D2,a467b905-fc0b-427b-8753-6d38dd_D3,a467b905-fc0b-427b-8753-6d38dd_D7_1,,8f5bf7df-cd1f-4300-a6c2-1aa47c_D1_1,a467b905-fc0b-427b-8753-6d38dd_D6,,FALSE,50,Male,White,Not Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N2a,31,5,,M1,,Not Reported/ Unknown,Stage IV,,,999,175,94.8,NA,No,,,NA,,,,,,No,,,,,Living,279,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Not Reported/ Unknown,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,279,0,NA,NA,50,High or alive at last follow-up,<50
05CO034,CO,05CO034-T,05CO034-N,TRUE,,f5ed5ebc-881d-456a-80d7-42c9e7_D2,42216d99-e8ff-43c9-b6db-28c3a6_D3,42216d99-e8ff-43c9-b6db-28c3a6_D7_1,,e2ef6cb4-e7d6-45e1-ac92-947fb5_D1_1,42216d99-e8ff-43c9-b6db-28c3a6_D6,,FALSE,54,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,29,1,,MX,,R0,Stage III,,,0,160,75.7,NA,No,,,NA,,,,,,No,,,,,Living,373,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,373,0,NA,NA,54,High or alive at last follow-up,50-60
05CO007,CO,,05CO007-N,TRUE,,963fc8db-f412-4427-a198-23f660_D2,,9899e1ad-62e1-4cc2-91fc-49b85c_D7,,6539f675-8d03-49eb-abc4-65f803_D1,9899e1ad-62e1-4cc2-91fc-49b85c_D6,,FALSE,85,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N2b,31,7,,MX,,R0,Stage III,,,0,152,49,NA,No,,,NA,,,,,,No,,,,,Living,363,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,363,0,NA,NA,85,High or alive at last follow-up,>70
05CO054,CO,05CO054-T,05CO054-N,TRUE,,da747cee-5026-4923-af63-ad9f81_D2,43192517-085e-450e-9481-0a6713_D3,43192517-085e-450e-9481-0a6713_D7_1,,be329c23-0f98-494d-b489-9047e9_D1_1,43192517-085e-450e-9481-0a6713_D6_1,,FALSE,86,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,20,0,,MX,,R0,Stage I,,,0,168,79,NA,No,,,NA,,,,,,No,,,,,Living,355,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,0,NA,NA,86,High or alive at last follow-up,>70
05CO029,CO,05CO029-T,05CO029-N,TRUE,,e14c2cbe-eca0-4745-97f6-8f27bd_D2,58a92726-4d1f-4e44-8938-52b97d_D3,58a92726-4d1f-4e44-8938-52b97d_D7,,848bb071-7372-4b79-abfe-9728da_D1,58a92726-4d1f-4e44-8938-52b97d_D6,,FALSE,55,Female,Black or African American,Not Hispanic or Latino,African,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,27,0,,MX,,R0,Stage II,,,0,168,116,NA,No,,,NA,,,,,,No,,,,,Living,358,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,358,0,NA,NA,55,High or alive at last follow-up,50-60
20CO003,CO,20CO003-T,20CO003-N,TRUE,,3e8019e8-125f-4615-a1fa-a448e9_D2,2d266d2d-4bb3-436c-a3e7-06acb2_D3,2d266d2d-4bb3-436c-a3e7-06acb2_D7_1,,9bd71309-d808-414e-8127-75b586_D1,2d266d2d-4bb3-436c-a3e7-06acb2_D6,,FALSE,60,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N1b,18,3,,M1,,R0,Stage IV,,,Not Performed,185,91,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,318,,NA,NA,No,No,,With tumor,,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,318,1,NA,NA,60,Low,50-60
01CO006,CO,01CO006-T,01CO006-N,TRUE,,b6b41ba2-6415-41aa-b5f5-4d47db_D2,f9d6fb1b-988e-4D88-9272-cc672f_D8,f9d6fb1b-988e-4d28-9272-cc672f_D7,,a354b1e9-7813-4274-957c-5e1768_D1,f9d6fb1b-988e-4d28-9272-cc672f_D6,,FALSE,75,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N2b,18,7,,M0,,RX,Stage III,,,0,157,57.7,NA,No,,,NA,,,,,,No,,,,,Living,365,NA,,NA,NA,No,Yes,,With tumor,,,Yes,NA,Distant Metastasis,Ovary,,,Yes,,RX,No,No,,NA,NA,NA,NA,1,365,0,NA,NA,75,High or alive at last follow-up,>70
15CO002,CO,15CO002-T,15CO002-N,TRUE,,974e136f-7020-4a38-b9c1-094df9_D2,c65afd57-530c-4366-b2c8-463a46_D2,74f7759a-279c-4098-b080-358900_D7_1,,d98655bc-7db0-4301-bffc-a59a1d_D1_1,74f7759a-279c-4098-b080-358900_D6_1,,FALSE,53,Female,Black or African American,Not Hispanic or Latino,African,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N0,15,0,,MX,,RX,Stage II,,,999,163,84.8,NA,No,,,NA,,,,,,No,,,,,Living,321,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,321,0,NA,NA,53,High or alive at last follow-up,50-60
11CO022,CO,11CO022-T,11CO022-N,TRUE,,88c621d7-7fb3-4825-abbe-82ae4c_D2,2b810478-7956-4a8b-870d-184859_D2,21c6f56a-8881-421b-81fa-c354cb_D7_1,,71dedc2c-428f-4229-aadb-c149cd_D1_1,21c6f56a-8881-421b-81fa-c354cb_D6_1,,FALSE,72,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4b,N0,5,0,,M1,,R0,Stage IV,,,Not Reported/ Unknown,174,53,NA,No,,,NA,,,,,,No,,,,,Living,382,NA,,NA,NA,No,No,,With tumor,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,382,0,NA,NA,72,High or alive at last follow-up,>70
05CO050,CO,05CO050-T,05CO050-N,TRUE,,87b0e853-43ea-4efb-8a22-dd221f_D2,5271982c-5de1-4d6e-b414-b1f3ef_D2,17cd2121-d347-431c-9cc7-fbab14_D7_1,,757d441d-5ff7-409b-8578-3ba7b3_D1_1,17cd2121-d347-431c-9cc7-fbab14_D6_1,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,54,3,,MX,,R0,Stage III,,,0,163,127,NA,No,,,NA,,,,,,No,,,,,Living,299,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,299,0,NA,NA,66,High or alive at last follow-up,60-70
09CO019,CO,09CO019-T,09CO019-N,TRUE,,c9f0f144-47f3-4d64-b29f-bcedfa_D2,79097be1-cd36-4a23-99d1-3d744f_D2,b913f361-c5c2-4e49-91ca-719bd8_D7_1,,10c76663-ccb6-4acf-be38-a3264a_D1_1,b913f361-c5c2-4e49-91ca-719bd8_D6_1,,FALSE,87,Male,Black or African American,Not Hispanic or Latino,African,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,17,0,,MX,,R0,Stage I,,,Not Reported/ Unknown,185,92.3,NA,No,,,NA,,,,,,No,,,,,Living,207,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Tumor free,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,207,0,NA,NA,87,High or alive at last follow-up,>70
11CO032,CO,11CO032-T,11CO032-N,TRUE,,1136008b-97ce-49b0-bf24-abbea6_D2,01d1ffca-4235-4dfe-bf62-56f71d_D3,01d1ffca-4235-4dfe-bf62-56f71d_D7_1,,7a8f4f4f-c503-46f3-8239-e717ba_D1_1,01d1ffca-4235-4dfe-bf62-56f71d_D6_1,,FALSE,57,Male,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,2,2,,M0,,R0,Stage III,,,Not Reported/ Unknown,165,57,NA,No,,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,57,High or alive at last follow-up,50-60
11CO043,CO,11CO043-T,11CO043-N,TRUE,,6d9f8b06-f28c-4e9b-823b-33ebb7_D2,591fb460-703a-437d-8d9a-ff2a35_D3,591fb460-703a-437d-8d9a-ff2a35_D7_1,,4eb92587-cfca-47b3-8cc9-0d4a64_D1_1,591fb460-703a-437d-8d9a-ff2a35_D6,,FALSE,67,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,165,67,NA,No,,,NA,,,,,,No,,,,,Living,375,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,375,0,NA,NA,67,High or alive at last follow-up,60-70
05CO011,CO,05CO011-T,05CO011-N,TRUE,,02cde0c0-6840-495b-9b11-007d82_D2,c1b66358-d103-493c-b8ec-92c43b_D2,8495cc54-eb88-40ab-b03f-363edf_D7,,36897a83-b98f-45af-955e-a75e47_D1,8495cc54-eb88-40ab-b03f-363edf_D6,,FALSE,39,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,41,0,,MX,,R0,Stage II,,,0,175,100,NA,No,,,NA,,,,,,No,,,,,Living,387,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,387,0,NA,NA,39,High or alive at last follow-up,<50
11CO021,CO,11CO021-T,11CO021-N,TRUE,,65867ab1-5eab-44a8-b2bb-d27263_D2,642fc6c3-8d4a-4e3d-ad0a-cc088a_D2,cf795cd2-317b-4897-a35e-390001_D7_1,,fa74656d-803c-4984-bbcd-8f3179_D1_1,cf795cd2-317b-4897-a35e-390001_D6_1,,FALSE,74,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N2a,5,5,,M1,,R0,Stage IV,,,Not Reported/ Unknown,168,75,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,95,,NA,NA,No,No,,With tumor,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,95,1,NA,NA,74,Low,>70
11CO018,CO,11CO018-T,11CO018-N,TRUE,,059a7065-3a5f-4eea-97e5-85ab01_D2,3d797911-d476-436f-9cce-33e20c_D8,3d797911-d476-436f-9cce-33e20c_D7_1,,7b852609-7cc7-4950-b18a-423b86_D1_1,3d797911-d476-436f-9cce-33e20c_D6,,FALSE,74,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,170,89,NA,No,,,NA,,,,,,No,,,,,Living,371,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,371,0,NA,NA,74,High or alive at last follow-up,>70
01CO014,CO,01CO014-T,01CO014-N,TRUE,,4c9dcc8c-ccdc-4336-8e23-107feb_D2,c9730cb4-b52c-4ca8-9652-4509d0_D2,be2d5946-3452-4003-880a-e0372e_D7_1,,323ea2fc-46f2-4d43-9b5d-ca5164_D1_1,be2d5946-3452-4003-880a-e0372e_D6_1,,FALSE,77,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N2a,19,5,,M0,,R0,Stage III,,,0,158,75.7,NA,No,,,NA,,,,,,No,,,,,Living,371,NA,,NA,NA,No,Yes,,With tumor,,,Yes,NA,Both Locoregional and Distant Metastasis,Omentum,,,Not Performed,,,No,No,,NA,NA,NA,NA,1,371,0,NA,NA,77,High or alive at last follow-up,>70
11CO077,CO,11CO077-T,11CO077-N,TRUE,,211cbcef-cb1f-4c80-a1c8-a76d3c_D2,5557e478-3e6f-475b-8acc-1b4159_D8,5557e478-3e6f-475b-8acc-1b4159_D7_1,,dee0705e-34e8-467b-a5f6-b3678c_D1_1,5557e478-3e6f-475b-8acc-1b4159_D6,,FALSE,67,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,180,80,NA,No,,,NA,,,,,,No,,,,,Living,383,NA,,NA,NA,No,Yes,,With tumor,,,Yes,NA,Distant Metastasis,Lung,,,No,,,Not Reported/ Unknown,Yes,,NA,NA,NA,NA,1,383,0,NA,NA,67,High or alive at last follow-up,60-70
22CO004,CO,22CO004-T,22CO004-N,TRUE,,9a48cf57-e1f0-4ea1-9804-d563f2_D2,a2f03d85-5f1a-4b3e-9dbf-74e67e_D3,a2f03d85-5f1a-4b3e-9dbf-74e67e_D7_1,,263fea68-40db-4402-9b99-c93b0c_D1_1,a2f03d85-5f1a-4b3e-9dbf-74e67e_D6_1,,FALSE,51,Male,White,Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,13,0,,M0,,R0,Stage II,,,0,178,86,NA,No,,,NA,,,,,,No,,,,,Living,346,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,346,0,NA,NA,51,High or alive at last follow-up,50-60
09CO014,CO,09CO014-T,09CO014-N,TRUE,,6e0d04fc-e6a8-41ed-b6f3-45537d_D2,8b9e4266-7754-4f2c-ac9e-329905_D2,1ea1d7ee-e382-4a68-8e7c-74e833_D7_1,,d97af421-cedf-4cc6-b1e5-3b1ad2_D1_1,1ea1d7ee-e382-4a68-8e7c-74e833_D6_1,,FALSE,66,Male,White,Not Hispanic or Latino,African,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,22,0,,MX,,RX,Stage II,,,Not Reported/ Unknown,185,125.6,NA,No,,,NA,,,,,,No,,,,,Living,323,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,323,0,NA,NA,66,High or alive at last follow-up,60-70
09CO006,CO,09CO006-T,09CO006-N,TRUE,,a27cf22d-836e-49a7-802f-47c1db_D2,c2c53076-b5db-4b7d-983c-a35740_D3,c2c53076-b5db-4b7d-983c-a35740_D7,,bcf6d821-c2f1-4d84-81e0-f41b45_D1,c2c53076-b5db-4b7d-983c-a35740_D6,,FALSE,86,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Reported/ Unknown,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,14,Not Reported/ Unknown,,MX,,RX,Stage I,,,0,180,74.5,NA,No,,,NA,,,,,,No,,,,,Living,39,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Unknown tumor status,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,39,0,NA,NA,86,High or alive at last follow-up,>70
16CO011,CO,16CO011-T,16CO011-N,TRUE,,c307b7b0-534a-45fa-a420-35f773_D2,a90eb718-6a8f-4cbf-89c1-f9e9bd_D2,7782134d-02db-44ee-adfa-fc1372_D7_1,,894e68d6-bf00-47b5-913c-f1c50f_D1_1,7782134d-02db-44ee-adfa-fc1372_D6,,FALSE,59,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1,4,2,,M0,,R0,Stage III,,,Not Performed,168,72,NA,No,,,NA,,,,,,No,,,,,Living,420,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,420,0,NA,NA,59,High or alive at last follow-up,50-60
27CO004,CO,27CO004-T,27CO004-N,TRUE,,71b2c1cc-0a31-4ca8-8beb-251e17_D2,d0511ea6-43c3-4c61-b08e-cf49b7_D3,d0511ea6-43c3-4c61-b08e-cf49b7_D7_1,,445994d9-9fa5-478c-91b7-abc726_D1_1,d0511ea6-43c3-4c61-b08e-cf49b7_D6_1,,FALSE,50,Female,White,Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N2a,24,5,,MX,,R0,Stage III,,,5,147,122.72,NA,No,,,NA,,,,,,No,,,,,Living,435,NA,,NA,NA,Not Applicable,Not Applicable,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,435,0,NA,NA,50,High or alive at last follow-up,<50
09CO015,CO,09CO015-T,09CO015-N,TRUE,,7fd2eea8-bf99-4f97-8b9e-fb703f_D2,1ab06c24-ffc0-4323-a0cc-e9f5c5_D2,d068de5f-8394-46bc-b03a-c6dc9c_D7_1,,2056d495-4d6d-4d84-a29a-80373d_D1_1,d068de5f-8394-46bc-b03a-c6dc9c_D6_1,,FALSE,68,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,32,2,,MX,,R0,Stage III,,,Not Reported/ Unknown,165,94.9,NA,No,,,NA,,,,,,No,,,,,Living,362,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,362,0,NA,NA,68,High or alive at last follow-up,60-70
11CO070,CO,11CO070-T,11CO070-N,TRUE,,7fd386f0-e7f6-4ee1-9cd7-b3318a_D2,c8694e31-2c8f-4eb6-a7ef-a137d9_D3,c8694e31-2c8f-4eb6-a7ef-a137d9_D7_1,,e465b51d-3c58-4d02-8552-7f5cd3_D1_1,c8694e31-2c8f-4eb6-a7ef-a137d9_D6_1,,FALSE,35,Male,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,5,3,,M0,,R0,Stage III,,,Not Reported/ Unknown,163,61,NA,No,,,NA,,,,,,No,,,,,Living,372,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,372,0,NA,NA,35,High or alive at last follow-up,<50
09CO018,CO,09CO018-T,09CO018-N,TRUE,,515040a4-bbfb-4a15-9e53-e7b6e6_D2,372c900a-fced-4eef-9dc4-7282ec_D2,743c74e4-cd76-4f38-8cb4-3c9107_D7_1,,74c4f1df-e3a5-423f-983d-3a0f94_D1_1,743c74e4-cd76-4f38-8cb4-3c9107_D6_1,,FALSE,52,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N1a,25,1,,MX,,R0,Stage III,,,Not Reported/ Unknown,168,82.2,NA,No,,,NA,,,,,,No,,,,,Living,273,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,273,0,NA,NA,52,High or alive at last follow-up,50-60
01CO001,CO,,01CO001-N,TRUE,,5a3aa99d-ca10-45f6-939f-12392a_D2,,760f15d2-444c-4deb-b133-62f3ca_D7,,32a96c14-8234-45e7-b15b-085a13_D1,760f15d2-444c-4deb-b133-62f3ca_D6,,FALSE,60,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N2b,29,23,,M0,,R0,Stage III,,,0,180,108.9,NA,No,,,NA,,,,,,No,,,,,Living,390,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,390,0,NA,NA,60,High or alive at last follow-up,50-60
14CO002,CO,,14CO002-N,TRUE,,903d5fe0-970a-47be-a97f-3cc914_D2,,5a85e6e7-35ab-4ca9-ab62-707e77_D7_1,,f089ce8f-3dd1-4cd5-8183-a9a0c4_D1_1,5a85e6e7-35ab-4ca9-ab62-707e77_D6_1,,FALSE,62,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,22,0,,MX,,RX,Stage II,,,0,174,91.8,NA,No,,,NA,,,,,,No,,,,,Living,12,NA,,NA,NA,No,No,,Tumor free,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,12,0,NA,NA,62,High or alive at last follow-up,60-70
11CO054,CO,11CO054-T,11CO054-N,TRUE,,b871c0c1-a97b-4ac1-887c-0317b6_D2,9bf309bc-0fb6-4060-aba2-888eb3_D2,f6a7f764-2495-4a1d-89a2-e12f51_D7_1,,7de55254-1dfe-43e0-8ee9-6e26e8_D1_1,f6a7f764-2495-4a1d-89a2-e12f51_D6_1,,FALSE,65,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,160,70,NA,No,,,NA,,,,,,No,,,,,Living,404,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,404,0,NA,NA,65,High or alive at last follow-up,60-70
09CO011,CO,09CO011-T,09CO011-N,TRUE,,46dfc1e4-0110-4d9f-888e-6a29ab_D2,1425a1a1-c835-47a2-a9b9-4db5d0_D8,1425a1a1-c835-47a2-a9b9-4db5d0_D7_1,,42f03c67-93e0-4c61-adeb-a0c82c_D1_1,1425a1a1-c835-47a2-a9b9-4db5d0_D6,,FALSE,75,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,14,0,,MX,,R0,Stage I,,,0,168,80.6,NA,No,,,NA,,,,,,No,,,,,Living,243,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Tumor free,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,243,0,NA,NA,75,High or alive at last follow-up,>70
16CO006,CO,16CO006-T,16CO006-N,TRUE,,62627b73-1763-48bc-8eea-e5bd76_D2,4bb08fad-fa5e-471e-978b-6b09ab_D2,97423edb-6f19-4b41-a7cb-af1635_D7_1,,c90a8f99-71b8-41bf-b60d-9be49c_D1_1,97423edb-6f19-4b41-a7cb-af1635_D6_1,,FALSE,64,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,7,0,,M1,,R2,Stage IV,,,Not Performed,172,80,NA,No,,,NA,,,,,,No,,,,,Living,177,NA,,NA,NA,No,Yes,,With tumor,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,177,0,NA,NA,64,High or alive at last follow-up,60-70
20CO004,CO,20CO004-T,20CO004-N,TRUE,,233ec093-9a30-4ef4-a12c-91757e_D2,e196a0b4-2a05-43de-bb30-ceb761_D2,f0bb6ff4-7cb8-427f-84bf-7f51d7_D7_1,,21d715d5-1958-42d0-b14a-efb87f_D1_1,f0bb6ff4-7cb8-427f-84bf-7f51d7_D6_1,,FALSE,55,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N2b,42,7,,MX,,R0,Stage III,,,Not Performed,173,200.5,NA,No,,,NA,,,,,,No,,,,,Living,347,NA,,NA,NA,No,Yes,,With tumor,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,347,0,NA,NA,55,High or alive at last follow-up,50-60
05CO003,CO,05CO003-T,05CO003-N,TRUE,,8fab37a4-cdf9-4ce8-9081-7b9148_D2,7cc7f69f-99f5-4b23-a9e0-ba0dc8_D8,7cc7f69f-99f5-4b23-a9e0-ba0dc8_D7,,4ecabbd2-ce60-46d1-a451-b8d106_D1,7cc7f69f-99f5-4b23-a9e0-ba0dc8_D6,,FALSE,,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,33,0,,MX,,R0,Stage II,,,0,180,84,NA,No,,,NA,,,,,,No,,,,,Living,321,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,321,0,NA,NA,NA,High or alive at last follow-up,
05CO032,CO,05CO032-T,05CO032-N,TRUE,,a313f6ef-5994-4d49-9e66-c26911_D2,695b0b00-a86b-43c0-a6c8-50a840_D3,695b0b00-a86b-43c0-a6c8-50a840_D7,,ccdcd5e5-685c-4cc7-b357-35a272_D1,695b0b00-a86b-43c0-a6c8-50a840_D6,,FALSE,79,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,16,1,,MX,,R0,Stage III,,,0,193,110,NA,No,,,NA,,,,,,No,,,,,Living,338,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,338,0,NA,NA,79,High or alive at last follow-up,>70
11CO052,CO,11CO052-T,11CO052-N,TRUE,,5cf5e61d-21ff-4678-9126-14e9bb_D2,0630ecb0-b664-4e75-bb3c-fb62ee_D3,0630ecb0-b664-4e75-bb3c-fb62ee_D7_1,,965f3b09-d548-48b9-8954-2fa73f_D1_1,0630ecb0-b664-4e75-bb3c-fb62ee_D6_1,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N2a,5,4,,M0,,R0,Stage III,,,Not Reported/ Unknown,156,80,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,223,,NA,NA,No,No,,With tumor,,,Yes,NA,Distant Metastasis,Liver,,,No,,,No,Yes,,NA,NA,NA,NA,1,223,1,NA,NA,66,Low,60-70
05CO020,CO,05CO020-T,05CO020-N,TRUE,,da95f6f8-be46-4ed8-a493-2c99f0_D2,803736b3-9ca9-4f9f-bdfe-8783e3_D3,803736b3-9ca9-4f9f-bdfe-8783e3_D7,,0a573420-cece-4cb1-ba68-00ede0_D1,803736b3-9ca9-4f9f-bdfe-8783e3_D6,,FALSE,93,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,12,0,,MX,,R0,Stage II,,,0,157,74.6,NA,No,,,NA,,,,,,No,,,,,Living,371,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,371,0,NA,NA,93,High or alive at last follow-up,>70
05CO049,CO,05CO049-T,05CO049-N,TRUE,,54565eae-05c5-4dae-bde9-ae4874_D2,d7608884-a0d6-4e9e-aac7-6cd813_D3,d7608884-a0d6-4e9e-aac7-6cd813_D7_1,,68f33ff4-7bd8-4464-b00b-a3106b_D1_1,d7608884-a0d6-4e9e-aac7-6cd813_D6_1,,FALSE,87,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,31,0,,MX,,R0,Stage II,,,0,168,80,NA,No,,,NA,,,,,,No,,,,,Living,328,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,328,0,NA,NA,87,High or alive at last follow-up,>70
05CO037,CO,05CO037-T,05CO037-N,TRUE,,067db520-1b1f-4569-9414-e37a6e_D2,e2e83b72-b14b-4b06-9461-1115d6_D2,5a007558-764c-463b-a788-fdbccb_D7_1,,5fd542b5-33a6-4657-943b-2749e0_D1_1,5a007558-764c-463b-a788-fdbccb_D6,,FALSE,50,Male,American Indian or Alaska Native,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,15,0,,MX,,R0,Stage II,,,0,160,83.4,NA,No,,,NA,,,,,,No,,,,,Living,340,NA,,NA,NA,Yes,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,340,0,NA,NA,50,High or alive at last follow-up,<50
11CO031,CO,11CO031-T,11CO031-N,TRUE,,359f5c81-2575-497e-8630-e4866f_D2,c6ae57a7-65a0-438e-bae2-97b1c8_D3,c6ae57a7-65a0-438e-bae2-97b1c8_D7_1,,5d22fc4e-2cfa-4dab-a46b-dd44b9_D1_1,c6ae57a7-65a0-438e-bae2-97b1c8_D6,,FALSE,53,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,9,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,157,55,NA,No,,,NA,,,,,,No,,,,,Living,386,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,386,0,NA,NA,53,High or alive at last follow-up,50-60
05CO015,CO,05CO015-T,05CO015-N,TRUE,,6797a69d-2f74-44b9-8147-cd4fac_D2,0aef1fe8-ca61-4113-81d0-d82ee7_D2,416bb805-e4cd-4ca6-8fdd-1eec2d_D7,,aa1c4fc6-9d37-4816-bf95-3a19dc_D1,416bb805-e4cd-4ca6-8fdd-1eec2d_D6,,FALSE,73,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,33,0,,MX,,R0,Stage II,,,0,170,66,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,130,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,130,1,NA,NA,73,Low,>70
05CO048,CO,05CO048-T,05CO048-N,TRUE,,64ed43a2-f083-43cb-9d0d-118495_D2,92f7419c-c57a-4b50-bdc9-4d09ca_D2,4976cbf9-cad4-48ce-b234-622c70_D7_1,,4f120ff2-622f-4dfd-876e-46e788_D1_1,4976cbf9-cad4-48ce-b234-622c70_D6,,FALSE,78,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4b,N2a,24,6,,MX,,R0,Stage III,,,0,152,49.4,NA,No,,,NA,,,,,,No,,,,,Living,334,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,334,0,NA,NA,78,High or alive at last follow-up,>70
05CO026,CO,05CO026-T,05CO026-N,TRUE,,8980bb9d-65c1-41cb-9f90-dddd5f_D2,41ee934e-f7a3-4ef5-8a83-e2ac56_D2,b2615b47-5ac2-4775-9205-50990d_D7_1,,a9f7cc96-dfaa-4b22-99a7-037ead_D1_1,b2615b47-5ac2-4775-9205-50990d_D6_1,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,75,1,,MX,,R0,Stage III,,,0,160,58.7,NA,No,,,NA,,,,,,No,,,,,Living,318,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,318,0,NA,NA,70,High or alive at last follow-up,60-70
11CO007,CO,11CO007-T,11CO007-N,TRUE,,7478980a-60fb-4f5e-aa1c-2d7941_D2,799893aa-d523-4a08-9ea7-611cca_D3,799893aa-d523-4a08-9ea7-611cca_D7_1,,784ff553-c9a7-4d30-b747-ffcbdf_D1_1,799893aa-d523-4a08-9ea7-611cca_D6_1,,FALSE,64,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,12,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,152,45,NA,No,,,NA,,,,,,No,,,,,Living,378,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,378,0,NA,NA,64,High or alive at last follow-up,60-70
11CO048,CO,11CO048-T,11CO048-N,TRUE,,cbd0e774-c741-4753-9c9e-391a7d_D2,cfb4831f-e9ee-4e11-80fb-958f6f_D2,43e0432b-343d-4e12-817f-21281c_D7_1,,474590db-eaf1-4d70-a4f7-81a026_D1_1,43e0432b-343d-4e12-817f-21281c_D6_1,,FALSE,64,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,167,72,NA,No,,,NA,,,,,,No,,,,,Living,383,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,383,0,NA,NA,64,High or alive at last follow-up,60-70
11CO045,CO,11CO045-T,11CO045-N,TRUE,,a84149b1-8453-45f0-8400-d7b12f_D2,f4bccfe4-98d0-466b-a6d7-44341b_D3,f4bccfe4-98d0-466b-a6d7-44341b_D7_1,,6e84e841-28fb-4443-8876-23c6bf_D1_1,f4bccfe4-98d0-466b-a6d7-44341b_D6_1,,FALSE,71,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,3,3,,M0,,R0,Stage III,,,Not Reported/ Unknown,155,59,NA,No,,,NA,,,,,,No,,,,,Living,385,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,385,0,NA,NA,71,High or alive at last follow-up,>70
14CO003,CO,14CO003-T,,TRUE,,,ea6df59d-5240-4927-b19d-d44590_D2,fd4edc52-09ef-4b01-be7c-f23f05_D7,,79cabe71-f083-48ec-9b50-0c97a3_D1_1,fd4edc52-09ef-4b01-be7c-f23f05_D6_1,,FALSE,74,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N2b,27,2,,M0,,R0,Stage III,,,0,166,84,NA,No,,,NA,,,,,,No,,,,,Living,504,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,504,0,NA,NA,74,High or alive at last follow-up,>70
21CO006,CO,21CO006-T,21CO006-N,TRUE,,5e886f1c-8165-4232-9591-d80799_D2,5f823547-ee16-45b7-a6a0-ef25d6_D3,5f823547-ee16-45b7-a6a0-ef25d6_D7_1,,737c4705-afed-4c22-b8ef-91fa00_D1_1,5f823547-ee16-45b7-a6a0-ef25d6_D6_1,,FALSE,76,Male,White,Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,18,0,,M0,,RX,Stage I,,,0,165,72.6,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Not Reported/ Unknown,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,76,High or alive at last follow-up,>70
11CO030,CO,11CO030-T,11CO030-N,TRUE,,bed27f66-ef3b-4868-b4ad-205018_D2,4cdeecb5-19fb-493c-91f5-eb0efc_D3,4cdeecb5-19fb-493c-91f5-eb0efc_D7_1,,7dc8c605-b0a0-4491-a2f2-ef457c_D1_1,4cdeecb5-19fb-493c-91f5-eb0efc_D6,,FALSE,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,4,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,164,67,NA,No,,,NA,,,,,,No,,,,,Living,369,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,369,0,NA,NA,54,High or alive at last follow-up,50-60
11CO027,CO,11CO027-T,11CO027-N,TRUE,,04ded2cd-3b57-4aec-9c11-48f58e_D2,5da00abd-5fa7-4deb-95f1-7982e0_D3,5da00abd-5fa7-4deb-95f1-7982e0_D7_1,,7afb9ddb-f1c1-40ac-9873-a34cc9_D1_1,5da00abd-5fa7-4deb-95f1-7982e0_D6_1,,FALSE,55,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,6,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,153,53,NA,No,,,NA,,,,,,No,,,,,Living,378,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,378,0,NA,NA,55,High or alive at last follow-up,50-60
11CO061,CO,11CO061-T,11CO061-N,TRUE,,47d2a435-b203-4438-ae72-53c424_D2,8c73f3a5-fea8-4942-90c0-966f66_D3,8c73f3a5-fea8-4942-90c0-966f66_D7_1,,127d1942-2f41-4487-9c09-702e20_D1_1,8c73f3a5-fea8-4942-90c0-966f66_D6_1,,FALSE,47,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,12,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,150,56,NA,No,,,NA,,,,,,No,,,,,Living,388,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,388,0,NA,NA,47,High or alive at last follow-up,<50
11CO062,CO,11CO062-T,11CO062-N,TRUE,,3765c09a-fff7-4b37-bf2b-452b23_D2,e8faa3a7-9fc7-428e-9334-a0afd0_D3,e8faa3a7-9fc7-428e-9334-a0afd0_D7_1,,ee8227b3-320c-49ce-9c94-5b0252_D1_1,e8faa3a7-9fc7-428e-9334-a0afd0_D6,,FALSE,74,Male,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,15,0,,M1,,R0,Stage IV,,,Not Reported/ Unknown,170,53,NA,No,,,NA,,,,,,No,,,,,Living,379,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,379,0,NA,NA,74,High or alive at last follow-up,>70
01CO013,CO,01CO013-T,01CO013-N,TRUE,,1fbb1add-4660-4ec1-b8c2-360f9f_D2,c7aeb685-31b3-445e-8177-a3e729_D3,c7aeb685-31b3-445e-8177-a3e729_D7,,de434a02-cb27-4b7e-8013-7c289a_D1_1,c7aeb685-31b3-445e-8177-a3e729_D6_1,,FALSE,57,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,16,0,,M0,,R0,Stage I,,,0,183,119.5,NA,No,,,NA,,,,,,No,,,,,Living,155,NA,,NA,NA,Not Performed,Not Performed,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,155,0,NA,NA,57,High or alive at last follow-up,50-60
11CO047,CO,11CO047-T,11CO047-N,TRUE,,23e938d0-92b8-4aea-90c1-4385df_D2,cd6a4013-2958-44b9-a4f1-45c9e4_D2,3ca0ab23-70ae-4083-bd7d-9f71d8_D7_1,,9eb5c82b-8609-47ac-bf8b-87782a_D1_1,3ca0ab23-70ae-4083-bd7d-9f71d8_D6_1,,FALSE,65,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,174,80,NA,No,,,NA,,,,,,No,,,,,Living,384,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,NA,NA,65,High or alive at last follow-up,60-70
11CO072,CO,11CO072-T,11CO072-N,TRUE,,16ac8458-5200-4302-9ad0-b311df_D2,0f238226-864c-4de0-8c61-01e729_D2,64b606d7-d40f-41ae-b220-a66324_D7_1,,0a628b4d-6b65-4105-812b-698836_D1_1,64b606d7-d40f-41ae-b220-a66324_D6_1,,FALSE,64,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,5,3,,M0,,R0,Stage III,,,Not Reported/ Unknown,156,73,NA,No,,,NA,,,,,,No,,,,,Living,133,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,133,0,NA,NA,64,High or alive at last follow-up,60-70
14CO005,CO,14CO005-T,14CO005-N,TRUE,,51590333-cfe5-4ce5-b8ff-58fa3c_D2,db3f5ad9-d14d-4126-a3e7-d80faa_D3,db3f5ad9-d14d-4126-a3e7-d80faa_D7_1,,2007507a-455c-4a72-bf89-9ee8c2_D1_1,db3f5ad9-d14d-4126-a3e7-d80faa_D6_1,,FALSE,75,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,19,0,,MX,,R0,Stage II,,,0,157,63.8,NA,No,,,NA,,,,,,No,,,,,Living,466,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,Not Applicable,,,,,,,,,NA,NA,NA,NA,0,466,0,NA,NA,75,High or alive at last follow-up,>70
01CO015,CO,01CO015-T,01CO015-N,TRUE,,b2978e90-cd2a-4665-b1bf-508a99_D2,6e20c8e9-ab75-4996-9296-445b00_D2,b873f54a-5a86-4dca-90f9-715820_D7_1,,3ac1f563-df29-48cd-ac47-86cd34_D1,b873f54a-5a86-4dca-90f9-715820_D6,,FALSE,88,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,,,,MX,,R0,Stage I,,,,193,77.11,NA,No,,,NA,,,,,,No,,,,,Living,374,NA,,NA,NA,Not Performed,Not Performed,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,374,0,NA,NA,88,High or alive at last follow-up,>70
11CO044,CO,11CO044-T,11CO044-N,TRUE,,2cc46aec-6142-4fb9-aca5-c442b9_D2,b605fafc-f7dd-44cc-9c86-da04e3_D2,7e3d5ae0-3dcc-4207-8dd2-59ab4b_D7_1,,1b7c35d8-3f4b-4d7c-acfe-049847_D1_1,7e3d5ae0-3dcc-4207-8dd2-59ab4b_D6_1,,FALSE,69,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,5,1,,M1,,R0,Stage IV,,,Not Reported/ Unknown,156,75,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,235,,NA,NA,No,No,,With tumor,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,235,1,NA,NA,69,Low,60-70
09CO022,CO,09CO022-T,09CO022-N,TRUE,,76498650-fdbf-4f5d-a19a-cce9a2_D2,f69deaeb-6b6f-4c61-8900-fd0f26_D3,f69deaeb-6b6f-4c61-8900-fd0f26_D7_1,,60805d52-8ca1-46d4-8101-0ad055_D1_1,f69deaeb-6b6f-4c61-8900-fd0f26_D6_1,,FALSE,71,Female,Black or African American,Not Hispanic or Latino,African,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N0,23,0,,MX,,R0,Stage II,,,Not Reported/ Unknown,170,101.2,NA,No,,,NA,,,,,,No,,,,,Living,315,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,315,0,NA,NA,71,High or alive at last follow-up,>70
01CO005,CO,01CO005-T,01CO005-N,TRUE,,0784c7b3-e6a4-42a8-9288-eb4ba0_D2,05a33362-82bb-48ac-8feb-ad2ea1_D2,59891744-2db3-4541-a86a-7f911f_D7,,26fc0181-e1ed-4853-9c67-535552_D1,59891744-2db3-4541-a86a-7f911f_D6,,FALSE,69,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,14,0,,M0,,R0,Stage II,,,0,162,84.1,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,531,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,531,1,NA,NA,69,High or alive at last follow-up,60-70
05CO028,CO,05CO028-T,05CO028-N,TRUE,,2666323d-522f-4f0a-823c-ff8866_D2,e0068ac5-f557-443a-bd4b-bdfcef_D3,e0068ac5-f557-443a-bd4b-bdfcef_D7,,71116934-bfd8-4ecc-a6c1-ed0bff_D1,e0068ac5-f557-443a-bd4b-bdfcef_D6,,FALSE,61,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,48,0,,M0,,R0,Stage I,,,0,157,67,NA,No,,,NA,,,,,,No,,,,,Living,326,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,326,0,NA,NA,61,High or alive at last follow-up,60-70
11CO079,CO,11CO079-T,11CO079-N,TRUE,,7bdfa5c9-d11f-4600-9c44-a87996_D2,f6afe41c-111d-4818-8485-fe95e0_D2,77c493b1-34ba-4efc-8def-987116_D7_1,,a266a66e-f9fb-4056-96a5-0f6c55_D1_1,77c493b1-34ba-4efc-8def-987116_D6_1,,FALSE,75,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1,3,1,,M0,,R0,Stage III,,,Not Reported/ Unknown,165,68,NA,No,,,NA,,,,,,No,,,,,Living,377,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,377,0,NA,NA,75,High or alive at last follow-up,>70
11CO057,CO,11CO057-T,11CO057-N,TRUE,,26acb513-3ffe-49ad-8581-9dfc97_D2,e515eb5c-8005-416a-9b42-59de9d_D8,e515eb5c-8005-416a-9b42-59de9d_D7_1,,428d09b8-eca7-432f-8af9-6b5697_D1_1,e515eb5c-8005-416a-9b42-59de9d_D6_1,,FALSE,73,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1,5,3,,M0,,R0,Stage III,,,Not Reported/ Unknown,178,90,NA,No,,,NA,,,,,,No,,,,,Living,399,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,399,0,NA,NA,73,High or alive at last follow-up,>70
05CO047,CO,05CO047-T,05CO047-N,TRUE,,1f79fed9-f0d4-4c45-acd2-ea1441_D2,f6173181-0993-4a5f-a4cd-5f30b1_D2,01bf1906-9bdc-41c3-89a0-b89ef6_D7_1,,f01e8a3e-9003-45dd-9f3e-5ad6a6_D1_1,506131e8-6460-472f-9e25-71f8b1_D6_1,,FALSE,56,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,19,0,,MX,,R0,Stage I,,,0,183,111,NA,No,,,NA,,,,,,No,,,,,Living,344,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,344,0,NA,NA,56,High or alive at last follow-up,50-60
11CO010,CO,11CO010-T,11CO010-N,TRUE,,206f3bd9-f62c-4663-8fdb-5b731b_D2,0f757044-9bc8-4ed4-90f3-e0a49a_D3,0f757044-9bc8-4ed4-90f3-e0a49a_D7_1,,6a61fdfd-3d84-425d-8c72-ce8302_D1_1,0f757044-9bc8-4ed4-90f3-e0a49a_D6_1,,FALSE,59,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,10,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,156,50,NA,No,,,NA,,,,,,No,,,,,Living,375,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,375,0,NA,NA,59,High or alive at last follow-up,50-60
01CO022,CO,01CO022-T,01CO022-N,TRUE,,0d5554d1-1653-4589-a44f-43113e_D2,b4e91300-405e-4239-b8da-5e1a42_D2,7a0266b4-b07c-41dc-8ddd-350e1b_D7_1,,863521b3-62a8-462c-9f1f-7fa758_D1_1,7a0266b4-b07c-41dc-8ddd-350e1b_D6,,FALSE,76,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,23,0,,MX,,R0,Stage I,,,0,162,95.88,NA,No,,,NA,,,,,,No,,,,,Living,376,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,376,0,NA,NA,76,High or alive at last follow-up,>70
11CO005,CO,11CO005-T,11CO005-N,TRUE,,176d1b96-8c6e-44fe-8a32-e15194_D2,bc574f73-89ba-44d7-992e-82622c_D3,bc574f73-89ba-44d7-992e-82622c_D7_1,,6dde8e08-dd45-40f2-91ef-224298_D1_1,bc574f73-89ba-44d7-992e-82622c_D6_1,,FALSE,66,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1,3,1,,M0,,R0,Stage III,,,999,160,50,NA,No,,,NA,,,,,,No,,,,,Living,384,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,NA,NA,66,High or alive at last follow-up,60-70
11CO039,CO,11CO039-T,11CO039-N,TRUE,,411d9597-c785-4de5-b449-29a80d_D2,d6584b4a-ca99-4a2a-8b4e-c8b22e_D2,e295a7d1-a0d0-4b0b-bdc2-729a0d_D7_1,,b400a501-7308-4808-8d50-40213d_D1_1,d6584b4a-ca99-4a2a-8b4e-c8b22e_D6_1,,FALSE,67,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,154,52,NA,No,,,NA,,,,,,No,,,,,Living,386,NA,,NA,NA,No,Not Reported/ Unknown,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,386,0,NA,NA,67,High or alive at last follow-up,60-70
06CO002,CO,06CO002-T,06CO002-N,TRUE,,82157a70-12f1-4913-b548-d98881_D2,4b263734-430f-41dc-a296-8691f0_D3,4b263734-430f-41dc-a296-8691f0_D7,,0cf1768a-8df5-4648-ba22-00f0fb_D1,4b263734-430f-41dc-a296-8691f0_D6,,FALSE,73,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N2a,18,4,,MX,,R0,Stage III,,,Not Performed,160,64,NA,No,,,NA,,,,,,No,,,,,Living,322,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,322,0,NA,NA,73,High or alive at last follow-up,>70
11CO060,CO,,11CO060-N,TRUE,,0c330883-ab58-4a5a-bff7-07d283_D2,,fe4b3b1c-9f7f-4109-8a76-ca1d6f_D7_1,,04373565-6aca-4d46-a6f3-abb811_D1_1,fe4b3b1c-9f7f-4109-8a76-ca1d6f_D6_1,,FALSE,71,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,160,65,NA,No,,,NA,,,,,,No,,,,,Living,398,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,398,0,NA,NA,71,High or alive at last follow-up,>70
09CO013,CO,09CO013-T,09CO013-N,TRUE,,63c1f7ac-b1ae-4c28-95aa-ce21e5_D2,dffcac99-9eac-4717-aeb6-f4a2e7_D8,dffcac99-9eac-4717-aeb6-f4a2e7_D7_1,,71972f70-36ac-4508-adc4-766715_D1_1,dffcac99-9eac-4717-aeb6-f4a2e7_D6,,FALSE,50,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,34,2,,M0,,R0,Stage III,,,0,178,130,NA,No,,,NA,,,,,,No,,,,,Living,183,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,,Unknown tumor status,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,183,0,NA,NA,50,High or alive at last follow-up,<50
16CO002,CO,16CO002-T,16CO002-N,TRUE,,6b0a3188-d8ca-4d50-a377-a8fe4c_D2,820a3f08-5bb1-44b3-a133-ee167e_D2,6f5853a3-1d47-4a54-94dc-970c1c_D7_1,,f96ed690-876c-4dc1-a919-025154_D1_1,6f5853a3-1d47-4a54-94dc-970c1c_D6_1,,FALSE,67,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1,6,1,,M0,,RX,Stage III,,,Not Performed,172,83,NA,No,,,NA,,,,,,No,,,,,Living,420,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,420,0,NA,NA,67,High or alive at last follow-up,60-70
11CO058,CO,11CO058-T,11CO058-N,TRUE,,019cd0c0-733d-4b25-90e3-d54ce0_D2,d3078fa8-0692-411f-8441-0c7c48_D8,d3078fa8-0692-411f-8441-0c7c48_D7_1,,b2642bf8-c902-49cd-a765-59c718_D1_1,d3078fa8-0692-411f-8441-0c7c48_D6_1,,FALSE,56,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,164,72,NA,No,,,NA,,,,,,No,,,,,Living,399,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,399,0,NA,NA,56,High or alive at last follow-up,50-60
05CO006,CO,05CO006-T,05CO006-N,TRUE,,df479b07-bbf6-472d-a580-c3fd0c_D2,37219a7c-6fe2-4684-a494-d0be08_D2,a8955d38-7a72-4f9d-9c70-5c0f08_D7,,0a182bf2-b58f-4152-b9b2-459e08_D1,a8955d38-7a72-4f9d-9c70-5c0f08_D6,,FALSE,83,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,23,3,,MX,,R0,Stage III,,,0,157,75,NA,No,,,NA,,,,,,No,,,,,Living,328,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,328,0,NA,NA,83,High or alive at last follow-up,>70
06CO001,CO,06CO001-T,06CO001-N,TRUE,,1bf00d93-240f-47e8-8055-f546b0_D2,87408d9e-4029-4e8f-b14c-8efc04_D3,87408d9e-4029-4e8f-b14c-8efc04_D7,,a5ceba47-6596-47ff-8fab-e835d3_D1,87408d9e-4029-4e8f-b14c-8efc04_D6,,FALSE,75,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,12,3,,MX,,R0,Stage III,,,Not Performed,175,73,NA,No,,,NA,,,,,,No,,,,,Living,84,NA,,NA,NA,No,Not Reported/ Unknown,,With tumor,,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,84,0,NA,NA,75,High or alive at last follow-up,>70
16CO003,CO,16CO003-T,16CO003-N,TRUE,,fc9b09af-23b8-4ffe-b6c6-41236d_D2,526c3664-5b9b-4a2b-a00e-a14623_D2,47b9deba-dea0-4e0c-8b0a-4864c3_D7_1,,b078ea81-4c88-4864-9de5-7c25a3_D1_1,47b9deba-dea0-4e0c-8b0a-4864c3_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,4,0,,M0,,R0,Stage II,,,Not Performed,169,59,NA,No,,,NA,,,,,,No,,,,,Living,376,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,376,0,NA,NA,63,High or alive at last follow-up,60-70
05CO004,CO,,,TRUE,,,,9fb0c084-16fd-4d54-ab60-d94303_D7,,ae22357c-a8a3-46d0-a1b1-657420_D1,9fb0c084-16fd-4d54-ab60-d94303_D6,,FALSE,40,Female,White,Hispanic or Latino,,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1b,39,3,,M0,,R0,Stage III,,,0,157,107,NA,No,,,NA,,,,,,No,,,,,Living,NA,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,0,NA,NA,40,High or alive at last follow-up,<50
05CO005,CO,,,TRUE,,,,"['a23ef085-a2a1-4ffc-9d1a-56c0f0_D7', '21880d70-69eb-4f09-bea9-8de3e6_D7_1']",,"['c8b34c3b-89de-4f3d-a1af-c06f5a_D1', 'c8b34c3b-89de-4f3d-a1af-c06f5a_D1']","['a23ef085-a2a1-4ffc-9d1a-56c0f0_D6', '21880d70-69eb-4f09-bea9-8de3e6_D6_1']",,FALSE,62,Male,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,14,0,,M0,,R0,Stage I,,,0,177,92,NA,No,,,NA,,,,,,No,,,,,Living,NA,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,0,NA,NA,62,High or alive at last follow-up,60-70
05CO014,CO,,,TRUE,,,,6968a80f-fd06-4669-b4bd-9a5cb5_D7,,acf5eda7-4858-4a52-8ebd-54326f_D1,6968a80f-fd06-4669-b4bd-9a5cb5_D6,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
05CO055,CO,,,TRUE,,,,ccaab7e8-e841-4397-80aa-370b58_D7_1,,16c0626f-d1a6-4e24-b371-552643_D1_1,ccaab7e8-e841-4397-80aa-370b58_D6_1,,FALSE,53,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T4a,N2b,37,8,,MX,,R0,Stage III,,,0,173,141,NA,No,,,NA,,,,,,No,,,,,Living,365,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,365,0,NA,NA,53,High or alive at last follow-up,50-60
11CO059,CO,,,TRUE,,,,d4afb9cf-2f90-44b9-bd60-d03069_D11,,4c4918cc-e239-4894-9deb-535e21_D1,d4afb9cf-2f90-44b9-bd60-d03069_D10,,FALSE,83,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N0,5,0,,M0,,R0,Stage II,,,Not Reported/ Unknown,150,59,NA,No,,,NA,,,,,,No,,,,,Living,398,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,398,0,NA,NA,83,High or alive at last follow-up,>70
16CO012,CO,,,TRUE,,,,6a9a1d66-d666-44df-a68e-ddc58d_D7_1,,dd8edec7-4c65-4a5a-b670-777661_D1_1,6a9a1d66-d666-44df-a68e-ddc58d_D6_1,,FALSE,74,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N0,5,0,,M0,,R0,Stage I,,,Not Performed,162,70,NA,No,,,NA,,,,,,No,,,,,Living,310,NA,,NA,NA,No,No,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,310,0,NA,NA,74,High or alive at last follow-up,>70
24CO005,CO,,,TRUE,,,,b75e68fd-cfa1-4e9e-b4c1-a57ad8_D7_1,,3888c00c-99c7-44da-9234-5959f8_D1_1,b75e68fd-cfa1-4e9e-b4c1-a57ad8_D6,,FALSE,41,Female,White,Not Hispanic or Latino,European,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T2,N1b,49,2,,MX,,RX,Stage III,,,0,165,94.3,NA,No,,,NA,,,,,,No,,,,,Living,NA,NA,,NA,NA,No,Yes,,Tumor free,,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,0,NA,NA,41,High or alive at last follow-up,<50
13CO001,CO,,,TRUE,,,,,,,,,,70,Male,Asian,Not Hispanic or Latino,,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,24,,,MX,,,Staging is not applicable or unknown,,,,167,49,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,70,,60-70
14CO001,CO,,,TRUE,,,,,,,,,,49,Female,Unknown,Hispanic or Latino,,,No,Colon,,,,NA,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",,,,T3,N1a,25,1,,M0,,R0,Stage III,,,,155,65,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,49,,<50
PT-NPJ7,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-P44H,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-Q2AG,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-QVJO,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-R55F,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-RN5K,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-RU72,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-UTHO,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-WVLH,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
PT-Y8DK,GBM,,,TRUE,,,,,,,,,TRUE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-03747,GBM,,,TRUE,withdrawn,,,CPT0217000010,,CPT0217980002,CPT0217000007,,FALSE,62,Male,White,Not Hispanic or Latino,,United States,No,Frontal Lobe,,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,180,91,27.89,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Acetominophen|Dexamethasone|Famotidine|Levetiracetam|Atorvastatin|Lisinopril,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,705,705,Main malignancy,NA,711,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,231,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,231,237,1,705,1,6,NA,62,High or alive at last follow-up,60-70
C3N-03183,GBM,C3N-03183-T,,TRUE,,,CPT0206670004,CPT0206670013,,CPT0206720002,CPT0206670007,,FALSE,53,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe and Basal ganglia and thalamus,Hemisphere and Temporal Lobe and Basal ganglia and thalamus,Left,,7,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,GFAP（+），Olig-2（+），ATRX（about 90%），P53（occasionally positive），Ki-67（about 50%），Syn（+），BRAFV600E（-），CD34（vessel positive），CK（occasionally positive），Vimentin（+）,"TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,175,80,26.12,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,315,315,Main malignancy,NA,321,Yes,Yes,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,315,1,6,NA,53,Low,50-60
C3N-01505,GBM,C3N-01505-T,,TRUE,,,CPT0089150003,CPT0089150006,,CPT0091300002,CPT0089150009,,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Right,,1.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH-1 negative ,,,175,80,25.99,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,acetaminphen|alprazolam|Vitamin D|dexamethasone|omeprazole|polyethylene glycol|simvastatin|tamsulosin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,192,192,Main malignancy,NA,192,Yes,Yes,No,With Tumor,Patient Deceased,,Yes,189,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,189,189,1,192,1,0,NA,74,Low,>70
C3N-03188,GBM,C3N-03188-T,,TRUE,,,CPT0207030003,CPT0207030013,,CPT0207080002,CPT0207030009,,FALSE,54,Male,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,Left Hemisphere and Right Hemisphere and Frontal Lobe,Bilateral,,8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP9(±), EGFR(+++), P53(-), Ki-67(about20%), ATRX(++-+++)","TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,175,88,28.73,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1022,1022,Main malignancy,NA,1028,Yes,Yes,No,With Tumor,Persistent Disease,Patient Deceased,Yes,452,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,452,458,1,1022,1,6,NA,54,High or alive at last follow-up,50-60
C3L-02984,GBM,C3L-02984-T,,TRUE,,,CPT0190240004,CPT0190240010,,CPT0191140002,CPT0190240007,,FALSE,34,Male,Asian,Not Hispanic or Latino,East_Asian,United States,No,Frontal Lobe,,Left,,3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"PDL1, no expression",,,173,98,32.69,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,,Yes,,,,,cyanocoblamin|levetiracetam|levocetirizine,Medical Record|Medical Record|Medical Record,No,Living,1469,NA,,1488,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1469,0,19,NA,34,High or alive at last follow-up,<50
C3L-02542,GBM,C3L-02542-T,,TRUE,,,CPT0161730003,CPT0161730009,,CPT0162540002,CPT0161730006,,FALSE,58,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Temporal Lobe,,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,CD34 Negative for ganglion cells,FISH negative for 1p36 deletion and Negative for 19q13 deletion,,160,67,26.21,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,Breast Cancer,Surgery,Unknown,Boswellia Serrata|Motrin|Probiotic|Turmeric|dexamethasone|ativan,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,154,180,Main malignancy,NA,180,No,No,Yes,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,180,1,0,NA,58,Low,50-60
C3L-01142,GBM,C3L-01142-T,,TRUE,,,CPT0218330004,CPT0218330010,,CPT0220250002,CPT0218330007,,FALSE,42,Female,Unknown,Unknown,European,Russia,No,Frontal Lobe,,Left,,3.3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,165,63,23.14,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,omeprazole|Levetiracetam|Lornoxicam|Dexamethasone|enalapril,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,0,NA,,8,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Not Applicable,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,8,NA,42,High or alive at last follow-up,<50
C3L-01834,GBM,C3L-01834-T,,TRUE,,,CPT0104220003,CPT0104220005,,CPT0105090002,['CPT0104220010'],,FALSE,68,Female,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Right,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,175,69,22.56,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Venlafaxine|Multi Vitamin|Vitamin B Complex|Vitamin D3|OsteoMatrix|Synthroid,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,482,497,Main malignancy,NA,497,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,449,Progression,,,,,,,,,,NA,NA,449,449,1,497,1,0,NA,68,High or alive at last follow-up,60-70
C3N-02256,GBM,C3N-02256-T,,TRUE,,,CPT0182580003,CPT0182580009,,CPT0182600002,CPT0182580006,,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Temporal Lobe,,Right,,2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,GFAP+,,,181,112,34,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,normodypine|losacor,Self-reported|Self-reported,No,Deceased,188,263,Main malignancy,NA,263,Yes,Yes,No,With Tumor,Unknown,,Yes,160,Recurrence,Site : left temporal,,,No,,,No,No,No,NA,NA,160,160,1,263,1,0,NA,65,Low,60-70
C3N-01814,GBM,C3N-01814-T,,TRUE,,,CPT0167860004,CPT0167860010,,CPT0167920004,CPT0167860007,,FALSE,48,Female,Unknown,Unknown,East_Asian,China,No,"Temporal, Parietal Lobe, and lateral  ventricle","Temporal parietal Lobe, and lateral  ventricle",Left,,7,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,"TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,153,52,22.21,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,383,NA,,386,NA,Unknown,Unknown,Unknown,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,383,0,3,NA,48,High or alive at last follow-up,<50
C3N-02770,GBM,C3N-02770-T,,TRUE,,,CPT0205670004,CPT0205670010,,CPT0205730002,CPT0205670007,,FALSE,70,Male,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,,Left,,5.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,MMP-9（+），EGFR（+++），P53（±），Ki-67（25%），ATRX（-）,"TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,170,75,25.95,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,10,No or minimal exposure to secondhand smoke,,,,,,,Insulin,Self Report,No,Deceased,779,779,Main malignancy,NA,785,Yes,Yes,No,With Tumor,Complete Remission,,Yes,550,New Primary Tumor,,,,,,,Yes,No,No,NA,NA,550,556,1,779,1,6,NA,70,High or alive at last follow-up,60-70
C3N-01364,GBM,C3N-01364-T,,TRUE,,,CPT0093450003,CPT0093450006,,CPT0093490002,CPT0093450009,,FALSE,34,Female,Unknown,Unknown,European,Poland,No,Temporal Lobe,,Left,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,158,58,23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,720,NA,,720,NA,No,No,No,Unknown Tumor Status,Persistent Disease,,Yes,480,Recurrence,Site : Brain ,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Yes,Unknown,Unknown,499,NA,480,480,1,720,0,0,NA,34,High or alive at last follow-up,<50
C3L-00365,GBM,C3L-00365-T,,TRUE,,,CPT0002410011,['CPT0002410013'],,CPT0004390002,CPT0002410008,,FALSE,59,Female,White,Not Hispanic or Latino,European,United States,No,Parietal Lobe,,Left,,1.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,162,54,20.61,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,30,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,280,322,Main malignancy,NA,322,Yes,Yes,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,322,1,0,NA,59,Low,50-60
C3L-03266,GBM,C3L-03266-T,,TRUE,,,CPT0189460003,CPT0189460009,,CPT0190220002,CPT0189460006,,FALSE,61,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Parietal Lobe,,Right,,2.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"ATRX- wild type, IDH1 R132H- wild type; H3K27M- wild type",,,163,66,24.89,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,2.2,Yes,,Yes,,,,,Amlodipine|Dexamethasone|Levetiracetam|Vitamin D|Vitamin C|Omeprazole|Levothyroxine|Atenolol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,223,281,Main malignancy,NA,281,Yes,Yes,Unknown,Unknown Tumor Status,Persistent Disease,,Yes,28,Progression,,,,,,,,,,NA,NA,28,28,1,281,1,0,NA,61,Low,60-70
C3N-01798,GBM,C3N-01798-T,,TRUE,,,CPT0167750004,CPT0167750010,,CPT0167810002,CPT0167750007,,FALSE,44,Male,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,,Left,,5,Small cell  glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,"TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,170,70,24.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,590,590,Main malignancy,NA,591,Yes,Yes,No,With Tumor,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,590,1,1,NA,44,High or alive at last follow-up,<50
C3L-01146,GBM,C3L-01146-T,,TRUE,,,CPT0218690004,CPT0218690010,,CPT0220330002,CPT0218690007,,FALSE,59,Male,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Right,,6.4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,175,96,31.35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Omeprazole|Dexamethasone|Amlodipine|Bisoprolol|Aminolevulinic acid|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,508,509,Main malignancy,NA,518,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,336,Progression,,,,,,,,,,NA,NA,336,345,1,509,1,9,NA,59,High or alive at last follow-up,50-60
C3L-03748,GBM,C3L-03748-T,,TRUE,,,CPT0217060003,CPT0217060009,,CPT0218000002,CPT0217060006,,FALSE,64,Female,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Left,,6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,165,68,24.79,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,"Acetaminophen|Ascorbic acid, vitamin C|Potassium & Magnesium Aspartate",Medical Record|Medical Record|Medical Record,No,Deceased,397,401,Main malignancy,NA,406,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,162,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,162,167,1,401,1,5,NA,64,Low,60-70
C3N-02783,GBM,C3N-02783-T,,TRUE,,,CPT0205890003,CPT0205890006,,CPT0205950002,CPT0205890009,,FALSE,24,Female,Unknown,Unknown,East_Asian,China,No,"Parietal, Occipital and Temporal Lobe",Parietal Lobe and Occipital Lobe and Temporal Lobe,Left,,8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,"TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,153,43,18.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,977,NA,,986,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,977,0,9,NA,24,High or alive at last follow-up,<50
C3L-02708,GBM,C3L-02708-T,,TRUE,,,CPT0189570004,CPT0189570010,,CPT0190620002,CPT0189570007,,FALSE,43,Male,White,Not Hispanic or Latino,European,United States,No,Parietal Lobe,,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,188,166,46.97,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Acetaminophen|Bupropion XL|Docusate|Ergocalciferol|Escitalopram|Levetiracetam|Multivitamin capsule|Ondansetron|Oxycodone-acetaminophen|Polyethylene glycol|Propanolol|Sennosides|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,738,738,Main malignancy,NA,738,Yes,Yes,Yes,With Tumor,Unknown,,Yes,525,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,525,525,1,738,1,0,NA,43,High or alive at last follow-up,<50
C3N-02782,GBM,C3N-02782-T,,TRUE,,,CPT0205780003,CPT0205780006,,CPT0205800002,CPT0205780009,,FALSE,47,Female,Unknown,Unknown,East_Asian,China,No,Parietal Lobe,,Right,,6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,"TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,164,56,20.82,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,985,NA,,988,NA,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,606,Recurrence,,,,,,,No,Yes,No,NA,NA,606,609,1,985,0,3,NA,47,High or alive at last follow-up,<50
C3N-02186,GBM,C3N-02186-T,,TRUE,,,CPT0168720003,CPT0168720009,,CPT0168760004,CPT0168720006,,FALSE,53,Male,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,,Right,,6.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown," Ki-67(70%), P53(15%), ATRX(+)","TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,175,67,21.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,264,NA,,265,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,99,Recurrence,Site : Brain ,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,99,100,1,264,0,1,NA,53,High or alive at last follow-up,50-60
C3N-01367,GBM,C3N-01367-T,,TRUE,,,CPT0093550003,CPT0093550006,,CPT0093570002,CPT0093550012,,FALSE,74,Male,Unknown,Unknown,European,Poland,No,Temporal Lobe,,Left,,3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,185,78,22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,74,,>70
C3L-01048,GBM,C3L-01048-T,,TRUE,,,CPT0217190003,CPT0217190009,,CPT0220100002,CPT0217190006,,FALSE,60,Male,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Left,,4.4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,168,69,24.45,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Dexamethasone  |Omeprazole                    |Cefazolin,Medical Record|Medical Record|Medical Record,No,Living,806,NA,,814,NA,Yes,Yes,No,With Tumor,Persistent Disease,Persistent Disease,Yes,216,Progression,,,,,,,,,,NA,NA,216,224,1,806,0,8,NA,60,High or alive at last follow-up,50-60
C3L-01149,GBM,C3L-01149-T,,TRUE,,,CPT0218770003,CPT0218770009,,CPT0220350002,CPT0218770006,,FALSE,48,Male,Unknown,Unknown,European,Russia,No,Parietal and Temporal Lobe,Parietal and temporal lobe,Left,,6.3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,173,91,30.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Omeprazole|Dexamethasone|Aminolevulinic acid,Medical Record|Medical Record|Medical Record,No,Living,666,NA,,677,NA,Yes,Yes,No,Unknown Tumor Status,Persistent Disease,Persistent Disease,Yes,584,Progression,,,,,,,Yes,Yes,No,NA,NA,584,595,1,666,0,11,NA,48,High or alive at last follow-up,<50
C3L-03260,GBM,C3L-03260-T,,TRUE,,,CPT0189250003,CPT0189250009,,CPT0190200002,CPT0189250006,,FALSE,75,Female,White,Not Hispanic or Latino,European,United States,No,Parietal Lobe,,Right,,1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"IDH R132H negative, wild type;  ATRX - positive, wild type; H3K27m negative, wild type",,,168,86,30.66,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Januvia|Pepcid|Lorazepam|Acetylcysteine|Humalog Solution|Lantus Solution|Dexamethasone|Lisinopril|Metformin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,42,43,Main malignancy,NA,43,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,43,1,0,NA,75,Low,>70
C3N-01192,GBM,C3N-01192-T,,TRUE,,,CPT0087950003,CPT0087950006,,CPT0087980002,CPT0087950009,,FALSE,60,Female,Unknown,Unknown,European,Poland,No,Frontal Lobe,,Left,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,GFAP+ CD68-/+,,,165,85,31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1209,1209,Unknown,NA,1215,Yes,Yes,No,Unknown Tumor Status,Complete Remission,Patient Deceased,Yes,498,Progression,,,,,,,,,,NA,NA,498,504,1,1209,1,6,NA,60,High or alive at last follow-up,50-60
C3L-03407,GBM,C3L-03407-T,,TRUE,,,CPT0190360004,CPT0190360010,,CPT0191160002,CPT0190360007,,FALSE,57,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,Frontal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,155,75,31.17,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,NA,Yes,,Yes,Unknown,,,,aspirin|atorvastatin|enalapril maleate|metformin|prednisone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,176,238,Main malignancy,NA,243,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,209,Progression,,,,,,,,,,NA,NA,209,214,1,238,1,5,NA,57,Low,50-60
C3L-03387,GBM,C3L-03387-T,,TRUE,,,CPT0224330003,CPT0224330006,,CPT0226180002,CPT0224330009,,FALSE,70,Male,Unknown,Unknown,European,Russia,No,Parietal Lobe,,Right,,9,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"GFAP, Ki-67",,,171,76,25.99,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,403,403,Main malignancy,NA,403,Yes,Yes,Unknown,With Tumor,Complete Remission,,Yes,293,Progression,,,,,,,,,,NA,NA,293,293,1,403,1,0,NA,70,Low,60-70
C3L-02970,GBM,C3L-02970-T,,TRUE,,,CPT0217880003,CPT0217880013,,CPT0219880002,CPT0217880006,,FALSE,58,Male,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Right,,3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"IDH-1 negative for IDH-1 R132H mutation  p53 Positive in approx 95% of tumor nuclei , ATRX: retained in tumor nuclei, thus wildtype (non-mutated) ",,,173,94,31.47,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,30,Exposure to secondhand smoke history not available,,,,,,,Vitamin D |Coenzyme Q10|dexamethasone|Diltiazem|Lofibra |efudex 5% cream |Flonase|Levetiracetam |magnesium |mirlax|zanaflex|Keppra|Hyzaar|Toprol-XL|Mulivitamin men +50|Omega-3 acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,381,381,Main malignancy,NA,381,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,381,1,0,NA,58,Low,50-60
C3L-01043,GBM,C3L-01043-T,,TRUE,,,CPT0127420003,CPT0127420009,,CPT0128550002,CPT0127420006,,FALSE,59,Male,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 negative,,,170,70,24.22,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,61.5,Yes,Yes,,,,,,Dexamethasone|Omeprazole|Lornoxicam|Sterofundin|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1,79,Main malignancy,NA,76,No,No,No,With Tumor,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,79,1,-3,NA,59,Low,50-60
C3L-01156,GBM,C3L-01156-T,,TRUE,,,CPT0218960004,CPT0218960010,,CPT0220410002,CPT0218960006,,FALSE,57,Male,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Right,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,171,73,24.96,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Omeprazole|Dexamethasone|Lornoxicam| Enalapril|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,182,291,Main malignancy,NA,302,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,178,Progression,,,,,,,,,,NA,NA,178,189,1,291,1,11,NA,57,Low,50-60
C3N-02183,GBM,C3N-02183-T,,TRUE,,,CPT0168480003,CPT0168480009,,CPT0168540004,CPT0168480006,,FALSE,63,Female,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Right,,6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"GFAP(+), Olog-2(-), Ki-67(80%), P53(30%), IDH1(-), MGMT(±), ATRX(50%), EGFR(-), H3K27M(-)",,,157,50,20.28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Amlodipine|Nimodipine|Captopril,Self Report|Self Report|Self Report,No,Deceased,340,340,Main malignancy,NA,343,No,No,No,With Tumor,Persistent Disease,,Yes,248,Recurrence,,,,,,,Unknown,Unknown,Unknown,NA,NA,248,251,1,340,1,3,NA,63,Low,60-70
C3L-03681,GBM,C3L-03681-T,,TRUE,,,CPT0221180003,CPT0221180009,,CPT0220510002,CPT0221180005,,FALSE,62,Female,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"Positive for GFAP, Vimentin, PTEN, P53 with High MIB-1. Negative for AE1/AE3 and CAM5.2","PDGFRA amplification (not detected), 19q13 Deletion (not detected), MET amplification (not detected), MYCN amplification (not detected), positive PD-L1 expression in 60% of tumor (IHC)",,157,76,30.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,Vitamin B12|Calcium Supplement|Fish Oil,Medical Record|Medical Record|Medical Record,No,Deceased,7,7,Unknown,NA,12,No,No,No,Unknown Tumor Status,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,7,1,5,NA,62,Low,60-70
C3L-01154,GBM,C3L-01154-T,,TRUE,,,CPT0218830004,CPT0218830010,,CPT0220370002,CPT0218830007,,FALSE,51,Female,Unknown,Unknown,European,Russia,No,"Parietal, Occipital, Temporal Lobe","Parietal, Occipital, temporal lobe",Right,,3.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,165,74,27.18,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Omeprazole |Dexamethasone|Paracetamol |Ketoprofen|Ondansetron|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,496,496,Main malignancy,NA,505,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,230,Progression,,,,,,,,,,NA,NA,230,239,1,496,1,9,NA,51,High or alive at last follow-up,50-60
C3L-03728,GBM,C3L-03728-T,,TRUE,,,CPT0225760003,CPT0225760009,,CPT0226080002,CPT0225760006,,FALSE,80,Female,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"IDH1 R132H wild-type (negative); ATRX: Negative (mutant); Olig2: some positive, some negative; CD34: positive; H3K27M: negative; PHH3: 6 mitoses per 10 high power fields. ",,,152,64,27.56,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,127,127,Main malignancy,NA,127,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,127,1,0,NA,80,Low,>70
C3N-01818,GBM,C3N-01818-T,,TRUE,,,CPT0168270003,CPT0168270009,,CPT0168320002,CPT0168270006,,FALSE,60,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Left,,6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9(-), EGFR(+++), Ki-67(++), P53(+++), IDH1(-), MGMT(±), ATRX(-), IDH1(-)",,,170,65,22.49,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,80,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,221,270,Unknown,NA,271,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,270,1,1,NA,60,Low,50-60
C3L-00674,GBM,C3L-00674-T,,TRUE,,,CPT0064650003,CPT0064650006,,CPT0066670002,CPT0064650009,,FALSE,45,Male,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Right,,4.9,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH-1-Negative; ATRX-Positive; H3me3-Positive,,,193,102,27.44,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Decadron,Medical Record,No,Deceased,385,478,Main malignancy,NA,478,Yes,Yes,Unknown,Unknown Tumor Status,Persistent Disease,,Yes,194,Recurrence,Site : Head,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Unknown,279,NA,194,194,1,478,1,0,NA,45,High or alive at last follow-up,<50
C3N-03186,GBM,C3N-03186-T,,TRUE,,,CPT0206880003,CPT0206880006,,CPT0206940002,CPT0206880009,,FALSE,54,Female,Unknown,Unknown,East_Asian,China,No,Occipital and Temporal Lobe,Right Hemisphere and Occipital Lobe and Temporal Lobe,Right,,8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9（vessel positive）, EGFR（+++）, P53（-）, Ki-67（about 25%）, ATRX（about 60%","TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,158,54,21.63,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,646,646,Main malignancy,NA,651,Yes,Yes,No,With Tumor,Complete Remission,,Yes,459,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,459,464,1,646,1,5,NA,54,High or alive at last follow-up,50-60
C3N-02181,GBM,C3N-02181-T,,TRUE,,,CPT0168380003,CPT0168380009,,CPT0168430002,CPT0168380006,,FALSE,53,Female,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Left,,4.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,160,70,27.34,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,388,NA,,389,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,143,Progression,,,,,,,,,,NA,NA,143,144,1,388,0,1,NA,53,High or alive at last follow-up,50-60
C3N-02784,GBM,C3N-02784-T,,TRUE,,,CPT0206000004,CPT0206000010,,CPT0206060002,CPT0206000007,,FALSE,37,Male,Unknown,Unknown,East_Asian,China,No,Frontal and Temporal Lobe,Left Hemisphere and Frontal Lobe and Temporal Lobe,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,"TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,175,90,29.39,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,20,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,391,391,Main malignancy,NA,396,Yes,Yes,No,With Tumor,Complete Remission,,Yes,555,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,555,560,1,391,1,5,NA,37,Low,<50
C3N-01517,GBM,C3N-01517-T,,TRUE,,,CPT0167530003,CPT0167530009,,CPT0167590002,CPT0167530006,,FALSE,49,Male,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"GFAP(+), Olig-2(+), IDH1(-), Ki-67(+++), P53(±), ATRX(+)","TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: yes",,172,78,26.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1023,NA,,1025,NA,Yes,Yes,No,Tumor Free,Complete Remission,,Yes,894,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,894,896,1,1023,0,2,NA,49,High or alive at last follow-up,<50
C3L-02707,GBM,C3L-02707-T,,TRUE,,,CPT0189850004,CPT0189850010,,CPT0190680002,CPT0189850007,,FALSE,58,Male,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Left,,2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,GFAP and P53 ,,,178,68,21.52,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Acetaminophen|Dexamethasone|Docusate|Famitodine|Fluoxetine|Levetiracetam|Losartan|Mirtazapine|Multivitamin-minerals-lutein|Oxycodone|Polyethylene glycol|Sulfamethoxazole-trimethoprim|Temozolomide|Tolterodine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,91,NA,,91,NA,Yes,Yes,No,With Tumor,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,91,0,0,NA,58,High or alive at last follow-up,50-60
C3L-02955,GBM,C3L-02955-T,,TRUE,,,CPT0196850003,CPT0196850006,,CPT0197750002,CPT0196850009,,FALSE,76,Female,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Right,,3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"IDH-1 negative in tumor cells, wildtype (non-mutated) for R132H, p53 only patchy, focal muclear positivity, ATRX: retained in tumor nuclei, thus wildtype (non-mutated) ",,,163,87,32.95,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,FUROsemide|Metoprolol tartrate|dexamethasone|famotidine|levetiracetam|Oxycodone|levothyroxine |mulivitamin |Omega-3 acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,350,378,Main malignancy,NA,378,Yes,Yes,Yes,With Tumor,Persistent Disease,,Yes,146,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,146,146,1,378,1,0,NA,76,Low,>70
C3N-03182,GBM,C3N-03182-T,,TRUE,,,CPT0206560003,CPT0206560006,,CPT0206610002,CPT0206560009,,FALSE,47,Male,Unknown,Unknown,East_Asian,China,No,Basal Ganglia,Right Basal Ganglia,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,GFAP（++），Olig-2（-），CD68（-），S100（Focal positive），Syn（-），BRAFV600E（-），EGFR（+++），MMP-9（-），IDH1（±），ATRX（Small cell positive 80%，Giant cell negative），P53（-），CD34（Vascular positive）,,,170,73,25.26,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,763,763,Main malignancy,NA,764,Unknown,Yes,No,With Tumor,Complete Remission,,Yes,502,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,502,503,1,763,1,1,NA,47,High or alive at last follow-up,<50
C3L-03392,GBM,C3L-03392-T,,TRUE,,,CPT0219080004,CPT0219080010,,CPT0220450002,CPT0219080007,,FALSE,50,Female,Unknown,Unknown,European,Russia,No,Parietal Lobe,,Right,,5.1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,159,71,28.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Omeprazole|Dexamethasone|Acetazolamide|Lornoxicam|Sterofundin|Etamsylate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,-9,147,Main malignancy,NA,156,No,Yes,No,With Tumor,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,147,1,9,NA,50,Low,<50
C3L-03405,GBM,C3L-03405-T,,TRUE,,,CPT0224600003,CPT0224600006,,CPT0226240002,CPT0224600009,,FALSE,59,Male,Unknown,Unknown,European,Russia,No,Frontal and Temporal Lobe,Frontal Lobe / Temporal Lobe,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,Ki-67 29%,,,168,76,26.93,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,87,87,Unknown,NA,87,No,No,No,Tumor Free,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,87,1,0,NA,59,Low,50-60
C3L-02465,GBM,C3L-02465-T,,TRUE,,,CPT0125570003,CPT0125570006,,CPT0124250002,CPT0125570009,,FALSE,50,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,Frontal Lobe,,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"H3K27 negative, p53 positive",,,180,125,38.34,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Acetaminophen|albuterol|Clonidine|Dulcolax|Effervescent potassium/chloride|Famotidine|Fentanyl|Hydralazine|Labetalol|Magnesium Sulfate|Miralax|Morphine|Narcan|Ocean Nasal Spray|Oxycodone|Phenergan|Senokot|Simethicone|Sodium Chloride|Tears Naturale|Versed|Zofran,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,550,591,Main malignancy,NA,591,Yes,Yes,Unknown,With Tumor,Persistent Disease,,Yes,102,Progression,,,,,,,,,,NA,NA,102,102,1,591,1,0,NA,50,High or alive at last follow-up,<50
C3N-03473,GBM,C3N-03473-T,,TRUE,,,CPT0207090003,CPT0207090013,,CPT0207150002,CPT0207090009,,FALSE,30,Female,Unknown,Unknown,East_Asian,China,No,"Frontal, Parietal and Temporal Lobe",Right Hemisphere and Frontal Lobe and Parietal Lobe and Temporal Lobe,Right,,7.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"ATRX（about 90%）, P53（about 80%）, Ki-67（about 50%）, EGFR（-）, MMP-9（++）","TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,175,62,20.24,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,297,297,Main malignancy,NA,301,Yes,Yes,Unknown,With Tumor,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,297,1,4,NA,30,Low,<50
C3L-01049,GBM,C3L-01049-T,,TRUE,,,CPT0217430008,CPT0217430014,,CPT0220120002,CPT0217430011,,FALSE,46,Male,Unknown,Unknown,European,Russia,No,Frontal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,172,86,29.07,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,, Dexamethasone|Omeprazole|Metformin and Sulfonamides|Cyanocobalamin|Sterofundin|Sodiym valproate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,69,191,Main malignancy,NA,201,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,191,1,10,NA,46,Low,<50
C3N-02185,GBM,C3N-02185-T,,TRUE,,,CPT0168590003,CPT0168590009,,CPT0168650002,CPT0168590006,,FALSE,61,Female,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,,Right,,8.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9(±)GFAP(+),Ki-67(30%), P53(++), IDH1(-), ATRX(+), EGFR(+++)","TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,158,50,20.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,386,NA,,387,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,279,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,279,280,1,386,0,1,NA,61,High or alive at last follow-up,60-70
C3N-01851,GBM,C3N-01851-T,,TRUE,,,CPT0186100003,CPT0186100009,,CPT0186120002,CPT0186100006,,FALSE,47,Male,Unknown,Unknown,European,Poland,No,Thalamus,thalamus,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,184,103,30.42,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,66,No or minimal exposure to secondhand smoke,,,20,,,,,,No,Deceased,363,363,Main malignancy,NA,377,No,Yes,No,With Tumor,Persistent Disease,,Yes,220,Progression,,,,,,,No,Yes,No,NA,NA,220,234,1,363,1,14,NA,47,Low,<50
C3N-01816,GBM,C3N-01816-T,,TRUE,,,CPT0168080003,CPT0168080009,,CPT0168120002,CPT0168080006,,FALSE,53,Female,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"GST-π(+), Olig-2(+), Ki-67(15%), MGMT(+), P53(+), GFAP(+), EGFR(+), BETA-TubulinIII(+), P170(+), VEGF(-), MMP-9(-), TOPO-II(-), IDH1(-), PTEN(-), ATRX(-), Syn(+), MAP2(+), NeuN(neure +)",,,156,65,26.71,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Phenobarbital Sodium|Phenobarbital and Sodium Bromide Tablets,Self Report|Self Report,No,Deceased,841,841,Main malignancy,NA,842,Yes,Yes,No,With Tumor,Complete Remission,,Yes,445,Recurrence,,,,,,,No,No,No,NA,NA,445,446,1,841,1,1,NA,53,High or alive at last follow-up,50-60
C3N-01369,GBM,C3N-01369-T,,TRUE,,,CPT0162020003,CPT0162020009,,CPT0162040002,CPT0162020006,,FALSE,57,Female,Unknown,Unknown,European,Poland,No,Temporal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,166,56,20,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,57,,50-60
C3L-02642,GBM,C3L-02642-T,,TRUE,,,CPT0201710003,CPT0201710009,,CPT0201790002,CPT0201710006,,FALSE,77,Male,Unknown,Unknown,European,Bulgaria,No,Frontal Lobe,,Right,,6.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,172,70,23.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Ampodipine|Telmisartan|Indipam,Medical Record|Medical Record|Medical Record,No,Deceased,828,828,Main malignancy,NA,834,Yes,Yes,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,828,1,6,NA,77,High or alive at last follow-up,>70
C3L-03390,GBM,C3L-03390-T,,TRUE,,,CPT0224390004,CPT0224390007,,CPT0226190002,CPT0224390011,,FALSE,44,Female,Unknown,Unknown,European,Russia,No,Parietal and Occipital Lobe,Parietal and Occipital Lobe,Right,,4.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,Ki-67 focally up to 30%,,,163,79,29.73,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,815,NA,,816,NA,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,649,Progression,,,,,,,No,Yes,No,NA,NA,649,650,1,815,0,1,NA,44,High or alive at last follow-up,<50
C3N-03088,GBM,C3N-03088-T,,TRUE,,,CPT0209440003,CPT0209440008,,CPT0209480002,CPT0209440005,,FALSE,31,Female,Unknown,Unknown,East_Asian,China,No,Occipital Lobe,,Right,,3.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"ATRX-OPT (-/+), BRAF (+), CD34 (-), GFAP (+), INI-1 (+), ki-67 (+, 15%), P53 (+/-), Olig2 (+), IDH1 (-), H3k27M (-), EGFvIII (-)",,,153,46,19.65,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,ibuprofen,Medical Record,No,Deceased,27,142,Unknown,NA,148,Yes,Yes,No,Tumor Free,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,142,1,6,NA,31,Low,<50
C3L-01155,GBM,C3L-01155-T,,TRUE,,,CPT0218890004,CPT0218890010,,CPT0220390002,CPT0218890007,,FALSE,66,Male,Unknown,Unknown,European,Russia,No,Frontal Lobe,,Right,,3.6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,183,91,27.17,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,362,NA,,373,NA,Unknown,Unknown,Unknown,With Tumor,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,362,0,11,NA,66,High or alive at last follow-up,60-70
C3N-03070,GBM,C3N-03070-T,,TRUE,,,CPT0208980003,CPT0208980009,,CPT0209010002,CPT0208980006,,FALSE,65,Female,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Right,,4.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,GFAP（+），Olig2（+），ATRX（-），CD34（vessel+），D2-40（-），P53（+），IDH1（+），H3k27M（-），PTEN（+/-），EMA（-），Ki-67（+，70%）,,,165,65,23.88,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,, astrocytoma,Surgery,No,,,No,Living,332,NA,,336,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,332,0,4,NA,65,High or alive at last follow-up,60-70
C3L-01045,GBM,C3L-01045-T,,TRUE,,,CPT0123530003,CPT0123530006,,CPT0124830002,CPT0123530009,,FALSE,73,Female,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,165,60,22.04,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,Dexamethasone|Acetazolamide|Omeprazole|Sterofundin,Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,0,66,Unknown,NA,66,Yes,No,No,With Tumor,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,66,1,0,NA,73,Low,>70
C3L-00677,GBM,C3L-00677-T,,TRUE,,,CPT0071100003,['CPT0071100009'],,CPT0071960002,CPT0071100006,,FALSE,69,Female,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Left,,4.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"IDH1-negative, ATRX-positive; H3me3-positive",,,164,52,19.32,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,29,Exposure to secondhand smoke history not available,,,,,,,Atenolol|Dexamethasone|Famotidine|NaCl|Myrbetriq,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,155,155,Main malignancy,NA,155,Yes,Yes,No,Unknown Tumor Status,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,155,1,0,NA,69,Low,60-70
C3N-02255,GBM,C3N-02255-T,,TRUE,,,CPT0182550003,CPT0182550009,,CPT0182570002,CPT0182550006,,FALSE,88,Male,Unknown,Unknown,European,Poland,No,Parietal Lobe,,Bilateral,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"GFAP(+), Vim(+), S100(+)",,,172,70,23.66,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,226,265,Main malignancy,NA,283,No,No,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,265,1,18,NA,88,Low,>70
C3L-01061,GBM,C3L-01061-T,,TRUE,,,CPT0217710008,CPT0217710014,,CPT0220160002,CPT0217710011,,FALSE,66,Male,Unknown,Unknown,European,Russia,No,Occipital Lobe,,Right,,3.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1 Negative,,,172,76,25.69,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Dexamethasone|Cefazolin|Lornixicam|Ondansetron|Bromdihydrochlorphenylbenzodiazepine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,840,NA,,851,NA,Yes,Yes,No,With Tumor,Persistent Disease,Persistent Disease,Yes,343,Progression,,,,,,,No,Yes,No,NA,NA,343,354,1,840,0,11,NA,66,High or alive at last follow-up,60-70
C3L-02041,GBM,C3L-02041-T,,TRUE,,,CPT0125510003,CPT0125510006,,CPT0124240002,CPT0125510009,,FALSE,51,Female,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Left,,0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"IDH1-positive, ATRX-negative, H3K27-negative",,,170,56,19.46,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Clonidine|Keppra|Pepcid|Dexamethasone|Oxycodone|Simethicone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1030,NA,,1030,NA,No,No,No,Unknown Tumor Status,Persistent Disease,,Yes,235,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,235,235,1,1030,0,0,NA,51,High or alive at last follow-up,50-60
C3L-01046,GBM,C3L-01046-T,,TRUE,,,CPT0127480003,CPT0127480010,,CPT0128570002,CPT0127480007,,FALSE,50,Male,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1/2 Mutational Analysis Testing Method,,,185,110,32.14,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",26.3,Yes,Yes,,,,,,Dexamethasone|Omeprazole|Acetazolamide|Sterofundin,Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,195,349,Main malignancy,NA,349,No,No,No,With Tumor,Patient Deceased,,Yes,195,Progression,,,,,,,,,,NA,NA,195,195,1,349,1,0,NA,50,Low,<50
C3N-01518,GBM,C3N-01518-T,,TRUE,,,CPT0167640003,CPT0167640009,,CPT0167700002,CPT0167640006,,FALSE,72,Female,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Right,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9(+, vessels+), EGFR(+++), P53(+++), Ki-67(about30%-60%), ATRX(+++), GFAP(+), Olig-2(+)","TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,164,70,26.03,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,Breast adenoma,Surgery,No,,,No,Deceased,805,805,Main malignancy,NA,806,No,No,No,With Tumor,Complete Remission,,Yes,538,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,538,539,1,805,1,1,NA,72,High or alive at last follow-up,>70
C3N-00662,GBM,C3N-00662-T,,TRUE,,,CPT0087680003,CPT0087680006,,CPT0087720002,CPT0087680009,,FALSE,77,Female,Unknown,Unknown,European,Poland,No,Temporal Lobe,,Right,,3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,153,61,26,Yes,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,57,No or minimal exposure to secondhand smoke,,,,Uterine leiomyomas,Surgery,No,indapamide|lisinopril|simvastatin,Medical Record|Medical Record|Medical Record,No,Deceased,116,116,Other reasons,NA,126,Yes,No,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,116,1,10,NA,77,Low,>70
C3L-03400,GBM,C3L-03400-T,,TRUE,,,CPT0224540004,CPT0224540007,,CPT0226220002,CPT0224540010,,FALSE,38,Female,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Left,,6.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,Ki-67 focally up to 30%,,,167,82,29.4,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Omeprazole|Dexamethasone|Acetazolamide|Lornoxicam|Sterofundin|Etamsylate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,786,NA,,804,NA,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,786,0,18,NA,38,High or alive at last follow-up,<50
C3N-01815,GBM,C3N-01815-T,,TRUE,,,CPT0167970003,CPT0167970009,,CPT0168030004,CPT0167970006,,FALSE,71,Female,Unknown,Unknown,East_Asian,China,No,hemisphere,hemisphere,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9(-), EGFR(++), P53(+++), ki-67(15%), ATRX(+","TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,158,58,23.23,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,Esophageal cancer,Unknown,No,Metoprolol|Valsartan|Nifedipine,Self Report|Self Report|Self Report,No,Deceased,96,121,Unknown,NA,122,No,No,No,Unknown Tumor Status,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,121,1,1,NA,71,Low,>70
C3N-01856,GBM,C3N-01856-T,,TRUE,,,CPT0162100003,CPT0162100009,,CPT0162120002,CPT0162100006,,FALSE,66,Male,Unknown,Unknown,European,Poland,No,Occipital lobe,,Right,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,178,80,25,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,B12,Self Report,No,Deceased,382,382,Main malignancy,NA,403,Yes,Yes,No,Unknown Tumor Status,Complete Remission,,Yes,281,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,281,302,1,382,1,21,NA,66,Low,60-70
C3L-02704,GBM,C3L-02704-T,,TRUE,,,CPT0189750004,CPT0189750010,,CPT0190660002,CPT0189750007,,FALSE,54,Male,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Right,,1.7,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,180,98,29.98,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,Enalapril|Glyburide|Levetiracetam|Metformin|Omeprazole|Rosuvastatin|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,186,NA,,186,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,186,0,0,NA,54,High or alive at last follow-up,50-60
C3L-01887,GBM,C3L-01887-T,,TRUE,,,CPT0104330003,CPT0104330006,,CPT0105110002,CPT0104330009,,FALSE,48,Male,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Left,,3.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,178,95,30.11,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Ativan |Ambien,Medical Record|Medical Record,No,Deceased,1622,1703,Main malignancy,NA,1704,Yes,Yes,No,With Tumor,Complete Remission,Patient Deceased,Yes,1468,New Primary Tumor,Site : Left temporal tumor ,,,Yes,,R1: Microscopic Residual Tumor,No,Yes,Yes,1468,NA,1468,1469,1,1703,1,1,NA,48,High or alive at last follow-up,<50
C3N-01857,GBM,C3N-01857-T,,TRUE,,,CPT0162140003,CPT0162140010,,CPT0162170002,CPT0162140007,,FALSE,69,Female,Unknown,Unknown,European,Poland,No,Temporal Lobe,,Right,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,164,60,22,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Levothyroxine,Self Report,No,Deceased,651,651,Main malignancy,NA,672,Yes,Yes,No,With Tumor,Unknown,,Yes,406,Recurrence,,,,,,,No,Yes,No,NA,NA,406,427,1,651,1,21,NA,69,High or alive at last follow-up,60-70
C3N-01196,GBM,C3N-01196-T,,TRUE,,,CPT0078580003,['CPT0078580013'],,CPT0078600002,CPT0078580006,,FALSE,67,Male,Unknown,Unknown,European,Poland,No,Frontal Lobe,,Right,,1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,172,90,30.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,230,653,Main malignancy,NA,656,Yes,Unknown,No,With Tumor,Persistent Disease,,Yes,194,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,194,197,1,653,1,3,NA,67,High or alive at last follow-up,60-70
C3N-01366,GBM,C3N-01366-T,,TRUE,,,CPT0093510003,CPT0093510006,,CPT0093540002,CPT0093510009,,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Frontal Lobe,,Right,,3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,182,97,29.28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,6,6,Main malignancy,NA,6,No,No,No,Tumor Free,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,6,1,0,NA,63,Low,60-70
C3N-00661,GBM,C3N-00661-T,,TRUE,,,CPT0087570003,CPT0087570006,,CPT0087650002,CPT0087570009,,FALSE,49,Male,Unknown,Unknown,European,Poland,No,Temporal Lobe,,Right,,7,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,176,105,33,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",2.3,No or minimal exposure to secondhand smoke,,,,,,,telmisartan,Medical Record,No,Living,1107,NA,,1119,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,339,Recurrence,Site : null,,,,,,Yes,No,No,NA,NA,339,351,1,1107,0,12,NA,49,High or alive at last follow-up,<50
C3L-03744,GBM,C3L-03744-T,,TRUE,,,CPT0216920008,CPT0216920018,,CPT0217940002,CPT0216920011,,FALSE,75,Male,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Right,,2.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,180,79,24.27,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Acetaminophen|Celecoxib|Cetirizine|Docusate|Finasteride|Hydrochlorothiazide|Ondansetron|Polyethylene glycol|Prednisone|Senna|Simvastatin|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1040,NA,,1043,NA,Yes,Yes,Yes,Tumor Free,Persistent Disease,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1040,0,3,NA,75,High or alive at last follow-up,>70
C3L-03968,GBM,C3L-03968-T,,TRUE,,,CPT0228220003,CPT0228220009,,CPT0228320002,CPT0228220006,,FALSE,60,Female,Unknown,Unknown,European,Bulgaria,No,Frontal and Parietal Lobe,Frontal-parietal lobe,Right,,3.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,160,60,23.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,986,NA,,992,NA,Yes,Yes,No,Tumor Free,Unknown,Unknown,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,986,0,6,NA,60,High or alive at last follow-up,50-60
C3L-02504,GBM,C3L-02504-T,,TRUE,,,CPT0175060003,CPT0175060009,,CPT0175520002,CPT0175060006,,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Parietal Lobe,,Left,,1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,ATRH-negative-wild type; IDH; R132H-negative-wild type; H3K27M-negative,,,168,70,25.07,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,45,Exposure to secondhand smoke history not available,,,,,,,Levothyroxine|Gabapentin|Finasteride|Doxazosin|Aspirin|Dexamethasone|Combigan/Latanoprost Ophthalmic Solution,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,866,873,Main malignancy,NA,873,Yes,Yes,Unknown,With Tumor,Unknown,Patient Deceased,Yes,454,New Primary Tumor,Site : left occipital lobe,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Unknown,454,NA,454,454,1,873,1,0,NA,71,High or alive at last follow-up,>70
C3N-02788,GBM,C3N-02788-T,,TRUE,,,CPT0206330003,"['CPT0206350006', 'CPT0206330009']",,CPT0206390002,"['CPT0206330006', 'CPT0206350009']",,FALSE,64,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Left,,6.6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9（-）, EGFR（+++）, P53（++）, Ki-67（15%）,ATRX（±）,GFAP（+）","TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,170,68,23.53,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,45,No or minimal exposure to secondhand smoke,,,,,,,Amlodipine besylate|EnalaprilMaleate,Self Report|Self Report,No,Deceased,845,845,Main malignancy,NA,850,Yes,Yes,No,With Tumor,Complete Remission,,Yes,450,Recurrence,,,,,,,No,Yes,No,NA,NA,450,455,1,845,1,5,NA,64,High or alive at last follow-up,60-70
C3L-04084,GBM,C3L-04084-T,,TRUE,,,CPT0217100003,CPT0217100013,,CPT0218020002,CPT0217100006,,FALSE,63,Female,White,Not Hispanic or Latino,European,United States,No,Parietal Lobe,,Left,,5.4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,152,55,23.82,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Clopidogrel|Gabapentin|Levetiracetam|Ondansetron|Oxycodone|Tapentadol|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,206,274,Main malignancy,NA,276,Yes,Yes,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,274,1,2,NA,63,Low,60-70
C3L-01157,GBM,C3L-01157-T,,TRUE,,,CPT0199770003,CPT0199770009,,CPT0200400002,CPT0199770006,,FALSE,66,Female,Unknown,Unknown,European,Russia,No,Temporal Lobe,,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,162,75,28.58,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,984,984,Main malignancy,NA,984,Yes,No,No,Tumor Free,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,984,1,0,NA,66,High or alive at last follow-up,60-70
C3L-02705,GBM,C3L-02705-T,,TRUE,,,CPT0189650004,CPT0189650010,,CPT0190640002,CPT0189650007,,FALSE,60,Male,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Right,,4.1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,196,98,25.61,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Basal cell carcinoma in situ of skin|Squamous cell carcinoma in situ,Unknown|Unknown,Yes|Yes,Acetaminophen|Albuterol|Bisacodyl|Dexamethasone|Enoxaparin|Glycopyrrolate|Guaifenesin|Lorazepam|Melatonin|Mirtazapine|Morphine|Scopolamine|Tramadol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,104,111,Main malignancy,NA,111,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,111,1,0,NA,60,Low,50-60
C3N-01334,GBM,C3N-01334-T,,TRUE,,,CPT0125220003,CPT0125220009,,CPT0125250002,CPT0125220006,,FALSE,64,Female,Unknown,Unknown,European,Poland,No,Parietal Lobe,,Right,,4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,KI67 30-40 %,GFAP +,,160,65,25,Unknown,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,7,7,Main malignancy,NA,15,No,No,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,7,1,8,NA,64,Low,60-70
C3N-03180,GBM,C3N-03180-T,,TRUE,,,CPT0206450003,CPT0206450006,,CPT0206500002,CPT0206450009,,FALSE,53,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,Right Hemisphere and Temporal Lobe,Right,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9（±）, EGFR（+++）, P53（±）, Ki-67（25%）, ATRX（+++）","TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,165,85,31.22,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,30,No or minimal exposure to secondhand smoke,,,,,,,Aspirin,Self Report,No,Deceased,511,511,Main malignancy,NA,515,Yes,Yes,Unknown,With Tumor,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,511,1,4,NA,53,High or alive at last follow-up,50-60
C3N-01852,GBM,C3N-01852-T,,TRUE,,,CPT0182500003,CPT0182500009,,CPT0182540002,CPT0182500006,,FALSE,59,Male,Unknown,Unknown,European,Poland,No,Frontal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,184,82,24.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,3,NA,,8,NA,Unknown,Unknown,Unknown,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,3,0,5,NA,59,High or alive at last follow-up,50-60
C3L-03727,GBM,C3L-03727-T,,TRUE,,,CPT0225730003,CPT0225730009,,CPT0226070002,CPT0225730006,,FALSE,71,Female,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"IDH! R132H: negative, wild type; ATRX: positive, wild type; H3K27M: negative, wild type; MIB-1: 13%; H3Me3: positive, nuclear staining retained",,,150,77,34.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Aspirin|Centrum Silver|Clonazepam|Diphenhydramine|Famotidine|Loperamide|sumatriptan|treximet|Vitamin C|Vitamin D3,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,613,721,Main malignancy,NA,721,Yes,Yes,Unknown,With Tumor,Persistent Disease,,Yes,457,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,457,457,1,721,1,0,NA,71,High or alive at last follow-up,>70
C3N-01368,GBM,C3N-01368-T,,TRUE,,,CPT0093590003,CPT0093590006,,CPT0093620002,CPT0093590009,,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Frontal Lobe,,Right,,3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,180,90,27.78,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Bisoprolol|Metformax,Medical Record|Medical Record,No,Deceased,245,245,Unknown,NA,267,No,No,No,With Tumor,Persistent Disease,,Yes,63,Recurrence,Site : Brain,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,76,NA,63,85,1,245,1,22,NA,65,Low,60-70
C3N-00665,GBM,C3N-00665-T,,TRUE,,,CPT0093360003,CPT0093360006,,CPT0093440002,CPT0093360009,,FALSE,65,Female,Unknown,Unknown,European,Poland,No,Frontal Lobe,,Right,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,164,58,21,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,,Yes,,,,,Acetylsalicylic acid|Vitamin D3|Metformin hydrochloride|Levothyroxine sodium|Bisoprolol fumarate|Telmisartan|Simvastatin,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,Living,1585,NA,,1590,NA,Yes,Yes,No,With Tumor,Complete Remission,Persistent Disease,Yes,1291,New Primary Tumor,Site : right frontal lobe,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,1297,NA,1291,1296,1,1585,0,5,NA,65,High or alive at last follow-up,60-70
C3N-03184,GBM,C3N-03184-T,,TRUE,,,CPT0206780003,CPT0206780006,,CPT0206830002,CPT0206780009,,FALSE,35,Male,Unknown,Unknown,East_Asian,China,No,Parietal Lobe,Left Hemisphere and Parietal Lobe,Left,,3.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"MMP-9（-）, EGFR（+++）, P53（-）, Ki-67（about 50%）, ATRX（±）","TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,185,90,26.3,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,15,No or minimal exposure to secondhand smoke,,,10,,,,,,No,Living,390,NA,,395,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,390,0,5,NA,35,High or alive at last follow-up,<50
C3L-02900,GBM,C3L-02900-T,,TRUE,,,CPT0218670003,CPT0218670009,,CPT0219910002,CPT0218670006,,FALSE,52,Male,White,Not Hispanic or Latino,European,United States,No,Occipital Lobe,,Right,,2.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH-1 positive for R132H mutation Ki-67 approximately 40% of tumor nuclei p53:Positive in tumor nuclei consistent with mutation GFAP:highlights tumor cells and processes CD68: Highlights a background of macrophages associated with hemorrhageATRX wildtype ,,,173,66,22.2,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,tylenol 500 |pepcid |neurontin |mulivitamin |Flomax|restoril ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1053,1053,Main malignancy,NA,1053,Yes,Yes,No,With Tumor,Persistent Disease,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1053,1,0,NA,52,High or alive at last follow-up,50-60
C3N-00663,GBM,C3N-00663-T,,TRUE,,,CPT0087730003,CPT0087730006,,CPT0087810002,CPT0087730009,,FALSE,39,Male,Unknown,Unknown,European,Poland,No,Frontal Lobe,,Bilateral,,7,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,182,100,30.19,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1,1,Main malignancy,NA,11,No,No,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1,1,10,NA,39,Low,<50
C3L-01327,GBM,C3L-01327-T,,TRUE,,,CPT0064890003,['CPT0064890006'],,CPT0066690002,CPT0064890009,,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Temporal Lobe,,Left,,2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,IDH1-wild type; ATRX-wild type; H3me3-wild type,,,175,77,25.07,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,ASA 325 |Dexamethasone|Acetaminophen|Albuterol|Clonidin|Dulcolax|Famotidine|Hydrolazine|KCL|Labetol|Magnesium Sulfate|Miralax|Morphine|Narcan|Oxycodone|Phenergan|Senokot|Zofran|Simethicone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,2,646,Main malignancy,NA,646,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,646,1,0,NA,74,High or alive at last follow-up,>70
C3N-02786,GBM,C3N-02786-T,,TRUE,,,CPT0206230003,CPT0206230009,,CPT0206280002,CPT0206230006,,FALSE,39,Female,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,Hemisphere and Frontal Lobe,Left,,6.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,"TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: yes",,166,67,24.31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,1047,NA,,1077,NA,Yes,Yes,No,With Tumor,Persistent Disease,Persistent Disease,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1047,0,30,NA,39,High or alive at last follow-up,<50
C3L-01040,GBM,C3L-01040-T,,TRUE,,,CPT0171580008,CPT0171580014,,CPT0171540002,CPT0171580011,,FALSE,77,Male,Unknown,Unknown,European,Russia,No,Frontal Lobe,,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,170,70,24.22,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,608,NA,,607,NA,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,559,Progression,,,,,,,,,,NA,NA,559,558,1,608,0,-1,NA,77,High or alive at last follow-up,>70
C3N-02188,GBM,C3N-02188-T,,TRUE,,,CPT0168830003,CPT0168830009,,CPT0168870002,CPT0168830006,,FALSE,59,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,,Right,,5.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown," GFAP (+++), EGFR (+++), Olig -2 (++)、P53 (+)、VEGF (+), TOPO -II (+), TubulinIII (+), ATRX (+), P170 (+), Ki -67 (35%), GST (+), MGMT (-), MMP 9 (-), IDH1 (-), PTEN (-)",,,180,70,21.6,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,411,411,Main malignancy,NA,414,Yes,Yes,No,With Tumor,Complete Remission,,Yes,260,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,260,263,1,411,1,3,NA,59,Low,50-60
C3N-01515,GBM,C3N-01515-T,,TRUE,,,CPT0079790003,CPT0079790006,,['CPT0080730002'],CPT0079790009,,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Right,,1.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,GFAP: diffuse positive; P53: about 5% positive; AE1/3: negative,,,160,71,27.73,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",1,Exposure to secondhand smoke history not available,,,50,,,,lactulose|metoprolol,Medical Record|Medical Record,No,Deceased,19,19,Main malignancy,NA,19,No,No,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,19,1,0,NA,73,Low,>70
C3L-00104,GBM,C3L-00104-T,,TRUE,,,CPT0092440003,CPT0092440006,,CPT0093800002,CPT0092440009,,FALSE,58,Male,White,Not Hispanic or Latino,European,United States,No,Frontal Lobe,,Left,,1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,188,115,32.54,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,35,Exposure to secondhand smoke history not available,,,,,,,lyrica|norco|aspirin|celebrex|plavix|viatmin B12|gabapentin|glipizide|metformin|metoprolol|omeprazole|actos|ramipril|rosuvastatin|valtrex,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,128,129,Unknown,NA,129,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,101,Progression,,,,,,,,,,NA,NA,101,101,1,129,1,0,NA,58,Low,50-60
C3N-02769,GBM,C3N-02769-T,,TRUE,,,CPT0205570003,CPT0205570006,,CPT0205620002,CPT0205570009,,FALSE,53,Male,Unknown,Unknown,East_Asian,China,No,Frontal Lobe,,Left,,5.3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,"TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: yes",,170,65,22.49,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,1115,1115,Main malignancy,NA,1121,Yes,Yes,No,With Tumor,Complete Remission,Patient Deceased,Yes,667,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,667,673,1,1115,1,6,NA,53,High or alive at last follow-up,50-60
C3N-02785,GBM,C3N-02785-T,,TRUE,,,CPT0206110003,CPT0206110006,,CPT0206170002,CPT0206110009,,FALSE,69,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe,Left Hemisphere and Temporal Lobe,Left,,5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,MMP-9（±），EGFR（+++），P53（±），Ki-67（30%），ATRX（+++）,"TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",,178,75,23.67,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,20,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,546,546,Main malignancy,NA,552,Yes,Yes,No,With Tumor,Complete Remission,,Yes,466,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,466,472,1,546,1,6,NA,69,High or alive at last follow-up,60-70
C3N-02190,GBM,C3N-02190-T,,TRUE,,,CPT0205450004,CPT0205450010,,CPT0205510002,CPT0205450007,,FALSE,53,Male,Unknown,Unknown,East_Asian,China,No,Occipital Lobe,,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,"EGFR (+++), P53 (20%), ATRX (90%), Ki -67 (50%), MMP 9 (-), H3K27M(-)","TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",,182,75,22.64,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Metoprolol Tartrate|Levoamlodipine Maleate,Self Report|Self Report,No,Deceased,311,311,Main malignancy,NA,317,Yes,Yes,No,With Tumor,Complete Remission,,Yes,261,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,261,267,1,311,1,6,NA,53,Low,50-60
C3N-01643,HNSCC,,,TRUE,disqualified,,,CPT0162890009,,CPT0162920002,CPT0162890006,,FALSE,68,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,2.6,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,6,0,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,172,84,28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",54,No or minimal exposure to secondhand smoke,,,,,,,"bisoprolol 1,25 mg|acetylsalicylic acid 75 mg once a day",Self Report|Self-reported,No,Living,1460,NA,,1474,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1460,0,14,NA,68,High or alive at last follow-up,60-70
C3L-00997,HNSCC,C3L-00997-T,C3L-00997-N,TRUE,,CPT0123190003,CPT0123180003,CPT0123180006,CPT0123190009,CPT0124760002,CPT0123180009,CPT0123190006,FALSE,47,Male,Unknown,Unknown,European,Ukraine,No,Oropharynx,,Unknown,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,13,1,cM0,Staging Incomplete,Not documented,R0: No residual tumor,Stage II,,,IHC staining not done,163,58,21.83,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",15,Yes,Yes,,,,,,,,No,Living,442,NA,,445,NA,Yes,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,442,0,3,NA,47,High or alive at last follow-up,<50
C3N-03849,HNSCC,C3N-03849-T,C3N-03849-N,TRUE,,CPT0237150003,CPT0237130004,CPT0237130010,CPT0237150006,CPT0237190002,CPT0237130007,CPT0237150009,FALSE,55,Male,Unknown,Unknown,East_Asian,China,No,Larynx,,Right,Unifocal,7,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2b,25,3,cM0,pM0,no,R0: No residual tumor,Stage IV,EGFR（+），P53（+），CyclinD1（+），HER2（-），VEGF（+），β-Cat（cytomembrane +），P16（-），P21（-）,,IHC staining not done,160,55,21.48,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,335,NA,,341,NA,No,No,No,Tumor Free,Not Applicable,,Yes,265,,Larynx,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,265,271,1,335,0,6,NA,55,High or alive at last follow-up,50-60
C3N-01858,HNSCC,C3N-01858-T,C3N-01858-N,TRUE,,CPT0163860003,CPT0163840003,CPT0163840009,,CPT0163900002,CPT0163840006,,FALSE,62,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,3.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN3b,15,1,cM0,pMx,,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,176,78,25,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,61.5,Exposure to secondhand smoke history not available,,,15,,,,"Xarelto 15 1x |Bisocard 2.5 1x |Prestarium 5 1/2 1x |clexane 0,4 x2|digoxin 0,1",Self Report|Self Report|Self Report|Medical Record|Self Report,No,Living,598,NA,,617,NA,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,200,,Larynx,,Biopsy with Histologic Confirmation,Unknown,,,Unknown,Unknown,Unknown,NA,NA,200,219,1,598,0,19,NA,62,High or alive at last follow-up,60-70
C3N-03487,HNSCC,C3N-03487-T,,TRUE,,,CPT0194960003,CPT0194960013,CPT0194980006,CPT0195070002,CPT0194960009,CPT0194980009,FALSE,53,Female,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT4a,pN0,5,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,164,132,49.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,728,NA,,714,NA,No,Yes,No,With Tumor,Complete Remission,,Yes,390,,Oral Cavity,,Biopsy with Histologic Confirmation,Yes,,,No,Yes,No,391,NA,390,376,1,728,0,-14,NA,53,High or alive at last follow-up,50-60
C3L-04791,HNSCC,C3L-04791-T,,TRUE,,,CPT0250310003,CPT0250310009,CPT0250330006,CPT0250450002,CPT0250310006,,FALSE,81,Male,Unknown,Unknown,European,Bulgaria,No,Larynx,,Midline,Unifocal,3,Keratinizing Squamous Cell Carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pNX,10,0,cMX,pMX,,R0: No residual tumor,Stage I,,,IHC staining not done,180,75,23.15,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Amiodarone Hydrochloride,Self Report,No,Living,273,NA,,281,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,273,0,8,NA,81,High or alive at last follow-up,>70
C3N-04273,HNSCC,C3N-04273-T,,TRUE,,,CPT0245230004,CPT0245230007,,CPT0245290002,CPT0245230010,,FALSE,73,Male,Unknown,Unknown,European,Poland,No,Oropharynx,,Right,Unifocal,2,Basaloid squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,22,8,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,172,75,25,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,38,No or minimal exposure to secondhand smoke,,,Unknown,,,,,,No,Deceased,377,425,Main malignancy,NA,431,No,No,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,425,1,6,NA,73,Low,>70
C3N-03664,HNSCC,C3N-03664-T,,TRUE,,,CPT0196210003,CPT0196210006,,CPT0196330002,CPT0196210009,,FALSE,58,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Midline,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2c,9,3,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,176,72,23.24,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,733,NA,,720,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,733,0,-13,NA,58,High or alive at last follow-up,50-60
C3N-01859,HNSCC,C3N-01859-T,C3N-01859-N,TRUE,,C3N-01859-04,CPT0163910003,CPT0163910009,,CPT0163950002,CPT0163910006,,FALSE,67,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2c,24,9,cM0,pMx,,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,160,63,24,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40,Yes,Yes,Yes,,ca planoepitheliale,Surgery,Yes,enalapryl,Self Report,No,Deceased,1039,1039,Unknown,NA,1057,Yes,No,No,Unknown Tumor Status,Persistent Disease,Patient Deceased,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1039,1,18,NA,67,High or alive at last follow-up,60-70
C3N-03781,HNSCC,C3N-03781-T,C3N-03781-N,TRUE,,CPT0245560003,CPT0245550003,CPT0245550009,,CPT0245590002,CPT0245550006,,FALSE,68,Male,Unknown,Unknown,European,Poland,No,Larynx,,Midline,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN0,3,0,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,170,88,30,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",22,No or minimal exposure to secondhand smoke,,,,,,,Primacor,Self Report,No,Deceased,1235,1235,Unknown,NA,1239,Yes,No,No,Tumor Free,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1235,1,4,NA,68,High or alive at last follow-up,60-70
C3N-03933,HNSCC,C3N-03933-T,C3N-03933-N,TRUE,,CPT0220620003,CPT0220610003,CPT0220610009,CPT0220620009,CPT0220710002,CPT0220610006,CPT0220620006,FALSE,70,Female,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,7,1,cM0,Staging Incomplete,no,R0: No residual tumor,Stage III,EBV - negative; p53 - negative; AE1/AE3 - positive; p63 - positive;,,IHC staining not done,160,65,25.39,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,749,NA,,722,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,749,0,-27,NA,70,High or alive at last follow-up,60-70
C3L-00999,HNSCC,C3L-00999-T,C3L-00999-N,TRUE,,CPT0123280003,CPT0123260003,CPT0123260006,CPT0123280009,CPT0124780002,CPT0123260009,CPT0123280006,FALSE,56,Male,Unknown,Unknown,European,Russia,No,Oral cavity,,Midline,Unifocal,2.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,17,0,cM0,No pathologic evidence of distant metastasis,Not documented,R0: No residual tumor,Stage II,,,IHC staining not done,176,82,26.47,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,36,Yes,Yes,Yes,,,,,,,No,Living,1137,NA,,1098,NA,No,No,No,With Tumor,Complete Remission,Persistent Disease,Yes,232,,Cervical Lymph Node,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,232,193,1,1137,0,-39,NA,56,High or alive at last follow-up,50-60
C3N-03009,HNSCC,C3N-03009-T,,TRUE,,,CPT0245060004,CPT0245060007,,CPT0245120002,CPT0245060010,,FALSE,58,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN0,14,0,cM0,pMx,,R0: No residual tumor,Stage I,,,IHC staining not done,170,52,17,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,31.5,Yes,Yes,,Unknown,,,,Beto ZK 25|Tritace|Agen|Torsemed|Acard,Self Report|Self Report|Self Report|Self Report|Self Report,No,Deceased,636,655,Unknown,NA,657,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,655,1,2,NA,58,High or alive at last follow-up,50-60
C3N-03015,HNSCC,C3N-03015-T,C3N-03015-N,TRUE,,CPT0245190003,CPT0245180003,CPT0245180006,CPT0245190006,CPT0245220002,CPT0245180009,CPT0245190009,FALSE,61,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,1,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2b,24,7,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,164,85,31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,"Bisocard 2,5|Vivace|Acard|Atrox",Self Report|Self Report|Self Report|Self Report,No,Living,1493,NA,,1499,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1493,0,6,NA,61,High or alive at last follow-up,60-70
C3N-01948,HNSCC,C3N-01948-T,,TRUE,,,CPT0163650003,CPT0163650009,CPT0163670006,CPT0163710002,CPT0163650006,,FALSE,55,Female,Unknown,Unknown,European,Poland,No,Oral cavity,,Right,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2b,26,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,168,55,19,Unknown,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Bisocard 2.5 mg 1/2 1x,Self Report,No,Living,422,NA,,435,NA,Yes,No,No,With Tumor,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,422,0,13,NA,55,High or alive at last follow-up,50-60
C3N-03490,HNSCC,C3N-03490-T,C3N-03490-N,TRUE,,CPT0195700003,CPT0195680003,CPT0195680006,CPT0195700006,CPT0195790002,CPT0195680009,CPT0195700009,FALSE,64,Male,Unknown,Unknown,European,Ukraine,No,Oropharynx,,Left,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,0,cM0,Staging Incomplete,No,R0: No residual tumor,Stage III,,,IHC staining not done,175,85,27.76,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,634,NA,,634,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,634,0,0,NA,64,High or alive at last follow-up,60-70
C3N-03012,HNSCC,C3N-03012-T,C3N-03012-N,TRUE,,CPT0226350003,CPT0226340003,CPT0226340009,,CPT0226380002,CPT0226340006,,FALSE,71,Male,Unknown,Unknown,European,Poland,No,Larynx,,Midline,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pTIVA,pN0,7,0,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,168,78,27,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",NA,No or minimal exposure to secondhand smoke,,,,ca planoepitheliale - larynx,Surgery,Unknown,,,No,Deceased,1333,1333,Unknown,NA,1333,Yes,No,No,Tumor Free,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1333,1,0,NA,71,High or alive at last follow-up,>70
C3N-01620,HNSCC,C3N-01620-T,C3N-01620-N,TRUE,,C3N-01620-05,CPT0095040003,CPT0095040006,,CPT0095090002,CPT0095040008,,FALSE,56,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,0,cM0,No pathologic evidence of distant metastasis,no,R0: No residual tumor,Stage III,,,0,190,113,31,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1202,NA,,1213,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1202,0,11,NA,56,High or alive at last follow-up,50-60
C3N-02730,HNSCC,C3N-02730-T,,TRUE,,,CPT0207870004,CPT0207870010,,CPT0207930002,CPT0207870007,,FALSE,40,Male,Unknown,Unknown,East_Asian,China,No,Oral cavity,,Right,Unifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN1,19,1,cM0,pM0,no,R0: No residual tumor,Stage III,,,IHC staining not done,172,70,23.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,amlodipine|diformin tablet,Medical Record|Medical Record,No,Living,365,NA,,371,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,365,0,6,NA,40,High or alive at last follow-up,<50
C3N-01758,HNSCC,C3N-01758-T,C3N-01758-N,TRUE,,C3N-01758-04,CPT0163340003,CPT0163340009,,CPT0163400002,CPT0163340006,,FALSE,59,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN1,6,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,165,65,23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,30,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,702,712,Main malignancy,NA,730,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,712,1,18,NA,59,High or alive at last follow-up,50-60
C3N-04277,HNSCC,C3N-04277-T,C3N-04277-N,TRUE,,CPT0245410003,CPT0245400003,CPT0245400009,CPT0245410006,CPT0245440002,CPT0245400006,,FALSE,72,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,1,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pNx,5,0,cM0,pMx,,R0: No residual tumor,Stage III,,,IHC staining not done,165,71,26,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,23.5,No or minimal exposure to secondhand smoke,,,,,,,Bisocard 2.5,Self Report,No,Living,1162,NA,,1162,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1162,0,0,NA,72,High or alive at last follow-up,>70
C3N-03045,HNSCC,C3N-03045-T,C3N-03045-N,TRUE,,CPT0235920003,CPT0235910003,CPT0235910009,CPT0235920006,CPT0235970002,CPT0235910006,,FALSE,77,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,Oral cavity,,Left,Unifocal,2.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),T2,N1,33,1,m0,Not identified,,RX: Presence of residual tumor cannot be assessed,Stage III,p16 was negative,,IHC staining not done,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,77,,>70
C3N-02275,HNSCC,C3N-02275-T,,TRUE,,,CPT0163740003,CPT0163740013,CPT0163720006,CPT0163780002,CPT0163740007,,FALSE,69,Male,Unknown,Unknown,European,Poland,No,Larynx,,Midline,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,5,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,Stage IV,,,IHC staining not done,170,91,31,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Insulin according to glucose lovel|acard 75 mg,Self Report|Self Report,No,Living,1358,NA,,1372,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1358,0,14,NA,69,High or alive at last follow-up,60-70
C3N-01339,HNSCC,C3N-01339-T,,TRUE,,,CPT0094490004,CPT0094490007,,CPT0094550002,CPT0094490010,,FALSE,68,Female,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,3.4,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,2,1,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,169,64,22,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,203,211,Main malignancy,NA,231,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,211,1,20,NA,68,Low,60-70
C3N-01337,HNSCC,C3N-01337-T,C3N-01337-N,TRUE,,CPT0088010003,CPT0087990003,CPT0087990006,CPT0088010009,CPT0088050002,CPT0087990009,CPT0088010006,FALSE,52,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN2b,10,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,164,55,20,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,13.2,Yes,,Yes,,,,,,,No,Living,616,NA,,629,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,616,0,13,NA,52,High or alive at last follow-up,50-60
C3N-03226,HNSCC,C3N-03226-T,,TRUE,,,CPT0194420003,CPT0194420013,CPT0194440006,CPT0194530002,CPT0194420009,CPT0194440009,FALSE,54,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN2b,6,3,cM0,Staging Incomplete,No,R0: No residual tumor,Stage IV,,,IHC staining not done,174,74,24.44,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,35,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,730,NA,,708,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,730,0,-22,NA,54,High or alive at last follow-up,50-60
C3N-02713,HNSCC,C3N-02713-T,C3N-02713-N,TRUE,,CPT0190860003,CPT0190850003,CPT0190850009,CPT0190860006,CPT0190950002,CPT0190850006,CPT0190860009,FALSE,64,Male,Unknown,Unknown,European,Ukraine,No,Larynx,,Left,Unifocal,3.3,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,1,1,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,Stage IV,p16 - negative; p53 - negative; EBV - negative; CK5/6 - patchy positive;,,IHC staining not done,180,67,20.68,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,45,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,744,NA,,720,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,744,0,-24,NA,64,High or alive at last follow-up,60-70
C3N-03619,HNSCC,C3N-03619-T,C3N-03619-N,TRUE,,CPT0195880003,CPT0195860003,CPT0195860006,CPT0195880006,CPT0195970002,CPT0195860009,CPT0195880008,FALSE,59,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,4,0,cM0,Staging Incomplete,No,R0: No residual tumor,Stage II,,,IHC staining not done,172,70,23.66,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,35,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,97,NA,,97,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,97,0,0,NA,59,High or alive at last follow-up,50-60
C3N-00871,HNSCC,C3N-00871-T,,TRUE,,,CPT0094420004,CPT0094420007,,CPT0094480008,CPT0094420010,,FALSE,58,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Midline,Unifocal,5.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2b,7,2,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,Stage IV,,,IHC staining not done,176,57,18,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,344,400,Main malignancy,NA,414,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,400,1,14,NA,58,Low,50-60
C3N-02693,HNSCC,,C3N-02693-N,TRUE,,C3N-02693-06,,CPT0226130009,,CPT0226170002,CPT0226130006,,FALSE,42,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,4.1,"Squamous cell carcinoma, non-keratinizing",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,11,0,cM0,pMx,,R0: No residual tumor,Stage III,,,IHC staining not done,195,102,26,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,1349,NA,,1349,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1349,0,0,NA,42,High or alive at last follow-up,<50
C3L-04844,HNSCC,C3L-04844-T,C3L-04844-N,TRUE,,CPT0248350003,CPT0248330003,CPT0248330009,,CPT0248360002,CPT0248330006,,FALSE,61,Female,Unknown,Unknown,European,Other: TSS did not collect,No,Oropharynx,,Right,Unifocal,6,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN3,79,5,cM0,pM0,Not applicable,R0: No residual tumor,Stage IV,,,IHC staining not done,167,58,20.73,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,50,Exposure to secondhand smoke history not available,,,40,,,,zopiclone|Rosuvastatin|Pantoprazole|Symbicort|benzydamine|amitriptyline|oxyneo,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1096,NA,,1057,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,Yes,702,,Oral Cavity,,Biopsy with Histologic Confirmation,Yes,,R0: No Residual Tumor,No,No,No,702,NA,702,663,1,1096,0,-39,NA,61,High or alive at last follow-up,60-70
C3N-03458,HNSCC,C3N-03458-T,,TRUE,,,CPT0246670003,CPT0246670009,,CPT0246710002,CPT0246670006,,FALSE,70,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN0,3,0,cM0,pMx,,R0: No residual tumor,Stage II,,,IHC staining not done,174,75,24,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,56.3,Yes,Yes,Yes,Unknown,,,,,,No,Living,1393,NA,,1399,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1393,0,6,NA,70,High or alive at last follow-up,60-70
C3N-01338,HNSCC,C3N-01338-T,C3N-01338-N,TRUE,,CPT0088080003,CPT0088060004,CPT0088060007,CPT0088080009,CPT0088120002,CPT0088060010,CPT0088080006,FALSE,50,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,13,1,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,175,75,24,Unknown,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,574,585,Unknown,NA,620,Yes,No,No,With Tumor,Complete Remission,Patient Deceased,Yes,492,,Locoregional Recurrence,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,492,527,1,585,1,35,NA,50,High or alive at last follow-up,<50
C3N-01947,HNSCC,C3N-01947-T,C3N-01947-N,TRUE,,CPT0226090003,CPT0226030003,CPT0226030009,CPT0226090009,CPT0226120002,CPT0226030006,CPT0226090006,FALSE,49,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,5.5,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2b,8,2,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,166,61,22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Nebilet,Medical Record,No,Living,1191,NA,,1204,NA,Yes,Yes,No,Unknown Tumor Status,Complete Remission,Unknown,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1191,0,13,NA,49,High or alive at last follow-up,<50
C3N-01645,HNSCC,C3N-01645-T,C3N-01645-N,TRUE,,CPT0088430003,CPT0088410003,CPT0088410006,CPT0088430006,CPT0088470002,CPT0088410009,,FALSE,71,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,9,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,172,84,28,Unknown,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,584,NA,,612,NA,No,No,No,With Tumor,Complete Remission,,Yes,374,,"Locoregional Recurrence, Cervical Lymph Node",,Convincing Image (i.e. CT/PET/MRI),Unknown,,,Unknown,Unknown,Unknown,NA,NA,374,402,1,584,0,28,NA,71,High or alive at last follow-up,>70
C3N-04611,HNSCC,C3N-04611-T,,TRUE,,,CPT0261520003,CPT0261520009,CPT0261550009,CPT0261640002,CPT0261520006,CPT0261550006,FALSE,55,Male,Unknown,Unknown,European,Ukraine,No,Larynx,,Right,Unifocal,6,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,175,75,24.49,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,Aspirin Cardio,Medical Record,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,55,,50-60
C3N-03011,HNSCC,C3N-03011-T,C3N-03011-N,TRUE,,CPT0226270003,CPT0226250004,CPT0226250010,,CPT0226330002,CPT0226250007,,FALSE,62,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,31,3,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,182,79,23.85,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,38,No or minimal exposure to secondhand smoke,,,,colon adenocarcinoma,"Radiation, Surgery, Chemotherapy",No,,,No,Deceased,598,598,Unknown,NA,598,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,396,,"Hypopharynx, Distant Metastasis (specify)",vertebrae,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,396,396,1,598,1,0,NA,62,High or alive at last follow-up,60-70
C3L-01237,HNSCC,C3L-01237-T,C3L-01237-N,TRUE,,CPT0199830003,CPT0199820003,CPT0199820009,CPT0199830009,CPT0200410002,CPT0199820006,CPT0199830006,FALSE,57,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN2,9,5,cM0,Staging Incomplete,Not documented,R0: No residual tumor,Stage IV,,,IHC staining not done,176,54,17.43,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",6,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,20,NA,,0,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,20,0,-20,NA,57,High or alive at last follow-up,50-60
C3N-01946,HNSCC,C3N-01946-T,C3N-01946-N,TRUE,,CPT0163610003,CPT0163600003,CPT0163600009,CPT0163610006,CPT0163640002,CPT0163600006,,FALSE,64,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,1.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,1,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,Stage II,,,IHC staining not done,176,83,26.79,No,Lifelong non-drinker,"Current reformed smoker, years unknown",NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1335,NA,,1346,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1335,0,11,NA,64,High or alive at last follow-up,60-70
C3N-01756,HNSCC,C3N-01756-T,C3N-01756-N,TRUE,,CPT0163170003,CPT0163160003,CPT0163160009,CPT0163170009,CPT0163200002,CPT0163160006,CPT0163170006,FALSE,62,Male,Unknown,Unknown,European,Poland,No,Hypopharynx,,Left,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN2c,9,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,164,57,21,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,22.5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,1547,NA,,1563,NA,Yes,No,No,Tumor Free,Persistent Disease,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1547,0,16,NA,62,High or alive at last follow-up,60-70
C3N-01945,HNSCC,C3N-01945-T,,TRUE,,,CPT0163530003,CPT0163530009,,CPT0163590002,CPT0163530006,,FALSE,61,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,5,2,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,Stage III,,,IHC staining not done,179,52,16,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,1115,1115,Unknown,NA,1128,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,Patient Deceased,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1115,1,13,NA,61,High or alive at last follow-up,60-70
C3L-04354,HNSCC,C3L-04354-T,C3L-04354-N,TRUE,,CPT0243140004,CPT0243090003,CPT0243090009,CPT0243140007,CPT0243240002,CPT0243090006,CPT0243140010,FALSE,60,Male,Unknown,Unknown,European,Bulgaria,No,Larynx,,Midline,Unifocal,2,Non-Keratinized Squamous Cell Carcinoma,G3 Poorly differentiated,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2 ,pNX,-1,0,cMX,pMX,,R0: No residual tumor,Stage II,,,IHC staining not done,180,85,26.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,9,Exposure to secondhand smoke history not available,,,,,,,Gliclazide|Bisoprolol fumarate,Self Report|Self Report,No,Living,1017,NA,,1024,NA,Yes,No,No,Tumor Free,Persistent Disease,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1017,0,7,NA,60,High or alive at last follow-up,50-60
C3L-00987,HNSCC,C3L-00987-T,,TRUE,,,CPT0127050003,CPT0127050009,,CPT0128500002,CPT0127050006,,FALSE,61,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Unknown,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,7,1,cM0,Staging Incomplete,Not documented,R0: No residual tumor,Stage III,,,IHC staining not done,182,80,24.15,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,43,Yes,Yes,,30,,,,,,No,Living,429,NA,,433,NA,Yes,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,429,0,4,NA,61,High or alive at last follow-up,60-70
C3L-04025,HNSCC,C3L-04025-T,,TRUE,,,CPT0256560003,CPT0256560009,CPT0256590010,CPT0256700002,CPT0256560006,CPT0256590007,FALSE,69,Male,Unknown,Unknown,European,Bulgaria,No,Oral cavity,,Right,Unifocal,1.5,Squamous cell verrucous carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,-1,0,Staging Incomplete,Staging Incomplete,,RX: Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,182,80,24.15,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,470,NA,,479,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,470,0,9,NA,69,High or alive at last follow-up,60-70
C3L-02621,HNSCC,C3L-02621-T,C3L-02621-N,TRUE,,CPT0201860004,CPT0201830004,CPT0201830010,CPT0201860010,CPT0201970002,CPT0201830007,CPT0201860007,FALSE,68,Male,Unknown,Unknown,European,Bulgaria,No,Larynx,,Unknown,Multifocal,0.6,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pNX,0,0,Staging Incomplete,Staging Incomplete,,R0: No residual tumor,Stage I,,,IHC staining not done,178,80,25.25,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,45,Yes,,Yes,20,,,,Amlodipine|Valsartan|Hydrochlorothiazide|Amiodarone,Self Report|Self Report|Self Report|Self Report,No,Living,314,NA,,327,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,314,0,13,NA,68,High or alive at last follow-up,60-70
C3N-02925,HNSCC,C3N-02925-T,,TRUE,,,CPT0184530003,CPT0184530009,CPT0184550009,CPT0184590002,CPT0184530006,CPT0184550006,FALSE,68,Female,Unknown,Unknown,East_Asian,China,No,Oral cavity,,Left,Unifocal,4.2,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2b,29,2,cM0,No pathologic evidence of distant metastasis,no,R0: No residual tumor,Stage IV,EGFR（+），P53（+），CyclinD1（+），HER2（-），VEGF（+），β-Cat（cytomembrane+），P16（partly+），P21（-）,,IHC staining not done,160,53,20.7,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1022,NA,,1028,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1022,0,6,NA,68,High or alive at last follow-up,60-70
C3N-03612,HNSCC,C3N-03612-T,,TRUE,,,CPT0194790003,CPT0194790013,CPT0194800006,CPT0194890002,CPT0194790009,CPT0194800009,FALSE,51,Male,Unknown,Unknown,European,Ukraine,No,Oropharynx,,Right,Unifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,0,cM0,Staging Incomplete,0,R0: No residual tumor,Stage III,,,IHC staining not done,174,91,30.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,697,NA,,669,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,697,0,-28,NA,51,High or alive at last follow-up,50-60
C3N-01752,HNSCC,C3N-01752-T,,TRUE,,,CPT0162940003,CPT0162940009,,CPT0162970002,CPT0162940006,,FALSE,73,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Right,Unifocal,5.6,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,26,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,168,55,19,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Bisocard 2.5 mg 1/2 x 1,Self Report,No,Deceased,998,998,Main malignancy,NA,1009,No,No,No,With Tumor,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,998,1,11,NA,73,High or alive at last follow-up,>70
C3N-03837,HNSCC,C3N-03837-T,C3N-03837-N,TRUE,,CPT0236640003,CPT0236620003,CPT0236620009,CPT0236640006,CPT0236680002,CPT0236620006,,FALSE,54,Male,Unknown,Unknown,East_Asian,China,No,Lip,,Midline,Unifocal,4.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,19,0,cM0,pM0,no,R0: No residual tumor,Stage III,,,IHC staining not done,165,65,23.88,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Metformin,Medical Record,No,Living,706,NA,,706,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,706,0,0,NA,54,High or alive at last follow-up,50-60
C3N-03027,HNSCC,C3N-03027-T,C3N-03027-N,TRUE,,CPT0226400003,CPT0226390003,CPT0226390009,CPT0226400009,CPT0226430002,CPT0226390006,CPT0226400006,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,1,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,0,0,cM0,pM0,,R0: No residual tumor,Stage II,,,IHC staining not done,174,62,20,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,48,No or minimal exposure to secondhand smoke,,,8,,,,,,No,Deceased,211,211,Other reasons,NA,221,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,211,1,10,NA,65,Low,60-70
C3N-01943,HNSCC,C3N-01943-T,C3N-01943-N,TRUE,,CPT0163430003,CPT0163410003,CPT0163410009,CPT0163430009,CPT0163470002,CPT0163410006,CPT0163430006,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT4a,pN3a,39,17,cM0,pMx,no distant metastasis,R1: Microscopic residual tumor,Stage IV,,,IHC staining not done,175,95,31,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,840,852,Main malignancy,NA,852,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,852,1,0,NA,63,High or alive at last follow-up,60-70
C3N-04278,HNSCC,C3N-04278-T,C3N-04278-N,TRUE,,CPT0245460003,CPT0245450003,CPT0245450009,CPT0245460006,CPT0245490002,CPT0245450006,CPT0245460009,FALSE,71,Male,Unknown,Unknown,European,Poland,No,Larynx,,Midline,Unifocal,4,Basaloid squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pNx,0,0,cM0,pMx,,R0: No residual tumor,Stage III,,,0,163,80,30,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,28.5,No or minimal exposure to secondhand smoke,,,,ca planoepitheliale (lungs),"Surgery,Chemotherapy",No,Bataloc ZOK 50|Tritace 5|Atrox 20|Polocard,Self Report|Self Report|Self Report|Medical Record,No,Living,576,NA,,582,NA,No,No,No,Unknown Tumor Status,Complete Remission,,Yes,455,,Hypopharynx,,Convincing Image (i.e. CT/PET/MRI),Unknown,,,Unknown,Unknown,Unknown,NA,NA,455,461,1,576,0,6,NA,71,High or alive at last follow-up,>70
C3N-03785,HNSCC,C3N-03785-T,,TRUE,,,CPT0245680003,CPT0245680009,,CPT0245720002,CPT0245680006,,FALSE,66,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Right,Multifocal,1.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pNx,0,0,cM0,pMx,,R0: No residual tumor,Stage I,MK002 - CK 5/6 (positive),,IHC staining not done,172,95,32,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,9.2,Yes,,Yes,,,,,Co-prestarium,Medical Record,No,Deceased,658,1152,Unknown,NA,1158,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1152,1,6,NA,66,High or alive at last follow-up,60-70
C3N-03620,HNSCC,C3N-03620-T,C3N-03620-N,TRUE,,CPT0196060003,CPT0196040003,CPT0196040006,CPT0196060009,CPT0196150002,CPT0196040009,CPT0196060006,FALSE,61,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Right,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,168,90,31.89,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,728,NA,,724,NA,No,Yes,No,Tumor Free,Complete Remission,,Yes,149,,"Oral Cavity, Cervical Lymph Node",,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,149,145,1,728,0,-4,NA,61,High or alive at last follow-up,60-70
C3N-02695,HNSCC,C3N-02695-T,,TRUE,,,CPT0244940004,CPT0244940007,,CPT0245000002,CPT0244940010,,FALSE,45,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Multifocal,3.7,"Squamous cell carcinoma, non-keratinizing",G1 Well differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,17,0,cM0,pMx,,R0: No residual tumor,Stage III,,,IHC staining not done,168,73,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,16.8,No or minimal exposure to secondhand smoke,,,,,,,"Bespres 160 |Cardilopin 2,5",Self Report|Self Report,No,Deceased,604,632,Main malignancy,NA,636,Yes,No,No,With Tumor,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,632,1,4,NA,45,High or alive at last follow-up,<50
C3L-00995,HNSCC,C3L-00995-T,C3L-00995-N,TRUE,,CPT0169920003,CPT0169890003,CPT0169890009,CPT0169920009,CPT0167190002,CPT0169890006,CPT0169920006,FALSE,56,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,6,1,cM0,Staging Incomplete,Not evaluated,R0: No residual tumor,Stage III,,,IHC staining not done,170,60,20.76,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,31,Exposure to secondhand smoke history not available,,,31,,,,,,No,Deceased,-10,-9,Other reasons,NA,1,No,No,No,Tumor Free,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,1,10,9,56,Low,50-60
C3L-02651,HNSCC,C3L-02651-T,C3L-02651-N,TRUE,,CPT0242000004,CPT0241980004,CPT0241980010,CPT0242000010,CPT0242110002,CPT0241980007,CPT0242000007,FALSE,81,Male,Unknown,Unknown,European,Bulgaria,No,Larynx,,Unknown,Unifocal,2.5,Keratinizing Squamous Cell Carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2 ,pNX,-1,0,cMX,pMX,,RX: Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,183,70,20.9,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,78,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,291,NA,,301,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,291,0,10,NA,81,High or alive at last follow-up,>70
C3L-02617,HNSCC,C3L-02617-T,C3L-02617-N,TRUE,,CPT0229190003,CPT0229190003,"['CPT0229190013', 'CPT0229210013']",CPT0229230009,CPT0229330002,"['CPT0229190006', 'CPT0229210006']",CPT0229230006,FALSE,64,Male,Unknown,Unknown,European,Bulgaria,No,Larynx,,Unknown,Unifocal,6,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,-1,0,Staging Incomplete,Staging Incomplete,,R0: No residual tumor,Stage II,,,IHC staining not done,178,73,23.04,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,66,Yes,,Yes,20,,,,BISOPROLOL|Perindopril arginine,Self Report|Self Report,No,Living,967,NA,,981,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,967,0,14,NA,64,High or alive at last follow-up,60-70
C3N-02716,HNSCC,C3N-02716-T,,TRUE,,,CPT0177390003,CPT0177390009,,CPT0177460002,CPT0177390006,,FALSE,76,Male,Unknown,Unknown,European,Ukraine,No,Lip,,Unknown,Unifocal,1.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pNX,0,0,cM0,Staging Incomplete,No,R0: No residual tumor,Stage I,p16 - positive; p53 - positive; CK5/6 - positive; EBV - negative;,,IHC staining not done,185,120,35.06,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,258,NA,,267,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,258,0,9,NA,76,High or alive at last follow-up,>70
C3N-00825,HNSCC,C3N-00825-T,,TRUE,,,CPT0094280004,CPT0094280007,,CPT0094340002,CPT0094280010,,FALSE,53,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Multifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,26,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage II,,,0,175,77,25,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,25.3,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1730,NA,,1758,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1730,0,28,NA,53,High or alive at last follow-up,50-60
C3N-04280,HNSCC,C3N-04280-T,,TRUE,,,CPT0245600003,CPT0245600009,,CPT0245620002,CPT0245600006,,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Larynx,,Midline,Unifocal,4,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,15,0,cM0,cMx,,R0: No residual tumor,Stage II,,,IHC staining not done,176,102,32,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,10,No or minimal exposure to secondhand smoke,,,,,,,Siofor|Co-Prestarium,Self Report|Self Report,No,Living,1058,NA,,1087,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1058,0,29,NA,65,High or alive at last follow-up,60-70
C3N-03042,HNSCC,C3N-03042-T,C3N-03042-N,TRUE,,CPT0235470002,CPT0235460003,CPT0235460009,,CPT0235610002,CPT0235460006,,FALSE,67,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,Oral cavity,,Right,Unifocal,5.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),T4a,N3b,41,4,M0,Not identified,Not identified,RX: Presence of residual tumor cannot be assessed,Stage IV,p16 was negative,,IHC staining not done,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,67,,60-70
C3N-04279,HNSCC,C3N-04279-T,C3N-04279-N,TRUE,,C3N-04279-05,CPT0245500003,CPT0245500009,,CPT0245540002,CPT0245500006,,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,6,0,cM0,pMx,,R0: No residual tumor,Stage II,,,IHC staining not done,182,76,22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,33.8,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,1139,NA,,1139,NA,Yes,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1139,0,0,NA,65,High or alive at last follow-up,60-70
C3N-02279,HNSCC,C3N-02279-T,C3N-02279-N,TRUE,,CPT0163800003,CPT0163790003,CPT0163790009,CPT0163800009,CPT0163830002,CPT0163790006,CPT0163800006,FALSE,59,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,4,0,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,167,48,17,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,39,Yes,Yes,Yes,,,,,,,No,Living,414,NA,,423,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,414,0,9,NA,59,High or alive at last follow-up,50-60
C3N-02714,HNSCC,C3N-02714-T,C3N-02714-N,TRUE,,CPT0177220003,CPT0177200003,CPT0177200009,CPT0177220009,CPT0177310002,CPT0177200006,CPT0177220006,FALSE,23,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Right,Unifocal,2.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,0,cM0,Staging Incomplete,No,R0: No residual tumor,Stage II,p16 - positive; p53 - positive; EBV - negative; CK5/6 - positive;,,IHC staining not done,182,89,26.87,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,907,NA,,720,NA,Yes,Yes,No,Tumor Free,Complete Remission,,Yes,301,,"Locoregional Recurrence, Cervical Lymph Node",,Convincing Image (i.e. CT/PET/MRI),Yes,,,No,No,No,313,NA,301,114,1,907,0,-187,NA,23,High or alive at last follow-up,
C3N-01755,HNSCC,C3N-01755-T,,TRUE,,,CPT0163090003,CPT0163090009,,CPT0163150002,CPT0163090006,,FALSE,68,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,5,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,PN1,3,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,176,77,24,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",NA,Yes,Yes,Yes,,,,,,,No,Living,1701,NA,,1709,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1701,0,8,NA,68,High or alive at last follow-up,60-70
C3N-00857,HNSCC,C3N-00857-T,C3N-00857-N,TRUE,,C3N-00857-05,CPT0094350004,CPT0094350007,,CPT0094410002,CPT0094350010,,FALSE,64,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4a,pN1,14,1,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,172,64,21,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,636,636,Unknown,NA,636,Yes,No,No,Unknown Tumor Status,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,636,1,0,NA,64,High or alive at last follow-up,60-70
C3N-03456,HNSCC,C3N-03456-T,,TRUE,,,CPT0246590003,CPT0246590009,,CPT0246610002,CPT0246590006,,FALSE,64,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,7,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN0,22,0,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,186,88,25,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,41,Yes,Yes,Yes,Unknown,,,,Clexane|Diuver,Medical Record|Medical Record,No,Living,1426,NA,,1429,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1426,0,3,NA,64,High or alive at last follow-up,60-70
C3N-03841,HNSCC,C3N-03841-T,C3N-03841-N,TRUE,,CPT0236870003,CPT0236850004,CPT0236850010,CPT0236870006,CPT0236910002,CPT0236850007,CPT0236870009,FALSE,59,Male,Unknown,Unknown,East_Asian,China,No,Larynx,,Midline,Unifocal,3,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,26,2,cM0,pM0,,R0: No residual tumor,Stage III,EGFR（+），P53（-），CyclinD1（+），HER2（-），VEGF（-），β-Cat（cytomembrane +），P16（-），P21（-）,,IHC staining not done,168,56,19.84,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,34,Exposure to secondhand smoke history not available,,,30,,,,,,No,Deceased,331,753,Unknown,NA,765,No,No,No,With Tumor,Complete Remission,,Yes,105,,"New Primary Tumor, Specify",Liver,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,105,117,1,753,1,12,NA,59,High or alive at last follow-up,50-60
C3N-01757,HNSCC,C3N-01757-T,C3N-01757-N,TRUE,,CPT0163250003,CPT0163240003,CPT0163240009,,CPT0163310002,CPT0163240006,,FALSE,64,Male,Unknown,Unknown,European,Poland,No,Larynx,,Midline,Unifocal,2.7,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pNx,2,0,cM0,pMx,no distant metastasis,R0: No residual tumor,Stage II,,,IHC staining not done,176,72,23,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,"Vivace 2,5 1 x 1/2",Self Report,No,Living,1337,NA,,1344,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1337,0,7,NA,64,High or alive at last follow-up,60-70
C3N-03013,HNSCC,C3N-03013-T,C3N-03013-N,TRUE,,CPT0245140003,CPT0245130003,CPT0245130006,,CPT0245170002,CPT0245130009,,FALSE,59,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pNx,0,0,cMx,pMx,,R0: No residual tumor,Stage II,,,IHC staining not done,175,90,29,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,ca planoepitheliale (tonsil),"Radiation,Chemotherapy",Yes,Prenessa|Bisocard 5|Atrox 20|Acard|cavinton,Self Report|Self Report|Self Report|Self Report|Self Report,No,Living,1389,NA,,1393,NA,Yes,No,No,Unknown Tumor Status,Complete Remission,Unknown,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1389,0,4,NA,59,High or alive at last follow-up,50-60
C3N-02700,HNSCC,C3N-02700-T,,TRUE,,,CPT0177010003,CPT0177010009,,CPT0177130002,CPT0177010006,,FALSE,80,Female,Unknown,Unknown,European,Ukraine,No,Lip,,Unknown,Unifocal,3.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,0,cM0,Staging Incomplete,No,R0: No residual tumor,Stage II,p16 - positive; p53 - positive; CK5/6 - positive; EBV - negative;,,IHC staining not done,165,68,24.98,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,5,NA,,8,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,5,0,3,NA,80,High or alive at last follow-up,>70
C3N-03878,HNSCC,C3N-03878-T,C3N-03878-N,TRUE,,CPT0237640003,CPT0237620004,CPT0237620007,CPT0237640009,CPT0237680002,CPT0237620010,CPT0237640006,FALSE,52,Male,Unknown,Unknown,East_Asian,China,No,Larynx,,Right,Unifocal,2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,77,3,cM0,pM0,,R0: No residual tumor,Stage III,EGFR（+），P53（-），CyclinD1（+），HER2（focal+），VEGF（-），β-Cat（cytomembrane +），P16（-），P21（+）,,IHC staining not done,170,55,19.03,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,10,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,650,NA,,649,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,650,0,-1,NA,52,High or alive at last follow-up,50-60
C3N-01340,HNSCC,C3N-01340-T,C3N-01340-N,TRUE,,CPT0094580003,CPT0094560004,CPT0094560010,CPT0094580006,CPT0094620002,CPT0094560007,,FALSE,72,Male,Unknown,Unknown,European,Poland,No,Larynx,,Midline,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,4,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R1: Microscopic residual tumor,Stage IV,,,IHC staining not done,175,77,25,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,ca plano laryngeal,Surgery,Unknown,Cardilopin 10mg 1X,Self Report,No,Deceased,1264,1388,Main malignancy,NA,1399,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1388,1,11,NA,72,High or alive at last follow-up,>70
C3N-01754,HNSCC,C3N-01754-T,C3N-01754-N,TRUE,,CPT0163020003,CPT0162990004,CPT0162990010,CPT0163020009,CPT0163080002,CPT0162990007,CPT0163020006,FALSE,64,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Right,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,5,0,cM0,pMx,,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,185,77,22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,41,Yes,Yes,,,,,,,,No,Living,1535,NA,,1549,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1535,0,14,NA,64,High or alive at last follow-up,60-70
C3N-02727,HNSCC,C3N-02727-T,,TRUE,,,CPT0177710003,"['CPT0177700009', 'CPT0177710009']",CPT0177730009,CPT0177820002,"['CPT0177700006', 'CPT0177710006']",CPT0177730006,FALSE,49,Male,Unknown,Unknown,European,Ukraine,No,Larynx,,Left,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pNX,0,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,Stage IV,p16 - negative; p53 - positive; EBV - negative; CK5/6 - positive;,,IHC staining not done,168,73,25.86,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,693,NA,,673,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,693,0,-20,NA,49,High or alive at last follow-up,<50
C3N-02333,HNSCC,C3N-02333-T,,TRUE,,,CPT0176770003,CPT0176770009,CPT0176790009,CPT0176950002,CPT0176770006,CPT0176790006,FALSE,61,Male,Unknown,Unknown,European,Ukraine,No,Larynx,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pNX,0,0,cM0,Staging Incomplete,No,R0: No residual tumor,Stage IV,p53 - positive; CK5/7 - positive; EBV - negative; p16 - negative;,,IHC staining not done,168,59,20.9,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,735,NA,,735,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,735,0,0,NA,61,High or alive at last follow-up,60-70
C3N-04276,HNSCC,C3N-04276-T,C3N-04276-N,TRUE,,C3N-04276-06,CPT0245350003,CPT0245350009,,CPT0245390002,CPT0245350012,,FALSE,68,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Cannot be assessed,Eighth Edition (2017),pT4a,pN0,23,0,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,175,90,29,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,36.8,No or minimal exposure to secondhand smoke,,,,laryngeal cancer (ca planoepitheliale),Surgery,Yes,"Bisocard 2,5",Self Report,No,Living,1165,NA,,1165,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,Yes,1106,,"New Primary Tumor, Specify",Lung tumor,"Biopsy with Histologic Confirmation, Convincing Image (i.e. CT/PET/MRI)",Unknown,,,Unknown,Unknown,Unknown,NA,NA,1106,1106,1,1165,0,0,NA,68,High or alive at last follow-up,60-70
C3N-03928,HNSCC,C3N-03928-T,C3N-03928-N,TRUE,,CPT0223460003,CPT0223450003,CPT0223450009,CPT0223460009,CPT0223550002,CPT0223450006,CPT0223460006,FALSE,60,Female,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G1 Well differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,13,1,cM0,Staging Incomplete,no,R0: No residual tumor,Stage III,,,IHC staining not done,163,103,38.77,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,702,NA,,694,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,702,0,-8,NA,60,High or alive at last follow-up,50-60
C3N-03888,HNSCC,C3N-03888-T,C3N-03888-N,TRUE,,CPT0222200003,CPT0222180003,CPT0222180009,CPT0222200009,CPT0222290002,CPT0222180006,CPT0222200006,FALSE,58,Male,Unknown,Unknown,European,Ukraine,No,Larynx,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,0,cM0,Staging Incomplete,no,R0: No residual tumor,Stage III,,,IHC staining not done,176,116,37.45,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,675,NA,,675,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,675,0,0,NA,58,High or alive at last follow-up,50-60
C3N-03433,HNSCC,C3N-03433-T,,TRUE,,,CPT0246540003,CPT0246540009,,CPT0246580002,CPT0246540006,,FALSE,76,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Right,Unifocal,2.4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN0,7,0,cM0,pMx,,R0: No residual tumor,Stage II,,,IHC staining not done,168,82,29,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40.5,No or minimal exposure to secondhand smoke,,,,,,,Bisocard 5|Polpril 5 mg|Siofor 1000|Insulin|Clexane,Self Report|Self Report|Self Report|Medical Record|Medical Record,No,Deceased,960,960,Unknown,NA,964,No,No,No,Tumor Free,Persistent Disease,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,960,1,4,NA,76,High or alive at last follow-up,>70
C3N-03783,HNSCC,C3N-03783-T,,TRUE,,,CPT0245730003,CPT0245730009,,CPT0245770002,CPT0245730006,,FALSE,67,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,7,2,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,176,100,32,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,50,Yes,,Yes,,,,,Axtil|Amlopin 5,Self Report|Self Report,No,Deceased,952,952,Main malignancy,NA,954,Yes,Yes,No,With Tumor,Complete Remission,Persistent Disease,Yes,721,,Oral Cavity,,Biopsy with Histologic Confirmation,No,,,No,No,No,NA,NA,721,723,1,952,1,2,NA,67,High or alive at last follow-up,60-70
C3N-03457,HNSCC,C3N-03457-T,,TRUE,,,CPT0246620003,CPT0246620009,,CPT0246660002,CPT0246620006,,FALSE,71,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,17,0,cM0,pMx,,R0: No residual tumor,Stage II,,,IHC staining not done,165,70,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,36.8,No or minimal exposure to secondhand smoke,,,,,,,"Con Cor Cor 1,25",Self Report,No,Living,1395,NA,,1400,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1395,0,5,NA,71,High or alive at last follow-up,>70
C3L-04849,HNSCC,C3L-04849-T,,TRUE,,,CPT0248520003,CPT0248520009,,CPT0248540002,CPT0248520006,,FALSE,63,Male,Unknown,Unknown,European,Other: TSS did not collect,No,Oral cavity,,Left,Unifocal,4.7,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN3,45,8,cM0,No pathologic evidence of distant metastasis,Not applicable,R1: Microscopic residual tumor,Stage IV,,,IHC staining not done,174,95,31.63,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,31.5,Exposure to secondhand smoke history not available,,,Unknown,,,,Ibuprofen,Medical Record,No,Living,356,NA,,315,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,356,0,-41,NA,63,High or alive at last follow-up,60-70
C3L-01138,HNSCC,C3L-01138-T,,TRUE,,,CPT0199700003,CPT0199700009,CPT0199710009,CPT0200380002,CPT0199700006,CPT0199710006,FALSE,62,Male,Unknown,Unknown,European,Ukraine,No,Larynx,,Left,Unifocal,6,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN1,12,1,cM0,Staging Incomplete,Not documented,R0: No residual tumor,Stage IV,,,IHC staining not done,182,70,21.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,54,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,367,NA,,361,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,367,0,-6,NA,62,High or alive at last follow-up,60-70
C3N-03488,HNSCC,C3N-03488-T,C3N-03488-N,TRUE,,CPT0194260003,CPT0194250003,CPT0194250013,CPT0194260006,CPT0194350002,CPT0194250009,CPT0194260009,FALSE,64,Male,Unknown,Unknown,European,Ukraine,No,Hypopharynx,,Right,Unifocal,5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,0,cM0,Staging Incomplete,No,R0: No residual tumor,Stage III,,,IHC staining not done,171,51,17.44,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,706,NA,,673,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,706,0,-33,NA,64,High or alive at last follow-up,60-70
C3N-03876,HNSCC,C3N-03876-T,C3N-03876-N,TRUE,,CPT0237500003,CPT0237480004,CPT0237480010,CPT0237500006,CPT0237540002,CPT0237480007,,FALSE,65,Male,Unknown,Unknown,East_Asian,China,No,Larynx,,Left,Unifocal,2.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN2b,27,5,cM0,pM0,no,R0: No residual tumor,Stage IV,EGFR（+），P53（+），CyclinD1（partly+），HER2（-），VEGF（-/+），β-Cat（cytomembrane +），P16（-），P21（partly+）,,IHC staining not done,172,57,19.27,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",22,Exposure to secondhand smoke history not available,,,20,,,,,,No,Deceased,422,465,Unknown,NA,470,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,465,1,5,NA,65,High or alive at last follow-up,60-70
C3N-03782,HNSCC,C3N-03782-T,,TRUE,,,CPT0245630003,CPT0245630009,,CPT0245670002,CPT0245630006,,FALSE,50,Female,Unknown,Unknown,European,Poland,No,Oral cavity,,Right,Unifocal,3,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pTIVA,pN0,12,0,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,165,61,22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,30,Yes,Yes,Yes,,,,,"Bisocard 2,5",Self Report,No,Living,1088,NA,,1092,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1088,0,4,NA,50,High or alive at last follow-up,<50
C3N-02694,HNSCC,C3N-02694-T,,TRUE,,,CPT0244890004,CPT0244890007,,CPT0244930002,CPT0244890010,,FALSE,57,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,2.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,13,2,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,180,93,28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,617,617,Main malignancy,NA,622,Yes,Yes,No,With Tumor,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,617,1,5,NA,57,High or alive at last follow-up,50-60
C3N-04275,HNSCC,C3N-04275-T,C3N-04275-N,TRUE,,C3N-04275-05,CPT0245300003,CPT0245300009,,CPT0245340002,CPT0245300006,,FALSE,61,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,7,0,cM0,pMx,,R0: No residual tumor,Stage II,,,IHC staining not done,175,73,23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,41,Yes,Yes,Yes,,,,,,,No,Living,1135,NA,,1137,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1135,0,2,NA,61,High or alive at last follow-up,60-70
C3N-00204,HNSCC,C3N-00204-T,C3N-00204-N,TRUE,,CPT0084650004,CPT0084630009,CPT0084630015,CPT0084650007,CPT0085320002,CPT0084630012,,FALSE,63,Female,Unknown,Unknown,European,Bulgaria,No,Larynx,,Left,Unifocal,3.2,Adenosquamous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,1,1,cM0,Staging Incomplete,Not specified,R0: No residual tumor,Stage III,,,IHC staining not done,153,45,19.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Bisor|Amlovasik|Skorpyl plus,Self-reported|Medical Record|Medical Record,No,Deceased,145,175,Main malignancy,NA,175,No,No,No,Unknown Tumor Status,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,175,1,0,NA,63,Low,60-70
C3L-00994,HNSCC,C3L-00994-T,C3L-00994-N,TRUE,,CPT0169740004,CPT0169730003,CPT0169730009,CPT0169750009,CPT0167170002,CPT0169730006,CPT0169750006,FALSE,50,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,5,0,cM0,Staging Incomplete,Not evaluated,R0: No residual tumor,Stage II,,,IHC staining not done,182,72,21.74,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,10.2,Exposure to secondhand smoke history not available,,,32,,,,,,No,Deceased,133,202,Main malignancy,NA,176,Yes,No,No,With Tumor,Complete Remission,,Yes,133,,"Oral Cavity, Locoregional Recurrence",,Biopsy with Histologic Confirmation,No,,,No,No,No,NA,NA,133,107,1,202,1,-26,NA,50,Low,<50
C3L-00977,HNSCC,C3L-00977-T,,TRUE,,,CPT0169640003,CPT0169640009,CPT0169650008,CPT0167150002,CPT0169640006,CPT0169650006,FALSE,56,Male,Unknown,Unknown,European,Russia,No,Oral cavity,,Midline,Unifocal,1.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN1,11,1,cM0,No pathologic evidence of distant metastasis,No documented,R0: No residual tumor,Stage III,,,IHC staining not done,182,110,33.21,No,Lifelong non-drinker,"Current reformed smoker, years unknown",NA,Yes,Yes,,,,,,Metformin|Isosorbide dinitrate|Famotidin|Atorvastatin,Medical Record|Self Report|Medical Record|Self Report,No,Deceased,1537,1537,Main malignancy,NA,1504,No,No,No,With Tumor,Complete Remission,Patient Deceased,Yes,853,,Distant Metastasis (specify),Lung,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,853,820,1,1537,1,-33,NA,56,High or alive at last follow-up,50-60
C3N-04152,HNSCC,C3N-04152-T,,TRUE,,,CPT0223970003,CPT0223970009,CPT0224000009,CPT0224090002,CPT0223970006,CPT0224000006,FALSE,54,Male,Unknown,Unknown,European,Other: Armenia,No,Oropharynx,,Left,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2b,18,3,cM0,Staging Incomplete,no,R0: No residual tumor,Stage IV,,,IHC staining not done,177,72,22.98,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,671,NA,,639,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,671,0,-32,NA,54,High or alive at last follow-up,50-60
C3N-03889,HNSCC,C3N-03889-T,,TRUE,,,CPT0222360003,CPT0222360009,CPT0222380009,CPT0222470002,CPT0222360006,CPT0222380006,FALSE,53,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,-1,0,cM0,Staging Incomplete,no,R0: No residual tumor,Stage IV,,,IHC staining not done,182,108,32.6,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,30,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,694,NA,,681,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,694,0,-13,NA,53,High or alive at last follow-up,50-60
C3L-03378,HNSCC,C3L-03378-T,C3L-03378-N,TRUE,,CPT0199890003,CPT0199880003,CPT0199880009,CPT0199890009,CPT0200430002,CPT0199880006,CPT0199890006,FALSE,54,Male,Unknown,Unknown,European,Russia,No,Oral cavity,,Midline,Unifocal,1.8,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2c,16,6,cM0,Staging Incomplete,Not documented,R0: No residual tumor,Stage IV,,,IHC staining not done,174,67,22.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,34,Yes,Yes,,,,,,Metformin|Gliclazide|Bisoprolol|Ketonal,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1175,NA,,1175,NA,No,No,No,With Tumor,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1175,0,0,NA,54,High or alive at last follow-up,50-60
C3N-03028,HNSCC,C3N-03028-T,C3N-03028-N,TRUE,,CPT0226450003,CPT0226440003,CPT0226440009,CPT0226450009,CPT0226480002,CPT0226440006,CPT0226450006,FALSE,59,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Right,Unifocal,3,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,21,7,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,180,70,21,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,39,No or minimal exposure to secondhand smoke,,,Unknown,,,,Acard|Atoris|Bisocard|Valzek|Amlopin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1010,NA,,1015,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1010,0,5,NA,59,High or alive at last follow-up,50-60
C3N-03008,HNSCC,C3N-03008-T,C3N-03008-N,TRUE,,CPT0245020003,CPT0245010003,CPT0245010006,,CPT0245050002,CPT0245010009,,FALSE,65,Female,Unknown,Unknown,European,Poland,No,Oral cavity,,Midline,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2c,38,7,cM0,pMx,,R0: No residual tumor,Stage IV,,,IHC staining not done,168,61,21,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,22.5,No or minimal exposure to secondhand smoke,,,5,,,,Bisocard,Self Report,No,Deceased,146,158,Main malignancy,NA,167,No,No,No,With Tumor,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,158,1,9,NA,65,Low,60-70
C3N-01944,HNSCC,C3N-01944-T,C3N-01944-N,TRUE,,CPT0163490003,CPT0163480003,CPT0163480009,CPT0163490009,CPT0163520002,CPT0163480006,CPT0163490006,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Midline,Unifocal,3.5,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Present,Cannot be assessed,Eighth Edition (2017),pT4a,pN1,6,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,167,73,26,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45,No or minimal exposure to secondhand smoke,,,,,,,indapamidum|atorvastatin,Self Report|Self Report,No,Living,610,NA,,618,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,558,,Oral Cavity,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,558,566,1,610,0,8,NA,65,High or alive at last follow-up,60-70
C3N-00822,HNSCC,C3N-00822-T,,TRUE,,,CPT0087820003,CPT0087820006,,CPT0087880002,CPT0087820009,,FALSE,53,Female,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,12,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,186,90,26,Unknown,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,978,978,Unknown,NA,983,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,978,1,5,NA,53,High or alive at last follow-up,50-60
C3N-00519,HNSCC,C3N-00519-T,C3N-00519-N,TRUE,,CPT0013460003,CPT0013430003,['CPT0013430006'],CPT0013460006,CPT0013520002,CPT0013430009,CPT0013460009,FALSE,67,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,23,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,173,70,23.39,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,40,Exposure to secondhand smoke history not available,,,5,,,,,,Yes,Deceased,258,258,Unknown,NA,261,Yes,No,No,Unknown Tumor Status,Persistent Disease,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,258,1,3,NA,67,Low,60-70
C3N-00829,HNSCC,C3N-00829-T,C3N-00829-N,TRUE,,CPT0013250003,CPT0013210004,CPT0013210007,,CPT0013310002,CPT0013210010,,FALSE,53,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN2b,4,2,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,174,75,24,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Deceased,952,958,Main malignancy,NA,965,Yes,Yes,No,With Tumor,Complete Remission,,Yes,442,,Locoregional Recurrence,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,No,No,NA,NA,442,449,1,958,1,7,NA,53,High or alive at last follow-up,50-60
C3N-00295,HNSCC,C3N-00295-T,C3N-00295-N,TRUE,,C3N-00295-05,CPT0008520008,['CPT0008520013'],,CPT0008550002,CPT0008520010,,FALSE,53,Female,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,2.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,Stage III,,,0,155,56,23.31,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,1679,NA,,1708,NA,Yes,No,No,Tumor Free,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1679,0,29,NA,53,High or alive at last follow-up,50-60
C3N-00828,HNSCC,C3N-00828-T,,TRUE,,,CPT0013130003,['CPT0013130006'],,CPT0013200002,CPT0013130009,,FALSE,67,Male,Unknown,Unknown,European,Poland,No,Larynx,,Left,Unifocal,4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R1: Microscopic residual tumor,Stage II,,,IHC staining not done,169,80,28.01,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,50,Exposure to secondhand smoke history not available,,,,,,,"spironol, nebilet, furosemid, amlodypina, roswera, nasen, vitacon",Self Report,Yes,Deceased,948,948,Unknown,NA,949,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,948,1,1,NA,67,High or alive at last follow-up,60-70
C3N-00297,HNSCC,C3N-00297-T,,TRUE,,,CPT0011130005,['CPT0011130008'],,CPT0011220002,CPT0011130011,,FALSE,69,Male,Unknown,Unknown,European,Poland,No,Larynx,,Unknown,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,2,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,172,50,16.9,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,1734,NA,,1744,NA,Unknown,Unknown,Unknown,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1734,0,10,NA,69,High or alive at last follow-up,60-70
C3N-00306,HNSCC,C3N-00306-T,C3N-00306-N,TRUE,,CPT0011320003,CPT0011290003,['CPT0011290005'],CPT0011320006,CPT0011380006,CPT0011290008,CPT0011320009,FALSE,50,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,16,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,176,91,29,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,645,NA,,658,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,645,0,13,NA,50,High or alive at last follow-up,<50
C3N-00846,HNSCC,C3N-00846-T,,TRUE,,,CPT0024810003,['CPT0024810006'],,CPT0024890002,CPT0024810009,,FALSE,67,Male,Unknown,Unknown,European,Ukraine,No,Oral cavity,,Left,Unifocal,2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pNX,0,0,cM0,Staging Incomplete,No.,R0:No residual tumor,Stage I,p16 - patchy positive; p53 - 90%; CK5/6 - positive;,,IHC staining not done,177,79,25.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,15,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,644,NA,,629,NA,Yes,No,No,With Tumor,Complete Remission,,Yes,615,,Cervical Lymph Node,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,615,600,1,644,0,-15,NA,67,High or alive at last follow-up,60-70
C3N-00498,HNSCC,C3N-00498-T,C3N-00498-N,TRUE,,CPT0013030003,CPT0013000004,['CPT0013000007'],CPT0013030010,CPT0013090002,CPT0013000010,,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Oral cavity,,Left,Unifocal,3,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,12,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,176,84,27.12,Unknown,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,polocard,Self Report,Yes,Living,1704,NA,,1715,NA,No,No,No,Tumor Free,Persistent Disease,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1704,0,11,NA,63,High or alive at last follow-up,60-70
C3N-00307,HNSCC,C3N-00307-T,C3N-00307-N,TRUE,,CPT0008960003,CPT0008930003,['CPT0008930009'],CPT0008960005,CPT0008970002,CPT0008930006,CPT0008960008,FALSE,70,Male,Unknown,Unknown,European,Poland,No,Larynx,,Right,Unifocal,3,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4a,pNX,0,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,173,100,33.41,Yes,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,squamous cell carcinoma,Surgery,No,"Bisocard 5|Amlopin 10|Clexane 0,6",Self Report|Medical Record|Self-reported and Medical Record,Yes,Deceased,270,270,Unknown,NA,282,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,270,1,12,NA,70,Low,60-70
C3N-00299,HNSCC,C3N-00299-T,,TRUE,,,CPT0008630003,['CPT0008630009'],,CPT0008670002,CPT0008630006,,FALSE,54,Male,Unknown,Unknown,European,Poland,No,Lip,,Unknown,Unifocal,3.1,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,8,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,176,64,20,Unknown,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Deceased,-20,231,Unknown,NA,251,Unknown,Unknown,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,231,1,20,NA,54,Low,50-60
C3L-05257,HNSCC,,C3L-05257-N,FALSE,,CPT0281470002,,,,,,,FALSE,56,Female,Unknown,Unknown,,Other: Montenegro,No,Hard palate,,Right,Unifocal,4.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,14,0,staging incomplete,staging incomplete,,RX: Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,178,83,26.2,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,,Yes,,,,,,,No,Living,1001,NA,,1017,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1001,0,16,NA,56,High or alive at last follow-up,50-60
C3L-02665,LSCC,C3L-02665-T,C3L-02665-N,TRUE,,CPT0192590004,CPT0192540004,CPT0192540010,CPT0192590007,CPT0192700002,CPT0192540007,CPT0192590010,FALSE,51,Male,Unknown,Unknown,European,Bulgaria,No,Middle Lobe,,Right,Multifocal,6,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pNX,-1,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,178,80,25.25,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,29,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,3,NA,,3,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,3,0,0,NA,51,High or alive at last follow-up,50-60
C3L-01663,LSCC,C3L-01663-T,C3L-01663-N,TRUE,,CPT0091620003,CPT0091610003,CPT0091610006,CPT0091620009,CPT0093630002,CPT0091610009,CPT0091620006,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,1.6,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN2,18,3,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,Stage III,"p40: Stongly Positive, TTF-1: Negative","PD-L1: Negative, TPS: 0%",IHC staining not done,165,57,20.94,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,Unknown,,,,alendronate (FOSAMAX) |Ascorbic Acid (VITAMIN C)|aspirin| Calcium|clopidogrel (PLAVIX)| Omega-3 Fatty Acids (FISH OIL),Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1723,1729,Main malignancy,NA,1729,Yes,Yes,No,With Tumor,Complete Remission,Patient Deceased,Yes,1204,Distant Metastasis,Liver,,Biopsy with Histologic Confirmation,,No,,Yes,Yes,Yes,NA,NA,1204,1204,1,1729,1,0,NA,73,High or alive at last follow-up,>70
C3N-02575,LSCC,C3N-02575-T,C3N-02575-N,TRUE,,CPT0147700003,CPT0147680004,CPT0147680007,CPT0147700009,CPT0147710002,CPT0147680010,CPT0147700006,FALSE,69,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Left,Unifocal,2.5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,12,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage I,"HER2（-）, TTF1（-）, EGFR（+），CK7（-），Ki-67（+,80％），β-Cat（membranous +）, P63（+）, ERCC1（-）, RRM1（-）, Syn（-），P40(+), ","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（-），NapsinA（-），CK20（-），CK5/6（+）",IHC staining not done,175,72,23.51,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,100,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,491,540,Unknown,NA,547,No,No,No,With Tumor,Not Applicable,,Yes,359,Distant Metastasis,Other,kidney,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,359,366,1,540,1,7,NA,69,High or alive at last follow-up,60-70
C3L-02546,LSCC,C3L-02546-T,C3L-02546-N,TRUE,,CPT0112660003,CPT0112650003,CPT0112650006,CPT0112660009,CPT0115180002,CPT0112650009,CPT0112660006,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,4,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,2,0,cM1,No pathologic evidence of distant metastasis,Possible tiny bone metastases to the anterior fourth rib,RX:Presence of residual tumor cannot be assessed,Stage I,"PD-L1: Positive, Low Expression, TPS: 15%",,IHC staining not done,182,82,24.7,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",40,Exposure to secondhand smoke history not available,,,,Squamous Cell Laryngeal Cancer,"Radiation,Surgery,Chemotherapy",Yes,Albuterol|Aspirin|Atorvastatin|Nystatin|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1432,NA,,1432,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1432,0,0,NA,74,High or alive at last follow-up,>70
C3L-00965,LSCC,C3L-00965-T,,TRUE,,,CPT0101130003,CPT0101130006,,CPT0100930002,CPT0101130009,,FALSE,63,Male,Unknown,Unknown,European,Russia,No,Upper Lobe,,Right,Unifocal,4,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,18,2,cM0,Staging Incomplete,Not documented,R0:No residual tumor,Stage II,,,IHC staining not done,161,61,23.53,No,Lifelong non-drinker,Current reformed smoker within past 15 years,42,Yes,,Yes,,,,,Amlodipine |Famotidine,Medical Record|Medical Record,No,Living,1857,NA,,1826,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1857,0,-31,NA,63,High or alive at last follow-up,60-70
C3L-02963,LSCC,C3L-02963-T,C3L-02963-N,TRUE,,CPT0197100003,CPT0197090003,CPT0197090006,CPT0197100006,CPT0197830002,CPT0197090009,CPT0197100009,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,3.2,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN0,16,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,"p40: positive , PD-L1 22C3 FDA (Keytruda) expressed tumor proportion score: 1% Intensity: weak ",,IHC staining not done,178,66,20.95,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,56,Exposure to secondhand smoke history not available,,,Unknown,,,,"Albuterol inhaler|Acetaminophen|Norvasc|Lipitor|Lasix|Lutein|colace|K-Dur,Klor-con|Protonix|pericolace|Flomax|Ultram|diovan",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1435,NA,,1435,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1435,0,0,NA,71,High or alive at last follow-up,>70
C3N-04162,LSCC,C3N-04162-T,C3N-04162-N,TRUE,,CPT0222740003,CPT0222730003,CPT0222730009,CPT0222740006,CPT0222830002,CPT0222730006,,FALSE,46,Male,Unknown,Unknown,European,Ukraine,No,Upper Lobe,,Left,Unifocal,6,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,-1,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,,,IHC staining not done,172,67,22.65,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,349,NA,,358,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,349,0,9,NA,46,High or alive at last follow-up,<50
C3L-02646,LSCC,C3L-02646-T,C3L-02646-N,TRUE,,CPT0202580004,CPT0202530004,CPT0202530010,,CPT0202660002,CPT0202530007,,FALSE,74,Male,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Left,Unifocal,5,Squamous cell carcinoma,G2 Moderately differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT3,pNX,-1,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,178,95,29.98,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,5,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,1027,1027,Main malignancy,NA,1034,Yes,Yes,No,With Tumor,Persistent Disease,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1027,1,7,NA,74,High or alive at last follow-up,>70
C3N-02285,LSCC,C3N-02285-T,C3N-02285-N,TRUE,,CPT0126760003,CPT0126740003,CPT0126740009,CPT0126760009,CPT0126800002,CPT0126740006,CPT0126760006,FALSE,72,Female,Unknown,Unknown,European,Poland,No,Lower Lobe,,Left,Unifocal,5,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,37,0,0,0,,R0:No residual tumor,Stage II,TTF1 (-) CK7 (+)  IN SEVERAL CELLS p40 (+),,IHC staining not done,157,65,26.37,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,35.3,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1527,NA,,1527,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1527,0,0,NA,72,High or alive at last follow-up,>70
C3N-03875,LSCC,C3N-03875-T,C3N-03875-N,TRUE,,CPT0237430003,CPT0237410004,CPT0237410010,CPT0237430006,CPT0237470002,CPT0237410007,CPT0237430009,FALSE,68,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,4.8,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,19,0,cM0,pM0,no,R0:No residual tumor,Stage I,HER2（-），TTF1（-），EGFR（+），CK7（-），Ki-67（+60％），β-Cat（cytomembrane+），P63（+），Syn（-），P40（+），CDX2（+/-），SPA（-），NapsinA（-），CK5/6（+），PD-L1 22C3（tumor cell（TPS）2％），ERCC1（+），ROS1（-），GATA3（-），RRM1（-）,,IHC staining not done,158,61,24.44,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,45,,,,digoxin |tongxinluo,Medical Record|Medical Record,No,Living,1017,NA,,1017,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1017,0,0,NA,68,High or alive at last follow-up,60-70
C3N-03424,LSCC,C3N-03424-T,C3N-03424-N,TRUE,,CPT0245790003,CPT0245780003,CPT0245780009,CPT0245790009,CPT0245820002,CPT0245780006,CPT0245790006,FALSE,74,Male,Unknown,Unknown,European,Poland,No,Lower Lobe,,Right,Unifocal,1.2,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,23,0,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,Stage I,p40+ p63+ ttf1-,,0,169,72,25.21,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1330,NA,,1339,NA,No,No,No,Unknown Tumor Status,Complete Remission,Unknown,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1330,0,9,NA,74,High or alive at last follow-up,>70
C3N-01017,LSCC,C3N-01017-T,C3N-01017-N,TRUE,,CPT0069900003,CPT0069890003,['CPT0069890009'],CPT0069900006,CPT0069980002,CPT0069890006,CPT0069900009,FALSE,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Nearby of hilar,Left,Unifocal,3.5,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,,,IHC staining not done,170,58,20.07,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,459,NA,,453,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,459,0,-6,NA,56,High or alive at last follow-up,50-60
C3L-00081,LSCC,C3L-00081-T,C3L-00081-N,TRUE,,CPT0001030003,CPT0001020003,CPT0001020164,CPT0001030009,CPT0000010163,CPT0001020005,CPT0001030006,FALSE,61,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,22,3,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,Stage II,,,IHC staining not done,157,80,32.29,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,xanax|bupropion|ProAir HFA 90|vitamin D3 2000|ibuprofen|Probiotic Formula oral capsule,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,472,473,Main malignancy,NA,473,No,Yes,No,With Tumor,Unknown,,Yes,188,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),209,Yes,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,209,209,188,188,1,473,1,0,NA,61,High or alive at last follow-up,60-70
C3L-02649,LSCC,C3L-02649-T,C3L-02649-N,TRUE,,CPT0204820003,CPT0204800003,CPT0204800009,CPT0204820009,CPT0204930002,CPT0204800006,CPT0204820006,FALSE,62,Male,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Left,Unifocal,8.8,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3A,pN2,16,2,cMx,,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,200,93,23.25,No,Lifelong non-drinker,Current reformed smoker within past 15 years,NA,Yes,,Yes,,,,,Doxazosin,Self-reported and Medical Record,No,Deceased,1019,1072,Main malignancy,NA,1072,No,Yes,No,With Tumor,Persistent Disease,Patient Deceased,Yes,235,Distant Metastasis,"Lung, Liver",,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,NA,NA,235,235,1,1072,1,0,NA,62,High or alive at last follow-up,60-70
C3L-01838,LSCC,C3L-01838-T,,TRUE,,,CPT0091820003,CPT0091820006,,CPT0093670002,CPT0091820009,,FALSE,70,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,4,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,170,81,28.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",33,Exposure to secondhand smoke history not available,,,,,,,Aspirin 81mg|Voltaren|nexium|Glucosamine-chondroit|lisinopril-hydrochlorothiazide|Zocor|Mens one daily ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1707,NA,,1707,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1707,0,0,NA,70,High or alive at last follow-up,60-70
C3N-02252,LSCC,C3N-02252-T,C3N-02252-N,TRUE,,CPT0128900003,CPT0128890003,CPT0128890009,CPT0128900009,CPT0130770002,CPT0128890006,CPT0128900006,FALSE,68,Female,White,Not Hispanic or Latino,European,United States,No,,,,,NA,Squamous cell carcinoma,G3 Poorly differentiated,,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,68,,60-70
C3L-03963,LSCC,C3L-03963-T,C3L-03963-N,TRUE,,CPT0227420003,CPT0227400003,CPT0227400009,CPT0227420009,CPT0227530002,CPT0227400006,CPT0227420006,FALSE,73,Male,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,6,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,170,85,29.41,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,60,Yes,Yes,Yes,,,,,Nebivolol|Fosinopril Sodium,Self Report|Self Report,No,Living,993,NA,,1000,NA,No,No,No,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,993,0,7,NA,73,High or alive at last follow-up,>70
C3N-03072,LSCC,C3N-03072-T,C3N-03072-N,TRUE,,CPT0209040003,CPT0209020004,CPT0209020010,,CPT0209080002,CPT0209020007,,FALSE,62,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,3.2,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN2,24,4,cM0,pM0,no,R0:No residual tumor,Stage III,HER2（-），TTF1（-），EGFR（+），CK7（-），Ki-67（+，60％），β-Cat（membrane +），P63（+），Syn（-），P40（+），CDX2（-），SPA（-），NapsinA（-），CK5/6（+），PD-L1 22C3（tumor cells（TPS）20％），ERCC1（-），ROS1（-），GATA3（-），RRM1（-）,,IHC staining not done,175,95,31.02,No,Lifelong non-drinker,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,azithromycin,Medical Record,No,Living,323,NA,,323,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,323,0,0,NA,62,High or alive at last follow-up,60-70
C3L-02969,LSCC,C3L-02969-T,C3L-02969-N,TRUE,,CPT0217490003,CPT0217420003,CPT0217420009,CPT0217490009,CPT0219800002,CPT0217420006,CPT0217490006,FALSE,76,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,3,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN0,26,0,unknown,unknown ,,R0:No residual tumor,Stage I,PD-L1 22C3 FDA (Keytruda) expressed tumor proportion score 99% intensity: Strong,,IHC staining not done,173,102,34.21,No,Lifelong non-drinker,Current reformed smoker within past 15 years,45,Exposure to secondhand smoke history not available,,,,,,,aspirin 325|Lipitor|Plavix|Dulaglutide |Glucosamine 1500 complex|Toujeo Solostar |Lisinopril |Lyrica |Lopressor|Omega-3 acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1427,NA,,1427,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1427,0,0,NA,76,High or alive at last follow-up,>70
C3N-03662,LSCC,C3N-03662-T,C3N-03662-N,TRUE,,CPT0219390003,CPT0219360003,CPT0219360009,,CPT0219480002,CPT0219360006,,FALSE,64,Male,Unknown,Unknown,European,Ukraine,No,Middle Lobe,,Right,Unifocal,4,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,11,3,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,TTF1 - negative; CK7 - negative; p63 - positive;,,IHC staining not done,180,85,26.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,6,NA,,12,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,6,0,6,NA,64,High or alive at last follow-up,60-70
C3N-03051,LSCC,C3N-03051-T,C3N-03051-N,TRUE,,CPT0208780003,CPT0208770003,CPT0208770009,CPT0208780009,CPT0208820002,CPT0208770006,CPT0208780006,FALSE,65,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN2,53,1,cM0,pM0,no,R0:No residual tumor,Stage III,"HER2（-），TTF1（-），EGFR（+），CK7（partly+），Ki-67（+,70％），β-Cat（cytomembrane +），P63（+），Syn（-），P40（+），CDX2（-），SPA（-），NapsinA（-），CK5/6（+），PD-L1 22C3（tumor cells（TPS）<1％），ERCC1（-），ROS1（-），GATA3（-），RRM1（few+）",,IHC staining not done,168,72,25.51,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,40,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,735,NA,,735,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,735,0,0,NA,65,High or alive at last follow-up,60-70
C3N-02434,LSCC,C3N-02434-T,C3N-02434-N,TRUE,,CPT0115860003,CPT0115830003,CPT0115830006,CPT0115860009,CPT0116430002,CPT0115830009,CPT0115860006,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,4.5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,Elastic Verhoeff-van gieson Stain for Elastin: Shows involvement of visceral pleura by carcinoma,,IHC staining not done,157,101,40.6,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40,Exposure to secondhand smoke history not available,,,,,,,amlodipine|aspirin|chlorthalidone|enalapril|metformin|metaprolol|triamcinolone acetonide 55,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1421,NA,,1396,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1421,0,-25,NA,74,High or alive at last follow-up,>70
C3L-02127,LSCC,C3L-02127-T,C3L-02127-N,TRUE,,CPT0130310003,CPT0130270003,CPT0130270006,CPT0130310009,CPT0130390002,CPT0130270009,CPT0130310006,FALSE,66,Male,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,4,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,13,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage II,,,IHC staining not done,178,80,25.25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,78,Yes,,Yes,,,,,Enalapril/Hydrochlothiazide,Self Report,No,Living,1447,NA,,1446,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1447,0,-1,NA,66,High or alive at last follow-up,60-70
C3N-02339,LSCC,C3N-02339-T,C3N-02339-N,TRUE,,CPT0136660003,CPT0136640003,CPT0136640013,CPT0136660009,CPT0136750002,CPT0136640009,CPT0136660006,FALSE,78,Male,Unknown,Unknown,European,Ukraine,No,Upper Lobe,,Left,Unifocal,7,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,21,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage II,TTF1 - negative; P63 - positive; CK5/6 - positive;,,IHC staining not done,172,92,31.1,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,170,NA,,176,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,170,0,6,NA,78,High or alive at last follow-up,>70
C3L-03961,LSCC,C3L-03961-T,C3L-03961-N,TRUE,,CPT0232690003,CPT0232670003,"['CPT0232640009', 'CPT0232670009']",CPT0232690009,CPT0232790002,"['CPT0232640006', 'CPT0232670006']",CPT0232690006,FALSE,48,Female,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,3,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,10,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,164,78,29,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,43.5,Yes,,Yes,,,,,,,No,Living,5,NA,,14,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,5,0,9,NA,48,High or alive at last follow-up,<50
C3L-04391,LSCC,C3L-04391-T,C3L-04391-N,TRUE,,CPT0234580003,CPT0234560003,CPT0234560009,CPT0234580009,CPT0235180002,CPT0234560006,CPT0234580006,FALSE,70,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,3.8,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN0,10,0,unknown,,,R0:No residual tumor,Stage I,PD-L1 22C3 FDA (Keytruda) expressed tumor proportion score 2% intensity: 1+,,IHC staining not done,175,71,23.03,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",10,Exposure to secondhand smoke history not available,,,Unknown,,,,amiodarone |Ascorbic Acid |B complex vitimins|Chelated Zinc|Vitamin B-12|Mag Aspart-potassium aspart|Melatonin |glucosamine chondroitin msm |Potassium chloride SA |selenuim |St. Johns wort |Bactrim-Septra|Vitamin E|Omega-3 acids|Thera M plus,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1155,NA,,1155,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1155,0,0,NA,70,High or alive at last follow-up,60-70
C3L-02619,LSCC,C3L-02619-T,C3L-02619-N,TRUE,,CPT0191930003,CPT0191860003,CPT0191860009,CPT0191930006,CPT0192020002,CPT0191860006,CPT0191930009,FALSE,70,Male,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Right,Unifocal,8.5,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,13,1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,182,120,36.23,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,72,Exposure to secondhand smoke history not available,,,,,,,Lercanidipine hydrochloride|Propafenone hydrochloride|Allopurinol,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,Living,505,NA,,514,NA,Yes,No,No,Tumor Free,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,505,0,9,NA,70,High or alive at last follow-up,60-70
C3N-02494,LSCC,C3N-02494-T,C3N-02494-N,TRUE,,CPT0234820003,CPT0234790003,CPT0234790009,CPT0234820006,CPT0234910002,CPT0234790006,CPT0234820009,FALSE,66,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Middle Lobe,,Right,Unifocal,3,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,16,0,cM0,No pathologic evidence of distant metastasis,No metastasis,RX:Presence of residual tumor cannot be assessed,Stage I,"Diffusely positive for p40, focal and weakly positive for BerEP4 and negative for TTF1 and Napsin-A",,0,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,66,,60-70
C3N-03880,LSCC,C3N-03880-T,C3N-03880-N,TRUE,,CPT0237710003,CPT0237690004,CPT0237690010,CPT0237710009,CPT0237750002,CPT0237690007,CPT0237710006,FALSE,76,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,2.2,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN1,24,1,cM0,pM0,no,R0:No residual tumor,Stage II,HER2（focal+），TTF1（-），EGFR（+），CK7（-），Ki-67（+40％），β-Cat（cytomembrane+），P63（+），Syn（-），P40（+），GATA3（-），CDX2（-），SPA（-），NapsinA（-），CK20（-），CK5/6（+），PD-L1 22C3（tumor cell（TPS）+95％），ERCC1（-），ROS1（-）,,IHC staining not done,170,85,29.41,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,108,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,736,NA,,736,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,736,0,0,NA,76,High or alive at last follow-up,>70
C3N-03092,LSCC,C3N-03092-T,C3N-03092-N,TRUE,,CPT0197520003,CPT0197480003,CPT0197480009,CPT0197520009,CPT0197660002,CPT0197480006,CPT0197520006,FALSE,61,Male,Unknown,Unknown,European,Ukraine,No,,,,,NA,Squamous cell carcinoma,G2 Moderately differentiated,,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,61,,60-70
C3L-02669,LSCC,C3L-02669-T,C3L-02669-N,TRUE,,CPT0202400004,CPT0202350004,CPT0202350010,CPT0202400010,CPT0202510002,CPT0202350007,CPT0202400007,FALSE,73,Male,Unknown,Unknown,European,Bulgaria,No,Middle Lobe,,Right,Unifocal,4,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,11,-1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,170,60,20.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,96.3,Yes,,Yes,,,,,Rosuvastatin|Trimetazidine dihydrochloride|Zofenopril calcium|Clopidogrel|Torasemide|Famotidine|Lercanidipine hydrochloride,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,Deceased,637,796,Main malignancy,NA,796,Unknown,Unknown,Unknown,With Tumor,Persistent Disease,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,796,1,0,NA,73,High or alive at last follow-up,>70
C3N-03877,LSCC,C3N-03877-T,C3N-03877-N,TRUE,,CPT0237570003,CPT0237550004,CPT0237550007,CPT0237570009,CPT0237610002,CPT0237550010,CPT0237570006,FALSE,53,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,7,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,35,25,cM0,pM0,no,R0:No residual tumor,Stage III,HER2（-），TTF1（-），EGFR（+），CK7（few+），Ki-67（+70％），β-Cat（cytomembrane +），P63（+），Syn（-），P40（+），CDX2（-），SPA（-），NapsinA（-），CK5/6（+），PD-L1 22C3（tumor cell（TPS）15％），ERCC1（few+），ROS1（-），GATA3（-），RRM1（-）,,IHC staining not done,183,88,26.28,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,irbesartan,Medical Record,No,Living,682,NA,,682,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,682,0,0,NA,53,High or alive at last follow-up,50-60
C3N-01846,LSCC,C3N-01846-T,C3N-01846-N,TRUE,,CPT0098800003,CPT0098770003,CPT0098770013,CPT0098800006,CPT0098810002,CPT0098770009,CPT0098800009,FALSE,70,Male,Unknown,Unknown,European,Ukraine,No,Middle Lobe,,Right,Unifocal,4,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage I,TTF1 - negative; p63 - positive; CK7 - negative; CK5/6 - positive;,,IHC staining not done,168,72,25.51,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,533,533,Main malignancy,NA,472,No,No,No,With Tumor,Complete Remission,,Yes,123,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,NA,NA,123,62,1,533,1,-61,NA,70,High or alive at last follow-up,60-70
C3L-02964,LSCC,C3L-02964-T,C3L-02964-N,TRUE,,CPT0197380003,CPT0197210003,CPT0197210009,CPT0197380006,CPT0199140002,CPT0197210006,CPT0197380009,FALSE,58,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,4.5,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,14,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage II,p40: positive ,,IHC staining not done,170,75,26,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,42,Exposure to secondhand smoke history not available,,,Unknown,,,,Lipitor|Wellbutrin|cozaar,Medical Record|Medical Record|Medical Record,No,Deceased,766,766,Main malignancy,NA,766,No,No,No,With Tumor,Not Applicable,Patient Deceased,Yes,402,Distant Metastasis,Other,"mediastinal lymphadenopathy, neck, hila",Biopsy with Histologic Confirmation,,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,NA,402,402,1,766,1,0,NA,58,High or alive at last follow-up,50-60
C3N-00247,LSCC,C3N-00247-T,,TRUE,,,CPT0089880003,CPT0089880006,,CPT0091400002,CPT0089880009,,FALSE,77,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,2.2,Adenosquamous Carcinoma; at least 66% squamous component,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN1,17,3,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,see comments below,,0,165,75,27.45,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",2.5,Exposure to secondhand smoke history not available,,,,,,,acetaminophen|Vitamin D|ibprofen|metaprolol|multiple vitamin|ranibizumab,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1580,NA,,1523,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1580,0,-57,NA,77,High or alive at last follow-up,>70
C3N-01018,LSCC,C3N-01018-T,C3N-01018-N,FALSE,,CPT0104950003,CPT0104930003,CPT0104930006,CPT0104950006,CPT0107500002,CPT0104930009,CPT0104950009,FALSE,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,4,Solid adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,,IHC staining not done,170,48,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,419,NA,,412,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,419,0,-7,NA,64,High or alive at last follow-up,60-70
C3N-02288,LSCC,C3N-02288-T,C3N-02288-N,TRUE,,CPT0186140003,CPT0186130003,CPT0186130009,CPT0186140006,CPT0186170002,CPT0186130006,CPT0186140009,FALSE,58,Female,Unknown,Unknown,European,Poland,No,Lower Lobe,,Left,Unifocal,8,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,18,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage III,,,0,154,60,25.3,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",40,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,1462,NA,,1462,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1462,0,0,NA,58,High or alive at last follow-up,50-60
C3L-01606,LSCC,C3L-01606-T,C3L-01606-N,TRUE,,CPT0086270003,CPT0086260003,CPT0086260006,CPT0086270009,CPT0087360002,CPT0086260009,CPT0086270006,FALSE,66,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,2.2,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,86,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,175,96,31.35,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,35,Exposure to secondhand smoke history not available,,,,,,,Albuterol|Arava|Leucovorin|levothyroxine|Prenisone|methotrexate|testosterone cypionate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1782,NA,,1782,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1782,0,0,NA,66,High or alive at last follow-up,60-70
C3L-02164,LSCC,C3L-02164-T,C3L-02164-N,TRUE,,CPT0175270003,CPT0175260003,CPT0175260013,CPT0175270009,CPT0175340002,CPT0175260006,CPT0175270006,FALSE,58,Male,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,2.5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,31,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage II,,,IHC staining not done,172,78,26.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",NA,Yes,,Yes,,,,,Levofloxacin|Probiotic|Salbutamol|Lidocaine|Sodium chloride,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,370,NA,,360,NA,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,54,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),67,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,67,67,54,44,1,370,0,-10,NA,58,High or alive at last follow-up,50-60
C3N-02374,LSCC,C3N-02374-T,C3N-02374-N,TRUE,,CPT0146400003,CPT0146380004,CPT0146380007,CPT0146400009,CPT0146410002,CPT0146380010,CPT0146400006,FALSE,67,Male,Unknown,Unknown,East_Asian,China,No,Other,Middle and lower lobe,Right,Unifocal,9,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,32,1,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,"HER2(focal +), TTF1(-), EGFR(+)，CK7(-)，Ki-67(+, 90％)，β-Cat(+/-), P63(+), ERCC1(+), RRM1(-), Syn(-), P40(+), GATA3(-), CDX2(-), SPA(-), NapsinA(-), CK20(-), CK5/6(+)",,IHC staining not done,162,59,22.48,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,42,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1061,NA,,1067,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1061,0,6,NA,67,High or alive at last follow-up,60-70
C3N-02675,LSCC,C3N-02675-T,C3N-02675-N,TRUE,,CPT0187380003,CPT0187370003,CPT0187370009,CPT0187380006,CPT0187410002,CPT0187370006,CPT0187380009,FALSE,69,Male,Unknown,Unknown,European,Poland,No,Upper Lobe,,Right,Multifocal,1.7,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN2,-1,1,Staging Incomplete,Staging Incomplete,,R2:Macroscopic residual tumor,Stage III,,,1,176,84,27,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",20,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1338,1338,Main malignancy,NA,1337,Yes,No,No,With Tumor,Unknown,Patient Deceased,Yes,750,Both Locoregional and Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,NA,NA,750,749,1,1338,1,-1,NA,69,High or alive at last follow-up,60-70
C3N-02523,LSCC,C3N-02523-T,C3N-02523-N,TRUE,,CPT0234950004,CPT0234930004,CPT0234930010,CPT0234950007,CPT0235050002,CPT0234930007,CPT0234950010,FALSE,61,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,2,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),T1b,N0,19,0,m0,Not identified,No metastasis,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,61,,60-70
C3L-02130,LSCC,C3L-02130-T,C3L-02130-N,TRUE,,CPT0130070003,CPT0130030003,CPT0130030006,CPT0130070009,CPT0130150002,CPT0130030009,CPT0130070006,FALSE,70,Male,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,3.3,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,11,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,175,85,27.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,24,Yes,,Yes,,,,,,,No,Deceased,1386,1407,Unknown,NA,1403,No,Yes,No,Tumor Free,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1407,1,-4,NA,70,High or alive at last follow-up,60-70
C3N-02426,LSCC,C3N-02426-T,C3N-02426-N,TRUE,,CPT0147200003,CPT0147180004,CPT0147180007,CPT0147200006,CPT0147220004,CPT0147180010,CPT0147200009,FALSE,69,Female,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,2,adenosquamous carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,22,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage I,"CK5/6(partly+),P40(partly+),P63(partly+),CK7(partly+),NapsinA(partly+),TTF-1(partly+),SPA(partly+),Syn(-),CgA(-),Ki-67(+,15%)",,IHC staining not done,158,60,24.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,338,442,Unknown,NA,442,No,No,No,With Tumor,Not Applicable,,Yes,274,New Primary Tumor,Other,teratoma,Convincing Image (i.e. CT/PET/MRI),,,R0: No Residual Tumor,No,No,No,NA,NA,274,274,1,442,1,0,NA,69,High or alive at last follow-up,60-70
C3N-02284,LSCC,C3N-02284-T,,TRUE,,,CPT0126670003,CPT0126670009,,CPT0126730002,CPT0126670006,,FALSE,69,Male,Unknown,Unknown,European,Poland,No,Mainstem bronchus,,Right,Unifocal,5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,17,0,0,0,0,R0:No residual tumor,Stage II,,,0,165,70,25.71,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1512,NA,,1531,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1512,0,19,NA,69,High or alive at last follow-up,60-70
C3L-00923,LSCC,C3L-00923-T,C3L-00923-N,TRUE,,CPT0063440003,CPT0063430003,['CPT0063430006'],CPT0063440009,CPT0065260002,CPT0063430009,CPT0063440006,FALSE,71,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,32,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,,,IHC staining not done,149,82,36.76,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,67.5,Exposure to secondhand smoke history not available,,,,,,,Atenolol|Levothyroxine|Probiotic |Multi Vitamin|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1792,NA,,1792,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1792,0,0,NA,71,High or alive at last follow-up,>70
C3N-03486,LSCC,C3N-03486-T,C3N-03486-N,TRUE,,CPT0195520003,CPT0195510003,CPT0195510006,CPT0195520006,CPT0195610002,CPT0195510009,CPT0195520009,FALSE,65,Male,Unknown,Unknown,European,Ukraine,No,Upper Lobe,,Left,Unifocal,3,Basaloid squamous cell carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,20,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage I,,,IHC staining not done,173,70,23.39,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,315,NA,,321,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,315,0,6,NA,65,High or alive at last follow-up,60-70
C3N-04127,LSCC,C3N-04127-T,C3N-04127-N,TRUE,,CPT0238130003,CPT0238110004,CPT0238110007,CPT0238130009,CPT0238170002,CPT0238110010,CPT0238130006,FALSE,63,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN2,33,1,cM0,pM0,no,R0:No residual tumor,Stage III,HER2（-），TTF1（-），EGFR（+），CK7（+），Ki-67（+，60％），β-Cat（cytomembrane +），P63（+），Syn（-），P40（+），GATA3（-），CDX2（-），SPA（-），NapsinA（-），CK20（-），CK5/6（+），PD-L1 22C3（tumor cell（TPS）＜1％），ROS1（-）,,IHC staining not done,167,59,21.16,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,58.5,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,765,NA,,765,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,765,0,0,NA,63,High or alive at last follow-up,60-70
C3L-02951,LSCC,C3L-02951-T,C3L-02951-N,TRUE,,CPT0197170003,CPT0197150003,CPT0197150006,CPT0197170006,CPT0197840002,CPT0197150009,CPT0197170009,FALSE,61,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,4.8,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,11,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage II,PD-L1 22C3 FDA (Keytruda) expressed tumor proportion score 2% intensity: 1+,,IHC staining not done,155,59,24.56,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,20,Exposure to secondhand smoke history not available,,,,,,,Albuterol inhaler|Symbicort inhaler|Hydrocodone-acetaminophen ,Medical Record|Medical Record|Medical Record,No,Living,1420,NA,,1420,NA,No,No,No,With Tumor,Not Applicable,Persistent Disease,Yes,853,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,Yes,,R0: No Residual Tumor,No,No,No,957,NA,853,853,1,1420,0,0,NA,61,High or alive at last follow-up,60-70
C3L-02629,LSCC,C3L-02629-T,C3L-02629-N,TRUE,,CPT0202220004,CPT0202170003,CPT0202170009,CPT0202220010,CPT0202330002,CPT0202170006,CPT0202220007,FALSE,57,Male,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Right,Unifocal,8,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,22,0,cM0,Staging Incomplete,0,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,176,98,31.64,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,20,,,,Insulin|Metformin hydrochloride,Self-reported and Medical Record|Self-reported and Medical Record,No,Living,40,NA,,40,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,40,0,0,NA,57,High or alive at last follow-up,50-60
C3L-04013,LSCC,C3L-04013-T,C3L-04013-N,TRUE,,CPT0233330003,CPT0233320003,CPT0233320009,CPT0233330009,CPT0233440002,CPT0233320006,CPT0233330006,FALSE,61,Male,Unknown,Unknown,European,Bulgaria,No,Other,Left lung,Left,Unifocal,8,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,9,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,165,72,26.45,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,48.8,Yes,,Yes,35,,,,Bisoprolol fumarate,Self Report,No,Living,5,NA,,13,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,5,0,8,NA,61,High or alive at last follow-up,60-70
C3N-00221,LSCC,C3N-00221-T,C3N-00221-N,TRUE,,CPT0111000004,CPT0111150004,CPT0111150007,CPT0111000007,CPT0111280005,CPT0111150015,,FALSE,78,Male,Unknown,Not Hispanic or Latino,African,United States,No,Middle Lobe,,Right,Unifocal,4.7,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,10,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,188,93,26.43,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",36,Yes,Yes,,,Prostate,Surgery,No,Symbicort|Verelan PM|Ferrous Sulfate|Potassium PO|Vitamin E PO|Asorbic Acid,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,548,NA,,549,NA,Yes,No,No,With Tumor,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,548,0,1,NA,78,High or alive at last follow-up,>70
C3L-00568,LSCC,C3L-00568-T,C3L-00568-N,TRUE,,CPT0023500003,CPT0023470003,['CPT0023470008'],CPT0023500009,CPT0024570002,CPT0023470005,CPT0023500006,FALSE,74,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Upper Lobe,,Right,Unifocal,4.7,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage I,,,IHC staining not done,160,73,28.52,No,Lifelong non-drinker,Current reformed smoker within past 15 years,39,Exposure to secondhand smoke history not available,,,,,,,combivent|aspirin|symbicort|lisinopril|Multi Vitamins ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,93,NA,,93,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,93,0,0,NA,74,High or alive at last follow-up,>70
C3N-04155,LSCC,C3N-04155-T,C3N-04155-N,TRUE,,CPT0223820003,CPT0223790003,CPT0223790009,,CPT0223910002,CPT0223790006,CPT0223820006,FALSE,76,Male,Unknown,Unknown,European,Ukraine,No,Middle Lobe,,Right,Unifocal,2.5,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,5,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage I,ALK - negative; p63 - positive; CK5/6 - positive;,,IHC staining not done,163,84,31.62,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,46,NA,,11,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,46,0,-35,NA,76,High or alive at last follow-up,>70
C3N-01025,LSCC,C3N-01025-T,C3N-01025-N,TRUE,,CPT0083990003,CPT0083980003,['CPT0083980009'],CPT0083990009,CPT0084010002,CPT0083980006,CPT0083990006,FALSE,52,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,"Right lung, not otherwise specified",Right,Unifocal,10,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,15,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,,,IHC staining not done,168,63,22.32,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,1.5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,7,NA,,0,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,7,0,-7,NA,52,High or alive at last follow-up,50-60
C3L-02552,LSCC,C3L-02552-T,C3L-02552-N,TRUE,,CPT0112600003,CPT0112580003,CPT0112580009,CPT0112600009,CPT0115170002,CPT0112580006,CPT0112600006,FALSE,68,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,3.7,Adenosquamous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,22,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,,"FISH Negative for rearrangement of the ALK gene region, Negative for the  rearrangement of the ROS 1 gene region ",IHC staining not done,195,121,31.82,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,79.5,Exposure to secondhand smoke history not available,,,20,,,,Glucophage|Lisinopril |Glipizide|Lipitor|Toprol-XL |Mult. vitamin|Triple Omega 3-6-9|Desyrel|Vitamin B-12|Aspirin 81 mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1387,1387,Other reasons,NA,1387,No,No,No,Unknown Tumor Status,Not Applicable,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1387,1,0,NA,68,High or alive at last follow-up,60-70
C3N-02375,LSCC,C3N-02375-T,C3N-02375-N,TRUE,,CPT0146500003,CPT0146480004,CPT0146480007,CPT0146500009,CPT0146510002,CPT0146480010,CPT0146500006,FALSE,59,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,29,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,"HER2(+), TTF1(focal +), EGFR(+)，CK7(focal+)，Ki-67(+, 60％)，β-Cat(membranous +), P63(+), ERCC1(+), RRM1(focal+), Syn(focal+)","Immunohistochemistry:P40(+), GATA3(-), CDX2(-)，SPA(-)，NapsinA(-)，CK20(-)，CK5/6(+)",IHC staining not done,172,67,22.65,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,29,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1179,NA,,1183,NA,No,No,No,Tumor Free,Not Applicable,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1179,0,4,NA,59,High or alive at last follow-up,50-60
C3L-02660,LSCC,C3L-02660-T,C3L-02660-N,TRUE,,CPT0202740003,CPT0202720003,CPT0202720009,CPT0202740009,CPT0202840002,CPT0202720006,CPT0202740006,FALSE,72,Male,Unknown,Unknown,European,Bulgaria,No,Other,Right lung,Right,Unifocal,3,Keratinizing squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,23,15,cM0,Staging Incomplete,0,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,172,72,24.34,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,NA,Yes,,Yes,,,,,,,No,Deceased,1,355,Main malignancy,NA,363,Yes,No,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,1,8,NA,72,Low,>70
C3L-01884,LSCC,C3L-01884-T,C3L-01884-N,TRUE,,CPT0104380003,CPT0104360003,CPT0104360006,CPT0104380009,CPT0105120002,CPT0104360011,CPT0104380006,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,3,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,17,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,,"PD-L1: Negative, TPS:0%",IHC staining not done,170,82,28.31,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,Acetaminophen|Aggrenox|Albuterol|Amoxicillin-clavulanate|Benazepril|Diphenhydramine|Finasteride|Fluticasone|Fluticasone-Salmeterol|Lovastatin|Multi Vitamins|Ranitidine|Tamsulosin|Tiotropium Bromide Monohydrate|Viagra,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1483,1653,Other reasons,NA,1653,No,No,No,Tumor Free,Not Applicable,Complete Remission,Yes,173,Distant Metastasis,Other,Vocal cord ,Biopsy with Histologic Confirmation,173,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,173,173,173,173,1,1653,1,0,NA,74,High or alive at last follow-up,>70
C3N-02300,LSCC,C3N-02300-T,C3N-02300-N,TRUE,,CPT0126830003,CPT0126810003,CPT0126810009,CPT0126830006,CPT0126870002,CPT0126810006,,FALSE,69,Female,Unknown,Unknown,European,Poland,No,Upper Lobe,,Left,Unifocal,5.6,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,11,0,0,0,,R0:No residual tumor,Stage II,TTF1 - CK7 + p40 + p63 + CK5/6 +,pT3 pN0 (IIB),IHC staining not done,159,77,30,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1479,NA,,1506,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1479,0,27,NA,69,High or alive at last follow-up,60-70
C3L-01285,LSCC,C3L-01285-T,C3L-01285-N,TRUE,,CPT0087210003,CPT0087190003,CPT0087190006,CPT0087210009,CPT0087480002,['CPT0087190009'],CPT0087210006,FALSE,54,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,7,1,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage II,,,IHC staining not done,177,67,21.39,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,celexa|albuterol|wellbutrin|meloxicam|prilosec|zanaflex|incruse ellipta|symbicort,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1697,NA,,1703,NA,No,No,No,Tumor Free,Unknown,Complete Remission,Yes,610,Distant Metastasis,Other,anterior shin left leg,Biopsy with Histologic Confirmation,617,Yes,RX: Presence of Residual Tumor cannot be assessed,No,No,No,617,617,610,616,1,1697,0,6,NA,54,High or alive at last follow-up,50-60
C3L-02627,LSCC,C3L-02627-T,C3L-02627-N,TRUE,,CPT0202040003,CPT0202020008,CPT0202020014,CPT0202040009,CPT0202150002,CPT0202020011,CPT0202040006,FALSE,64,Female,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Right,Unifocal,2,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN0,11,0,cM0,Staging Incomplete,0,R0:No residual tumor,Stage I,,,IHC staining not done,160,70,27.34,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,45,Yes,,Yes,,,,,,,No,Living,1411,NA,,1417,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1411,0,6,NA,64,High or alive at last follow-up,60-70
C3L-00993,LSCC,C3L-00993-T,C3L-00993-N,TRUE,,CPT0102840003,CPT0102790003,CPT0102790006,CPT0102840009,CPT0101090002,CPT0102790009,CPT0102840006,FALSE,75,Male,Unknown,Unknown,European,Ukraine,No,Lower Lobe,,Right,Unifocal,6,Squamous cell carcinoma,G2 Moderately differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT2b,pN2,5,3,cM0,No pathologic evidence of distant metastasis,Not documented,R0:No residual tumor,Stage III,,,IHC staining not done,178,72,22.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,,,No,Deceased,-1,-1,Unknown,NA,2,No,No,No,Tumor Free,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,1,3,1,75,Low,>70
C3N-02425,LSCC,C3N-02425-T,C3N-02425-N,TRUE,,CPT0183270003,CPT0183250004,CPT0183250010,CPT0183270009,CPT0183310002,CPT0183250007,CPT0183270006,FALSE,61,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,7,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,36,0,cM0,No pathologic evidence of distant metastasis,no,R0:No residual tumor,Stage II,"HER2(partly+), TTF1(-), EGFR(+),CK7(-),Ki-67(+,70％),β-Cat(membranous +), P63(+), ERCC1(partly+), RRM1(-), Syn(-),P40(+)","Immunohistochemistry:GATA3(-), CDX2(-),SPA(-),NapsinA(-),CK20(-),CK5/6(+)",IHC staining not done,167,60,21.51,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1064,NA,,1073,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1064,0,9,NA,61,High or alive at last follow-up,60-70
C3L-02170,LSCC,C3L-02170-T,,TRUE,,,CPT0175560003,CPT0175560009,,CPT0175640002,CPT0175560006,,FALSE,73,Male,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Right,Unifocal,4.5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,15,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage I,,,IHC staining not done,166,93,33.75,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,38,Yes,,Yes,,,,,Indacaterol/Glycopyrronium,Self Report,No,Living,27,NA,,6,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,27,0,-21,NA,73,High or alive at last follow-up,>70
C3L-02624,LSCC,C3L-02624-T,C3L-02624-N,FALSE,,CPT0227070003,CPT0227020003,CPT0227020009,CPT0227070009,CPT0227170002,CPT0227020006,CPT0227070006,FALSE,63,Male,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,10,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,178,85,26.83,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40,Yes,,Yes,,,,,Atorvastaitin/amlodipine,Self Report,No,Deceased,776,832,Other reasons,NA,839,No,No,No,With Tumor,Not Applicable,Patient Deceased,Yes,130,New Primary Tumor,Liver,,Convincing Image (i.e. CT/PET/MRI),,,RX: Presence of Residual Tumor cannot be assessed,No,No,Yes,NA,NA,130,137,1,832,1,7,NA,63,High or alive at last follow-up,60-70
C3N-00555,LSCC,C3N-00555-T,C3N-00555-N,TRUE,,CPT0068320003,CPT0068280003,['CPT0068280009'],CPT0068320006,CPT0068390002,CPT0068280006,CPT0068320009,FALSE,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,Middle Lobe,,Right,Unifocal,5.5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,4,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,"P63+, TTF1-, NAPSIN A-",,IHC staining not done,170,59,20.42,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.2,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,787,NA,,782,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,787,0,-5,NA,59,High or alive at last follow-up,50-60
C3N-01893,LSCC,C3N-01893-T,C3N-01893-N,TRUE,,CPT0126470003,CPT0126450003,CPT0126450009,CPT0126470009,CPT0126510002,CPT0126450006,CPT0126470006,FALSE,70,Male,Unknown,Unknown,European,Poland,No,Upper Lobe,,Left,Unifocal,5.1,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,1,15,1,0,0,,R0:No residual tumor,Stage III,"TTF negative, CK 7 & napsin A negative, p40 positive",,IHC staining not done,162,66,25.15,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,663,663,Main malignancy,NA,671,No,Yes,No,With Tumor,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,663,1,8,NA,70,High or alive at last follow-up,60-70
C3N-03093,LSCC,C3N-03093-T,C3N-03093-N,TRUE,,CPT0197860003,CPT0197740003,CPT0197740009,CPT0197860009,CPT0198000002,CPT0197740006,CPT0197860006,FALSE,70,Female,Unknown,Unknown,European,Ukraine,No,,,,,NA,Squamous cell carcinoma,G3 Poorly differentiated,,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,70,,60-70
C3L-01455,LSCC,C3L-01455-T,C3L-01455-N,TRUE,,CPT0108600003,CPT0108560003,CPT0108560006,CPT0108600009,CPT0108340002,CPT0108560009,CPT0108600006,FALSE,88,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,17,1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,183,89,26.58,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,16,33,Unknown,NA,36,No,No,No,Unknown Tumor Status,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,33,1,3,NA,88,Low,>70
C3N-03848,LSCC,C3N-03848-T,C3N-03848-N,TRUE,,CPT0237080003,CPT0237060004,CPT0237060010,CPT0237080006,CPT0237120002,CPT0237060007,CPT0237080009,FALSE,56,Female,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN2,23,3,cM0,pM0,no,R0:No residual tumor,Stage III,CK5/6+，P40+，TTF1-，CK7-，NapsinA-,,IHC staining not done,158,65,26.04,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Euthyrox,Medical Record,No,Living,635,NA,,635,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,474,Distant Metastasis,Other,pleura,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,474,474,1,635,0,0,NA,56,High or alive at last follow-up,50-60
C3L-02968,LSCC,C3L-02968-T,C3L-02968-N,TRUE,,CPT0196820003,CPT0196810003,CPT0196810006,CPT0196820006,CPT0197760002,CPT0196810009,CPT0196820009,FALSE,64,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,6,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,19,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage II,,,IHC staining not done,168,72,25.66,Yes,Lifelong non-drinker,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,Prostate ,Surgery,Yes,Albuterol inhaler|Acetaminophen|Wellbutrin|Voltaren|methodone|B complex vitimins|Calcium carbonate |mulivitamin |aspirin 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1375,NA,,1375,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1375,0,0,NA,64,High or alive at last follow-up,60-70
C3N-03204,LSCC,C3N-03204-T,C3N-03204-N,TRUE,,CPT0209510003,CPT0209490003,CPT0209490009,CPT0209510009,CPT0209550002,CPT0209490006,CPT0209510006,FALSE,62,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,3,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN0,43,0,cM0,pM0,no,R0:No residual tumor,Stage I,"HER2(-),TTF1(-),EGFR(+),CK7(partially+),Ki-67(+,75%),β-Cat(membranous+),P63(+)，Syn(-)，P40(+)，GATA3(-)，ALK(Ventana)(-)，ALK-Neg-Tissue(-)，CDX2(partial+)，SPA(-)，NapsinA(-)，CK20(-)，CK5/6(+)，PD-L1 22C3 tumor cells(TPS)5%，RRM1(weakly+)，ERCC1（+）",,IHC staining not done,173,80,26.73,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,, aspirin|diltiazem|trimetazidine|isosorbide mononitrate|lipitor,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,835,NA,,835,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,835,0,0,NA,62,High or alive at last follow-up,60-70
C3L-00445,LSCC,C3L-00445-T,C3L-00445-N,TRUE,,CPT0130440004,CPT0130410003,CPT0130410006,CPT0130440010,CPT0130530002,CPT0130410009,CPT0130440007,FALSE,74,Male,Unknown,Unknown,European,Bulgaria,No,Middle Lobe,,Right,Unifocal,5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,25,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,178,95,29.98,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40,Yes,,Yes,,,,,Amiodarone|Bisoprolol|Quinapril|Spironolactone|Chlophazoline|Vildagliptine/Metformin|Vitamin A and E,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,Deceased,3,3,Unknown,NA,3,No,No,No,Tumor Free,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,3,1,0,NA,74,Low,>70
C3N-02283,LSCC,C3N-02283-T,,TRUE,,,CPT0126530003,CPT0126530009,,CPT0126580002,CPT0126530006,,FALSE,67,Male,Unknown,Unknown,European,Poland,No,Upper Lobe,,Right,Unifocal,4.1,Spindle cell carcinoma with undifferentiated non small carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2b,1,16,4,0,0,0,R0:No residual tumor,Stage II,TTF1 (-) CK7 (-) p40 (-) panCK (+) Wimentyna (+++) Ki67 (+) w ok. 90-100% jąder komórkowych EMA (-) SMA (-) Desmina (-) S100 (-) NSE (-) reakcja dodatnia ogniskowo MyoD1 (-) CD56 (+) ogniskowo Chromogranina (-) ,,4,181,98,29,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,90,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,108,NA,,160,NA,Unknown,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,108,0,52,NA,67,High or alive at last follow-up,60-70
C3N-02289,LSCC,C3N-02289-T,C3N-02289-N,TRUE,,CPT0186210003,CPT0186180003,CPT0186180009,CPT0186210006,CPT0186960002,CPT0186180006,CPT0186210009,FALSE,73,Male,Unknown,Unknown,European,Poland,No,Upper Lobe,,Right,Unifocal,5,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,9,0,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,Stage II,"p40+, p63+, CK7-/+, CD56-/+, TTF1-",,0,180,75,23.15,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1407,NA,,1411,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1407,0,4,NA,73,High or alive at last follow-up,>70
C3L-03962,LSCC,C3L-03962-T,C3L-03962-N,TRUE,,CPT0233160003,CPT0233120003,CPT0233120013,CPT0233160009,CPT0233260002,CPT0233120006,CPT0233160006,FALSE,65,Male,Unknown,Unknown,European,Bulgaria,No,Mainstem bronchus,,Left,Unifocal,2,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,17,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,178,75,23.67,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,20,Yes,,Yes,10,,,,Ranitidine,Self Report,No,Living,5,NA,,13,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,5,0,8,NA,65,High or alive at last follow-up,60-70
C3L-03272,LSCC,C3L-03272-T,C3L-03272-N,TRUE,,CPT0225470003,CPT0225380003,CPT0225380009,CPT0225470009,CPT0226050002,CPT0225380006,CPT0225470006,FALSE,67,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,7.3,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4,pN1,22,8,staging incomplete,No pathologic  evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,185,116,33.71,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,Unknown,,,,Amlodipine|Lexiscan|Cardiolite|Tretrofosmin,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,155,NA,,155,NA,No,Yes,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,155,0,0,NA,67,High or alive at last follow-up,60-70
C3N-01411,LSCC,C3N-01411-T,C3N-01411-N,TRUE,,CPT0105430003,CPT0105420003,CPT0105420006,CPT0105430009,CPT0107860002,CPT0105420009,CPT0105430006,FALSE,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,4,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,,IHC staining not done,170,48,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,445,NA,,442,NA,No,No,No,With Tumor,Persistent Disease,,Yes,424,Locoregional Recurrence,Lung,,Convincing Image (i.e. CT/PET/MRI),,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,424,421,1,445,0,-3,NA,64,High or alive at last follow-up,60-70
C3L-00415,LSCC,C3L-00415-T,C3L-00415-N,TRUE,,CPT0010060003,CPT0010050003,['CPT0010050009'],CPT0010060009,CPT0019860002,CPT0010050006,CPT0010060006,FALSE,64,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,6.5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,36,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage II,,,IHC staining not done,158,69,27.64,No,Lifelong non-drinker,Current reformed smoker within past 15 years,35,Exposure to secondhand smoke history not available,,,,,,,Albuterol|hydrodiuril|Lisinopril|collagen|B-12 Vitamin|Flaxseed oil|Vitamin D,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1786,NA,,1786,NA,No,Yes,No,With Tumor,Unknown,Persistent Disease,Yes,356,New Primary Tumor,Lung,,Convincing Image (i.e. CT/PET/MRI),,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,356,356,1,1786,0,0,NA,64,High or alive at last follow-up,60-70
C3N-03882,LSCC,C3N-03882-T,C3N-03882-N,TRUE,,CPT0237780003,CPT0237760003,CPT0237760009,CPT0237780009,CPT0237820002,CPT0237760006,CPT0237780006,FALSE,68,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,4,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN1,22,5,cM0,pM0,no,R0:No residual tumor,Stage II,HER2（-），TTF1（-），EGFR（+），CK7（-），Ki-67（+80％），β-Cat（cytomembrane +），P63（+），Syn（-），P40（+），GATA3（-），CDX2（-），SPA（-），NapsinA（-），CK20（-），CK5/6（+），PD-L1 22C3（tumor cell（TPS）<1％），ERCC1（-），ROS1（-）,,IHC staining not done,168,70,24.8,No,Lifelong non-drinker,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,715,NA,,715,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,715,0,0,NA,68,High or alive at last follow-up,60-70
C3L-01000,LSCC,C3L-01000-T,C3L-01000-N,TRUE,,CPT0123370003,CPT0123350003,CPT0123350006,CPT0123370009,CPT0124800002,CPT0123350009,CPT0123370006,FALSE,59,Male,Unknown,Unknown,European,Russia,No,Upper Lobe,,Right,Unifocal,4.2,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,9,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,Stage I,,,IHC staining not done,182,110,33.21,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,84,Yes,,Yes,,,,,Bisoprolol|Valsartan|Amlodipine,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,Living,1376,NA,,1380,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1376,0,4,NA,59,High or alive at last follow-up,50-60
C3L-02650,LSCC,C3L-02650-T,C3L-02650-N,TRUE,,CPT0205000003,CPT0204990003,CPT0204990009,CPT0205000009,CPT0205110002,CPT0204990006,CPT0205000006,FALSE,53,Male,Unknown,Unknown,European,Bulgaria,No,Other,lung,Right,Multifocal,8,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,18,2,cM0,Staging Incomplete,unknown,R0:No residual tumor,Stage III,,,IHC staining not done,175,95,31.02,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Yes,,Yes,,,,,Insulin,Medical Record,No,Living,1422,NA,,1422,NA,No,Yes,No,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1422,0,0,NA,53,High or alive at last follow-up,50-60
C3L-02358,LSCC,C3L-02358-T,C3L-02358-N,TRUE,,CPT0112730003,CPT0112720003,CPT0112720009,CPT0112730009,CPT0115190002,CPT0112720006,CPT0112730006,FALSE,75,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,4.4,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,17,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,VVG: Confirmed viscera pleural invasion,"PD-L1: Negative, TPS: 0%",IHC staining not done,168,87,30.82,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",70,Exposure to secondhand smoke history not available,,,,Mature t/NK-cell Lymphomas|Cervical Cancer Stage 3,Unknown|Surgery,Yes|Yes," atorvastatin (LIPITOR)|clindamycin-benzoyl peroxide (BENZACLIN) gel|clobetasol (TEMOVATE)|lisinopril (PRINIVIL,ZESTRIL)|metoprolol tartrate (LOPRESSOR)|Misc Natural Products (OSTEO BI-FLEX ADV JOINT SHIELD PO)|omeprazole (PRILOSEC OTC)",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1448,NA,,1448,NA,No,Yes,No,With Tumor,Persistent Disease,Persistent Disease,Yes,398,Distant Metastasis,Bone,,Biopsy with Histologic Confirmation,,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,NA,398,398,1,1448,0,0,NA,75,High or alive at last follow-up,>70
C3L-02168,LSCC,C3L-02168-T,C3L-02168-N,TRUE,,CPT0175410003,CPT0175390003,CPT0175390009,CPT0175410009,CPT0175480002,CPT0175390006,CPT0175410006,FALSE,66,Male,Unknown,Unknown,European,Bulgaria,No,Middle Lobe,,Right,Unifocal,3.9,Keratinizing squamous cell carcinoma,G1 Well differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,18,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage II,,,IHC staining not done,177,90,28.73,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,Prostate carcinoma,Surgery,Yes,,,No,Living,1421,NA,,1413,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1421,0,-8,NA,66,High or alive at last follow-up,60-70
C3L-02625,LSCC,C3L-02625-T,C3L-02625-N,TRUE,,CPT0191750003,CPT0191710003,CPT0191710009,CPT0191750006,CPT0191850005,CPT0191710006,CPT0191750009,FALSE,66,Male,Unknown,Unknown,European,Bulgaria,No,Other,Left lung,Left,Multifocal,3,Keratinizing squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,15,2,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,173,79,26.4,No,Lifelong non-drinker,Current reformed smoker within past 15 years,36,Exposure to secondhand smoke history not available,,,,,,,Metoprolol succinate|Perindopril arginine|Atorvastatin|Ciprofloxacin|Levofloxacin|Rutin|Vitamin C|Dicynone,Self Report|Self Report|Self Report|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,503,489,Main malignancy,NA,497,Yes,No,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,489,1,8,NA,66,High or alive at last follow-up,60-70
C3N-01028,LSCC,C3N-01028-T,C3N-01028-N,TRUE,,CPT0091090003,CPT0091050003,CPT0091050006,CPT0091090009,CPT0091160002,CPT0091050009,CPT0091090006,FALSE,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Right,Unifocal,5,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,,IHC staining not done,170,61,21.11,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,345,345,Unknown,NA,338,Unknown,Yes,No,Unknown Tumor Status,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,345,1,-7,NA,72,Low,>70
C3N-02435,LSCC,C3N-02435-T,C3N-02435-N,TRUE,,CPT0241210003,CPT0241170003,CPT0241170009,CPT0241210009,CPT0241820002,CPT0241170006,CPT0241210006,FALSE,64,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,3.2,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,N1,7,2,M0,,,RX:Presence of residual tumor cannot be assessed,Stage II,p40: positive; TTF-1: rare positive cells; Napsin-A: Negative; P63: Positive; CK5/6: positive; 34BE12: positive,,IHC staining not done,167,66,23.59,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,52.5,Exposure to secondhand smoke history not available,,,,,,,acetaminophen|albuterol|clonazepam|sertaline|sprivia|varenicline,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1086,NA,,1042,NA,No,Yes,No,With Tumor,Complete Remission,Complete Remission,Yes,541,New Primary Tumor,"Liver, Other",Left and Right Breast Implant and capsule ,Biopsy with Histologic Confirmation,,,,No,No,Yes,NA,NA,541,497,1,1086,0,-44,NA,64,High or alive at last follow-up,60-70
C3N-03441,LSCC,C3N-03441-T,C3N-03441-N,TRUE,,CPT0245890003,CPT0245880003,CPT0245880009,CPT0245890009,CPT0245920002,CPT0245880006,CPT0245890006,FALSE,67,Male,Unknown,Unknown,European,Poland,No,Upper Lobe,,Left,Unifocal,3,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT1b,pN2,4,1,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,Stage III,p40+ p63+ ttf1-,,1,164,51,18.96,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1332,NA,,1338,NA,Yes,Yes,No,Unknown Tumor Status,Unknown,Unknown,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1332,0,6,NA,67,High or alive at last follow-up,60-70
C3L-04071,LSCC,C3L-04071-T,C3L-04071-N,TRUE,,CPT0221220003,CPT0221200003,CPT0221200009,CPT0221220009,CPT0220490002,CPT0221200006,CPT0221220006,FALSE,69,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,2.9,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,0,cM0,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,"Positive for CK7, p40; Negative for CK20, TTF1, Napsin A, NKX3.1",,0,178,79,24.96,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,79.5,No or minimal exposure to secondhand smoke,,,50,,,,aspirin|coQ10|Fish Oil|Breo Ellipta|ipratropium albuterol|Centrum Ultra Men's multivitamin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1144,NA,,1117,NA,No,No,No,Unknown Tumor Status,Unknown,Unknown,Yes,271,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,,,,Yes,No,Yes,NA,NA,271,244,1,1144,0,-27,NA,69,High or alive at last follow-up,60-70
C3N-01020,LSCC,C3N-01020-T,C3N-01020-N,TRUE,,CPT0117770003,CPT0117720003,CPT0117720006,CPT0117770009,CPT0118970002,CPT0117720009,CPT0117770006,FALSE,65,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,Left,Unifocal,4,Squamous cell carcinoma,G3 Poorly differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,5,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,,IHC staining not done,150,43,19.11,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,403,NA,,396,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,403,0,-7,NA,65,High or alive at last follow-up,60-70
C3N-00497,LSCC,C3N-00497-T,C3N-00497-N,TRUE,,CPT0079110003,CPT0079100003,['CPT0079100006'],CPT0079110006,CPT0079140002,CPT0079100009,CPT0079110009,FALSE,64,Female,Unknown,Unknown,European,Poland,No,Middle Lobe,,Right,Unifocal,5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,10,2,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,Stage II,,,IHC staining not done,159,53,20.96,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,31,Exposure to secondhand smoke history not available,,,,,,,Diaprel|Anapran |Tulip ,Medical Record|Medical Record|Medical Record,No,Living,1812,NA,,1843,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1812,0,31,NA,64,High or alive at last follow-up,60-70
C3N-01194,LSCC,C3N-01194-T,C3N-01194-N,TRUE,,CPT0079060003,CPT0079050003,['CPT0079050006'],CPT0079060006,CPT0079090002,CPT0079050009,CPT0079060009,FALSE,69,Male,Unknown,Unknown,European,Poland,No,Lower Lobe,,Right,Unifocal,4,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,0,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,Stage I,,,IHC staining not done,173,93,31,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,45,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1741,NA,,1758,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1741,0,17,NA,69,High or alive at last follow-up,60-70
C3L-02648,LSCC,C3L-02648-T,C3L-02648-N,TRUE,,CPT0204660003,CPT0204600003,CPT0204600007,CPT0204660009,CPT0204750002,CPT0204600010,CPT0204660006,FALSE,72,Male,Unknown,Unknown,European,Bulgaria,No,Other,Left lung,Left,Unifocal,3,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,16,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,186,95,27.46,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,3,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1,261,Unknown,NA,268,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,261,1,7,NA,72,Low,>70
C3L-03678,LSCC,C3L-03678-T,,TRUE,,,CPT0190550003,CPT0190550009,,CPT0191230002,CPT0190550006,,FALSE,49,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,18,3,cM0,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage III,"Positive for P40, P63, CK5/6, TTF-1. Negative for CK-7, CK-20, NAPSIN, PSA, SYNAPTOPHYSIN, CD56, CHROMOGRANIN",,IHC staining not done,173,109,36.49,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,70,Yes,Yes,,,,,,alprazolam|varenicline,Medical Record|Medical Record,No,Deceased,485,485,Unknown,NA,492,No,Yes,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,485,1,7,NA,49,High or alive at last follow-up,<50
C3L-02891,LSCC,C3L-02891-T,C3L-02891-N,TRUE,,CPT0218310003,CPT0218280003,CPT0218280009,CPT0218310009,CPT0219890002,CPT0218280006,CPT0218310006,FALSE,66,Female,White,Not Hispanic or Latino,European,United States,No,Other,Base of upper lobe/superior lower lobe ,Left,Unifocal,2.7,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT1c,pN1,15,5,unknown,unknown ,,RX:Presence of residual tumor cannot be assessed,Stage II,p40: positive ,PD-L1 22C3 FDA Keytruda expressed tumor proportion score: 50% intensity strong ,IHC staining not done,157,57,22.86,No,Lifelong non-drinker,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,synthroid|prilosec|dyazide |mult vitamin |levoxyl |aspirin 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1412,NA,,1412,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1412,0,0,NA,66,High or alive at last follow-up,60-70
C3L-00927,LSCC,C3L-00927-T,C3L-00927-N,TRUE,,CPT0063500003,CPT0063480003,['CPT0063480006'],CPT0063500009,CPT0065270002,['CPT0063480009'],CPT0063500006,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,3.5,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,17,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage III,,,IHC staining not done,188,93,26.31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,57,Exposure to secondhand smoke history not available,,,,,,,Hydrocodone-acetaminophen|albuterol|lisinopril|zocor|glucosamine chond complex MSM|motrin|fish oil|Advair Diskus|Chantix |Tricor|Prilosec|multivitamin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1777,NA,,1777,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1777,0,0,NA,74,High or alive at last follow-up,>70
C3N-03886,LSCC,C3N-03886-T,C3N-03886-N,TRUE,,CPT0221660003,CPT0221650003,CPT0221650009,,CPT0221750002,CPT0221650006,CPT0221660006,FALSE,60,Male,Unknown,Unknown,European,Ukraine,No,Lower Lobe,,Left,Unifocal,4.2,Basaloid squamous cell carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,15,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage I,p63 - patchy positive; CK7 - negative; AE1/AE3 - positive; NSE - negative;,,IHC staining not done,188,106,29.99,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Insulin,Medical Record,No,Living,360,NA,,311,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,360,0,-49,NA,60,High or alive at last follow-up,50-60
C3L-04014,LSCC,C3L-04014-T,C3L-04014-N,TRUE,,CPT0233640003,CPT0233600003,CPT0233600009,CPT0233640009,CPT0233750002,CPT0233600006,CPT0233640006,FALSE,57,Male,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Right,Unifocal,2,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN0,9,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,172,72,24.34,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,43.5,Yes,,Yes,,,,,,,No,Living,444,NA,,459,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,444,0,15,NA,57,High or alive at last follow-up,50-60
C3N-03076,LSCC,C3N-03076-T,C3N-03076-N,TRUE,,CPT0236430003,CPT0236420003,CPT0236420009,CPT0236430006,CPT0236470002,CPT0236420006,CPT0236430009,FALSE,68,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,4.4,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,34,0,cM0,pM0,no,R0:No residual tumor,Stage II,HER2（+），TTF1（-），EGFR（-），CK7（+），Ki-67（+70％），β-Cat（cytomembrane +），P63（+），Syn（-），P40（+），CDX2（-），SPA（-），NapsinA（-），CK5/6（+），PD-L1 22C3（tumor cells（TPS）<1％），ERCC1（+），ROS1（-），GATA3（-），RRM1（+）,,IHC staining not done,170,56,19.38,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,40,,,,,,No,Living,332,NA,,332,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,332,0,0,NA,68,High or alive at last follow-up,60-70
C3N-03425,LSCC,C3N-03425-T,C3N-03425-N,TRUE,,CPT0245840003,CPT0245830003,CPT0245830009,CPT0245840009,CPT0245870002,CPT0245830006,CPT0245840006,FALSE,64,Female,Unknown,Unknown,European,Poland,No,Upper Lobe,,Left,Unifocal,3,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,-1,0,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,Stage I,TTF1- p40+ p63+,,0,164,57,21.19,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,braest cancer,"Radiation,Surgery,Chemotherapy,Other(hormontherapy)",No,,,No,Living,1332,NA,,1340,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1332,0,8,NA,64,High or alive at last follow-up,60-70
C3L-02163,LSCC,C3L-02163-T,C3L-02163-N,TRUE,,CPT0175160003,CPT0175120003,CPT0175120013,CPT0175160009,CPT0175220002,CPT0175120006,CPT0175160006,FALSE,57,Male,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,4.5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,9,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage II,,,IHC staining not done,160,74,28.91,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,20,Exposure to secondhand smoke history not available,,,,,,,Perindopril|Lacidipine,Self Report|Self Report,No,Living,727,NA,,724,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,727,0,-3,NA,57,High or alive at last follow-up,50-60
C3N-04124,LSCC,C3N-04124-T,C3N-04124-N,TRUE,,CPT0237990003,CPT0237970004,CPT0237970007,CPT0237990009,CPT0238030002,CPT0237970010,CPT0237990006,FALSE,62,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN0,31,0,cM0,pM0,no,R0:No residual tumor,Stage I,HER2（-），TTF1（-），EGFR（+），CK7（-），Ki-67（+，70％），β-Cat（cytomembrane +），P63（+），Syn（-），P40（+），CDX2（-），SPA（-），NapsinA（-），CK5/6（+），PD-L1 22C3（tumor cell（TPS）90％），ERCC1（-），ROS1（-），GATA3（-），CK20（-）,,IHC staining not done,169,60,21.01,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,19,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,974,NA,,974,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,974,0,0,NA,62,High or alive at last follow-up,60-70
C3L-00904,LSCC,C3L-00904-T,C3L-00904-N,TRUE,,CPT0007760003,CPT0007740003,['CPT0007740006'],CPT0007760009,CPT0002920002,CPT0007740009,CPT0007760006,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,4.4,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,13,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,Stage II,"Neoplastic cells strongly positive for p40 and p63;TTF-1 is negative, supportive of squamous differentiation","GMS and Kinyon stains negative for fungal and acid-fast organisms, respectively",IHC staining not done,165,53,19.47,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,56,Exposure to secondhand smoke history not available,,,,,,,tylenol,Medical Record,No,Deceased,761,795,Main malignancy,NA,795,No,No,No,Unknown Tumor Status,Not Applicable,,Yes,546,Distant Metastasis,"Lung, Liver, Other",pancreas,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,NA,NA,546,546,1,795,1,0,NA,71,High or alive at last follow-up,>70
C3N-00211,LSCC,C3N-00211-T,,TRUE,,,CPT0090440003,CPT0090440006,,CPT0092490002,CPT0090440009,,FALSE,40,Male,Unknown,Unknown,European,Bulgaria,No,Middle Lobe,,Right,Unifocal,4.5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,4,2,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,,,IHC staining not done,176,120,38.74,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Ibuprofen,Self Report,No,Deceased,0,92,Main malignancy,NA,92,No,No,No,Unknown Tumor Status,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,92,1,0,NA,40,Low,<50
C3N-01892,LSCC,C3N-01892-T,C3N-01892-N,TRUE,,CPT0126400003,CPT0126390003,CPT0126390009,CPT0126400009,CPT0126440002,CPT0126390006,CPT0126400006,FALSE,77,Male,Unknown,Unknown,European,Poland,No,Upper Lobe,,Right,Unifocal,6.5,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,21,0,0,0,,R0:No residual tumor,Stage II,,,IHC staining not done,165,83,30,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Euthyrox |Euphylin long ,Self Report|Self Report,No,Deceased,903,903,Main malignancy,NA,926,No,No,No,With Tumor,Complete Remission,Patient Deceased,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,903,1,23,NA,77,High or alive at last follow-up,>70
C3L-00603,LSCC,C3L-00603-T,C3L-00603-N,TRUE,,CPT0064050003,CPT0064040003,['CPT0064040009'],CPT0064050008,CPT0065370002,CPT0064040006,CPT0064050006,FALSE,72,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,3,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,26,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,Stage I,,,IHC staining not done,178,113,35.68,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",67.5,Exposure to secondhand smoke history not available,,,,Basal cell carcinoma of skin of nose|Colon Caner - Adenocarcinoma,Unknown|Surgery,Yes|Yes,Metoprolol tartrate|Captopril|Levothyroxine|Glimepiride|Hydralazine|Potassium Chloride|Fenofibrate|Allopurinol|Simvastatin|Hydrochlorothiazide|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1794,NA,,1794,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1794,0,0,NA,72,High or alive at last follow-up,>70
C3L-03965,LSCC,C3L-03965-T,C3L-03965-N,TRUE,,CPT0207250003,CPT0207210003,CPT0207210009,CPT0207250006,CPT0207360002,CPT0207210006,CPT0207250009,FALSE,54,Male,Unknown,Unknown,European,Bulgaria,No,Other,Right lung,Right,Unifocal,4.2,Squamous cell carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN2,13,7,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,170,107,37.02,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40,Exposure to secondhand smoke history not available,,,,,,,Olmesartan medoxomil,Self Report,No,Living,1422,NA,,1429,NA,Yes,Yes,No,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1422,0,7,NA,54,High or alive at last follow-up,50-60
C3N-03851,LSCC,C3N-03851-T,C3N-03851-N,TRUE,,CPT0237210003,CPT0237200004,CPT0237200010,CPT0237210006,CPT0237260002,CPT0237200007,,FALSE,44,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,4.5,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN1,32,1,cM0,pM0,no,R0:No residual tumor,Stage II,CK7（-）、CK20（-）、CK5/6（-）、Ki-67（about 60%+）、CHGA（-）、CD56（-）、TTF1（-）、P40（+）、P63（+）、NapsinA（-）,,IHC staining not done,178,75,23.67,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,25,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,642,NA,,642,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,642,0,0,NA,44,High or alive at last follow-up,<50
C3L-02349,LSCC,C3L-02349-T,C3L-02349-N,TRUE,,CPT0112550003,CPT0112540003,CPT0112540006,CPT0112550009,CPT0115160002,CPT0112540009,CPT0112550006,FALSE,81,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,1.9,Squamous cell carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,6,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,p40: Diffusely Positive,"PD-L1: Positive, Low Expression, TPS: 10%",IHC staining not done,165,50,18.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,Albuterol|Amlodipine|Calcium Carb-Cholecalciferol|Carvedilol|Ibuprofen|Ipratropium-Albuterol|Simvastatin|SM Nicotine Patch,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1442,NA,,1442,NA,No,No,No,With Tumor,Not Applicable,Persistent Disease,Yes,1016,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,,,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,NA,NA,1016,1016,1,1442,0,0,NA,81,High or alive at last follow-up,>70
C3N-01799,LUAD,C3N-01799-T,C3N-01799-N,TRUE,,CPT0089360003,CPT0089340003,CPT0089340006,CPT0089360006,CPT0091320002,CPT0089340009,CPT0089360009,FALSE,81,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,3.5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,13,1,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,173,82,27.37,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",0.3,Exposure to secondhand smoke history not available,,,,Prostate Cancer,Surgery,Yes,aspirin|Calcium-Magnesium |flonase|glucosa-chondr-Na|krill oil|losartan|Restasis 0.05% OPHTH Emulsion|tiotropium ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1545,NA,,1545,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1545,0,0,NA,81,High or alive at last follow-up,>70
C3L-01890,LUAD,C3L-01890-T,C3L-01890-N,TRUE,,CPT0092940003,CPT0092930003,CPT0092930006,CPT0092940006,CPT0093850002,CPT0092930008,CPT0092940009,FALSE,58,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,3,Lepidic adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,15,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage I,"IHC performed shows neoplastic cells are positive for TTF-1, supporting the diagnosis of adenocarcinoma of the lung",,IHC staining not done,153,53,22.6,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,33,Exposure to secondhand smoke history not available,,,4,,,,albuterol|Norvasc|Lotensin|symbicort|zyrtec|norco|spiriva,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,671,NA,,671,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,671,0,0,NA,58,High or alive at last follow-up,50-60
C3N-00572,LUAD,C3N-00572-T,C3N-00572-N,TRUE,,CPT0015420003,CPT0015410003,['CPT0015410006'],CPT0015420006,CPT0015440002,CPT0015410009,CPT0015420009,FALSE,48,Female,Unknown,Unknown,East_Asian,Vietnam,No,Lower Lobe,,Right,Unifocal,2,"Adenocarcinoma, mixed subtype",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,2,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,Stage I,,"TTF1 – positive, NAPSIN A - positive",IHC staining not done,156,44,18.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,431,NA,,431,NA,No,No,No,Unknown Tumor Status,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,431,0,0,NA,48,High or alive at last follow-up,<50
C3N-02423,LUAD,C3N-02423-T,C3N-02423-N,TRUE,,CPT0147000003,CPT0146980004,CPT0146980007,CPT0147000006,CPT0147010002,CPT0146980010,CPT0147000009,FALSE,70,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,3,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,31,0,cM0,Staging Incomplete,NO,R0:No residual tumor,Stage I,"HER2(-), TTF1(+), EGFR(+),CK7(+),Ki-67(+, 20％),β-Cat(membranous +), P63(-), ERCC1(-), RRM1(+), Syn(-),P40(-), GATA3(-), CDX2(-),SPA(+),NapsinA(+),CK20(-),CK5/6(-)",,IHC staining not done,168,79,27.99,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,100,Exposure to secondhand smoke history not available,,,,,,,adalat,Self-reported and Medical Record,No,Living,695,NA,,701,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,695,0,6,NA,70,High or alive at last follow-up,60-70
C3N-02729,LUAD,C3N-02729-T,C3N-02729-N,TRUE,,CPT0148300003,CPT0148280004,CPT0148280007,CPT0148300006,CPT0148310002,CPT0148280010,CPT0148300009,FALSE,45,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,4.5,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,15,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,"HER2（-）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,173,60,20.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,694,820,Unknown,NA,832,No,Yes,No,With Tumor,Complete Remission,Complete Remission,Yes,640,Distant Metastasis,"Lung, Brain",,Convincing Image (i.e. CT/PET/MRI),,No,,No,No,No,NA,NA,640,652,1,820,1,12,NA,45,High or alive at last follow-up,<50
C3L-00263,LUAD,C3L-00263-T,C3L-00263-N,TRUE,,CPT0011750003,CPT0011710004,['CPT0011710010'],CPT0011750005,CPT0012420002,CPT0011710007,CPT0011750008,FALSE,79,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,6.5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,11,0,cM0,Staging Incomplete,None specified,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,188,80,22.77,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,27,Exposure to secondhand smoke history not available,,,,,,,"Chlorhexidine Gluconate|Scrub, Isopropyl|Alcohol, Duraprep|0.25% Marcaine with EPI|1.5g Zinacef IV|Bupivacaine 0.25%|Epinephrine|Hydromorphine|Ondansetron|Lactated Ringers|SEVO|Fentanyl|Rocuronium|Zofran|Propofol/Lido|Versed|Amiodarone|Ascorbic Acid|Aspirin|Cholecalciferol|Digoxin|Docusate|Doxazosin|Enoxaparin|Metoprolol|Multivitamin with Minerals|Nitroglycerin|Omega-3 Polyunsaturated Fatty Acids|Oxycodone|Saw Palmetto|Simvastatin|Warfarin",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Living,1157,NA,,1157,NA,No,No,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1157,0,0,NA,79,High or alive at last follow-up,>70
C3N-01410,LUAD,C3N-01410-T,C3N-01410-N,TRUE,,CPT0118010003,CPT0117970003,CPT0117970006,CPT0118010006,CPT0119210002,CPT0117970009,CPT0118010009,FALSE,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,Right,Unifocal,5,Solid adenocarcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN0,4,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,,"TTF1 – focal positive, NAPSIN A – positive, P40 - negative",IHC staining not done,160,48,18.75,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,436,NA,,436,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,436,0,0,NA,64,High or alive at last follow-up,60-70
C3N-00578,LUAD,C3N-00578-T,C3N-00578-N,TRUE,,CPT0069370003,CPT0069360003,['CPT0069360009'],CPT0069370006,CPT0069450002,CPT0069360006,CPT0069370009,FALSE,48,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not Applicable,Left,Unifocal,4,Colloid adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,15,5,cM0,Staging Incomplete,Not known,R0:No residual tumor,Stage III,,"TTF1 – positive, NAPSIN A – positive",IHC staining not done,170,64,22.15,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,6.3,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,24,24,Unknown,NA,24,Unknown,Yes,No,Unknown Tumor Status,Not Applicable,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,24,1,0,NA,48,Low,<50
C3N-02587,LUAD,C3N-02587-T,C3N-02587-N,TRUE,,CPT0148100003,CPT0148080004,CPT0148080007,CPT0148100006,CPT0148110002,CPT0148080010,CPT0148100009,FALSE,59,Female,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Left,Unifocal,2,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,10,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage I,"HER2（-）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,5％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-） ","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,151,50,21.93,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Telmisartan|gliclazide,Self-reported and Medical Record|Self-reported and Medical Record,No,Living,1111,NA,,1123,NA,No,No,No,Tumor Free,Not Applicable,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1111,0,12,NA,59,High or alive at last follow-up,50-60
C3L-00893,LUAD,C3L-00893-T,C3L-00893-N,TRUE,,CPT0083140003,CPT0083100003,['CPT0083100006'],CPT0083140006,CPT0081760002,CPT0083100009,CPT0083140009,FALSE,71,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,Lower Lobe,,Right,Unifocal,3.5,Acinar adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,17,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,"cytokeratin (megative for metastatis disease), CD45 , calretinin (proliferative mesolthelial cells), S100 (weak patchy positivity, no neural differentiation is appreciated), TTF1 (negative), EMA (negative)",,0,173,87,29.1,No,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",40,Exposure to secondhand smoke history not available,,,Unknown,,,,Losartan Potassium|Metoprolol Tartrate|Naproxen|Atorvastatin|Flecainide|Savaysa,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,Living,23,NA,,23,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,23,0,0,NA,71,High or alive at last follow-up,>70
C3N-01488,LUAD,C3N-01488-T,C3N-01488-N,TRUE,,CPT0118180003,CPT0118160003,CPT0118160006,CPT0118180006,CPT0119390002,CPT0118160009,CPT0118180009,FALSE,54,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,Right,Unifocal,4,Adenocarcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,8,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,"TTF1 -  weakly positive, NAPSIN A – positive, P40 - negative",IHC staining not done,170,50,17.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,409,NA,,409,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,409,0,0,NA,54,High or alive at last follow-up,50-60
C3N-01413,LUAD,C3N-01413-T,C3N-01413-N,TRUE,,CPT0105550003,CPT0105510003,CPT0105510006,CPT0105550006,CPT0107980002,CPT0105510009,CPT0105550009,FALSE,62,Female,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Left,Unifocal,4,Adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,"TTF1 - positive, NAPSIN A – positive, P40 - negative",IHC staining not done,153,70,29.9,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,444,NA,,444,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,444,0,0,NA,62,High or alive at last follow-up,60-70
C3N-01030,LUAD,C3N-01030-T,C3N-01030-N,TRUE,,CPT0091260003,CPT0091240003,CPT0091240006,CPT0091260005,CPT0091500002,CPT0091240009,CPT0091260008,FALSE,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Right,Unifocal,4.5,squamous versus adenocarcinoma pending IHC,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – positive, P63 - negative",,IHC staining not done,168,65,23.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,443,NA,,443,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,443,0,0,NA,56,High or alive at last follow-up,50-60
C3N-02588,LUAD,C3N-02588-T,C3N-02588-N,TRUE,,CPT0148200003,CPT0148180004,CPT0148180007,CPT0148200006,CPT0148210002,CPT0148180010,CPT0148200009,FALSE,69,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,4.5,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,39,0,cM0,pM1b,no,R0:No residual tumor,Stage II,"HER2（week +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,80％），β-Cat （membranous +）, P63（focal +）, ERCC1（focal +）, RRM1（+）, Syn（-），P40（-）, GATA3（-），CDX2（-），SPA（-），NapsinA（-），CK20（-），CK5/6（-）",,IHC staining not done,180,80,24.69,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1106,NA,,1121,NA,No,No,No,Tumor Free,Not Applicable,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1106,0,15,NA,69,High or alive at last follow-up,60-70
C3N-00552,LUAD,C3N-00552-T,C3N-00552-N,TRUE,,CPT0068130003,CPT0068100003,['CPT0068100009'],CPT0068130006,CPT0068210002,CPT0068100006,CPT0068130009,FALSE,49,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not otherwise specified,Right,Unifocal,5,Solid adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – positive, P63 - positive",,IHC staining not done,156,50,20.55,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,396,NA,,396,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,396,0,0,NA,49,High or alive at last follow-up,<50
C3L-01889,LUAD,C3L-01889-T,C3L-01889-N,TRUE,,CPT0092250003,CPT0092240003,CPT0092240006,CPT0092250006,CPT0093760002,CPT0092240009,CPT0092250009,FALSE,71,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,2.2,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,,,IHC staining not done,167,98,35.03,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",60,Exposure to secondhand smoke history not available,,,,,,,Alprazolam|Augmented Betamethasone Dipropionate Ointment|B Complex PO|Cholecalciferol|Clobetasol Ointment|Diphenhydramine|Estradiol|Hydroxyzine|Ibuprofen|Levothyroxine|Mometasone|Omega-3 Fatty Acids|Pravastatin|Probiotic Product|Tumeric PO,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1799,NA,,1799,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1799,0,0,NA,71,High or alive at last follow-up,>70
C3N-00169,LUAD,C3N-00169-T,C3N-00169-N,TRUE,,CPT0014930003,CPT0014860003,['CPT0014860006'],CPT0014930006,CPT0016620002,CPT0014860009,CPT0014930009,FALSE,57,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not otherwise specified,Left,Unifocal,4,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – positive, P63 - negative",,IHC staining not done,170,66,22.84,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,12,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,376,NA,,376,NA,Yes,Yes,No,Unknown Tumor Status,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,376,0,0,NA,57,High or alive at last follow-up,50-60
C3L-00422,LUAD,C3L-00422-T,C3L-00422-N,TRUE,,CPT0082890003,CPT0082850004,['CPT0082850007'],CPT0082890006,CPT0081740002,CPT0082850010,CPT0082890009,FALSE,35,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,Lower Lobe,,Left,Unifocal,3.5,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,16,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,160,100,39.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Fentanyl|Cefazolin/D5W|Levofloxacin|Naproxen|Methocarbamol|Cetirizine|Atorvastatin|Ethinyl Estradiol-Norgestimate|Fentanyl|Alamine Lotion|Ortho Tri-Cyclen|Zyrtec,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Living,1916,NA,,1916,NA,No,No,No,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1916,0,0,NA,35,High or alive at last follow-up,<50
C3L-00083,LUAD,C3L-00083-T,C3L-00083-N,TRUE,,CPT0091870003,CPT0091860003,CPT0091860006,CPT0091870006,CPT0093680002,CPT0091860013,CPT0091870009,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,20,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,,Elastic stains performed and due not demonstrate visceral pleural invasion,IHC staining not done,177,92,29.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Lisinopril-hydrochlorothiazide|Lisinopril|Metoprolol Succinate XL|Amoxicillin|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1790,NA,,1790,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1790,0,0,NA,71,High or alive at last follow-up,>70
C3N-00551,LUAD,C3N-00551-T,C3N-00551-N,TRUE,,CPT0067950003,CPT0067940003,['CPT0067940009'],CPT0067950006,CPT0068030002,CPT0067940006,CPT0067950009,FALSE,54,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,,Unifocal,5,Mixed acinar and micropapillary adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,2,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A - positive",,IHC staining not done,170,52,17.99,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,391,NA,,391,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,391,0,0,NA,54,High or alive at last follow-up,50-60
C3N-01842,LUAD,C3N-01842-T,,TRUE,,,CPT0098130003,CPT0098130006,,CPT0098170002,CPT0098130009,,FALSE,69,Male,Unknown,Unknown,European,Ukraine,No,Lower Lobe,,Right,Unifocal,2,Adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,1,0,cM0,Staging Incomplete,No,R0:No residual tumor,Stage I,CK7 - positive; TTF1 - positive; p63 - positive; CK5/6 - negative;,,IHC staining not done,173,95,31.74,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Enalapril|Glibenclamide,Medical Record|Medical Record,No,Living,681,NA,,681,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,681,0,0,NA,69,High or alive at last follow-up,60-70
C3N-02089,LUAD,C3N-02089-T,C3N-02089-N,TRUE,,CPT0118360003,CPT0118340003,CPT0118340009,CPT0118360006,CPT0119570002,CPT0118340006,CPT0118360009,FALSE,76,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,Right,Unifocal,5.5,Acinar adenocarcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,7,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – focal positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,167,62,22.23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,403,NA,,398,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,403,0,-5,NA,76,High or alive at last follow-up,>70
C3L-01682,LUAD,C3L-01682-T,C3L-01682-N,TRUE,,CPT0110890003,CPT0110860004,CPT0110860007,CPT0110890006,CPT0112370002,CPT0110860010,CPT0110890009,FALSE,78,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,0,cM0,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,"TTF-1, P40, Napsin, elastin -Result: moderately differentiated adenocarcinoma of left lung; Monoclonal Mouse Anti-PD-L1, Result: No expression",,IHC staining not done,163,64,24.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",9,Yes,,Yes,,,,,Evista|Florinef|synthroid |Gabpentin|Cyclobenzaprine,Self Report|Self Report|Self Report|Self Report|Self Report,No,Living,1617,NA,,1555,NA,No,No,No,Tumor Free,Not Applicable,Unknown,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1617,0,-62,NA,78,High or alive at last follow-up,>70
C3N-01016,LUAD,C3N-01016-T,C3N-01016-N,TRUE,,CPT0083810003,CPT0083780003,['CPT0083780009'],CPT0083810006,CPT0083830002,CPT0083780006,CPT0083810009,FALSE,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,4,Acinar adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,6,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,"TTF1 – positive, NAPSIN A – positive",,IHC staining not done,160,51,19.92,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,428,NA,,428,NA,No,Yes,No,With Tumor,Persistent Disease,,Yes,306,Locoregional Recurrence,Other,Bilateral cervical lymph nodes,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,306,306,1,428,0,0,NA,56,High or alive at last follow-up,50-60
C3N-00580,LUAD,C3N-00580-T,C3N-00580-N,TRUE,,CPT0069720003,CPT0069700003,['CPT0069700009'],CPT0069720006,CPT0069800002,CPT0069700006,CPT0069720009,FALSE,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,4.5,Papillary adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – positive",,IHC staining not done,168,54,19.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,6.3,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,386,NA,,386,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,386,0,0,NA,56,High or alive at last follow-up,50-60
11LU013,LUAD,11LU013-T,,TRUE,,,CPT0053040004,['CPT0053040007'],,CPT0040210002,CPT0053040010,,FALSE,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Left,Unifocal,6,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,7,4,cM0,Staging Incomplete,none,R0:No residual tumor,Stage III,,,IHC staining not done,156,52,21.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,Yes,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,59,,50-60
C3N-02000,LUAD,C3N-02000-T,C3N-02000-N,TRUE,,CPT0109700003,CPT0109680004,CPT0109680007,CPT0109700006,CPT0139090002,CPT0109680010,CPT0109700009,FALSE,46,Female,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,2.5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN1,14,2,cM0,Staging Incomplete,NO,R0:No residual tumor,Stage II,"HER2（focally +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+, 10％），β-Cat（membranous +）, P63（-）, ERCC1（-）, RRM1（+）, Syn（-），P40（+）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（partial +），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,162,63,24.01,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,azithromycin ,Medical Record,No,Living,1086,NA,,1091,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1086,0,5,NA,46,High or alive at last follow-up,<50
C3N-01489,LUAD,C3N-01489-T,C3N-01489-N,TRUE,,CPT0105980003,CPT0105940003,CPT0105940006,CPT0105980006,CPT0108270002,CPT0105940009,CPT0105980009,FALSE,65,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,3.5,Adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,14,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,170,48,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,434,NA,,427,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,434,0,-7,NA,65,High or alive at last follow-up,60-70
C3N-00737,LUAD,C3N-00737-T,C3N-00737-N,TRUE,,CPT0090200003,CPT0090170004,CPT0090170007,CPT0090200006,CPT0091440002,CPT0090170010,CPT0090200008,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,2.2,adenocarcinoma with neuroendocrine differentiation,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,10,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,TTF: Positive; Synaptophysin: partial tumor positive; Chromogranin: negative; Ki-67: focally positive; P40: negative,,IHC staining not done,170,83,28.5,No,Lifelong non-drinker,Current reformed smoker within past 15 years,50,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,384,NA,,384,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,0,NA,71,High or alive at last follow-up,>70
C3N-01405,LUAD,C3N-01405-T,C3N-01405-N,TRUE,,CPT0105370004,CPT0105330003,CPT0105330006,CPT0105370007,CPT0107800002,CPT0105330009,CPT0105370010,FALSE,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Right,Unifocal,5,Solid adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,0,cM0,Staging Incomplete,Not Specified,R0:No residual tumor,Stage I,"CK5/6(+), CK7(+), p63(-) and TTF-1(-)",,IHC staining not done,167,50,17.93,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,418,NA,,418,NA,Unknown,Yes,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,418,0,0,NA,59,High or alive at last follow-up,50-60
C3N-01416,LUAD,C3N-01416-T,C3N-01416-N,TRUE,,CPT0105740003,CPT0105710003,CPT0105710006,CPT0105740006,CPT0108160002,CPT0105710009,CPT0105740009,FALSE,67,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,4,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,"TTF1 – positive, NAPSIN A – positive, P40 ",,IHC staining not done,170,48,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,434,NA,,434,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,434,0,0,NA,67,High or alive at last follow-up,60-70
C3N-02149,LUAD,C3N-02149-T,C3N-02149-N,TRUE,,CPT0118650003,CPT0118620003,CPT0118620009,CPT0118650006,CPT0119870002,CPT0118620006,CPT0118650009,FALSE,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,Right,Unifocal,6,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN0,7,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,"TTF1 – positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,160,50,19.53,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.8,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,413,NA,,406,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,413,0,-7,NA,64,High or alive at last follow-up,60-70
C3N-02424,LUAD,C3N-02424-T,C3N-02424-N,TRUE,,CPT0147100003,CPT0147080004,CPT0147080007,CPT0147100006,CPT0147110002,CPT0147080010,CPT0147100009,FALSE,64,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,5,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,8,5,cM0,Staging Incomplete,NO,R0:No residual tumor,Stage II,"HER2(-), TTF1(+), EGFR(+),CK7(+),Ki-67(+,70％),β-Cat(membranous +), P63(-), ERCC1(-), RRM1(+), Syn(-),P40(-), GATA3(-), CDX2(-),SPA(+),NapsinA(+),CK20(-),CK5/6(-)",,IHC staining not done,164,64,23.8,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,30,Exposure to secondhand smoke history not available,,,30,,,,,,No,Living,355,NA,,365,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,0,10,NA,64,High or alive at last follow-up,60-70
C3L-00279,LUAD,C3L-00279-T,C3L-00279-N,TRUE,,CPT0082770003,CPT0082740004,['CPT0082740007'],CPT0082770006,CPT0081730001,CPT0082740010,CPT0082770009,FALSE,72,Female,White,Unknown,European,United States,No,Upper Lobe,,Left,Unifocal,4,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,165,75,27.45,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,"NaCl 0.9%|Cyanocobalamin 500 mcg|Calcium Carbonate 1500 mg|Pantoprazole 40 mg EC|Atorvastatin 10mg|Magnesium Oxide|Heparin 5,000|Ascorbic Acid 500 mg|Omega-3 Fish Oil|Oxycodone/Acetaminophen|Acitaminophen 325 mg|Mg Hydrox/ALh/smc|Docusate Sodium|Magnesium sulf/SW|Magnesium Sulf/D5W|Morphine 2 mg/mL|Ondansetron 2 mg/mL|Potassium Cl/SW Premix|Potassium Chloride 10%|Promethazine/NS|Promethazine 12.5 mg Supp|Sotalol 60 mg|Vitamin E 400|Losartan 50 mg|Calcium Carbonate|Vitamin B-12|Heparin 1,000|Diphenhydramine 50 mg/mL|Fentanyl 50 mcg/mL|Flumazenil 0.1 mg/mL|Midazolam 1 mg|Naloxone 0.4 mg/mL|Cholecalciferol|Enoxaparin|Dabigatran|Omeprazole|Spiriva|Advair|Simvastatin|Plavix|Metropolol",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Living,606,NA,,606,NA,No,No,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,606,0,0,NA,72,High or alive at last follow-up,>70
C3N-02379,LUAD,C3N-02379-T,C3N-02379-N,TRUE,,CPT0146600003,CPT0146580004,CPT0146580007,CPT0146600006,CPT0146610002,CPT0146580010,CPT0146600009,FALSE,57,Female,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,4,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,24,4,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,"HER2(partial +), TTF1(+), EGFR(+),CK7(+),Ki-67(+, 60％),β-Cat(membranous +), P63(partial+), ERCC1(+), RRM1(+), Syn(-),P40(-)","Immunohistochemistry:GATA3(-), ALK(Ventana)(-), ALK-Neg-Tissue(-),CDX2(-),SPA(partial +),NapsinA(partial +),CK20(-),CK5/6(-)",IHC staining not done,168,65,23.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,429,443,Unknown,NA,450,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,443,1,7,NA,57,High or alive at last follow-up,50-60
C3L-00095,LUAD,C3L-00095-T,C3L-00095-N,TRUE,,CPT0001690003,CPT0001660013,['CPT0001660008'],CPT0001690006,CPT0003910002,CPT0001660005,CPT0001690009,FALSE,62,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,2.4,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,13,0,cM0,Staging Incomplete,Not Applicable,R0:No residual tumor,Stage I,,,IHC staining not done,175,106,34.61,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,25,Exposure to secondhand smoke history not available,,,,,,,Insulin Glargine|Trazodone|Albuterol Sulfate|Lisinopril|Glimepiride|Furosemide|Ipratropium|Metformin|Atorvastatin,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,Living,1794,NA,,1794,NA,No,No,No,With Tumor,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1794,0,0,NA,62,High or alive at last follow-up,60-70
C3N-02572,LUAD,C3N-02572-T,C3N-02572-N,TRUE,,CPT0147600003,CPT0147580004,CPT0147580007,CPT0147600006,CPT0147610002,CPT0147580010,CPT0147600009,FALSE,49,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,3,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,16,4,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,,,IHC staining not done,169,70,24.51,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,melbine|acarbose,Medical Record|Medical Record,No,Living,1135,NA,,1141,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1135,0,6,NA,49,High or alive at last follow-up,<50
C3N-00559,LUAD,C3N-00559-T,C3N-00559-N,TRUE,,CPT0068650003,CPT0068610003,['CPT0068610006'],CPT0068650006,CPT0068730002,CPT0068610009,CPT0068650009,FALSE,55,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,2.5,Acinar adenocarcinoma and papillary adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,8,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A - positive",,IHC staining not done,152,48,20.78,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,398,NA,,398,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,398,0,0,NA,55,High or alive at last follow-up,50-60
C3N-00545,LUAD,C3N-00545-T,C3N-00545-N,TRUE,,CPT0066930003,CPT0066890003,"['CPT0066890009', 'CPT0066910009']",CPT0066930005,CPT0067010002,"['CPT0066890006', 'CPT0066910006']",CPT0066930008,FALSE,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Right,Unifocal,1.2,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pN2,2,0,cM0,Staging Incomplete,not specified,R0:No residual tumor,Stage I,,,IHC staining not done,165,53,19.47,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,21.8,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,650,NA,,644,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,650,0,-6,NA,59,High or alive at last follow-up,50-60
11LU016,LUAD,11LU016-T,,TRUE,,,CPT0052940004,['CPT0052940014'],,CPT0037120002,CPT0052940010,,FALSE,62,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,,Right,Unifocal,3,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN2,9,4,cM0,Staging Incomplete,none,R0:No residual tumor,Stage III,,,IHC staining not done,165,51,18.73,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,Yes,Deceased,445,445,Main malignancy,NA,441,No,No,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,445,1,-4,NA,62,High or alive at last follow-up,60-70
C3L-02345,LUAD,C3L-02345-T,C3L-02345-N,TRUE,,CPT0114010003,CPT0113990003,CPT0113990006,CPT0114010006,CPT0115310002,CPT0113990009,CPT0114010009,FALSE,61,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,2.8,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,16,0,cM1,No pathologic evidence of distant metastasis,Metastatic Adenocarcinoma to Left Adrenal Gland,R0:No residual tumor,Stage I,GMS/silver and AFB/Kinyoun are all Negative    ,"PD-L1: Positive, Low Expression, TPS: 2%",IHC staining not done,172,67,22.55,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,25,Exposure to secondhand smoke history not available,,,,Skin Cancer,Unknown,Yes,Estradiol|Crestor|Aspirin|Calcium Carbonate / Vitamin D3|Cholecalciferol|Glucosamine-Chondroitin Complex|Super B Complex-Vitamin C|Flaxseed Oil|Womens Multi-Vitamin|Pristiq,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1376,NA,,1376,NA,No,Yes,Yes,With Tumor,Persistent Disease,Persistent Disease,Yes,351,Distant Metastasis,Other,Right adrenal mass ,Convincing Image (i.e. CT/PET/MRI),,Yes,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Yes,NA,376,351,351,1,1376,0,0,NA,61,High or alive at last follow-up,60-70
C3L-00093,LUAD,C3L-00093-T,C3L-00093-N,TRUE,,CPT0086320003,CPT0086310003,CPT0086310006,CPT0086320006,CPT0087370002,CPT0086310009,CPT0086320009,FALSE,66,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,3,"Adenocarcinoma, acinar predominant ",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,10,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage I,,Properal controlled elastic staining demonstrates focal visceral pleural invasion,IHC staining not done,157,84,34.08,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Endometrial Carcinoma,Surgery,Yes,Tramadol|Meformin-XR|Lisinopril|Amlodipine|Carvedilol|Atorvastatin|Krill Oil PO|Grape Seed Extract|Tumeric|Resveratrol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1698,1703,Main malignancy,NA,1703,No,No,No,With Tumor,Not Applicable,Persistent Disease,Yes,382,Locoregional Recurrence,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,382,382,1,1703,1,0,NA,66,High or alive at last follow-up,60-70
C3L-00510,LUAD,C3L-00510-T,C3L-00510-N,TRUE,,CPT0011930003,CPT0011910004,['CPT0011910014'],CPT0011930006,CPT0012490002,CPT0011910007,CPT0011930009,FALSE,80,Female,Unknown,Unknown,Ad_Mixed_American,United States,No,Lower Lobe,,Right,Unifocal,2.8,Adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,4,0,Staging Incomplete,Staging Incomplete,,R2:Macroscopic residual tumor,Stage I,,,IHC staining not done,165,85,31.35,No,Lifelong non-drinker,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,Aleve|Multivitamins|Tetrofosmin|Acetaminophen|Benzonatate|Levaquin|Lasix|Tessalon Perles|Aspirin|Omega-3|Polyunsaturated Fatty Acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Living,38,NA,,40,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,38,0,2,NA,80,High or alive at last follow-up,>70
C3L-00913,LUAD,C3L-00913-T,C3L-00913-N,TRUE,,CPT0106100003,CPT0106110003,CPT0106110006,CPT0106100006,CPT0107080002,CPT0106110009,CPT0106100008,FALSE,66,Male,White,Not Hispanic or Latino,European,United States,No,Other,Upper lobe extending into middle lobe,Right,Unifocal,7.5,Adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,19,1,cM1,No pathologic evidence of distant metastasis,Extension into the chest wall at the right posterior 5th and 6th ribs.,R0:No residual tumor,Stage III,,"Special Stains for AFB and Fungus (GMS) were performed on J4, 2-3 and K12, 2-3: Negative",IHC staining not done,182,56,16.91,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,100,Exposure to secondhand smoke history not available,,,,,,,Senna-docusate|Morphine ER|Hydromorphone,Medical Record|Medical Record|Medical Record,No,Deceased,73,73,Main malignancy,NA,73,No,No,No,With Tumor,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,73,1,0,NA,66,Low,60-70
11LU022,LUAD,11LU022-T,,TRUE,,,CPT0052170004,['CPT0052170014'],,CPT0038140002,CPT0052170010,,FALSE,53,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,,Left,Unifocal,4,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,2,0,cM0,Staging Incomplete,,R0:No residual tumor,Stage I,,,IHC staining not done,159,55,21.76,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,Yes,Living,7,NA,,0,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,7,0,-7,NA,53,High or alive at last follow-up,50-60
C3L-00412,LUAD,C3L-00412-T,C3L-00412-N,TRUE,,CPT0023320003,CPT0023310003,['CPT0023310009'],CPT0023320006,CPT0024540002,CPT0023310006,CPT0023320009,FALSE,64,Male,American Indian or Alaska Native,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Multifocal,2.2,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,32,11,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,Stage III,,,IHC staining not done,183,84,25.12,No,Lifelong non-drinker,Current reformed smoker within past 15 years,46,Exposure to secondhand smoke history not available,,,,,,,bactroban|nicoderm|elavil|prilosec|plavix|celexa|toprolol|proventil|flomax|albuterol|neurontin|lipitor|alavert|asa|duoneb|multiple vitamins|vitamin B complex|KEPPRA,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,162,162,Main malignancy,NA,162,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,72,Both Locoregional and Distant Metastasis,"Bone, Other",Anterior left pelvis ,Convincing Image (i.e. CT/PET/MRI),No,No,,Yes,Yes,No,NA,NA,72,72,1,162,1,0,NA,64,Low,60-70
C3N-01415,LUAD,C3N-01415-T,C3N-01415-N,TRUE,,CPT0105680003,CPT0105630003,CPT0105630006,CPT0105680006,CPT0108100002,CPT0105630009,CPT0105680009,FALSE,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,5,Adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,8,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,"TTF1 – positive, NAPSIN A – positive, P40  - negative",,IHC staining not done,170,48,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,792,NA,,420,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,792,0,-372,NA,72,High or alive at last follow-up,>70
C3N-00549,LUAD,C3N-00549-T,C3N-00549-N,TRUE,,CPT0067470004,CPT0067450003,['CPT0067450009'],CPT0067470007,CPT0067550002,CPT0067450006,CPT0067470010,FALSE,58,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,5,"Adenocaricnoma, mixed sub-type (solid and acinar)",G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,5,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – negative, NAPSIN A – focal positive, P63  - negative",,IHC staining not done,168,60,21.26,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,791,NA,,785,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,791,0,-6,NA,58,High or alive at last follow-up,50-60
C3N-02433,LUAD,C3N-02433-T,C3N-02433-N,TRUE,,CPT0147400003,CPT0147380004,CPT0147380007,CPT0147400006,CPT0147410002,CPT0147380010,CPT0147400009,FALSE,68,Female,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,2.5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,12,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage I,"HER2（+）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,8％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,165,74,27.18,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1137,NA,,1144,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1137,0,7,NA,68,High or alive at last follow-up,60-70
C3N-01021,LUAD,C3N-01021-T,C3N-01021-N,TRUE,,CPT0105010004,CPT0104970003,CPT0104970006,CPT0105010007,CPT0107560002,CPT0104970009,CPT0105010010,FALSE,44,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,13,10,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,"TTF1 – positive, NAPSIN A – positive, P40  - negative",,IHC staining not done,158,50,20.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,434,NA,,428,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,434,0,-6,NA,44,High or alive at last follow-up,<50
C3N-00203,LUAD,C3N-00203-T,C3N-00203-N,TRUE,,CPT0090370003,CPT0090340003,CPT0090340006,CPT0090370006,CPT0092480002,CPT0090340009,CPT0090370009,FALSE,72,Male,Unknown,Unknown,European,Bulgaria,No,Lower Lobe,,Left,Unifocal,5.2,Squamous cell carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,6,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,"NAPSIN A – focal positive, P40  - negative",,IHC staining not done,173,60,20.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,49,Yes,,Yes,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,72,,>70
C3L-01330,LUAD,C3L-01330-T,C3L-01330-N,TRUE,,CPT0083420003,CPT0083390004,CPT0083390010,CPT0083420006,CPT0081800001,CPT0083390007,CPT0083420009,FALSE,68,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,2.5,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,7,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,0,168,113,40.11,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",2,Yes,,Yes,,,,,Celecoxib|Metoprolol|Losartan|Topiramate|Esomeeprazole|Calcium 1000|Glucosamine-Chondroitin|Hydrocortisone|Nexium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1595,NA,,1595,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1595,0,0,NA,68,High or alive at last follow-up,60-70
C3N-00574,LUAD,C3N-00574-T,C3N-00574-N,TRUE,,CPT0090900004,CPT0090860003,CPT0090860006,CPT0090900007,CPT0090980002,CPT0090860013,CPT0090900010,FALSE,40,Male,Unknown,Unknown,East_Asian,Vietnam,No,Lower Lobe,,Right,Unifocal,3,Adenosquamous carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,,"TTF1 - focal positive, NAPSIN A - focal positive, P40 - negative",IHC staining not done,162,57,21.72,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,397,NA,,392,NA,No,Yes,No,With Tumor,Persistent Disease,,Yes,199,Locoregional Recurrence,Other,Columnar Bone and Pleura,Convincing Image (i.e. CT/PET/MRI),No,,RX: Presence of Residual Tumor cannot be assessed,No,No,Unknown,NA,NA,199,194,1,397,0,-5,NA,40,High or alive at last follow-up,<50
11LU035,LUAD,11LU035-T,,TRUE,,,CPT0051690004,['CPT0051690007'],,CPT0034540002,CPT0051690010,,FALSE,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,,Right,Unifocal,3,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,3,0,cM0,Staging Incomplete,none,R0:No residual tumor,Stage I,,,IHC staining not done,168,57,20.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5,No or minimal exposure to secondhand smoke,,,,,,,,,Yes,Living,7,NA,,0,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,7,0,-7,NA,59,High or alive at last follow-up,50-60
C3N-01071,LUAD,C3N-01071-T,C3N-01071-N,TRUE,,CPT0070080003,CPT0070060003,['CPT0070060009'],CPT0070080006,CPT0070160002,CPT0070060006,CPT0070080009,FALSE,48,Male,Unknown,Unknown,East_Asian,Vietnam,No,Lower Lobe,,Right,Unifocal,2.5,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – focal positive, CK OSCAR - positive",,IHC staining not done,165,57,20.94,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,30,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,44,NA,,9,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,44,0,-35,NA,48,High or alive at last follow-up,<50
C3N-00550,LUAD,C3N-00550-T,C3N-00550-N,TRUE,,CPT0067770003,CPT0067620003,['CPT0067620009'],CPT0067770006,CPT0067850002,CPT0067620006,CPT0067770009,FALSE,52,Female,Unknown,Unknown,East_Asian,Vietnam,No,Lower Lobe,,Left,Unifocal,4,Papillary adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,20,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,,,IHC staining not done,173,72,24.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,401,NA,,396,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,401,0,-5,NA,52,High or alive at last follow-up,50-60
C3N-00167,LUAD,C3N-00167-T,C3N-00167-N,TRUE,,CPT0013630003,CPT0013600003,['CPT0013600013'],CPT0013630006,CPT0016510002,CPT0013600009,CPT0013630009,FALSE,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Lower Lobe,,Right,Unifocal,2.5,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN1,7,4,cM0,No pathologic evidence of distant metastasis,Not documented,R0:No residual tumor,Stage II,"TTF1 – positive, NAPSIN A - positive",,IHC staining not done,168,50,17.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,842,NA,,835,NA,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,336,Distant Metastasis,Bone,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,NA,NA,336,329,1,842,0,-7,NA,64,High or alive at last follow-up,60-70
C3L-00001,LUAD,C3L-00001-T,C3L-00001-N,TRUE,,CPT0001590003,CPT0001580009,CPT0001580164,CPT0001590005,CPT0000150163,CPT0001580165,CPT0001590008,FALSE,61,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,3.7,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,8,1,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage II,Lymph node metastasis positive for pancytokeratin,,IHC staining not done,180,72,22.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,,Yes,1,,,,Restasis|hydroxychloroquine|pilocarpine|Calcium 600 + D|Omega-3|triamcinolone acetonide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1837,NA,,1837,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1837,0,0,NA,61,High or alive at last follow-up,60-70
C3N-01074,LUAD,C3N-01074-T,,TRUE,,,CPT0105270003,CPT0105270006,,CPT0107740002,CPT0105270009,,FALSE,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Left,Unifocal,4,Solid adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,3,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – focal positive, P40 – negative",,IHC staining not done,157,62,25.15,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,229,229,Unknown,NA,225,Unknown,Unknown,Unknown,Unknown Tumor Status,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,229,1,-4,NA,56,Low,50-60
C3L-01632,LUAD,C3L-01632-T,C3L-01632-N,TRUE,,CPT0086770003,CPT0086750003,CPT0086750006,CPT0086770006,CPT0087410002,CPT0086750009,CPT0086770009,FALSE,60,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,3.5,"Adenocarcinoma, micropapillary and acinar",G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,11,1,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage II,Histochemical Stains: Elastic statin confirms the visceral pleura invasion,,IHC staining not done,177,127,40.67,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,NovoLog|Levemir|Acetaminophen-oxycodone|Aspirin|Hydrochlorothiazide|Lovastatin,Self Report|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,717,717,Main malignancy,NA,717,No,Yes,No,With Tumor,Persistent Disease,,Yes,298,Distant Metastasis,Bone,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,NA,NA,298,298,1,717,1,0,NA,60,High or alive at last follow-up,50-60
C3N-02155,LUAD,C3N-02155-T,C3N-02155-N,TRUE,,CPT0118830003,CPT0118810003,CPT0118810009,CPT0118830006,CPT0120050002,CPT0118810006,CPT0118830009,FALSE,45,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,Left,Unifocal,6,Adenocarcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN0,11,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,"TTF1 – weakly positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,165,56,20.57,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,423,NA,,416,NA,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,338,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,NA,NA,338,331,1,423,0,-7,NA,45,High or alive at last follow-up,<50
C3N-00217,LUAD,C3N-00217-T,C3N-00217-N,TRUE,,CPT0090600003,CPT0090570004,CPT0090570007,CPT0090600006,CPT0092500002,CPT0090570010,CPT0090600009,FALSE,59,Female,Unknown,Unknown,European,Bulgaria,No,Upper Lobe,,Left,Unifocal,3.2,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,17,0,cM0,Staging Incomplete,not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A - positive",,IHC staining not done,165,70,25.71,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,29,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,668,NA,,668,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,668,0,0,NA,59,High or alive at last follow-up,50-60
C3N-02002,LUAD,C3N-02002-T,C3N-02002-N,TRUE,,CPT0109710003,CPT0109720004,CPT0109720007,CPT0109710006,CPT0139130002,CPT0109720010,CPT0109710009,FALSE,76,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Multifocal,2.8,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,15,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage I,"HER2（weak +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（+），P40（-）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-）,CDX2（-）,SPA（+）,NapsinA（+）,CK20（-）,CK5/6（-）",IHC staining not done,171,64,21.89,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,prostate cancer,Surgery,Yes,Bicalutamide|ZoLadex,Medical Record|Medical Record,No,Living,355,NA,,358,NA,No,No,No,With Tumor,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,0,3,NA,76,High or alive at last follow-up,>70
C3N-02145,LUAD,C3N-02145-T,C3N-02145-N,TRUE,,CPT0118600003,CPT0118570003,CPT0118570009,CPT0118600006,CPT0119810002,CPT0118570006,CPT0118600008,FALSE,68,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,,Unifocal,3,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,9,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – positive, P40 – focal positive",,IHC staining not done,153,55,23.5,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,405,NA,,399,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,405,0,-6,NA,68,High or alive at last follow-up,60-70
C3N-02586,LUAD,C3N-02586-T,C3N-02586-N,TRUE,,CPT0148000003,CPT0147980004,CPT0147980007,CPT0148000006,CPT0148010002,CPT0147980010,CPT0148000009,FALSE,73,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,3.1,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,23,2,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,HER2（-），TTF1（+），EGFR（+），CK7（+），Ki-67（+，5%），β-Cat（membrane +），P63（-），ERCC1（-），RRM1（partly week+），Syn（-），P40(-),Immunohistochemistry:GATA3（-），ALK(Ventana)（-），ALK-Neg-Tissue（-），CDX2（-），SPA（focal +），NapsinA（+），CK20（-），CK5/6（-）,IHC staining not done,176,74,23.89,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,41,Exposure to secondhand smoke history not available,,,,,,,aspirin|simvastatin|enalapril,Medical Record|Medical Record|Medical Record,No,Deceased,30,30,Unknown,NA,41,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,30,1,11,NA,73,Low,>70
C3L-02219,LUAD,C3L-02219-T,C3L-02219-N,TRUE,,CPT0104650003,CPT0104630003,CPT0104630006,CPT0104650006,CPT0105160002,CPT0104630009,CPT0104650009,FALSE,77,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,4.5,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,9,4,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage III," TTF-1: Positive, consisten with lung origin. PAX8: Negative","PD-L1: Negative, TPS: 0%",IHC staining not done,170,94,32.53,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,20,Exposure to secondhand smoke history not available,,,,,,,"aspirin |atorvastatin (LIPITOR)|Carboxymethylcellul-Glycerin (REFRESH OPTIVE)|clopidogrel (PLAVIX)|cyanocobalamin injection|HYDROcodone-acetaminophen (NORCO)|  lisinopril (PRINIVIL,ZESTRIL)|metoprolol tartrate (LOPRESSOR)|omeprazole (PRILOSEC) |PENTASA |potassium chloride SA",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,931,931,Main malignancy,NA,931,No,No,Yes,With Tumor,Persistent Disease,,Yes,217,Locoregional Recurrence,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,RX: Presence of Residual Tumor cannot be assessed,No,No,Yes,NA,NA,217,217,1,931,1,0,NA,77,High or alive at last follow-up,>70
C3N-00180,LUAD,C3N-00180-T,C3N-00180-N,TRUE,,CPT0066810003,CPT0066780003,['CPT0066780009'],CPT0066810006,CPT0071670002,CPT0066780006,CPT0066810009,FALSE,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Hilar area,Left,Multifocal,4.5,Solid adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,7,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,"TTF1 – negative, NAPSIN A – positive, P63 – negative",,IHC staining not done,170,50,17.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7.5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,355,355,Unknown,NA,347,Unknown,Yes,No,Unknown Tumor Status,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,1,-8,NA,56,Low,50-60
C3L-01862,LUAD,C3L-01862-T,,TRUE,,,CPT0092530003,CPT0092530006,,CPT0093710002,CPT0092530009,,FALSE,81,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,2.7,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN2,14,2,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,Stage III,CDX-2 and TTF-1 are positive,Histochemical Stains: Reticulin stain shows intact pleural elastic layer,IHC staining not done,177,88,28.09,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,Basal cell skin cancer ,Unknown,Unknown,Aspirin|Erythromycin with ethanol|Fluticasone|Gabapentin|Multi Vitamins|Neomycin-polymyxin-dexameth|Omeprazole|Simvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,581,594,Main malignancy,NA,594,No,No,No,With Tumor,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,594,1,0,NA,81,High or alive at last follow-up,>70
C3N-00704,LUAD,C3N-00704-T,C3N-00704-N,TRUE,,CPT0062810003,CPT0055100004,['CPT0055100014'],CPT0062810006,CPT0062910002,CPT0055100010,,FALSE,68,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,1.5,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,147,51,23.65,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,50,Exposure to secondhand smoke history not available,,,,,,,Ancodipine|Symbicort|Plavix|Insulin,Medical Record|Medical Record|Medical Record|Medical Record,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,68,,60-70
C3N-02158,LUAD,C3N-02158-T,C3N-02158-N,TRUE,,CPT0118890003,CPT0118880003,CPT0118880009,CPT0118890006,CPT0120110002,CPT0118880006,CPT0118890009,FALSE,54,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,,Unifocal,6,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN2,7,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,"TTF1 – weakly positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,155,56,23.31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,423,NA,,417,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,423,0,-6,NA,54,High or alive at last follow-up,50-60
C3N-02421,LUAD,C3N-02421-T,C3N-02421-N,TRUE,,CPT0146800003,CPT0146780004,CPT0146780007,CPT0146800006,CPT0146810002,CPT0146780010,CPT0146800009,FALSE,58,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,2.5,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,16,0,cM0,Staging Incomplete,no,R0:No residual tumor,Stage I,"HER2(-), TTF1(+), EGFR(+),CK7(+),Ki-67(+,15％),β-Cat(membranous +), P63(-), ERCC1(-), RRM1(+), Syn(-),P40(-), GATA3(-), ALK(Ventana)(-), ALK-Neg-Tissue(-),CDX2(-),SPA(+),NapsinA(+),CK20(-),CK5/6(-)",,IHC staining not done,168,62,21.97,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40,Exposure to secondhand smoke history not available,,,,,,,irbesartan,Medical Record,No,Living,1171,NA,,1176,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1171,0,5,NA,58,High or alive at last follow-up,50-60
C3N-00556,LUAD,C3N-00556-T,C3N-00556-N,TRUE,,CPT0090720003,CPT0090700003,CPT0090700006,CPT0090720006,CPT0090800002,CPT0090700009,CPT0090720009,FALSE,69,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,6,"Adenosquamous carcinoma (approx. 75% adeno, 25% squamous)",G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,"TTF1 – positive, NAPSIN A – positive, P63 – focal positive",,IHC staining not done,170,48,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,394,NA,,390,NA,No,Yes,No,With Tumor,Not Applicable,,Yes,341,Both Locoregional and Distant Metastasis,Other,"Cervical and mediastinal lymph node, Columnar Bone",Biopsy with Histologic Confirmation,No,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,NA,341,337,1,394,0,-4,NA,69,High or alive at last follow-up,60-70
C3N-00294,LUAD,C3N-00294-T,,TRUE,,,CPT0008450003,['CPT0008450009'],,CPT0008490002,CPT0008450006,,FALSE,57,Male,Unknown,Unknown,European,Poland,No,Lower Lobe,,Right,Unifocal,6,Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,14,1,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,Stage II,"CKAE1/3 (+), TTF-1 (+), CK7( -),CK5/6 (-), p40 (-), Thyroglobulin (–), ki67(+)",,IHC staining not done,168,80,28,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",29.3,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,1848,NA,,1848,NA,No,No,No,With Tumor,Complete Remission,Patient Deceased,Yes,244,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),,Unknown,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Unknown,NA,NA,244,244,1,1848,0,0,NA,57,High or alive at last follow-up,50-60
C3N-01072,LUAD,C3N-01072-T,C3N-01072-N,TRUE,,CPT0084170003,CPT0084140003,CPT0084140006,CPT0084170006,CPT0084190002,CPT0084140009,CPT0084170009,FALSE,62,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Left,Unifocal,2.5,Acinar adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,2,1,cM0,Staging Incomplete,Not known,R0:No residual tumor,Stage III,"TTF1 – positive, NAPSIN A – positive, P63 - positive",,IHC staining not done,165,55,20.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,449,NA,,442,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,449,0,-7,NA,62,High or alive at last follow-up,60-70
C3L-00094,LUAD,C3L-00094-T,C3L-00094-N,TRUE,,CPT0000930003,CPT0000920017,['CPT0000920012'],CPT0000930006,CPT0003900002,CPT0000920005,CPT0000930009,FALSE,69,Male,White,Not Hispanic or Latino,European,United States,No,Middle Lobe,,Right,Unifocal,2.5,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,10,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,188,128,36.1,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,48,Exposure to secondhand smoke history not available,,,,,,,Lotrel|Lipitor|Toprol XL|Glucophage|Saw Palmetto|Glucosamine Chondroitin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,889,889,Main malignancy,NA,889,No,No,No,With Tumor,Unknown,,Yes,638,New Primary Tumor,Lung,,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,NA,638,638,1,889,1,0,NA,69,High or alive at last follow-up,60-70
C3L-00144,LUAD,C3L-00144-T,C3L-00144-N,TRUE,,CPT0001970003,CPT0001960003,['CPT0001960008'],CPT0001970006,CPT0003980002,CPT0001960012,CPT0001970009,FALSE,58,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,2,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,26,0,cM0,Staging Incomplete,Not applicable,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,165,71,26.08,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,42,Exposure to secondhand smoke history not available,,,30,,,,nicodern|lisinopril|ipratropium|omeprazole|motrin|flexeril|hydrodiuril|Albuterol|Advair Diskus,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,578,NA,,578,NA,No,Yes,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,578,0,0,NA,58,High or alive at last follow-up,50-60
C3N-00223,LUAD,C3N-00223-T,C3N-00223-N,TRUE,,CPT0111480003,CPT0111300003,CPT0111300006,CPT0111480006,CPT0111560002,CPT0111300009,CPT0111480008,FALSE,69,Female,Asian,Not Hispanic or Latino,East_Asian,United States,No,Upper Lobe,,Right,Unifocal,3.1,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),"pT2a: Tumor> 3 cm but <= 4 cm in greatest dimension or tumor involving the main bronchus, invading the visceral pleura and with associated atelectasis or obstructive pneumonitis",pNO: No regional node involvement ,27,0,Unknown,Presence of metastatic disease cannot be assessed,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,150,50,22.21,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Lipid reducing medication|Anti-hypertensive medication,Self Report|Self Report,No,Living,49,NA,,50,NA,No,No,No,Unknown Tumor Status,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,49,0,1,NA,69,High or alive at last follow-up,60-70
C3N-02380,LUAD,C3N-02380-T,C3N-02380-N,TRUE,,CPT0146700003,CPT0146680004,CPT0146680007,CPT0146700006,CPT0146710002,CPT0146680010,CPT0146700009,FALSE,56,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,34,0,cM0,Staging Incomplete,NO,R0:No residual tumor,Stage II,"HER2(-), TTF1(+), EGFR(+),CK7(+),Ki-67(+,5％),β-Cat(membranous +), P63(-), ERCC1(+), RRM1(+), Syn(-),P40(-), GATA3(-), ALK(Ventana)(-), ALK-Neg-Tissue(-),CDX2(-),SPA(partial +),NapsinA(+),CK20(-),CK5/6(-)",,IHC staining not done,165,81,29.75,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,8.1,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1059,NA,,1066,NA,No,Yes,No,Tumor Free,Persistent Disease,,Yes,237,New Primary Tumor,Lung,,Convincing Image (i.e. CT/PET/MRI),,,R0: No Residual Tumor,No,No,No,NA,NA,237,244,1,1059,0,7,NA,56,High or alive at last follow-up,50-60
C3L-01924,LUAD,C3L-01924-T,C3L-01924-N,TRUE,,CPT0114690003,CPT0114660004,CPT0114660007,CPT0114690006,CPT0116660002,CPT0114660010,CPT0114690009,FALSE,68,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,2.1,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,5,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,"TTF-1, napsin A and CK7, and  negative for p63 supporting the above diagnosis. Additionally, an elastic  stain      (VVG) was performed on block B4 as reveals no definite  involvement of the visceral pleura",PD-L1: positive (70%); high PD-L1 expression ,0,163,83,31.43,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,25,Exposure to secondhand smoke history not available,,,Unknown,,,,Albuterol|Norvasc|Neurontin|Remicade|Cozaar,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1133,NA,,1133,NA,No,No,No,Tumor Free,Complete Remission,Persistent Disease,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1133,0,0,NA,68,High or alive at last follow-up,60-70
C3N-00433,LUAD,C3N-00433-T,C3N-00433-N,TRUE,,CPT0021490003,CPT0021450003,['CPT0021450006'],CPT0021490006,CPT0021500002,CPT0021450009,CPT0021490008,FALSE,57,Male,Unknown,Unknown,European,Ukraine,No,Upper Lobe,,Right,Unifocal,3.5,Adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,8,0,cM0,Staging Incomplete,No.,R0:No residual tumor,Stage I,р63 Protein (4A4) – Focal positivity; Cytokeratin 5/6 (D5/16/B4) – Negative; Thyrioid Transcription Factor (TTF-1) (8G7G3/1) – Positive; Synaptophysin (SP11) – Negative;,,0,169,83,29.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,60,NA,,10,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,60,0,-50,NA,57,High or alive at last follow-up,50-60
C3L-01683,LUAD,C3L-01683-T,C3L-01683-N,TRUE,,CPT0111590003,CPT0110980004,CPT0110980007,CPT0111590006,CPT0112390002,CPT0110980010,CPT0111590009,FALSE,77,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Multifocal,3.3,Adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,0,cM0,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,"CK 7, TTF-1, Napsin A, CK 5, CK 20 and p40",,0,183,79,23.73,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,33.8,Yes,Yes,,,,,,Diovan|Crestor|Xanax,Self Report|Self Report|Self Report,No,Deceased,1046,1046,Unknown,NA,1053,No,No,No,With Tumor,Not Applicable,,Yes,704,New Primary Tumor,Other,"Skin, Right Flank",Biopsy with Histologic Confirmation,,,,No,No,No,NA,NA,704,711,1,1046,1,7,NA,77,High or alive at last follow-up,>70
C3N-00293,LUAD,C3N-00293-T,C3N-00293-N,TRUE,,CPT0008420003,CPT0008410003,['CPT0008410006'],CPT0008420006,CPT0008430002,CPT0008410009,CPT0008420009,FALSE,73,Male,Unknown,Unknown,European,Poland,No,Upper Lobe,,Right,Unifocal,3.5,Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,28,0,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,Stage I,,,IHC staining not done,178,83,26,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,1832,NA,,1870,NA,No,No,No,Unknown Tumor Status,Unknown,Unknown,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1832,0,38,NA,73,High or alive at last follow-up,>70
C3L-00009,LUAD,C3L-00009-T,C3L-00009-N,TRUE,,CPT0001390003,CPT0001380003,CPT0001380164,CPT0001390013,CPT0000100163,CPT0001380005,CPT0001390009,FALSE,76,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,1.8,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,10,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage I,,,IHC staining not done,172,85,28.67,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,62,Exposure to secondhand smoke history not available,,,,,,,atrovastatin|budesonide-formoterol|insulin|albuterol|bisacodyl,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,545,577,Unknown,NA,586,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,577,1,9,NA,76,High or alive at last follow-up,>70
C3N-00546,LUAD,C3N-00546-T,C3N-00546-N,TRUE,,CPT0067110003,CPT0067070003,['CPT0067070013'],CPT0067110006,CPT0067190002,CPT0067070006,CPT0067110009,FALSE,58,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not Applicable,Left,Unifocal,6,Solid adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,3,0,cM0,Staging Incomplete,Not known,R0:No residual tumor,Stage II,"TTF1 – positive, NAPSIN A – positive, P63 – negative",,IHC staining not done,170,52,17.99,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.8,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,382,NA,,375,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,382,0,-7,NA,58,High or alive at last follow-up,50-60
C3N-01414,LUAD,C3N-01414-T,C3N-01414-N,TRUE,,CPT0105610003,CPT0105600003,CPT0105600006,CPT0105610006,CPT0108040002,CPT0105600009,CPT0105610009,FALSE,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,Upper Lobe,,Left,Unifocal,5,Acinar adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,0,cM0,Staging Incomplete,Not Specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A - positive",,IHC staining not done,160,50,19.53,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,820,NA,,449,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,820,0,-371,NA,59,High or alive at last follow-up,50-60
C3N-02087,LUAD,C3N-02087-T,C3N-02087-N,TRUE,,CPT0118240003,CPT0118200003,CPT0118200006,CPT0118240006,CPT0119450002,CPT0118200009,CPT0118240009,FALSE,61,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unspecified,,Unifocal,4,Acinar adenocarcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN2,7,2,cM0,Staging Incomplete,Unspecified,R0:No residual tumor,Stage III,"TTF1 – positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,150,50,22.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,303,303,Main malignancy,NA,296,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,303,1,-7,NA,61,Low,60-70
C3L-00140,LUAD,C3L-00140-T,C3L-00140-N,TRUE,,CPT0001810003,CPT0001800013,['CPT0001800008'],CPT0001810006,CPT0003960002,CPT0001800005,CPT0001810009,FALSE,70,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,1.9,Papillary adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,8,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,Stage I,,,0,180,68,20.99,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,2.5,Exposure to secondhand smoke history not available,,,Unknown,,,,Ipratropium-Albuterol|Allopurinol|Atenolol|Hydrochlorothiazide|Vitamin D|Amlodipine|Aspirin|Lovastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1802,NA,,1802,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1802,0,0,NA,70,High or alive at last follow-up,60-70
C3N-02529,LUAD,C3N-02529-T,C3N-02529-N,TRUE,,CPT0147500003,CPT0147480004,CPT0147480007,CPT0147500006,CPT0147510002,CPT0147480010,CPT0147500009,FALSE,79,Female,Unknown,Unknown,East_Asian,China,No,Middle Lobe,,Right,Unifocal,4,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,27,1,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,"HER2（+）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,60％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,156,57,23.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,664,849,Unknown,NA,855,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,849,1,6,NA,79,High or alive at last follow-up,>70
C3L-00368,LUAD,C3L-00368-T,C3L-00368-N,TRUE,,CPT0063750003,CPT0063730003,['CPT0063730009'],CPT0063750006,CPT0065310002,['CPT0063730006'],CPT0063750009,FALSE,67,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,2.5,Adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,9,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage I,,,IHC staining not done,157,72,29.21,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",25,Exposure to secondhand smoke history not available,,,,Breast,Surgery,No,Cartia XT|melatonin|valerian Root|B-complex-c|Theralith XR|Apixaban|Lipitor|Cardizem CD|Aldactone|coreg|celexa|tamsulosin|Aspirin 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,141,NA,,141,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,141,0,0,NA,67,High or alive at last follow-up,60-70
C3N-02067,LUAD,C3N-02067-T,C3N-02067-N,TRUE,,CPT0109850003,CPT0109830004,CPT0109830007,CPT0109850006,CPT0139390002,CPT0109830010,CPT0109850009,FALSE,37,Female,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,2,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN2,11,8,cM0,Staging Incomplete,NO,R0:No residual tumor,Stage III,"HER2（focal +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（partially+），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,164,65,24.17,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1081,NA,,1086,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,112,Distant Metastasis,Bone,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,NA,NA,112,117,1,1081,0,5,NA,37,High or alive at last follow-up,<50
C3N-02422,LUAD,C3N-02422-T,,TRUE,,,CPT0146880004,CPT0146880007,,CPT0146910002,CPT0146880010,,FALSE,56,Female,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Right,Unifocal,3.8,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,14,3,cM1b,pM1b,no,R0:No residual tumor,Stage IV,"HER2(-), TTF1(+), EGFR(+),CK7(+),Ki-67(+, 5％),β-Cat(membranous +), P63(+), ERCC1(+), RRM1(+), Syn(+),P40(-), GATA3(-), ALK(Ventana)(+), ALK-Neg-Tissue(-),CDX2(-),SPA(+),NapsinA(+),CK20(-),CK5/6(-)",,IHC staining not done,161,65,25.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,nifedipine,Self Report,No,Deceased,552,650,Main malignancy,NA,653,No,Yes,No,With Tumor,Persistent Disease,,Yes,118,Distant Metastasis,"Bone, Liver, Other",adrenal gland,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,118,121,1,650,1,3,NA,56,High or alive at last follow-up,50-60
C3L-00080,LUAD,C3L-00080-T,C3L-00080-N,TRUE,,CPT0001070003,CPT0001060010,CPT0001060164,CPT0001070006,CPT0000020163,CPT0001060005,CPT0001070009,FALSE,58,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,3.5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,Stage I,"A properly controlled CD56 innumohistchemical stain is strongly positive in focal areas, supportive of neuroendocrine differentiation focally. ",,IHC staining not done,170,88,30.62,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,40,Exposure to secondhand smoke history not available,,,,,,,Lopressor|coumadin|celexa|Lipitor|Flomax|Asa,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1805,NA,,1805,NA,Yes,Yes,No,With Tumor,Complete Remission,Persistent Disease,Yes,1000,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,NA,NA,1000,1000,1,1805,0,0,NA,58,High or alive at last follow-up,50-60
C3N-00547,LUAD,C3N-00547-T,C3N-00547-N,TRUE,,CPT0067290003,CPT0067250003,['CPT0067250009'],CPT0067290006,CPT0067370002,CPT0067250006,CPT0067290009,FALSE,60,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Left,Unifocal,5,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,7,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage II,"TTF1 – positive, NAPSIN A – positive",,IHC staining not done,170,51,17.65,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,474,NA,,468,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,474,0,-6,NA,60,High or alive at last follow-up,50-60
C3N-01023,LUAD,C3N-01023-T,C3N-01023-N,TRUE,,CPT0105190003,CPT0105060003,CPT0105060006,CPT0105190006,CPT0107620002,CPT0105060009,CPT0105190009,FALSE,58,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,6,Solid adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,17,3,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage III,"TTF1 – positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,170,48,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,422,NA,,415,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,422,0,-7,NA,58,High or alive at last follow-up,50-60
C3N-01024,LUAD,C3N-01024-T,C3N-01024-N,TRUE,,CPT0105250003,CPT0105230003,CPT0105230006,CPT0105250006,CPT0107680002,CPT0105230009,CPT0105250009,FALSE,66,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,5.5,Adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,0,cM0,No pathologic evidence of distant metastasis,Not specified,R0:No residual tumor,Stage II,"TTF1 – positive, NAPSIN A – positive, P40 - negative",,IHC staining not done,160,46,17.97,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,419,NA,,412,NA,No,Yes,No,With Tumor,Persistent Disease,,Yes,413,Locoregional Recurrence,Other,Inguinal lymph nodes and pleura,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,413,406,1,419,0,-7,NA,66,High or alive at last follow-up,60-70
C3L-00973,LUAD,C3L-00973-T,C3L-00973-N,TRUE,,CPT0102480003,CPT0102450003,CPT0102450006,CPT0102480006,CPT0101050002,CPT0102450009,CPT0102480009,FALSE,76,Male,Unknown,Unknown,European,Russia,No,Lower Lobe,,Right,Unifocal,5,Adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,8,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,Stage I,,,IHC staining not done,169,176,61.62,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Losartan,Self Report,No,Living,1435,NA,,1414,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1435,0,-21,NA,76,High or alive at last follow-up,>70
C3L-02348,LUAD,C3L-02348-T,C3L-02348-N,TRUE,,CPT0115090003,CPT0115070003,CPT0115070006,CPT0115090006,CPT0115320002,CPT0115070009,CPT0115090009,FALSE,58,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Multifocal,6.5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,13,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,Stage II,,"FISH analysis all negative for ALK gene, ROS1 gene, RET gene",IHC staining not done,152,63,27.27,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,71.8,Exposure to secondhand smoke history not available,,,,,,,"Symbicort|claritin|Glucophage|Proventil, ventolin proair|Budesonide",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1425,NA,,1425,NA,No,Yes,No,Tumor Free,Unknown,Unknown,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1425,0,0,NA,58,High or alive at last follow-up,50-60
C3L-02508,LUAD,C3L-02508-T,C3L-02508-N,TRUE,,CPT0125830003,CPT0125810003,CPT0125810006,CPT0125830006,CPT0124270002,CPT0125810009,CPT0125830009,FALSE,65,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Upper Lobe,,Left,Unifocal,4,"Lepidic adenocarcinoma, Invasive mucinous adenocarcinoma",G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,14,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,170,74,25.42,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,"Valsartan|omega-3, polyunsaturated fatty acids|Ranitidine|Atorvastatin|Atenolol|Amlodipine",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1013,NA,,1013,NA,No,No,No,Unknown Tumor Status,Unknown,Unknown,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1013,0,0,NA,65,High or alive at last follow-up,60-70
C3N-00560,LUAD,C3N-00560-T,C3N-00560-N,TRUE,,CPT0068830003,CPT0068800003,['CPT0068800009'],CPT0068830006,CPT0068910002,CPT0068800006,CPT0068830009,FALSE,55,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,5,Adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,9,2,cM0,Staging Incomplete,Not known,R0:No residual tumor,Stage III,"TTF1 - positive, NAPSIN A – weakly positive, P63 - negative",,IHC staining not done,160,62,24.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,378,NA,,378,NA,No,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,378,0,0,NA,55,High or alive at last follow-up,50-60
C3L-00604,LUAD,C3L-00604-T,C3L-00604-N,TRUE,,CPT0063840003,CPT0063810003,['CPT0063810009'],CPT0063840006,CPT0065330002,CPT0063810006,CPT0063840009,FALSE,61,Female,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Multifocal,3.2,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,12,7,cM0,No pathologic evidence of distant metastasis,Not applicable ,R0:No residual tumor,Stage III,,,IHC staining not done,170,63,21.75,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Zovirax|Multi Vitamin|Vitamin D|Synthroid,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1801,NA,,1801,NA,Yes,Yes,Yes,With Tumor,Persistent Disease,Persistent Disease,Yes,332,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,No,No,Yes,NA,NA,332,332,1,1801,0,0,NA,61,High or alive at last follow-up,60-70
C3N-00199,LUAD,C3N-00199-T,C3N-00199-N,TRUE,,CPT0014290003,CPT0014260003,['CPT0014260009'],CPT0014290006,CPT0015050002,CPT0014260006,CPT0014290009,FALSE,65,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Left,Unifocal,2.8,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,7,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,175,87,28.35,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",15,Exposure to secondhand smoke history not available,,,,,,,levothyroxine|finasteride|melatonin|tramadol|testosterone|gabapentin|anastrozole|omeprazole|lisinopril,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1721,NA,,1693,NA,No,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1721,0,-28,NA,65,High or alive at last follow-up,60-70
C3N-00579,LUAD,C3N-00579-T,C3N-00579-N,TRUE,,CPT0069550003,CPT0069520003,['CPT0069520006'],CPT0069550006,CPT0069630002,CPT0069520009,CPT0069550009,FALSE,67,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Unknown,Right,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A – positive",,IHC staining not done,160,61,23.83,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,477,NA,,477,NA,Yes,Yes,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,477,0,0,NA,67,High or alive at last follow-up,60-70
C3N-02582,LUAD,C3N-02582-T,C3N-02582-N,TRUE,,CPT0147900003,CPT0147880004,CPT0147880007,CPT0147900006,CPT0147910002,CPT0147880010,CPT0147900009,FALSE,77,Male,Unknown,Unknown,East_Asian,China,No,Upper Lobe,,Left,Unifocal,5.8,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,37,1,cM0,Staging Incomplete,no,R0:No residual tumor,Stage II,"HER2（partly weak+）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,177,73,23.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",31,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,802,888,Unknown,NA,899,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,888,1,11,NA,77,High or alive at last follow-up,>70
C3L-02350,LUAD,C3L-02350-T,C3L-02350-N,TRUE,,CPT0104760003,CPT0104750003,CPT0104750006,CPT0104760006,CPT0105180002,CPT0104750009,CPT0104760009,FALSE,69,Male,White,Not Hispanic or Latino,European,United States,No,Upper Lobe,,Right,Unifocal,3,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,7,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,Stage I,,PD-L1 Negative TPS 0%,IHC staining not done,178,91,28.69,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",12,Exposure to secondhand smoke history not available,,,,Testicular Cancer|Lung ,"Radiation,Surgery,Chemotherapy|Surgery",Yes|Yes,eliquis|monopril ,Medical Record|Medical Record,No,Living,1418,NA,,1418,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1418,0,0,NA,69,High or alive at last follow-up,60-70
C3N-00738,LUAD,C3N-00738-T,C3N-00738-N,TRUE,,CPT0112080003,CPT0112060003,CPT0112060006,CPT0112080006,CPT0112180002,CPT0112060009,CPT0112080009,FALSE,70,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Upper Lobe,,Right,Unifocal,2.2,Adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,28,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,157,55,22.43,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,25,Exposure to secondhand smoke history not available,,,,,,,Albuterol|Xarelto,Medical Record|Medical Record,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,70,,60-70
C3N-00959,LUAD,C3N-00959-T,C3N-00959-N,TRUE,,CPT0079850003,CPT0079830003,['CPT0079830006'],CPT0079850005,CPT0080770002,CPT0079830009,CPT0079850008,FALSE,66,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,4,Acinar adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,Stage I,,Elastic Stain of visceral pleura: no invasion of visceral pleura by tumor ,IHC staining not done,170,74,25.37,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",19,Exposure to secondhand smoke history not available,,,,,,,amlodipine|atorvastatin|naproxen sodium|Mens Multivitamin,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1641,NA,,1591,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,Yes,911,New Primary Tumor,Other,Bladder,Convincing Image (i.e. CT/PET/MRI),,,,No,Yes,No,NA,NA,911,861,1,1641,0,-50,NA,66,High or alive at last follow-up,60-70
C3N-02003,LUAD,C3N-02003-T,C3N-02003-N,TRUE,,CPT0109760003,CPT0109740004,CPT0109740007,CPT0109760006,CPT0139170002,CPT0109740010,CPT0109760009,FALSE,56,Male,Unknown,Unknown,East_Asian,China,No,Lower Lobe,,Right,Unifocal,4,Adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,10,3,cM0,Staging Incomplete,NO,R0:No residual tumor,Stage III,"HER2（partial +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,80％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-）","Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（partial +），NapsinA（+），CK20（-），CK5/6（-）",IHC staining not done,161,68,26.23,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,56,Exposure to secondhand smoke history not available,,,,,,,hypotensor,Self-reported and Medical Record,No,Living,353,NA,,358,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,353,0,5,NA,56,High or alive at last follow-up,50-60
C3N-00175,LUAD,C3N-00175-T,C3N-00175-N,TRUE,,CPT0013910003,CPT0013880003,['CPT0013880006'],CPT0013910005,CPT0016600002,CPT0013880009,CPT0013910008,FALSE,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other,Not specified,Right,Unifocal,4.5,Adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,9,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,Stage I,"TTF1 – positive, NAPSIN A - positive",,IHC staining not done,171,49,16.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,308,308,Unknown,NA,301,No,No,No,Unknown Tumor Status,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,308,1,-7,NA,72,Low,>70
C3N-01823,LUAD,C3N-01823-T,C3N-01823-N,TRUE,,CPT0097600003,CPT0097580003,CPT0097580006,CPT0097600006,CPT0097610002,CPT0097580009,CPT0097600009,FALSE,63,Male,Unknown,Unknown,European,Ukraine,No,Upper Lobe,,Left,Unifocal,4,Adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,21,17,cM0,Staging Incomplete,No,R0:No residual tumor,Stage III,TTF-1 - positive; p63 - negative; CK7 - positive; CK5/6 - negative;,,IHC staining not done,173,75,25.06,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,351,351,Main malignancy,NA,351,No,Yes,No,With Tumor,Complete Remission,,Yes,181,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,NA,NA,181,181,1,351,1,0,NA,63,Low,60-70
C3L-02549,LUAD,C3L-02549-T,C3L-02549-N,TRUE,,CPT0113220003,CPT0113210003,CPT0113210006,CPT0113220006,CPT0115250002,CPT0113210009,CPT0113220009,FALSE,69,Male,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Left,Unifocal,12,Lepidic adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,17,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,Stage II,,"PD-L1: Positive, Low Expression, TPS: 15%",IHC staining not done,180,96,29.63,Yes,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,Unknown,Prostate Cancer,Surgery,Yes,Lipitor|Lexapro,Medical Record|Medical Record,No,Deceased,447,447,Main malignancy,NA,447,No,Yes,No,With Tumor,Unknown,,Yes,216,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,Yes,216,NA,216,216,1,447,1,0,NA,69,High or alive at last follow-up,60-70
C3L-02365,LUAD,C3L-02365-T,C3L-02365-N,TRUE,,CPT0114880003,CPT0114840003,CPT0114840006,CPT0114880009,CPT0116900002,CPT0114840009,CPT0114880006,FALSE,62,Female,White,Not Hispanic or Latino,European,United States,No,Lower Lobe,,Right,Unifocal,4.2,Adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,3,1,cM0,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,Stage II,"CK7, TTF-1 NAPSIN, P40, CHROMOGRANIN, SYNAPTOPHYSIN, CD56",,IHC staining not done,155,53,21.92,No,Lifelong non-drinker,Current reformed smoker within past 15 years,47,Yes,Yes,,,,,,Hydrocodone-acetaminophen|Albuterol Sulfate|fluticasone-vilanterol,Medical Record|Medical Record|Medical Record,No,Deceased,625,627,Main malignancy,NA,635,No,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,627,1,8,NA,62,High or alive at last follow-up,60-70
02OV032,OV,02OV032-T,,TRUE,,,0c87932d-b6fd-4eb5-b86a-a34d07_D5,0c87932d-b6fd-4eb5-b86a-a34d07_D7_1,,38bc3eb3-b978-43c0-a2be-50eeda_D1_1,0c87932d-b6fd-4eb5-b86a-a34d07_D6_1,,FALSE,57,Female,Black or African American,Not Hispanic or Latino,African,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,347,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,347,0,NA,NA,57,High or alive at last follow-up,50-60
04OV057,OV,04OV057-T,,TRUE,,,7069e990-4a4e-4984-a66d-4d835a_D5,7069e990-4a4e-4984-a66d-4d835a_D7,,cced71f0-58dc-4e46-a02c-2af508_D1,7069e990-4a4e-4984-a66d-4d835a_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,982,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,982,0,NA,NA,63,High or alive at last follow-up,60-70
04OV028,OV,04OV028-T,,TRUE,,,41d0619e-b299-42e2-ac32-29e784_D5,41d0619e-b299-42e2-ac32-29e784_D7_1,,1cec1511-2570-4921-bac0-5ceea7_D1_1,41d0619e-b299-42e2-ac32-29e784_D6_1,,FALSE,59,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,420,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,Yes,NA,NA,NA,NA,1,420,0,NA,NA,59,High or alive at last follow-up,50-60
15OV001,OV,15OV001-T,15OV001-N,TRUE,,7edfd606-4bee-4529-9fec-1ca7f0_D5,7c7ce2d7-6c8a-424e-8e6c-d14ad1_D5,7c7ce2d7-6c8a-424e-8e6c-d14ad1_D7_1,,60daddeb-d877-481a-9901-883bb8_D1_1,7c7ce2d7-6c8a-424e-8e6c-d14ad1_D6_1,,FALSE,44,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,366,NA,,NA,NA,No,No,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,366,0,NA,NA,44,High or alive at last follow-up,<50
17OV011,OV,17OV011-T,,TRUE,,,cfd76f9a-ce60-4ec7-8e6b-a8fc31_D2,cfd76f9a-ce60-4ec7-8e6b-a8fc31_D7,,d606e01a-a0b6-4126-ade0-dd9fba_D1_1,cfd76f9a-ce60-4ec7-8e6b-a8fc31_D6,,FALSE,79,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,271,NA,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,271,0,NA,NA,79,High or alive at last follow-up,>70
01OV007,OV,01OV007-T,01OV007-N,TRUE,,1abbcb28-f221-4cd4-8c01-37b9bb_D1_D5,9b90eb78-2f50-4aeb-b010-d642f9_D5,9b90eb78-2f50-4aeb-b010-d642f9_D7,,31178af6-5271-4859-a086-f74006_D1,9b90eb78-2f50-4aeb-b010-d642f9_D6,,FALSE,68,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,369,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,369,0,NA,NA,68,High or alive at last follow-up,60-70
04OV018,OV,04OV018-T,,TRUE,,,f6c215ea-5381-4521-bb61-be8e97_D5,f6c215ea-5381-4521-bb61-be8e97_D7_1,,5d9282ce-5954-476d-ba32-aa73d0_D1_1,f6c215ea-5381-4521-bb61-be8e97_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,387,NA,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,Yes,NA,Locoregional Recurrence,Abdomen;,,,No,,,,No,Yes,NA,NA,NA,NA,1,387,0,NA,NA,63,High or alive at last follow-up,60-70
04OV063,OV,04OV063-T,,TRUE,,,bd266bdd-12e4-42cb-9c49-911bfc_D5,bd266bdd-12e4-42cb-9c49-911bfc_D7,,1c7e6865-4a6b-41ee-8e3b-456330_D1,bd266bdd-12e4-42cb-9c49-911bfc_D6,,FALSE,50,Female,Asian,Not Hispanic or Latino,South_Asian,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,1397,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Locoregional Recurrence,Pelvis;Abdomen;,,,No,,,,No,No,NA,NA,NA,NA,1,1397,0,NA,NA,50,High or alive at last follow-up,<50
17OV003,OV,,17OV003-N,TRUE,,b9c1f22e-61f7-45ed-b3b4-5094c7_D5,,,,,,,FALSE,55,Female,White,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,NA,NA,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,Yes,NA,Distant Metastasis,Other (specify);Chest;,,,,No,,,Yes,No,NA,NA,NA,NA,1,NA,0,NA,NA,55,High or alive at last follow-up,50-60
01OV023,OV,01OV023-T,01OV023-N,TRUE,,2b73e01c-347a-4dae-a71d-752aeb_D5,d38f40fb-dd78-43b2-8b7b-4b6977_D5,d38f40fb-dd78-43b2-8b7b-4b6977_D7,,cd900fda-2bc7-495e-8e11-3ef2ac_D1,d38f40fb-dd78-43b2-8b7b-4b6977_D6,,FALSE,58,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,376,NA,,NA,NA,No,Yes,No,Unknown tumor status,Partial Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,376,0,NA,NA,58,High or alive at last follow-up,50-60
17OV039,OV,17OV039-T,,TRUE,,,ce1e5dfc-2ef1-4633-af93-5ea4d9_D5,ce1e5dfc-2ef1-4633-af93-5ea4d9_D7,,0dadc0a2-6f5f-4fe1-81bf-62a50a_D1,ce1e5dfc-2ef1-4633-af93-5ea4d9_D6,,FALSE,54,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,Not Reported/ Unknown,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,155,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,155,0,NA,NA,54,High or alive at last follow-up,50-60
17OV015,OV,17OV015-T,,TRUE,,,6530147a-efe9-4df6-ac2f-03ece3_D5,6530147a-efe9-4df6-ac2f-03ece3_D7,,63e27b5b-492d-455a-9881-185955_D1,6530147a-efe9-4df6-ac2f-03ece3_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,284,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,284,0,NA,NA,63,High or alive at last follow-up,60-70
17OV017,OV,17OV017-T,,TRUE,,,49bd51fe-48a1-4828-b66e-b30c38_D5,49bd51fe-48a1-4828-b66e-b30c38_D7,,012ff650-0db2-41a2-a309-383835_D1,32b962ad-4f52-4778-90eb-0ef7d5_D6,,FALSE,79,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,11-20 mm,Stage III,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,360,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,360,0,NA,NA,79,High or alive at last follow-up,>70
17OV005,OV,,17OV005-N,TRUE,,8df6697b-56a1-4ff0-97cf-42b966_D5,,,,,,,FALSE,71,Female,White,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,NA,,NA,NA,No,Yes,No,With tumor,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,1,NA,NA,71,,>70
17OV028,OV,17OV028-T,,TRUE,,,52c064a7-78d9-4a1a-85b4-27c6d1_D5,52c064a7-78d9-4a1a-85b4-27c6d1_D7,,80a5ccde-c851-47fb-8c0d-238b16_D1,d4377e17-ca1c-4411-a386-8d5f4c_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,Not Reported/ Unknown,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,29,,NA,NA,No,Yes,No,With tumor,Not Reported/ Unknown,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,29,1,NA,NA,57,Low,50-60
02OV008,OV,02OV008-T,,TRUE,,,fbb41c94-aabd-49cc-90b2-882c3e_D5,fbb41c94-aabd-49cc-90b2-882c3e_D7,,5ffd8c6c-0807-4be5-b0d1-dc475f_D1,fbb41c94-aabd-49cc-90b2-882c3e_D6,,FALSE,50,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,449,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,449,0,NA,NA,50,High or alive at last follow-up,<50
04OV005,OV,04OV005-T,,TRUE,,,3d3e1888-d67e-4c69-ba83-112d0f_D5,3d3e1888-d67e-4c69-ba83-112d0f_D7,,cade384a-f9d2-4e3b-9aa5-a0e64e_D1,3d3e1888-d67e-4c69-ba83-112d0f_D6,,FALSE,72,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,352,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,352,0,NA,NA,72,High or alive at last follow-up,>70
01OV017,OV,01OV017-T,01OV017-N,TRUE,,1556af7e-c2ae-4fce-9aae-87c459_D1_D5,1a10c200-3895-4648-b951-94f99f_D5,1a10c200-3895-4648-b951-94f99f_D7,,cd0c6f13-08d2-4a74-846b-3872e0_D1,1a10c200-3895-4648-b951-94f99f_D6,,FALSE,56,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,396,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,396,0,NA,NA,56,High or alive at last follow-up,50-60
02OV001,OV,02OV001-T,,TRUE,,,9a7a86d3-bbf2-4d36-941d-c75c03_D1_D5,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
11OV002,OV,11OV002-T,11OV002-N,TRUE,,6e81377c-d0d6-4881-87f6-01c909_D5,665f4f0f-130c-4b09-9762-cd0696_D2,665f4f0f-130c-4b09-9762-cd0696_D7_1,,af8fcd15-fda9-49e8-9e04-5ce523_D1_1,665f4f0f-130c-4b09-9762-cd0696_D6_1,,FALSE,65,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Ovary,,,,NA,Serous Adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,65,,60-70
02OV041,OV,02OV041-T,,TRUE,,,5b5c81b1-4e73-48d3-9469-108edd_D2,5b5c81b1-4e73-48d3-9469-108edd_D7,,2315af2e-1e3c-45ca-b4f0-ce2f23_D1,5b5c81b1-4e73-48d3-9469-108edd_D6,,FALSE,41,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,290,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,290,0,NA,NA,41,High or alive at last follow-up,<50
17OV025,OV,17OV025-T,,TRUE,,,e7b656bf-3c34-4ba1-bdf3-c7eefe_D5,e7b656bf-3c34-4ba1-bdf3-c7eefe_D7,,05256b36-6dfa-4f41-b13b-df0a38_D1,e7b656bf-3c34-4ba1-bdf3-c7eefe_D6,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,Not Reported/ Unknown,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,303,NA,,NA,NA,No,Yes,Not Reported/ Unknown,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,303,0,NA,NA,66,High or alive at last follow-up,60-70
17OV018,OV,17OV018-T,,TRUE,,,28d0abdb-f682-4bd3-9425-a9c508_D5,28d0abdb-f682-4bd3-9425-a9c508_D7,,4fb7c54a-fefd-4a43-9dcc-f59e89_D1,28d0abdb-f682-4bd3-9425-a9c508_D6,,FALSE,62,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,352,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,352,0,NA,NA,62,High or alive at last follow-up,60-70
01OV029,OV,01OV029-T,01OV029-N,TRUE,,340a3769-3031-41ae-bb08-a2f696_D5,51a4ce2f-4166-4c6b-a7e0-942d0a_D5,51a4ce2f-4166-4c6b-a7e0-942d0a_D7,,d726284d-b766-4653-9245-738d99_D1,51a4ce2f-4166-4c6b-a7e0-942d0a_D6,,FALSE,48,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,48,,<50
17OV010,OV,17OV010-T,,TRUE,,,7c2aeacf-a30d-4104-b60a-7545ee_D2,7c2aeacf-a30d-4104-b60a-7545ee_D7_1,,a1941d5e-aa5a-46d1-b995-3d4278_D1_1,7c2aeacf-a30d-4104-b60a-7545ee_D6_1,,FALSE,65,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,greater than 20 mm,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,355,NA,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,0,NA,NA,65,High or alive at last follow-up,60-70
17OV027,OV,17OV027-T,,TRUE,,,38f29517-c046-4da5-ba0d-67d614_D2,38f29517-c046-4da5-ba0d-67d614_D7,,dc7c7f4c-af59-44eb-ae32-2e4228_D1,38f29517-c046-4da5-ba0d-67d614_D6,,FALSE,51,Female,White,Unknown,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,greater than 20 mm,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,118,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,118,0,NA,NA,51,High or alive at last follow-up,50-60
20OV005,OV,20OV005-T,,TRUE,,,3a380577-c134-47ba-a1ce-988d7c_D5,3a380577-c134-47ba-a1ce-988d7c_D7,,e20828d6-1399-43d5-96de-21ae37_D1,3a380577-c134-47ba-a1ce-988d7c_D6,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,358,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,358,0,NA,NA,70,High or alive at last follow-up,60-70
14OV011,OV,14OV011-T,14OV011-N,TRUE,,1db5574d-aca7-403c-8100-6e705f_D5,2115808b-6a0d-49bc-a8d7-b83bde_D5,2115808b-6a0d-49bc-a8d7-b83bde_D7_1,,554dab31-c7f5-4765-a1e3-9ceb94_D1_1,2115808b-6a0d-49bc-a8d7-b83bde_D6_1,,FALSE,58,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,498,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Locoregional Recurrence,Abdomen;,,,Yes,,,,No,No,NA,NA,NA,NA,1,498,0,NA,NA,58,High or alive at last follow-up,50-60
02OV006,OV,02OV006-T,,TRUE,,,8120e7d6-bd09-4334-841c-70a214_D2,8120e7d6-bd09-4334-841c-70a214_D7,,45698791-f0d6-4ab7-9b4a-3d8bf4_D1,8120e7d6-bd09-4334-841c-70a214_D6,,FALSE,44,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,455,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,455,0,NA,NA,44,High or alive at last follow-up,<50
26OV009,OV,26OV009-T,,TRUE,,,35a345a4-e954-4c81-ae3f-7797cd_D5,35a345a4-e954-4c81-ae3f-7797cd_D7,,266c4207-1a8e-4343-bf1f-3304d0_D1,35a345a4-e954-4c81-ae3f-7797cd_D6,,FALSE,60,Female,White,Unknown,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,Yes,,,,,Living,727,NA,,NA,NA,No,Yes,No,Not Reported/ Unknown,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,727,0,NA,NA,60,High or alive at last follow-up,50-60
02OV036,OV,02OV036-T,,TRUE,,,3b044c9b-ac09-4b4b-8f37-462411_D2,97cab1b7-a9ba-4c11-9f39-c8c54d_D7,,936e1c41-7756-465c-b292-29d4a0_D1,3b044c9b-ac09-4b4b-8f37-462411_D6,,FALSE,55,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,357,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,357,0,NA,NA,55,High or alive at last follow-up,50-60
26OV008,OV,26OV008-T,,TRUE,,,2433b136-fc7b-4cea-b958-bc6efb_D5,2433b136-fc7b-4cea-b958-bc6efb_D7,,4179faf1-53d6-40ba-9d58-f111a7_D1,2433b136-fc7b-4cea-b958-bc6efb_D6,,FALSE,65,Female,White,Unknown,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,11-20 mm,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,Yes,,,,,Deceased,NA,400,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,Not Applicable,NA,,,,,,,,,,,NA,NA,NA,NA,0,400,1,NA,NA,65,Low,60-70
17OV004,OV,,17OV004-N,TRUE,,3fbf076a-824b-4eac-b6dc-bf5e59_D5,,,,,,,FALSE,62,Female,American Indian or Alaska Native,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,NA,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,0,NA,NA,62,High or alive at last follow-up,60-70
02OV023,OV,02OV023-T,,TRUE,,,2ed8beb2-bc63-4bad-b5fe-1916a0_D5,2ed8beb2-bc63-4bad-b5fe-1916a0_D7,,7d942a6f-236e-4659-89a2-6711ae_D1,2ed8beb2-bc63-4bad-b5fe-1916a0_D6,,FALSE,46,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,364,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,364,0,NA,NA,46,High or alive at last follow-up,<50
04OV039,OV,04OV039-T,,TRUE,,,7d953d1d-84b6-4ecd-b1d7-1ed865_D5,7d953d1d-84b6-4ecd-b1d7-1ed865_D7,,d82ca4fc-d74c-4658-8920-897974_D1,1dcde92b-2a59-427d-a7e6-48b476_D6,,FALSE,46,Female,Unknown,Not Hispanic or Latino,East_Asian,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,326,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,326,0,NA,NA,46,High or alive at last follow-up,<50
04OV037,OV,04OV037-T,,TRUE,,,e9d416e7-f661-400a-896e-388545_D5,e9d416e7-f661-400a-896e-388545_D7,,5eef476a-4c66-43fe-bd3e-9d4aa5_D1,e9d416e7-f661-400a-896e-388545_D6,,FALSE,71,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,343,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,343,0,NA,NA,71,High or alive at last follow-up,>70
04OV051,OV,04OV051-T,,TRUE,,,76e77c6b-c80e-4391-bdbb-e1dcea_D5,76e77c6b-c80e-4391-bdbb-e1dcea_D7,,aecb5251-5486-4adb-b842-24a6dc_D1,76e77c6b-c80e-4391-bdbb-e1dcea_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,924,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,924,0,NA,NA,57,High or alive at last follow-up,50-60
04OV040,OV,04OV040-T,,TRUE,,,50997c44-1c8b-4d34-b535-4a6cc2_D5,50997c44-1c8b-4d34-b535-4a6cc2_D7,,fbe99290-8eba-45ae-ad79-38442b_D1,50997c44-1c8b-4d34-b535-4a6cc2_D6,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,329,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Both Locoregional and Distant Metastasis,Abdomen;Chest;,,,,Not Reported/ Unknown,,,Not Reported/ Unknown,Not Reported/ Unknown,NA,NA,NA,NA,1,329,0,NA,NA,70,High or alive at last follow-up,60-70
01OV030,OV,01OV030-T,,TRUE,,,5ea22f5e-307b-491d-801f-8b7fa6_D5,5ea22f5e-307b-491d-801f-8b7fa6_D7,,907f990e-2b1a-49dc-8944-48e146_D1,5ea22f5e-307b-491d-801f-8b7fa6_D6,,FALSE,73,Female,White,Unknown,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,338,NA,,NA,NA,No,Yes,No,Unknown tumor status,Partial Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,338,0,NA,NA,73,High or alive at last follow-up,>70
26OV002,OV,26OV002-T,,TRUE,,,6319b36b-533c-4e86-8e12-80552e_D2,6319b36b-533c-4e86-8e12-80552e_D7,,70daa657-8dd1-48e7-a69b-e3d7d1_D1,6319b36b-533c-4e86-8e12-80552e_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,331,NA,,NA,NA,No,Yes,Yes,Tumor free,Not Reported/ Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,331,0,NA,NA,57,High or alive at last follow-up,50-60
02OV046,OV,02OV046-T,,TRUE,,,8e6a9f67-7c53-4386-9ba0-e48101_D2,8e6a9f67-7c53-4386-9ba0-e48101_D7,,defe3f04-27ab-400d-aeac-bcd160_D1,8e6a9f67-7c53-4386-9ba0-e48101_D6,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,217,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,217,0,NA,NA,61,High or alive at last follow-up,60-70
01OV039,OV,01OV039-T,01OV039-N,TRUE,,51171486-e865-4140-b726-e77088_D5,8e17b45e-6a06-4e4e-913d-7b1edb_D5,8e17b45e-6a06-4e4e-913d-7b1edb_D7_1,,360dd010-08a6-40ba-adca-6b53e5_D1_1,8e17b45e-6a06-4e4e-913d-7b1edb_D6_1,,FALSE,51,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,373,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,373,0,NA,NA,51,High or alive at last follow-up,50-60
17OV014,OV,17OV014-T,,TRUE,,,46c73531-f531-4ec3-97fe-b39d9d_D5,46c73531-f531-4ec3-97fe-b39d9d_D7_1,,61688352-1332-4b68-8412-b53178_D1_1,46c73531-f531-4ec3-97fe-b39d9d_D6,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,Not Reported/ Unknown,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,303,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,303,0,NA,NA,66,High or alive at last follow-up,60-70
17OV040,OV,17OV040-T,,TRUE,,,f4034d75-d533-47c2-8453-068e37_D2,f4034d75-d533-47c2-8453-068e37_D7,,e0fd3f72-2df3-4696-9114-a5b31b_D1,f4034d75-d533-47c2-8453-068e37_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,225,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,225,0,NA,NA,57,High or alive at last follow-up,50-60
04OV033,OV,04OV033-T,,TRUE,,,285fed94-1495-448e-879b-b55de9_D5,285fed94-1495-448e-879b-b55de9_D7,,ecdf88ff-20cc-4cb8-992e-5de6ac_D1,285fed94-1495-448e-879b-b55de9_D6,,FALSE,57,Female,Unknown,Not Hispanic or Latino,African,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,367,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,367,0,NA,NA,57,High or alive at last follow-up,50-60
17OV033,OV,17OV033-T,,TRUE,,,4253f4a4-50b9-409a-b9a8-f94658_D2,4bc2d3ea-1611-4fc3-85ee-5b06c4_D7,,a2a8e97b-09a2-465c-b585-16e53d_D1,4253f4a4-50b9-409a-b9a8-f94658_D6,,FALSE,75,Female,American Indian or Alaska Native,Not Hispanic or Latino,Ad_Mixed_American,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,greater than 20 mm,Staging is not applicable or unknown,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,232,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,232,0,NA,NA,75,High or alive at last follow-up,>70
04OV053,OV,04OV053-T,,TRUE,,,79b60f32-6cca-4cb6-9a1e-22a3ac_D5,79b60f32-6cca-4cb6-9a1e-22a3ac_D7,,46a46133-bb15-4d38-8a83-15c186_D1,79b60f32-6cca-4cb6-9a1e-22a3ac_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,1954,NA,,NA,NA,No,Yes,No,With tumor,Partial Response,,Yes,NA,Locoregional Recurrence,Lymph Node only (specify location);,,,Yes,,,,Yes,No,NA,NA,NA,NA,1,1954,0,NA,NA,63,High or alive at last follow-up,60-70
01OV018,OV,01OV018-T,,TRUE,,,eb0a53df-7620-4024-8d2d-051142_D5,eb0a53df-7620-4024-8d2d-051142_D7,,c4e10fb8-4e89-4c88-88f2-9cab9b_D1,eb0a53df-7620-4024-8d2d-051142_D6,,FALSE,44,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,391,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Distant Metastasis,"vaginal cuff, right hepatorenal recess, liver, and spleen",,,,No,,,Yes,No,NA,NA,NA,NA,1,391,0,NA,NA,44,High or alive at last follow-up,<50
04OV050,OV,04OV050-T,,TRUE,,,0cc794c3-5bf5-4621-b238-58a0f6_D5,0cc794c3-5bf5-4621-b238-58a0f6_D7,,73f0ce85-40bf-4244-b233-d2e764_D1,0cc794c3-5bf5-4621-b238-58a0f6_D6,,FALSE,73,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,1994,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1994,0,NA,NA,73,High or alive at last follow-up,>70
04OV021,OV,04OV021-T,,TRUE,,,fe83e13f-9754-403b-8f74-d6caf8_D5,fe83e13f-9754-403b-8f74-d6caf8_D7_1,,67f382d0-dd95-4c54-8123-246343_D1_1,fe83e13f-9754-403b-8f74-d6caf8_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,219,NA,,NA,NA,No,Yes,No,Not Reported/ Unknown,Not Reported/ Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,219,0,NA,NA,57,High or alive at last follow-up,50-60
04OV054,OV,04OV054-T,,TRUE,,,9c8e78bf-b03e-4ba0-9909-5ff070_D5,9c8e78bf-b03e-4ba0-9909-5ff070_D7,,80ee169f-1b99-4e16-b57c-085868_D1,9c8e78bf-b03e-4ba0-9909-5ff070_D6,,FALSE,43,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,330,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,Yes,NA,Both Locoregional and Distant Metastasis,Abdomen;Other (specify);Pelvis;,,,,No,,,Yes,No,NA,NA,NA,NA,1,330,1,NA,NA,43,Low,<50
04OV048,OV,04OV048-T,,TRUE,,,161317f3-1a39-438e-af45-cd2502_D5,161317f3-1a39-438e-af45-cd2502_D7,,61eae7d1-c81a-45c9-b8fa-017c02_D1,161317f3-1a39-438e-af45-cd2502_D6,,FALSE,60,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,1402,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,No,NA,NA,NA,NA,1,1402,1,NA,NA,60,High or alive at last follow-up,50-60
04OV017,OV,04OV017-T,,TRUE,,,eb3f3494-7057-4afe-b212-e6e9a3_D5,eb3f3494-7057-4afe-b212-e6e9a3_D7_1,,7401f279-d5a9-4555-890d-19c38f_D1_1,eb3f3494-7057-4afe-b212-e6e9a3_D6_1,,FALSE,65,Female,White,Hispanic or Latino,Ad_Mixed_American,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,425,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,No,NA,NA,NA,NA,1,425,0,NA,NA,65,High or alive at last follow-up,60-70
04OV023,OV,04OV023-T,,TRUE,,,d4791079-c826-4fc7-9d9b-ee20ba_D5,11b5a745-03a6-4c05-9000-534bf3_D7,,7671658a-0610-4167-b2ba-0ba841_D1,11b5a745-03a6-4c05-9000-534bf3_D6,,FALSE,37,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,398,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,398,0,NA,NA,37,High or alive at last follow-up,<50
04OV031,OV,04OV031-T,,TRUE,,,318d53c3-216b-4de1-a098-77d6dd_D5,e67153d3-61af-49d6-9402-599b39_D7,,3f6e343a-2105-49d1-a38f-a7e2f3_D1,318d53c3-216b-4de1-a098-77d6dd_D6,,FALSE,59,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,381,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,381,0,NA,NA,59,High or alive at last follow-up,50-60
01OV013,OV,,01OV013-N,TRUE,,8ed739dd-ae0f-4881-971a-db3cf4_D1_D5,,95c2a5bf-a27b-4c83-8791-160e03_D7,,7c01454f-a189-4a70-881f-313126_D1,95c2a5bf-a27b-4c83-8791-160e03_D6,,FALSE,69,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,411,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,411,0,NA,NA,69,High or alive at last follow-up,60-70
18OV001,OV,18OV001-T,,TRUE,,,a03d1103-b809-42c4-ad5c-5aff58_D5,a03d1103-b809-42c4-ad5c-5aff58_D7,,b6a10ca7-bb8c-4d2b-a20d-19386e_D1,a03d1103-b809-42c4-ad5c-5aff58_D6,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,,Stage I,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,61,High or alive at last follow-up,60-70
26OV013,OV,26OV013-T,,TRUE,,,0331bd9b-94a5-4d02-ae43-6288e9_D2,9bb753e1-120d-4ea8-b43c-c8fa80_D7,,6b420957-5153-4dbb-8d5d-ea4add_D1,0331bd9b-94a5-4d02-ae43-6288e9_D6,,FALSE,74,Female,White,Unknown,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,Not Reported/ Unknown,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,Yes,,,,,Living,536,NA,,NA,NA,No,No,No,Not Reported/ Unknown,Not Reported/ Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,536,0,NA,NA,74,High or alive at last follow-up,>70
02OV015,OV,02OV015-T,,TRUE,,,9e0d47e0-f633-468b-b82b-4d752d_D5,9e0d47e0-f633-468b-b82b-4d752d_D7,,d3154472-d098-47a6-bd18-ed7d74_D1,9e0d47e0-f633-468b-b82b-4d752d_D6,,FALSE,74,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,378,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,378,0,NA,NA,74,High or alive at last follow-up,>70
04OV055,OV,04OV055-T,,TRUE,,,d109a3c0-350e-47f5-bda0-61899c_D5,d109a3c0-350e-47f5-bda0-61899c_D7,,99d3d57c-8487-43c1-9964-5b0f03_D1,d109a3c0-350e-47f5-bda0-61899c_D6,,FALSE,62,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,977,,NA,NA,No,Yes,No,Not Reported/ Unknown,Not Reported/ Unknown,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,977,1,NA,NA,62,High or alive at last follow-up,60-70
02OV005,OV,02OV005-T,,TRUE,,,1772e913-f62e-446a-8cf3-720348_D5,1772e913-f62e-446a-8cf3-720348_D7,,302a6175-8bba-4efd-a492-76e0f0_D1,1772e913-f62e-446a-8cf3-720348_D6,,FALSE,77,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,370,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,370,0,NA,NA,77,High or alive at last follow-up,>70
17OV036,OV,17OV036-T,,TRUE,,,80873a0c-1f40-4d51-bab1-3f2071_D5,80873a0c-1f40-4d51-bab1-3f2071_D7,,f0147adf-97a9-482c-af88-90da35_D1,80873a0c-1f40-4d51-bab1-3f2071_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,1-10 mm,Staging is not applicable or unknown,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,Yes,,,,,Living,204,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,204,0,NA,NA,63,High or alive at last follow-up,60-70
11OV010,OV,,11OV010-N,TRUE,,61f76fe6-a1c6-41b8-bdc2-2f9209_D5,,,,,,,FALSE,52,Female,Asian,Not Hispanic or Latino,,,No,,,,,NA,,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,52,,50-60
04OV011,OV,04OV011-T,,TRUE,,,a8853382-b726-4ce8-98d5-ca89df_D5,a8853382-b726-4ce8-98d5-ca89df_D7,,c36b85ce-4c29-4bc4-9ae4-6fa57b_D1,a8853382-b726-4ce8-98d5-ca89df_D6,,FALSE,85,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,124,NA,,NA,NA,No,Yes,No,Unknown tumor status,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,124,0,NA,NA,85,High or alive at last follow-up,>70
04OV024,OV,04OV024-T,,TRUE,,,af95e2c6-25c4-4ab8-bf06-3e15ff_D5,af95e2c6-25c4-4ab8-bf06-3e15ff_D7_1,,beb66f4d-8bfc-4d56-abaf-4bdba1_D1_1,af95e2c6-25c4-4ab8-bf06-3e15ff_D6_1,,FALSE,48,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,"Yes, History of Other Cancer Greater Than One Year Ago",,,NA,,,,,,No,,,,,Living,455,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,455,0,NA,NA,48,High or alive at last follow-up,<50
01OV019,OV,,01OV019-N,TRUE,,f02d54bd-b3c7-4375-bc82-167395_D1_D5,,2f901c90-617e-46da-9fac-d68369_D7,,a29b9c62-ac2d-4292-9085-2dbf80_D1,2f901c90-617e-46da-9fac-d68369_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,355,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,0,NA,NA,57,High or alive at last follow-up,50-60
01OV041,OV,01OV041-T,,TRUE,,,3490835c-c004-45ed-91f3-7c206f_D5,3490835c-c004-45ed-91f3-7c206f_D7_1,,4f43b1d3-ad52-439a-a91e-2e568c_D1_1,3490835c-c004-45ed-91f3-7c206f_D6_1,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,11-20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,343,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,343,0,NA,NA,70,High or alive at last follow-up,60-70
04OV045,OV,04OV045-T,,TRUE,,,69d552be-7cb2-4bb4-b602-a27b3e_D5,69d552be-7cb2-4bb4-b602-a27b3e_D7,,67019441-8b3d-4bda-bdf4-21a297_D1,69d552be-7cb2-4bb4-b602-a27b3e_D6,,FALSE,55,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,261,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,261,0,NA,NA,55,High or alive at last follow-up,50-60
01OV008,OV,,01OV008-N,TRUE,,b22659b9-e12c-4725-a7db-a833de_D1_D5,,308ad404-7079-4ff8-8232-12ee2e_D7,,3a7fef0d-d5e4-4154-adc0-dd19f5_D1,308ad404-7079-4ff8-8232-12ee2e_D6,,FALSE,55,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,55,High or alive at last follow-up,50-60
01OV026,OV,01OV026-T,,TRUE,,,347e379b-77c0-4dd3-aa25-18c9d1_D5,347e379b-77c0-4dd3-aa25-18c9d1_D7,,6ad15aed-b0a2-4542-8cd8-4a0682_D1,347e379b-77c0-4dd3-aa25-18c9d1_D6,,FALSE,77,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,112,,NA,NA,No,Yes,No,Unknown tumor status,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,112,1,NA,NA,77,Low,>70
26OV011,OV,26OV011-T,,TRUE,,,44a9e976-f859-4a0d-9f4f-70b95b_D2,44a9e976-f859-4a0d-9f4f-70b95b_D7,,94fc93b5-c989-42a0-b139-8d1f92_D1,44a9e976-f859-4a0d-9f4f-70b95b_D6,,FALSE,64,Female,White,Unknown,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,Yes,,,,,Living,177,NA,,NA,NA,No,No,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,177,0,NA,NA,64,High or alive at last follow-up,60-70
17OV029,OV,17OV029-T,,TRUE,,,74a45e5a-a35a-4c60-a4b4-f3f5ea_D5,74a45e5a-a35a-4c60-a4b4-f3f5ea_D7,,18c969bc-5783-4667-a9cf-30149e_D1,74a45e5a-a35a-4c60-a4b4-f3f5ea_D6,,FALSE,44,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,greater than 20 mm,Staging is not applicable or unknown,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,297,NA,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,Yes,NA,Distant Metastasis,Abdomen;,,,,No,,,Yes,No,NA,NA,NA,NA,1,297,0,NA,NA,44,High or alive at last follow-up,<50
17OV013,OV,17OV013-T,,TRUE,,,05387aad-2a1f-42c2-8d6f-950598_D2,05387aad-2a1f-42c2-8d6f-950598_D7,,0a152159-6ef5-4f7b-be73-c15ec3_D1_1,05387aad-2a1f-42c2-8d6f-950598_D6,,FALSE,49,Female,Black or African American,Not Hispanic or Latino,African,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,49,High or alive at last follow-up,<50
17OV030,OV,17OV030-T,,TRUE,,,cfb8cb2c-53c6-40d7-8069-a1a804_D5,cfb8cb2c-53c6-40d7-8069-a1a804_D7,,ef0d574a-0abb-4e12-bef4-c01511_D1,8234f8ea-bdbd-45b0-bd0b-16f1e7_D6,,FALSE,43,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,279,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,279,0,NA,NA,43,High or alive at last follow-up,<50
04OV012,OV,04OV012-T,,TRUE,,,08296da7-70ea-44df-8646-09f2cc_D5,08296da7-70ea-44df-8646-09f2cc_D7,,9751077c-61c1-49df-9b6f-db7d6e_D1,08296da7-70ea-44df-8646-09f2cc_D6,,FALSE,58,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,328,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,328,0,NA,NA,58,High or alive at last follow-up,50-60
14OV029,OV,,14OV029-N,TRUE,,994f9b8e-46cb-413f-8ec8-2c2fed_D5,,,,,,,FALSE,57,Female,White,Unknown,,,No,Ovary,,,,NA,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",,,,,,,,,,,,Stage II,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,57,,50-60
04OV036,OV,04OV036-T,,TRUE,,,dd3a1c3b-6b49-4ec8-b6df-cdf22e_D5,dd3a1c3b-6b49-4ec8-b6df-cdf22e_D7,,f4bcf727-f39b-4b0d-aaa5-cdcf0b_D1,10c2d629-0287-4511-ac25-f29031_D6,,FALSE,39,Female,Asian,Not Hispanic or Latino,South_Asian,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,342,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,342,0,NA,NA,39,High or alive at last follow-up,<50
13OV003,OV,13OV003-T,,TRUE,,,407c600a-c0ac-41a6-8d87-fd8a3c_D2,407c600a-c0ac-41a6-8d87-fd8a3c_D7_1,,d571ff93-f970-4fb1-939d-432b08_D1_1,407c600a-c0ac-41a6-8d87-fd8a3c_D8_1,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G1 Well differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,NA,NA,,NA,NA,No,Yes,No,With tumor,Progressive Disease,,No,NA,Locoregional Recurrence,,,,,,,,,,NA,NA,NA,NA,0,NA,0,NA,NA,57,High or alive at last follow-up,50-60
01OV010,OV,,01OV010-N,TRUE,,0745488e-0bfb-4d1f-8228-dedf76_D1_D5,,a42f5b74-1bab-41cd-b5f7-0182fa_D7,,ada95f64-bd0f-40be-b5ef-f2f483_D1,a42f5b74-1bab-41cd-b5f7-0182fa_D6,,FALSE,52,Female,Black or African American,Unknown,African,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,21,NA,,NA,NA,No,No,No,Unknown tumor status,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,21,0,NA,NA,52,High or alive at last follow-up,50-60
04OV044,OV,04OV044-T,,TRUE,,,3dcf8b3c-c0c5-4dfa-9543-5d30fb_D5,9bff7220-903a-4afb-9a63-1dbc3c_D7,,ea3b2f6d-f072-4830-b5e8-80a57a_D1,3dcf8b3c-c0c5-4dfa-9543-5d30fb_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,278,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Locoregional Recurrence,Abdomen;,,,Not Reported/ Unknown,,,,Not Reported/ Unknown,Not Reported/ Unknown,NA,NA,NA,NA,1,278,0,NA,NA,63,High or alive at last follow-up,60-70
04OV013,OV,04OV013-T,,TRUE,,,4ccb249a-6722-491e-97e9-e3b4e7_D5,4ccb249a-6722-491e-97e9-e3b4e7_D7,,9c2d08e0-9dc3-4aec-95bb-b75855_D1,4ccb249a-6722-491e-97e9-e3b4e7_D6,,FALSE,53,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,404,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,404,0,NA,NA,53,High or alive at last follow-up,50-60
02OV022,OV,02OV022-T,,TRUE,,,27f3ca2d-a86f-479d-8e7e-5307c7_D5,27f3ca2d-a86f-479d-8e7e-5307c7_D7,,01de44a7-81fa-4e25-aba5-9b215e_D1,27f3ca2d-a86f-479d-8e7e-5307c7_D6,,FALSE,58,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,365,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,365,0,NA,NA,58,High or alive at last follow-up,50-60
17OV002,OV,17OV002-T,17OV002-N,TRUE,,78c151c7-0d5b-4aae-88d3-87463b_D5,627e6e36-3dca-4ee5-9755-6f3510_D5,627e6e36-3dca-4ee5-9755-6f3510_D7,,c0998304-329c-46ff-9678-616f3d_D1,627e6e36-3dca-4ee5-9755-6f3510_D6,,FALSE,48,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,371,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,371,0,NA,NA,48,High or alive at last follow-up,<50
04OV058,OV,04OV058-T,,TRUE,,,91b287fd-eadb-442d-abcd-20b741_D5,91b287fd-eadb-442d-abcd-20b741_D7,,d035cd3d-9ecd-4c59-a1ca-a247fe_D1,91b287fd-eadb-442d-abcd-20b741_D6,,FALSE,71,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Deceased,NA,1256,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,No,NA,NA,NA,NA,1,1256,1,NA,NA,71,High or alive at last follow-up,>70
04OV027,OV,04OV027-T,,TRUE,,,2224c03f-b7b1-4368-887e-2b4cdf_D5,2224c03f-b7b1-4368-887e-2b4cdf_D7_1,,a7f1dbca-1fbf-49a3-9ac4-6aa2f4_D1_1,2224c03f-b7b1-4368-887e-2b4cdf_D6_1,,FALSE,59,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,416,NA,,NA,NA,No,Yes,No,With tumor,Partial Response,,Yes,NA,Both Locoregional and Distant Metastasis,Chest;Abdomen;,,,,Not Reported/ Unknown,,,Not Reported/ Unknown,Not Reported/ Unknown,NA,NA,NA,NA,1,416,0,NA,NA,59,High or alive at last follow-up,50-60
01OV047,OV,01OV047-T,,TRUE,,,2a237fd4-f966-4563-bab1-61dbd7_D2,2a237fd4-f966-4563-bab1-61dbd7_D7,,38fd7771-eaa7-4d4c-aea2-00fe7a_D1,2a237fd4-f966-4563-bab1-61dbd7_D6,,FALSE,68,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,352,NA,,NA,NA,No,Yes,No,With tumor,Partial Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,352,0,NA,NA,68,High or alive at last follow-up,60-70
04OV001,OV,04OV001-T,,TRUE,,,42d860a3-8a0c-4c44-a09a-9ad8cf_D5,42d860a3-8a0c-4c44-a09a-9ad8cf_D7,,02f6afea-1e5b-4151-bafd-c577d3_D1,42d860a3-8a0c-4c44-a09a-9ad8cf_D6,,FALSE,50,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,355,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,355,0,NA,NA,50,High or alive at last follow-up,<50
02OV044,OV,02OV044-T,,TRUE,,,6c9a5bdc-0f0e-4cc8-aec5-63091c_D2,6c9a5bdc-0f0e-4cc8-aec5-63091c_D7,,3e46ddab-ce45-439a-8812-43eb90_D1,6c9a5bdc-0f0e-4cc8-aec5-63091c_D6,,FALSE,36,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,243,NA,,NA,NA,No,No,No,With tumor,Not Reported/ Unknown,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,243,0,NA,NA,36,High or alive at last follow-up,<50
17OV001,OV,17OV001-T,17OV001-N,TRUE,,bd22174a-86c1-489f-bcb7-93e12b_D5,1c9145ad-1981-4871-aa7e-8b11de_D5,1c9145ad-1981-4871-aa7e-8b11de_D7,,c295497a-fc2a-43be-ad45-606652_D1,1c9145ad-1981-4871-aa7e-8b11de_D6,,FALSE,56,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,384,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,384,0,NA,NA,56,High or alive at last follow-up,50-60
04OV049,OV,04OV049-T,,TRUE,,,15524912-685a-47ce-a824-567848_D5,15524912-685a-47ce-a824-567848_D7,,68cd7f58-ee24-490b-b3d1-ddad43_D1,15524912-685a-47ce-a824-567848_D6,,FALSE,63,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,greater than 20 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,1857,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1857,0,NA,NA,63,High or alive at last follow-up,60-70
04OV008,OV,04OV008-T,,TRUE,,,efc971f8-54c5-4531-a792-705ecf_D5,efc971f8-54c5-4531-a792-705ecf_D7,,cedd3881-6311-4c1d-9e9d-191243_D1,efc971f8-54c5-4531-a792-705ecf_D6,,FALSE,53,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,351,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,351,0,NA,NA,53,High or alive at last follow-up,50-60
04OV004,OV,04OV004-T,,TRUE,,,e3ebe010-cd31-4b5d-8fcb-b7103b_D5,e3ebe010-cd31-4b5d-8fcb-b7103b_D7,,0a3efca2-3684-4fc6-a20d-af55ba_D1,e3ebe010-cd31-4b5d-8fcb-b7103b_D6,,FALSE,54,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,285,NA,,NA,NA,No,Yes,No,With tumor,Partial Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,285,0,NA,NA,54,High or alive at last follow-up,50-60
02OV029,OV,02OV029-T,,TRUE,,,d945689a-dcf3-44f4-a42f-1ded6d_D2,d945689a-dcf3-44f4-a42f-1ded6d_D7_1,,e42b4c26-8c2b-444f-92f9-10c232_D1_1,d945689a-dcf3-44f4-a42f-1ded6d_D6_1,,FALSE,48,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,177,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,177,0,NA,NA,48,High or alive at last follow-up,<50
01OV002,OV,,,FALSE,,,,467256db-a312-4346-9ac0-e49e44_D7,,2bb86ca8-2768-44d3-8dd8-ebb273_D1,467256db-a312-4346-9ac0-e49e44_D6,,FALSE,45,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,415,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,415,0,NA,NA,45,High or alive at last follow-up,<50
01OV045,OV,,,FALSE,,,,62f5840e-6cd7-4200-b651-645e53_D7_1,,1d5572aa-ce3a-4928-8d93-86774f_D1_1,62f5840e-6cd7-4200-b651-645e53_D6_1,,FALSE,51,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,Yes,,,,,Living,387,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,387,0,NA,NA,51,High or alive at last follow-up,50-60
01OV046,OV,,,FALSE,,,,558333b0-ea23-4303-9e3c-4932b1_D7,,238d15a7-4791-4cef-945a-48c5e4_D1,558333b0-ea23-4303-9e3c-4932b1_D8,,FALSE,54,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage IV,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,13,NA,,NA,NA,Not Reported/ Unknown,Not Reported/ Unknown,Not Reported/ Unknown,Tumor free,Not Reported/ Unknown,,Not Reported/ Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,13,0,NA,NA,54,High or alive at last follow-up,50-60
01OV049,OV,,,FALSE,,,,256ac9f5-1e19-44b4-92fb-fef3fc_D7,,d7a7b9e7-3121-404f-9fd4-22673a_D1,256ac9f5-1e19-44b4-92fb-fef3fc_D6,,FALSE,54,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,317,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,317,0,NA,NA,54,High or alive at last follow-up,50-60
02OV035,OV,,,FALSE,,,,2dc28da8-7ff1-4b9b-b5bd-17cc25_D7_1,,06ac6957-d65b-4d29-b412-9dd1e2_D1_1,2dc28da8-7ff1-4b9b-b5bd-17cc25_D6_1,,FALSE,61,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,336,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,336,0,NA,NA,61,High or alive at last follow-up,60-70
02OV040,OV,,,FALSE,,,,927f0958-db5a-4bc5-92b7-2a3695_D7,,93b7f944-b465-4778-9c86-106f96_D1,927f0958-db5a-4bc5-92b7-2a3695_D6,,FALSE,65,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,309,NA,,NA,NA,No,Yes,No,With tumor,Complete Response,,Yes,NA,Not Reported/ Unknown,Abdomen;,,,,,,,Yes,No,NA,NA,NA,NA,1,309,0,NA,NA,65,High or alive at last follow-up,60-70
02OV042,OV,,,FALSE,,,,8d78194e-fbef-4819-a7b5-b73ae9_D7,,120aa31e-f256-4f22-baf4-873bf8_D1,8d78194e-fbef-4819-a7b5-b73ae9_D6,,FALSE,56,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,254,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,254,0,NA,NA,56,High or alive at last follow-up,50-60
02OV045,OV,,,FALSE,,,,ad5c848c-ae26-42c8-874e-387a09_D7,,b87e9510-8002-40d0-8079-f6b8f8_D1,5c3971ee-87c7-4dff-b66e-f18892_D6,,FALSE,53,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,253,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,253,0,NA,NA,53,High or alive at last follow-up,50-60
04OV041,OV,,,FALSE,,,,1b2ab076-c72f-4bbe-b9f9-657d24_D7,,244351b1-dec2-40ef-aa8c-118072_D1,1b2ab076-c72f-4bbe-b9f9-657d24_D6,,FALSE,68,Female,White,Not Hispanic or Latino,European,,No,Fallopian tube,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,315,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,315,0,NA,NA,68,High or alive at last follow-up,60-70
11OV009,OV,,,FALSE,,,,51c1c79e-5a8e-4b0a-bf92-1c0cab_D7,,30bf6cbf-c613-4128-86f5-de7bf0_D1,51c1c79e-5a8e-4b0a-bf92-1c0cab_D6,,FALSE,66,Female,Asian,Not Hispanic or Latino,East_Asian,,No,Ovary,,,,NA,Serous Adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,,Stage I,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,381,NA,,NA,NA,No,No,No,Tumor free,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,381,0,NA,NA,66,High or alive at last follow-up,60-70
13OV004,OV,,,FALSE,,,,1de8d3d8-fc0e-4be0-8aa7-127c7b_D7_1,,5d6c64a7-34f3-416b-aa85-e01e9e_D1_1,1de8d3d8-fc0e-4be0-8aa7-127c7b_D6_1,,FALSE,70,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,NA,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,0,NA,NA,70,High or alive at last follow-up,60-70
17OV019,OV,,,FALSE,,,,3946a96c-e0ae-442f-83b4-a9350e_D7,,02ac4d5b-a5e7-4e2c-8ede-f752fc_D1,3946a96c-e0ae-442f-83b4-a9350e_D6,,FALSE,57,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,1-10 mm,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,368,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,368,0,NA,NA,57,High or alive at last follow-up,50-60
17OV034,OV,,,FALSE,,,,2563cb02-d58a-4286-8634-7502cd_D7,,5918ebb7-1c63-407a-bf01-af3f09_D1,2563cb02-d58a-4286-8634-7502cd_D6,,FALSE,66,Female,White,Not Hispanic or Latino,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,267,NA,,NA,NA,No,Yes,No,With tumor,Stable Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,267,0,NA,NA,66,High or alive at last follow-up,60-70
22OV001,OV,,,FALSE,,,,2b4ce90c-8036-4207-ac3e-54a76f_D7,,4b216777-ce44-45f7-9df1-9d873a_D1,2b4ce90c-8036-4207-ac3e-54a76f_D6,,FALSE,60,Female,White,Not Hispanic or Latino,European,,No,Peritoneum,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,No,,,,,Living,293,NA,,NA,NA,No,Yes,No,Tumor free,Complete Response,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,293,0,NA,NA,60,High or alive at last follow-up,50-60
26OV010,OV,,,FALSE,,,,c17b0ff9-9057-4848-a0cc-abb25f_D7,,c4bdeb24-c38a-421e-83eb-9d1225_D1,c17b0ff9-9057-4848-a0cc-abb25f_D6,,FALSE,57,Female,White,Unknown,European,,No,Ovary,,,,NA,Serous Adenocarcinoma,G3 Poorly differentiated,,,,,,,,,,,,Stage III,,,,NA,NA,NA,No,,,NA,,,,,,Yes,,,,,Living,506,NA,,NA,NA,No,Yes,No,Not Reported/ Unknown,Not Reported/ Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,506,0,NA,NA,57,High or alive at last follow-up,50-60
C3N-03884,PDA,C3N-03884-T,C3N-03884-N,TRUE,,CPT0237850004,CPT0237840004,CPT0237840010,,CPT0237890002,CPT0237840007,CPT0237850007,FALSE,64,Female,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,2.3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,41,4,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,EGFR（+），Ki-67（10%），P53（+），HER2（-），E-Cad（cytomembrane+），hMLH1（-），hMSH2（+），SMAD4（+），hMSH6（+），PMS2（+），P16（+），C-Myc（-/+）,,IHC staining not done,155,49,20.4,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,598,680,Unknown,NA,686,No,Yes,No,With Tumor,Complete Remission,,Yes,455,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,455,461,1,680,1,6,NA,64,High or alive at last follow-up,60-70
C3L-00589,PDA,C3L-00589-T,C3L-00589-N,TRUE,,CPT0063990003,CPT0063970004,['CPT0063970010'],CPT0063990006,CPT0065360002,CPT0063970007,CPT0063990009,FALSE,80,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,25,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,175,84,27.43,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,12,Exposure to secondhand smoke history not available,,,,,,,tamsulosin|lisinopril |omeprazole|levothyroxine|cymbalta|Lipitor|valtrex|zovirax|keflex,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1752,NA,,1752,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Response,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1752,0,0,NA,80,High or alive at last follow-up,>70
C3L-03123,PDA,C3L-03123-T,C3L-03123-N,TRUE,,CPT0166780004,CPT0166760004,CPT0166760010,CPT0166780007,CPT0166790002,CPT0166760007,,FALSE,60,Female,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,4.1,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,13,1,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,Stage II,,,IHC staining not done,159,94,37.1,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Amlodipine|Potassium Chloride|Tramadol,Medical Record|Medical Record|Medical Record,No,Living,1503,NA,,1510,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Response,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1503,0,7,NA,60,High or alive at last follow-up,50-60
C3L-01687,PDA,C3L-01687-T,C3L-01687-N,TRUE,,C3L-01687-04,CPT0094630004,CPT0094630007,,CPT0094670002,['CPT0094630010'],,FALSE,78,Female,Unknown,Unknown,East_Asian,Other: TSS did not collect,No,Head,,,Unifocal,5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,34,23,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,147,67,31.05,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,, Valsartan|Plavix|HCTZ|Fluoxetine|Diltiazem|Tylenol Arthritis|Probiotics|Vitamin D3|Slow K,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,376,376,Main malignancy,NA,381,No,Yes,No,With Tumor,Persistent Disease,,Yes,259,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,259,264,1,376,1,5,NA,78,Low,>70
C3L-00599,PDA,C3L-00599-T,,TRUE,,,CPT0081260004,['CPT0081260010'],,CPT0081300002,CPT0081260007,,FALSE,62,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,17,1,cM0,No pathologic evidence of distant metastasis,pMx,R0:  No residual tumor,Stage II,,,IHC staining not done,176,78,25.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Deceased,1305,1305,Main malignancy,NA,1316,No,Yes,No,With Tumor,Complete Remission,,Yes,1034,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,1034,1045,1,1305,1,11,NA,62,High or alive at last follow-up,60-70
C3L-01054,PDA,C3L-01054-T,C3L-01054-N,TRUE,,CPT0124000003,CPT0123990003,CPT0123990006,,CPT0124920002,CPT0123990009,CPT0124000006,FALSE,38,Female,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,21,2,cM1,No pathologic evidence of distant metastasis,Not documented,R2:  Macroscopic residual tumor,Stage IV,,,IHC staining not done,170,60,20.76,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,860,860,Main malignancy,NA,868,No,Yes,No,With Tumor,Persistent Disease,,Yes,457,Locoregional Recurrence,Tumor Bed,,Positive Biomarker(s),No,,,No,No,No,NA,NA,457,465,1,860,1,8,NA,38,High or alive at last follow-up,<50
C3L-02890,PDA,C3L-02890-T,C3L-02890-N,TRUE,,CPT0166680004,CPT0166650006,CPT0166650012,,CPT0166690002,CPT0166650009,,FALSE,65,Male,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,7.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,10,6,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,Stage II,Cytokertains (AE1/3) and Vimentin: positive,CD68: negative,IHC staining not done,170,64,22.15,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,Unknown,,,,Ativan|Coversyl|Advair|Metformin|Trazodone|Crestor|Insulin lantus|Metoprolol|Forxiga|Lorazepam|Oxycodone|Pantoprazole|Vitamin D|ASA|Aventyl|Cannabis,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1007,1007,Main malignancy,NA,1022,No,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,868,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,868,883,1,1007,1,15,NA,65,High or alive at last follow-up,60-70
C3N-01379,PDA,C3N-01379-T,,FALSE,,,CPT0088840004,CPT0088840007,,CPT0088890001,CPT0088840010,,FALSE,65,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,0,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,158,62,24,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,15,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,971,971,Unknown,NA,974,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,592,Locoregional Recurrence,Peritoneal Surface,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,592,595,1,971,1,3,NA,65,High or alive at last follow-up,60-70
C3L-03630,PDA,C3L-03630-T,C3L-03630-N,TRUE,,CPT0198930003,CPT0198910005,CPT0198910011,,CPT0198940002,CPT0198910008,,FALSE,78,Male,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN1,5,3,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,174,105,34.85,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Asprin|Fosinopril|Lasix|Rosuvastatin|Lantus 36|Levothyroxine|Levodopa-carbidopa|Isosorbide|Bisoprolol|Vitalux,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,78,NA,,83,NA,Unknown,Unknown,Unknown,Tumor Free,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,78,0,5,NA,78,High or alive at last follow-up,>70
C3L-03356,PDA,C3L-03356-T,C3L-03356-N,TRUE,,CPT0198440004,CPT0198420004,CPT0198420010,,CPT0198450002,CPT0198420007,,FALSE,71,Male,Unknown,Unknown,European,Other: South Wales,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,11,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,169,82,28.71,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Zpolicone|Metformin|Lantus insulin|Lispro insulin|Ezetimibe|Tylenol 3|Ranibizumab|Multivitamin|Lutein|Saw Palmetto|Melatonin|Diclofenac,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,550,NA,,556,NA,No,Yes,No,With Tumor,Complete Remission,,Yes,497,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,497,503,1,550,0,6,NA,71,High or alive at last follow-up,>70
C3N-01166,PDA,C3N-01166-T,,TRUE,,,CPT0093980004,CPT0093980007,,CPT0094020002,['CPT0093980010'],,FALSE,62,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,7,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,171,53,18,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,32,Yes,Yes,Yes,,,,,,,No,Living,679,NA,,683,NA,No,Yes,No,With Tumor,Persistent Disease,,Yes,745,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,745,749,1,679,0,4,NA,62,High or alive at last follow-up,60-70
C3N-04126,PDA,C3N-04126-T,,TRUE,,,CPT0238040005,CPT0238040011,,CPT0238100002,CPT0238040008,,FALSE,42,Male,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,32,12,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,EGFR（+），Ki-67（+，40%），P53（-），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（-），hMSH6（+），PMS2（+），P16（-），C-Myc（weak+）,,IHC staining not done,180,79,24.38,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,amlodipine|inject insulin,Medical Record|Medical Record,No,Deceased,257,348,Main malignancy,NA,352,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,348,1,4,NA,42,Low,<50
C3N-04283,PDA,C3N-04283-T,C3N-04283-N,TRUE,,CPT0247050003,CPT0247040003,CPT0247040006,CPT0247050008,CPT0247080002,CPT0247040009,CPT0247050005,FALSE,66,Female,Unknown,Unknown,European,Poland,No,Other,head and body,,Multifocal,7,Ductal adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,2,17,8,Staging Incomplete,No pathologic evidence of distant metastasis,,R2:  Macroscopic residual tumor,Stage III,,,IHC staining not done,160,50,19,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1,1,Other reasons,NA,8,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1,1,7,NA,66,Low,60-70
C3L-04495,PDA,C3L-04495-T,C3L-04495-N,TRUE,,CPT0239140004,CPT0239100009,CPT0239100015,,CPT0239150002,CPT0239100012,CPT0239140007,FALSE,36,Female,Unknown,Unknown,European,Canada,No,Other,Body and tail,,Unifocal,4.8,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,11,4,cM0,No pathologic evidence of distant metastasis,Not applicable,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,170,72,24.91,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Morphine|Synthroid,Medical Record|Medical Record,No,Deceased,288,288,Main malignancy,NA,288,No,No,No,With Tumor,Not Applicable,,Yes,36,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,36,36,1,288,1,0,NA,36,Low,<50
C3N-03853,PDA,C3N-03853-T,C3N-03853-N,TRUE,,CPT0237290004,CPT0237270005,CPT0237270008,,CPT0237330002,CPT0237270011,,FALSE,49,Female,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,39,5,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,EGFR（+），Ki-67（+，about 80％），P53（+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（+），hMSH6（-），PMS2（+），P16（-），C-Myc（-/+）,,IHC staining not done,170,80,27.68,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,259,393,Unknown,NA,398,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,393,1,5,NA,49,Low,<50
C3L-02610,PDA,C3L-02610-T,C3L-02610-N,TRUE,,CPT0125010003,CPT0124980004,CPT0124980010,CPT0125010009,CPT0125020002,CPT0124980007,CPT0125010006,FALSE,80,Male,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),T3,N0,15,0,M0,No pathologic evidence of distant metastasis,No distant metastasis,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,166,60,21.63,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,Skin Cancer (squamous cell - ear),Unknown,Yes,Metoprolol|Rivaroxaban|Folic Acid|Vitamin B12|Multivitamins|Atorvastatin|Valsartan,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,190,190,Unknown,NA,197,No,No,No,With Tumor,Not Applicable,,Yes,151,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,153,NA,151,158,1,190,1,7,NA,80,Low,>70
C3N-03000,PDA,C3N-03000-T,,TRUE,,,CPT0226490004,CPT0226490010,,CPT0226510002,CPT0226490006,,FALSE,57,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,5.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,17,5,Staging Incomplete,pM1,liver,R1:  Microscopic residual tumor,Stage IV,,,IHC staining not done,175,85,27,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,487,487,Main malignancy,NA,495,No,Yes,No,With Tumor,Persistent Disease,,Yes,438,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,Yes,No,NA,NA,438,446,1,487,1,8,NA,57,High or alive at last follow-up,50-60
C3L-03388,PDA,C3L-03388-T,C3L-03388-N,TRUE,,CPT0239920004,CPT0239910004,CPT0239910010,,CPT0240550002,CPT0239910007,CPT0239920007,FALSE,68,Male,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,3.2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,19,5,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,Stage III,,,IHC staining not done,174,80,26.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,11,11,Unknown,NA,18,No,No,No,Unknown Tumor Status,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,11,1,7,NA,68,Low,60-70
C3L-01689,PDA,C3L-01689-T,C3L-01689-N,TRUE,,CPT0094760003,CPT0094740004,CPT0094740007,CPT0094760009,CPT0094770002,['CPT0094740010'],CPT0094760006,FALSE,62,Male,Unknown,Unknown,European,Other: Canada,No,Head,,,Unifocal,3.6,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,16,2,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,182,93,28.08,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Pancreatic digestive enzymes|Probiotics|Multivitamin,Medical Record|Medical Record|Medical Record,No,Deceased,594,594,Main malignancy,NA,601,No,Yes,No,With Tumor,Unknown,,Yes,289,Distant Metastasis,Other : Superior mesentery artery,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,289,296,1,594,1,7,NA,62,High or alive at last follow-up,60-70
C3N-02768,PDA,C3N-02768-T,C3N-02768-N,TRUE,,CPT0207990004,CPT0207980005,CPT0207980011,CPT0207990010,CPT0208030002,CPT0207980008,CPT0207990007,FALSE,46,Male,Unknown,Unknown,East_Asian,China,No,Tail,,,Unifocal,3,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,24,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage II,"EGFR（+），Ki-67（+, 40％），P53（+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（-／+），MUC1（weak+），MUC2（-），MUC5AC（+），P16（+），C-Myc（+）",,IHC staining not done,170,77,26.64,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,366,430,Main malignancy,NA,436,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,430,1,6,NA,46,Low,<50
C3N-03430,PDA,C3N-03430-T,,TRUE,,,CPT0226650004,CPT0226650010,,CPT0226670002,CPT0226650007,,FALSE,54,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Eighth Edition (2017),no resection,no resection,0,0,1,Staging Incomplete,"liver, peritoneum",R2:  Macroscopic residual tumor,Staging is not applicable or unknown,,,IHC staining not done,164,50,18,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,7.3,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,30,39,Main malignancy,NA,49,No,No,No,With Tumor,Not Applicable,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,39,1,10,NA,54,Low,50-60
C3L-03371,PDA,C3L-03371-T,C3L-03371-N,FALSE,,CPT0275880003,CPT0275870003,CPT0275870009,,CPT0265930002,CPT0275870006,CPT0275880006,FALSE,53,Male,Unknown,Unknown,,Russia,No,Head,,,Unifocal,2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN0,25,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,,,IHC staining not done,168,67,23.74,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Creon|Omeprazole,Medical Record|Medical Record,No,Deceased,560,560,Main malignancy,NA,569,No,Yes,No,Tumor Free,Complete Remission,Progressive Disease,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,560,1,9,NA,53,High or alive at last follow-up,50-60
C3N-01388,PDA,C3N-01388-T,,TRUE,,,CPT0088320003,CPT0088320006,,CPT0088350002,CPT0088320009,,FALSE,53,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,46,6,Staging Incomplete,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,166,51,18,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,NovoRapid Penfill - Insulini aspartum ,Self Report,No,Deceased,1056,811,Main malignancy,NA,825,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,311,Distant Metastasis,Tumor Bed,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,311,325,1,811,1,14,NA,53,High or alive at last follow-up,50-60
C3L-01971,PDA,C3L-01971-T,C3L-01971-N,TRUE,,CPT0108960003,CPT0108930003,CPT0108930006,,CPT0108360002,CPT0108930009,,FALSE,66,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,20,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,183,85,25.36,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,losartan|Omeprazole|Baby aspirin,Medical Record|Medical Record|Medical Record,No,Deceased,38,276,Unknown,NA,276,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,276,1,0,NA,66,Low,60-70
C3N-01900,PDA,C3N-01900-T,C3N-01900-N,FALSE,,C3N-01900-04,CPT0162600005,CPT0162600011,,CPT0162650002,CPT0162600008,,FALSE,53,Male,Unknown,Unknown,,Poland,No,Head,,,Unifocal,2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,15,3,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage II,,,IHC staining not done,176,80,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,NA,No or minimal exposure to secondhand smoke,,,,,,,ramipril|insulin,Medical Record|Medical Record,No,Deceased,831,831,Main malignancy,NA,832,No,Yes,No,With Tumor,Complete Remission,Not Applicable,Yes,529,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,529,530,1,831,1,1,NA,53,High or alive at last follow-up,50-60
C3L-03628,PDA,C3L-03628-T,C3L-03628-N,TRUE,,CPT0198730004,CPT0198700005,CPT0198700011,,CPT0198740002,CPT0198700008,,FALSE,69,Female,Unknown,Unknown,European,Other: Denmark,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,35,20,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,Cytokeratin AE1/AE3 Immunostain,,IHC staining not done,160,51,19.92,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Candesartan|Etidronate/calcium,Medical Record|Medical Record,No,Deceased,596,596,Main malignancy,NA,601,No,Yes,No,With Tumor,Complete Remission,,Yes,352,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,352,357,1,596,1,5,NA,69,High or alive at last follow-up,60-70
C3N-01998,PDA,C3N-01998-T,C3N-01998-N,TRUE,,CPT0138990003,CPT0139000004,CPT0139000007,CPT0138990009,CPT0139020002,CPT0139000010,CPT0138990006,FALSE,69,Male,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,7,3,cM0,Staging Incomplete,no,R0:  No residual tumor,Stage II,"EGFR（+），Ki-67（+70％），P53（partly+），HER2（weak+），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（+），MUC1（+），MUC2（-），MUC5AC（focally, +），P16（partly +），C-Myc（partly +）",,IHC staining not done,165,55,20.2,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,insulin,Self-reported and Medical Record,No,Deceased,4,186,Main malignancy,NA,193,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,186,1,7,NA,69,Low,60-70
C3L-01637,PDA,C3L-01637-T,C3L-01637-N,TRUE,,CPT0086210003,CPT0086190004,CPT0086190007,CPT0086210009,CPT0087390002,['CPT0086190010'],CPT0086210006,FALSE,78,Female,White,Not Hispanic or Latino,European,United States,No,Body,,,Unifocal,2.6,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,6,3,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,165,71,26.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",60,Exposure to secondhand smoke history not available,,,,,,,Biotin|lovastatin|Centrum Silver |ocuvite preservision oral tablet |Fish Oil |Vitamin E |Vitamin D  |Calcuim 600 +D|Latanoprost |lisinopril ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,715,715,Main malignancy,NA,715,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,268,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Unknown,Unknown,NA,NA,268,268,1,715,1,0,NA,78,High or alive at last follow-up,>70
C3N-00249,PDA,C3N-00249-T,C3N-00249-N,TRUE,,CPT0025760003,CPT0025750003,['CPT0025750006'],,CPT0028460002,['CPT0025750009'],CPT0025760006,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Body,,,Unifocal,4.2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,25,3,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,165,76,27.79,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",2,Exposure to secondhand smoke history not available,,,,,,,Vitamin E|Omega-3 Fatty Acids|Lactobacillus ,Medical Record|Medical Record|Medical Record,No,Deceased,1590,1590,Main malignancy,NA,1571,Yes,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,579,Distant Metastasis,Peritoneal Surface,,Positive Biomarker(s),No,,,Unknown,Yes,Yes,NA,NA,579,560,1,1590,1,-19,NA,71,High or alive at last follow-up,>70
C3N-00198,PDA,C3N-00198-T,C3N-00198-N,TRUE,,CPT0014060003,CPT0014040003,['CPT0014040009'],CPT0014060009,CPT0015030002,['CPT0014040006'],,FALSE,55,Male,White,Not Hispanic or Latino,European,United States,No,Body,,,Multifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,32,7,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,185,110,31.92,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,pioglitazone|glimepriride|liraglutide|hydrocodone-acetaminophen|tamsulosin|Naproxen|metformin|sildenafil|amlodipine|omeprazole|ursodiol|losartan|doxycycline hyclate|fenofibrate micronized,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1592,NA,,1592,NA,Yes,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,458,Locoregional Recurrence,Other : Right Upper Quadrant Omental Nodule,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Yes,Unknown,NA,NA,458,458,1,1592,0,0,NA,55,High or alive at last follow-up,50-60
C3L-03394,PDA,C3L-03394-T,C3L-03394-N,TRUE,,CPT0224470004,CPT0224460004,CPT0224460010,,CPT0226210002,CPT0224460007,CPT0224470007,FALSE,65,Female,Unknown,Unknown,European,Russia,No,Body,,,Unifocal,1.5,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1C,pN0,5,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,,,IHC staining not done,167,71,25.46,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,635,635,Main malignancy,NA,638,No,Yes,No,With Tumor,Complete Remission,,Yes,558,Locoregional Recurrence,Tumor Bed,,Positive Biomarker(s),No,,,No,No,No,NA,NA,558,561,1,635,1,3,NA,65,High or alive at last follow-up,60-70
C3N-01907,PDA,C3N-01907-T,,FALSE,,,CPT0162830005,CPT0162830011,,CPT0162870002,CPT0162830008,,FALSE,62,Male,Unknown,Unknown,,Poland,No,Body,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,0,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,167,85,30,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,42,Yes,,Yes,,,,,metformax|glibetic|suvardio|Co-Bespres ,Self Report|Self Report|Self Report|Self Report,No,Deceased,407,440,Main malignancy,NA,440,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,267,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,267,267,1,440,1,0,NA,62,High or alive at last follow-up,60-70
C3N-02971,PDA,C3N-02971-T,,TRUE,,,CPT0185920004,CPT0185920010,,CPT0187270002,CPT0185920007,,FALSE,78,Female,White,Not Hispanic or Latino,European,United States,No,Tail,,,Unifocal,5.6,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN0,11,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,152,69,29.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,albuterol|amlodipine|amoxicillin|aspirin|dihenhydramine|doucaste|esomeprazole|fenofibrate|fluticasone-salmeterol|gabapentin|insulin aspart|losartan|metoprolol|montelukast|nystatin|rosuvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,70,70,Main malignancy,NA,61,No,Yes,No,With Tumor,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,70,1,-9,NA,78,Low,>70
C3N-03173,PDA,C3N-03173-T,C3N-03173-N,TRUE,,CPT0186050004,CPT0186040004,CPT0186040010,CPT0186050010,CPT0187290002,CPT0186040013,CPT0186050007,FALSE,64,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2.9,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,25,4,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,174,91,30.11,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",3,Exposure to secondhand smoke history not available,,,,,,,diazepam|ranitidine|digestive enzymes,Medical Record|Medical Record|Medical Record,No,Living,32,NA,,32,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,32,0,0,NA,64,High or alive at last follow-up,60-70
C3N-03754,PDA,C3N-03754-T,,TRUE,,,CPT0246810003,CPT0246810013,,CPT0246830002,CPT0246810006,,FALSE,44,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),2,2,21,10,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,181,83,25,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,24,No or minimal exposure to secondhand smoke,,,20,,,,concor|tritace,Medical Record|Medical Record,No,Deceased,767,815,Main malignancy,NA,815,No,Yes,No,With Tumor,Persistent Disease,Progressive Disease,Yes,417,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,417,417,1,815,1,0,NA,44,High or alive at last follow-up,<50
C3L-01598,PDA,C3L-01598-T,C3L-01598-N,TRUE,,CPT0091680003,CPT0091660003,CPT0091660006,,CPT0093640002,['CPT0091660009'],CPT0091680006,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,Other,Distal pancreas,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,165,103,37.79,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,bumetanide|warfarin|pravastatin|losartan|glyburide|coreg|Osteo-BI-Flex triple strength,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,913,913,Main malignancy,NA,913,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,288,Distant Metastasis,Peritoneal Surface,,Biopsy with Histologic Confirmation,No,,,No,Yes,No,NA,NA,288,288,1,913,1,0,NA,73,High or alive at last follow-up,>70
C3L-02809,PDA,C3L-02809-T,C3L-02809-N,TRUE,,CPT0174800003,CPT0174700004,CPT0174700010,CPT0174800007,CPT0175500002,CPT0174700007,,FALSE,84,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,5.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,19,2,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,170,98,33.67,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,Aspirin|Coumadin|Hydralazine|Burnex|Glipizide|Potassium|Losartan|Simvastatin|Atorvastatin|Carvedilol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,68,68,Main malignancy,NA,68,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,68,1,0,NA,84,Low,>70
C3L-01453,PDA,C3L-01453-T,C3L-01453-N,TRUE,,CPT0108410003,CPT0108400003,CPT0108400006,CPT0108410009,CPT0108330002,['CPT0108400009'],CPT0108410006,FALSE,69,Male,White,Hispanic or Latino,European,United States,No,Tail,,,Unifocal,5.2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,4,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,"p63, CK5 positive, Weak CK7 positive, Weak CD56 positive, 5% MIB-1",,IHC staining not done,168,79,28.24,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Androgel|Lisinopril|Invokana|Metformin HCl ER|Colestipol HCl|Atorvastatin|Flomax|Aspirin|Multivitamin,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,Living,5,NA,,5,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,5,0,0,NA,69,High or alive at last follow-up,60-70
C3L-02109,PDA,C3L-02109-T,,TRUE,,,CPT0109010004,CPT0109010007,,CPT0109040002,CPT0109010010,,FALSE,79,Female,Unknown,Unknown,European,Canada,No,Body,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT4,pN1,15,2,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,159,81,32.04,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Amlodipine|Lumigan Eye Drops|Vitamin D|Aleve|Zopliclone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,261,NA,,275,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,261,0,14,NA,79,High or alive at last follow-up,>70
C3L-02606,PDA,C3L-02606-T,C3L-02606-N,TRUE,,CPT0124530003,CPT0124500004,CPT0124500010,CPT0124530009,CPT0124540002,CPT0124500006,CPT0124530006,FALSE,68,Female,Unknown,Unknown,European,Other: TSS did not collect,No,Head,,,Unifocal,4,Adenosquamous carcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,26,2,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R1:  Microscopic residual tumor,Stage II,"CKAE1/3, p40, D2-40, Musto, ERG, HHV8",,IHC staining not done,169,57,20,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,12.5,Exposure to secondhand smoke history not available,,,,,,,Morphine|Zoplicone,Medical Record|Medical Record,No,Deceased,403,403,Main malignancy,NA,411,No,Yes,No,With Tumor,Persistent Disease,,Yes,251,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,No,No,NA,NA,251,259,1,403,1,8,NA,68,Low,60-70
C3N-03666,PDA,C3N-03666-T,,TRUE,,,CPT0246720003,CPT0246720009,,CPT0246740002,CPT0246720006,,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),2,1,23,2,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage III,"Beta-katenina (odczyn cytoplazmatyczny), S100 (w adipocytach i pniach nerwowych), CD117 (w komórkach tucznych), DOG1 (-), SMA (w części komórek wrzecionowatych), CD34 (w śródbłonkach w nielicznych komórkach wrzecionowatych)",,IHC staining not done,165,71,26,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,lisinoratio|insulin ,Self Report|Self Report,No,Deceased,701,701,Main malignancy,NA,711,No,Yes,No,With Tumor,Persistent Disease,,Yes,348,Distant Metastasis,Tumor Bed,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,348,358,1,701,1,10,NA,63,High or alive at last follow-up,60-70
C3N-01997,PDA,C3N-01997-T,C3N-01997-N,TRUE,,CPT0138890003,CPT0138900004,CPT0138900007,,CPT0138920002,CPT0138900010,CPT0138890006,FALSE,63,Male,Unknown,Unknown,East_Asian,China,No,Tail,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,7,0,cM0,Staging Incomplete,no,R0:  No residual tumor,Stage I,EGFR（+），Ki-67（+40％），P53（+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），MUC1（-），MUC2（-），MUC5AC（+），P16（-），C-Myc（+）,,IHC staining not done,168,52,18.42,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,1002,1035,Unknown,NA,1035,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1035,1,0,NA,63,High or alive at last follow-up,60-70
C3N-02589,PDA,C3N-02589-T,C3N-02589-N,TRUE,,CPT0162670004,CPT0162660004,CPT0162660010,CPT0162670010,CPT0162700002,CPT0162660007,CPT0162670007,FALSE,71,Male,Unknown,Unknown,European,Poland,No,Head,,,Multifocal,2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,21,0,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,175,73,23,No,Lifelong non-drinker,"Current reformed smoker, years unknown",NA,No or minimal exposure to secondhand smoke,,,,,,,gliklazyd,Medical Record,No,Deceased,398,398,Main malignancy,NA,401,No,Yes,No,With Tumor,Complete Remission,,Yes,378,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,378,NA,378,381,1,398,1,3,NA,71,Low,>70
C3L-04479,PDA,C3L-04479-T,C3L-04479-N,TRUE,,CPT0238940004,CPT0238920004,CPT0238920010,,CPT0238950002,CPT0238920007,CPT0238940007,FALSE,66,Male,Unknown,Unknown,European,Other: TSS did not collect,No,Head,,,Unifocal,1.7,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,11,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,174,89,29.23,Yes,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,Unknown,Squamous Cell carcinoma in situ of the face,Surgery,Yes,Pantoprazole|Metoprolol|Olmesartan/hydrochlorothiazide,Medical Record|Medical Record|Medical Record,No,Living,1104,NA,,1104,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Response,Yes,922,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,Yes,No,No,NA,NA,922,922,1,1104,0,0,NA,66,High or alive at last follow-up,60-70
C3N-01168,PDA,C3N-01168-T,,TRUE,,,CPT0094030003,CPT0094030006,,CPT0094070002,['CPT0094030009'],,FALSE,60,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,10,3,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,,,IHC staining not done,158,51,20,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,415,415,Main malignancy,NA,418,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,320,Distant Metastasis,Other : spleen,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,320,323,1,415,1,3,NA,60,Low,50-60
C3L-02463,PDA,C3L-02463-T,C3L-02463-N,TRUE,,CPT0126200003,CPT0126160004,CPT0126160007,CPT0126200009,CPT0124290002,CPT0126160010,CPT0126200006,FALSE,63,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,20,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,183,74,22.22,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,Pantoprazole|Cefuroxime,Medical Record|Medical Record,No,Living,740,NA,,741,NA,No,Yes,No,Unknown Tumor Status,Unknown,Unknown,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,740,0,1,NA,63,High or alive at last follow-up,60-70
C3L-03743,PDA,C3L-03743-T,C3L-03743-N,TRUE,,CPT0264180003,CPT0264150003,CPT0264150006,CPT0264180009,CPT0265780002,CPT0264150009,CPT0264180006,FALSE,71,Female,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2.9,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,13,2,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,158,50,20.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Beta-carotine|Calcium|Centrum Silver|Hydochlorothiazide|Lovastatin|Vitamin C|Vitamin D3,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,48,732,Main malignancy,NA,732,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,732,1,0,NA,71,High or alive at last follow-up,>70
C3L-01051,PDA,C3L-01051-T,C3L-01051-N,TRUE,,CPT0123670003,CPT0123650003,CPT0123650006,,CPT0124870002,CPT0123650009,CPT0123670006,FALSE,60,Male,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,1,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,Stage II,,,IHC staining not done,186,95,27.46,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,,,No,Living,0,NA,,9,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,9,NA,60,High or alive at last follow-up,50-60
C3N-03211,PDA,C3N-03211-T,C3N-03211-N,TRUE,,CPT0209650004,CPT0209640005,CPT0209640011,,CPT0209690002,CPT0209640008,CPT0209650007,FALSE,43,Male,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,17,4,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage III,"EGFR（+）,Ki-67（+5％）,P53（-）,HER2（-）,E-Cad（+），hMLH1（+）,hMSH2（+）, SMAD4（+）,MUC1（+），MUC2（-），MUC5AC（+），P16（-），C-Myc（+）",,IHC staining not done,165,65,23.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,278,286,Unknown,NA,290,No,Yes,No,With Tumor,Persistent Disease,,Yes,210,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,210,214,1,286,1,4,NA,43,Low,<50
C3N-02940,PDA,C3N-02940-T,,TRUE,,,CPT0208550005,CPT0208550011,,CPT0208610002,CPT0208550008,,FALSE,64,Male,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN02,24,4,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage III,EGFR（+），Ki-67（+ 5％），P53（+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（+），MUC2（-），MUC5AC（-），P16（+），C-Myc（+）,,IHC staining not done,182,85,25.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1015,NA,,1018,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1015,0,3,NA,64,High or alive at last follow-up,60-70
C3L-02115,PDA,C3L-02115-T,C3L-02115-N,TRUE,,CPT0109130003,CPT0109110004,CPT0109110007,,CPT0109140002,CPT0109110012,CPT0109130006,FALSE,80,Male,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,14,11,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,Stage II,"MOC31, D2-40",,IHC staining not done,181,77,23.53,Yes,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",26,Exposure to secondhand smoke history not available,,,Unknown,Basal cell carcinoma,Surgery,Yes,Hydrochlorothiazide|Levothyroxine|Amlodipine|Potassium Chloride|Vitamin C|Vitamin D|Calcium Magnesium|Omega 3|Hawthorn|Saw Palmetto|Alfa caps|Ranitidine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,723,723,Main malignancy,NA,731,No,Yes,No,With Tumor,Complete Remission,,Yes,701,Distant Metastasis,Other : cervical and thoracic spine,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,701,709,1,723,1,8,NA,80,High or alive at last follow-up,>70
C3N-00436,PDA,C3N-00436-T,C3N-00436-N,TRUE,,CPT0077880003,CPT0077860003,['CPT0077860009'],CPT0077880009,CPT0077920002,CPT0077860006,CPT0077880006,FALSE,69,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,11,0,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage II,,,IHC staining not done,158,73,29,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,insulin,Medical Record,Yes,Deceased,718,718,Main malignancy,NA,734,No,Yes,No,With Tumor,Persistent Disease,Progressive Disease,Yes,621,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),Yes,,R1: Microscopic Residual Tumor,No,No,No,650,NA,621,637,1,718,1,16,NA,69,High or alive at last follow-up,60-70
C3N-01716,PDA,C3N-01716-T,,TRUE,,,CPT0125130003,CPT0125130009,,CPT0125150002,CPT0125130006,,FALSE,50,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,35,17,cM0,pM1,no,R1:  Microscopic residual tumor,Stage IV,,,IHC staining not done,182,95,28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,nebilet|Xarelto Rivaroxabanum,Self Report|Self Report,No,Deceased,384,335,Main malignancy,NA,339,Unknown,Yes,No,With Tumor,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,335,1,4,NA,50,Low,<50
C3L-04475,PDA,C3L-04475-T,C3L-04475-N,TRUE,,CPT0248320003,CPT0238820005,CPT0238820011,CPT0248320009,CPT0238860002,CPT0238820008,CPT0248320006,FALSE,77,Male,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,2.7,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,21,10,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage III,,,IHC staining not done,173,68,22.55,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,NA,Exposure to secondhand smoke history not available,,,,,,,ASA 81|Metoprolol,Medical Record|Medical Record,No,Deceased,881,893,Main malignancy,NA,893,No,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,829,Distant Metastasis,Other : Distal femur,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,829,829,1,893,1,0,NA,77,High or alive at last follow-up,>70
C3L-04473,PDA,C3L-04473-T,C3L-04473-N,TRUE,,CPT0238740004,CPT0238710004,CPT0238710010,,CPT0238750002,CPT0238710007,,FALSE,67,Female,Unknown,Unknown,South_Asian,Other: India,No,Other,Head and body,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,18,12,cM0,No pathologic evidence of distant metastasis,Not applicable,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,154,56,23.59,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Right breast cancer,Surgery,Yes,Paliperidone|divalproex|Bupropion|sulfasalazine|folic acid|methotrexate|hydroxychloroquine|empowerplus|digestplus|manjistha supreme|pancreatic enzymes|perfect amino xp,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,290,290,Unknown,NA,245,No,No,No,With Tumor,Not Applicable,,Yes,164,Locoregional Recurrence,Other : Retroperitoneal,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,164,119,1,290,1,-45,NA,67,Low,60-70
C3N-00516,PDA,C3N-00516-T,,TRUE,,,CPT0078090004,['CPT0078090010'],,CPT0078150002,CPT0078090007,,FALSE,68,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,11,0,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,165,60,22.04,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,38,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1152,1152,Main malignancy,NA,1166,No,Yes,No,With Tumor,Complete Remission,,Yes,403,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,403,417,1,1152,1,14,NA,68,High or alive at last follow-up,60-70
C3L-03129,PDA,C3L-03129-T,,FALSE,,,CPT0166930004,CPT0166930014,,CPT0166970002,CPT0166930007,,FALSE,68,Male,Unknown,Unknown,,China,No,Tail,,,Unifocal,5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,12,4,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,Stage II,"CD117 and CD34 positive; S100, desmin and actin negative; ki-67 staining index 2-3%",,IHC staining not done,183,82,24.55,No,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,Unknown,,,,Nicorette gum|AndroGel,Medical Record|Medical Record,No,Living,1421,NA,,1428,NA,No,Yes,No,With Tumor,Complete Remission,Stable Disease,Yes,579,New Primary Tumor,Other : pancreatic head,,Positive Biomarker(s),Yes,,R0: No Residual Tumor,No,Yes,No,635,NA,579,586,1,1421,0,7,NA,68,High or alive at last follow-up,60-70
C3L-04848,PDA,C3L-04848-T,C3L-04848-N,TRUE,,CPT0248440003,CPT0248410004,CPT0248410010,,CPT0248450002,CPT0248410007,,FALSE,71,Female,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,4.7,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,15,3,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,164,81,30.12,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,L-thyroxine|rosuvastatin|nifedipine|Pantoprazole|telmisartan|hydrochlorothiazide|atenolol|zopiclone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,196,196,Unknown,NA,196,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,196,1,0,NA,71,Low,>70
C3L-00881,PDA,C3L-00881-T,C3L-00881-N,TRUE,,CPT0017130003,CPT0017040004,['CPT0017040010'],,CPT0015340002,CPT0017040007,CPT0017130006,FALSE,80,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2.2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,24,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,AE1-Metastatic tumor to lymph node,,1,175,91,29.6,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,3,NA,,11,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,3,0,8,NA,80,High or alive at last follow-up,>70
C3L-00277,PDA,C3L-00277-T,C3L-00277-N,TRUE,,CPT0011540003,CPT0011520003,CPT0011520009,,CPT0012450002,CPT0011520006,CPT0011540010,FALSE,69,Male,White,Unknown,European,United States,No,Tail,,,Unifocal,5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,15,1,Staging Incomplete,Staging Incomplete,,R2:  Macroscopic residual tumor,Stage II,,,IHC staining not done,183,80,24,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Zinacef|NaCl 0.9%|Metformin|Prilosec|Bupivacaine|Diphenhydramine|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Deceased,730,610,Main malignancy,NA,615,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,610,1,5,NA,69,High or alive at last follow-up,60-70
C3N-00513,PDA,C3N-00513-T,C3N-00513-N,TRUE,,CPT0077810003,CPT0077790004,['CPT0077790010'],,CPT0077850001,CPT0077790007,CPT0077810006,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,2,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,170,52,17,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,28.5,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,394,394,Main malignancy,NA,414,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,394,1,20,NA,63,Low,60-70
C3N-02579,PDA,C3N-02579-T,,TRUE,,,CPT0207780004,CPT0207780007,,CPT0207830002,CPT0207780010,,FALSE,51,Female,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,0.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1a,pN0,9,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,"AE1/AE3(epithele +), CK19(epithele +), CD138(plasmocyte +), CD38(plasmocyte +), IgG(plasmocyte +), IgG4(plasmocyte +), P53(-), ALK-Tissue(-), Ki-67(+)",,IHC staining not done,156,55,22.6,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,melbine (DMBG),Medical Record,No,Deceased,245,358,Unknown,NA,363,No,Yes,No,With Tumor,Persistent Disease,,Yes,195,Distant Metastasis,Other : abdominal wall,,Convincing Image (i.e. CT/PET/MRI),Yes,,R0: No Residual Tumor,No,No,No,225,NA,195,200,1,358,1,5,NA,51,Low,50-60
C3L-01037,PDA,C3L-01037-T,C3L-01037-N,TRUE,,CPT0170260004,CPT0170240004,CPT0170240010,,CPT0167230002,CPT0170240007,CPT0170260007,FALSE,42,Male,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,4.5,Undifferentiated carcinoma,G4 Undifferentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,29,2,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,Stage II,,,IHC staining not done,178,84,26.51,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,300,300,Main malignancy,NA,308,No,No,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,300,1,8,NA,42,Low,<50
C3L-03395,PDA,C3L-03395-T,C3L-03395-N,TRUE,,CPT0276030003,CPT0276010003,CPT0276010009,,CPT0265950002,CPT0276010006,CPT0276030009,FALSE,78,Male,Unknown,Unknown,European,Russia,No,Tail,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,11,6,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,,,IHC staining not done,154,57,24.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,88,88,Unknown,NA,92,No,Yes,No,Tumor Free,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,88,1,4,NA,78,Low,>70
C3N-03780,PDA,C3N-03780-T,C3N-03780-N,TRUE,,CPT0246950003,CPT0246940003,CPT0246940009,CPT0246950009,CPT0246980002,CPT0246940006,CPT0246950006,FALSE,69,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,0,2,0,IB,IB,no,R1:  Microscopic residual tumor,Stage I,,,IHC staining not done,160,77,30,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,amlodypine|levotyroxin|kandesartan|hydrochlorothiazyde|betaksolol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,20,20,Other reasons,NA,28,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,20,1,8,NA,69,Low,60-70
C3L-01036,PDA,C3L-01036-T,C3L-01036-N,TRUE,,CPT0123460003,CPT0123440003,CPT0123440009,,CPT0124820002,CPT0123440006,CPT0123460006,FALSE,64,Male,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,2,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,Stage II,,,IHC staining not done,178,80,25.25,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1247,881,Main malignancy,NA,888,No,Yes,No,With Tumor,Persistent Disease,,Yes,351,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,351,358,1,881,1,7,NA,64,High or alive at last follow-up,60-70
C3L-02897,PDA,C3L-02897-T,,TRUE,,,CPT0217700004,CPT0217700010,,CPT0219810002,CPT0217700007,,FALSE,80,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2.7,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,15,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,,,IHC staining not done,178,93,29.55,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Creon ,Medical Record,No,Living,256,NA,,256,NA,No,No,No,Tumor Free,Not Applicable,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,256,0,0,NA,80,High or alive at last follow-up,>70
C3N-03439,PDA,C3N-03439-T,,TRUE,,,CPT0246260004,CPT0246260007,,CPT0246300002,CPT0246260010,,FALSE,56,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,1.7,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),1c,1,12,1,0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage II,,,IHC staining not done,163,47,17,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,458,458,Main malignancy,NA,462,No,Yes,No,With Tumor,Persistent Disease,,Yes,204,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,204,208,1,458,1,4,NA,56,High or alive at last follow-up,50-60
C3N-00957,PDA,C3N-00957-T,C3N-00957-N,TRUE,,CPT0089750004,CPT0089720003,CPT0089720006,,CPT0091380002,['CPT0089720009'],CPT0089750007,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Tail,,,Unifocal,5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,9,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,173,77,25.69,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",11.8,Exposure to secondhand smoke history not available,,,,,,,ammonium lactate|aspirin|Vitamin B|clopidogrel|diclofenac sodium transderm gel|Dutasteride|fluticasone|losartan|Loastatin|metoprolol|Nitroglycerin|tamsulosin|Vitamin D3,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1189,NA,,1167,NA,Unknown,Yes,Unknown,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1189,0,-22,NA,74,High or alive at last follow-up,>70
C3L-00819,PDA,C3L-00819-T,C3L-00819-N,TRUE,,CPT0064110003,CPT0064090003,['CPT0064090009'],CPT0064110006,CPT0065380002,CPT0064090006,CPT0064110009,FALSE,74,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2.8,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,20,3,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,183,100,29.86,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Finasteride|Loratadine|Mylanta|Irbesartan|Tylenol|Lomotil,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,601,603,Main malignancy,NA,603,Yes,Yes,No,With Tumor,Unknown,,Yes,327,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,327,327,1,603,1,0,NA,74,High or alive at last follow-up,>70
C3N-04282,PDA,C3N-04282-T,C3N-04282-N,TRUE,,CPT0247000003,CPT0246990003,CPT0246990009,,CPT0247030002,CPT0246990006,,FALSE,75,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G3 Poorly differentiated,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),3,1,9,2,Staging Incomplete,1,liver,R1:  Microscopic residual tumor,Stage IV,,,IHC staining not done,169,47,16,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45,Exposure to secondhand smoke history not available,,,,,,,formoterol|euphylin|triamcynolon,Medical Record|Medical Record|Medical Record,No,Deceased,303,303,Main malignancy,NA,312,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,95,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,95,104,1,303,1,9,NA,75,Low,>70
C3N-03086,PDA,C3N-03086-T,,TRUE,,,CPT0209310004,CPT0209310014,,CPT0209360002,CPT0209310007,CPT0209320007,FALSE,69,Male,Unknown,Unknown,East_Asian,China,No,Body,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,22,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage II,"EGFR（+）,Ki-67（+,10％）,P53（-）,HER2（+）,E-Cad（+），hMLH1（+）,hMSH2（+）, SMAD4（+）,MUC1（+），MUC2（-），MUC5AC（+），P16（-），C-Myc（-）",,IHC staining not done,165,56,20.57,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,733,NA,,737,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,733,0,4,NA,69,High or alive at last follow-up,60-70
C3N-03428,PDA,C3N-03428-T,,TRUE,,,CPT0226680005,CPT0226680011,,CPT0226720002,CPT0226680008,,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Eighth Edition (2017),no resection,no resection,0,0,1,1,liver,R2:  Macroscopic residual tumor,Staging is not applicable or unknown,,,IHC staining not done,161,60,23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,184,286,Main malignancy,NA,295,No,Yes,No,With Tumor,Persistent Disease,,Yes,49,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,49,58,1,286,1,9,NA,63,Low,60-70
C3L-03635,PDA,C3L-03635-T,,TRUE,,,CPT0238530005,CPT0238530011,,CPT0238560002,CPT0238530008,,FALSE,63,Male,Unknown,Unknown,European,Other: TSS did not collect,No,Tail,,,Unifocal,3.2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,Unknown value,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,IHC staining not done,168,73,25.94,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Ventolin|Finasteride|Paroxetine|Rosuvastatin|Percocet,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,854,854,Main malignancy,NA,826,No,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,565,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,565,537,1,854,1,-28,NA,63,High or alive at last follow-up,60-70
C3L-00625,PDA,C3L-00625-T,,TRUE,,,CPT0081470004,CPT0081470010,,CPT0081510001,CPT0081470007,CPT0081500010,FALSE,34,Female,Unknown,Unknown,European,Other: Canada,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,19,5,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,Stage II,,,IHC staining not done,167,62,22.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,2.5,Exposure to secondhand smoke history not available,,,,,,,Tylenol 3|Tramadol|Ativan,Medical Record|Medical Record|Medical Record,No,Deceased,1198,1198,Main malignancy,NA,1198,No,Yes,No,With Tumor,Complete Remission,,Yes,417,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,Yes,No,NA,NA,417,417,1,1198,1,0,NA,34,High or alive at last follow-up,<50
C3L-00189,PDA,C3L-00189-T,C3L-00189-N,TRUE,,C3L-00189-04,CPT0081060004,['CPT0081060007'],,CPT0081100002,CPT0081060010,,FALSE,68,Female,Unknown,Unknown,European,Other: Canada,No,Head,,,Unifocal,2.7,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,13,2,cM0,No pathologic evidence of distant metastasis,pMx,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,157,84,34.28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Verapamil|Aspirin,Medical Record|Medical Record,No,Deceased,1036,1036,Main malignancy,NA,1043,No,Yes,No,With Tumor,Complete Remission,,Yes,424,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,424,431,1,1036,1,7,NA,68,High or alive at last follow-up,60-70
C3N-03061,PDA,C3N-03061-T,C3N-03061-N,TRUE,,CPT0208850004,CPT0208840004,CPT0208840010,,CPT0208890002,CPT0208840014,,FALSE,62,Female,Unknown,Unknown,East_Asian,China,No,Body,,,Unifocal,3,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,8,1,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage II,"EGFR（+）,Ki-67（+40％）,P53（-）,HER2（-）,E-Cad（+），hMLH1（+）,hMSH2（+）, SMAD4（+）,MUC1（+），MUC2（-），MUC5AC（+），P16（-），C-Myc（+）",,IHC staining not done,150,43,19.11,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,120,139,Unknown,NA,142,No,Yes,No,With Tumor,Persistent Disease,,Yes,33,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,33,36,1,139,1,3,NA,62,Low,60-70
C3N-03440,PDA,C3N-03440-T,C3N-03440-N,TRUE,,CPT0246220004,CPT0246210004,CPT0246210007,CPT0246220010,CPT0246250002,CPT0246210010,CPT0246220007,FALSE,54,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,0,6,0,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage I,,,IHC staining not done,170,65,22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,315,NA,,317,NA,No,Yes,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,315,0,2,NA,54,High or alive at last follow-up,50-60
C3L-01662,PDA,C3L-01662-T,,TRUE,,,CPT0092630003,CPT0092630006,,CPT0093720002,CPT0092630009,,FALSE,60,Female,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,10,cM0,No pathologic evidence of distant metastasis,Not Applicable,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,160,72,28.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,"Pancrelipase, Lip-Prot-Amyl",Medical Record,No,Deceased,322,344,Main malignancy,NA,344,Yes,Yes,No,With Tumor,Unknown,,Yes,272,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,272,272,1,344,1,0,NA,60,Low,50-60
C3N-00303,PDA,C3N-00303-T,,TRUE,,,CPT0008800003,['CPT0008800009'],,CPT0008850002,CPT0008800006,,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,20,4,cM0,No pathologic evidence of distant metastasis,x,R0:  No residual tumor,Stage III,,,IHC staining not done,164,69,25,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,21.5,Yes,Yes,,,,,,,,Yes,Deceased,599,599,Main malignancy,NA,613,No,Yes,No,With Tumor,Persistent Disease,,Yes,97,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,97,111,1,599,1,14,NA,65,High or alive at last follow-up,60-70
C3L-01703,PDA,C3L-01703-T,,TRUE,,,CPT0094940004,CPT0094940007,CPT0094960008,CPT0094970002,['CPT0094940010'],CPT0094960010,FALSE,62,Male,Unknown,Unknown,European,Other: Canada,No,Other,Body and tail,,Unifocal,6.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,6,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage II,,,IHC staining not done,171,79,27.02,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,287,287,Main malignancy,NA,293,No,No,No,With Tumor,Not Applicable,,Yes,175,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,175,181,1,287,1,6,NA,62,Low,60-70
C3L-03632,PDA,C3L-03632-T,C3L-03632-N,TRUE,,C3L-03632-04,CPT0238440005,CPT0238440011,,CPT0238470002,CPT0238440008,,FALSE,74,Male,Unknown,Unknown,European,Other: TSS did not collect,No,Head,,,Unifocal,2.1,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,12,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,IHC staining not done,172,77,26.03,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,3,,,,Clonazepam|Oralair|Tylenol|cholestyramine/sucrose|olanzapine|clomipramine|Esomeprazole|Ramipril|Latanoprostye drops|Vitamin supplements,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1121,NA,,1121,NA,No,No,No,Tumor Free,Not Applicable,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1121,0,0,NA,74,High or alive at last follow-up,>70
C3N-01383,PDA,C3N-01383-T,,TRUE,,,CPT0094230004,CPT0094230007,,CPT0094270002,CPT0094230010,,FALSE,80,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,7,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,,,IHC staining not done,168,90,31,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",60,No or minimal exposure to secondhand smoke,,,,,,,metformin|telmistartan|nebivolol|fluticasone+solmeterol|glikopironium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,791,791,Main malignancy,NA,805,No,Yes,No,With Tumor,Persistent Disease,Not Applicable,Yes,477,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,477,491,1,791,1,14,NA,80,High or alive at last follow-up,>70
C3N-02010,PDA,C3N-02010-T,C3N-02010-N,TRUE,,CPT0241510004,CPT0241500004,CPT0241500010,CPT0241510007,CPT0241760002,CPT0241500007,,FALSE,62,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Head,,,Unifocal,4.1,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,36,5,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,"CK-7: Positive in tumor cells ; MUC-5: positive diffusely; IMP3: poitive; MUC-6: Positive, focally (less than 10% tumor cells); CDX-2: Moderatly positive; MUC2: Negative",,IHC staining not done,157,93,37.73,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,25,Exposure to secondhand smoke history not available,,,,,,,acetaminophen|ibuprofen|meclizine|omeprazole,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,449,NA,,449,NA,No,Yes,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,449,0,0,NA,62,High or alive at last follow-up,60-70
C3L-01124,PDA,C3L-01124-T,C3L-01124-N,TRUE,,CPT0218220004,CPT0218200004,CPT0218200010,,CPT0220240002,CPT0218200007,CPT0218220007,FALSE,70,Female,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,2.2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),PT2,PN2,15,5,CM0,Staging Incomplete,Not documented,R0:  No residual tumor,Stage III,,,IHC staining not done,154,67,28.25,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,399,NA,,378,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,399,0,-21,NA,70,High or alive at last follow-up,60-70
C3N-01382,PDA,C3N-01382-T,,TRUE,,,CPT0094180003,CPT0094180006,,CPT0094220002,CPT0094180009,,FALSE,74,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,37,4,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,,,IHC staining not done,160,78,30,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,734,734,Main malignancy,NA,738,No,Yes,No,With Tumor,Persistent Disease,,Yes,379,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,379,383,1,734,1,4,NA,74,High or alive at last follow-up,>70
C3N-00302,PDA,C3N-00302-T,,TRUE,,,CPT0008750003,['CPT0008750009'],,CPT0008790002,['CPT0008750012'],,FALSE,58,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,14,9,cM1,pM1,liver,R1:  Microscopic residual tumor,Stage IV,,,IHC staining not done,168,80,28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,Yes,Deceased,323,323,Main malignancy,NA,331,No,Yes,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,323,1,8,NA,58,Low,50-60
C3L-00102,PDA,C3L-00102-T,C3L-00102-N,TRUE,,CPT0001750003,CPT0001730017,['CPT0001730008'],CPT0001750006,CPT0003940002,CPT0001730005,CPT0001750009,FALSE,42,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,6,5,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,183,90,26.93,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Norco|morphine|Lantus Solotar|NovolognFlex Pen,Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,249,249,Main malignancy,NA,249,No,Yes,No,With Tumor,Persistent Disease,,Yes,172,Distant Metastasis,Other : abdomen,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,239,NA,172,172,1,249,1,0,NA,42,Low,<50
C3L-04080,PDA,C3L-04080-T,,TRUE,,,CPT0221470005,CPT0221470011,CPT0221490010,CPT0220550002,CPT0221470008,CPT0221490007,FALSE,70,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,19,1,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage II,,,IHC staining not done,185,98,28.63,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,Atenolol|diltiazem|Tylenol PM Extra Strength|insulin|lisinopril|oxycodone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,20,20,Main malignancy,NA,26,No,No,No,Unknown Tumor Status,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,20,1,6,NA,70,Low,60-70
C3N-00518,PDA,C3N-00518-T,C3N-00518-N,TRUE,,CPT0078030003,CPT0078000003,['CPT0078000009'],CPT0078030009,CPT0078080002,CPT0078000006,CPT0078030006,FALSE,69,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,6,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,2,0,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,175,80,26,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,422,427,Main malignancy,NA,448,No,Yes,No,With Tumor,Persistent Disease,,Yes,340,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,Yes,No,NA,NA,340,361,1,427,1,21,NA,69,Low,60-70
C3L-02116,PDA,C3L-02116-T,,TRUE,,,CPT0109200004,CPT0109200007,,CPT0109240002,CPT0109200010,CPT0109230006,FALSE,67,Male,Unknown,Unknown,East_Asian,China,No,Body,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,14,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,Caldesmon and Desmin positive; S100 neg; CD117 and CD34 negative,,IHC staining not done,170,76,26.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Bisoprolol|Metformin|Lantus Insulin|Tinzaparin|Ferrous Fumarate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1024,1063,Main malignancy,NA,1105,No,No,No,With Tumor,Not Applicable,Not Applicable,Yes,673,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Yes,No,NA,NA,673,715,1,1063,1,42,NA,67,High or alive at last follow-up,60-70
C3N-03665,PDA,C3N-03665-T,,TRUE,,,CPT0226760004,CPT0226760010,,CPT0226800002,CPT0226760007,,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,2,43,4,0,0,no,R0:  No residual tumor,Stage III,,,IHC staining not done,174,76,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,8.3,No or minimal exposure to secondhand smoke,,,,,,,tolura|insulin ,Self Report|Self Report,No,Living,728,NA,,737,NA,No,Yes,No,With Tumor,Complete Remission,,Yes,412,Distant Metastasis,Peritoneal Surface,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,412,421,1,728,0,9,NA,63,High or alive at last follow-up,60-70
C3L-04072,PDA,C3L-04072-T,C3L-04072-N,TRUE,,CPT0221250004,CPT0221240004,CPT0221240010,CPT0221250007,CPT0220470002,CPT0221240007,,FALSE,55,Male,Black or African American,Not Hispanic or Latino,African,United States,No,Head,,,Unifocal,4.9,Ductal adenocarcinoma,G3 Poorly differentiated,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,27,6,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,p40 - neagtive; pancytokeratin - negative; vimentin - positive,,IHC staining not done,173,42,13.99,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,NA,No or minimal exposure to secondhand smoke,,,Unknown,,,,Magnesium Oxide|Metoprolol Tartrate|Oxycodone|Pantoprazole|Sodium Bicarbonate|Calcitonin|Bisacodyl|Cefuroxime axetil|Enoxaparin|Lidocaine % patch|Docusate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,213,225,Main malignancy,NA,229,No,Yes,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,225,1,4,NA,55,Low,50-60
C3N-02998,PDA,C3N-02998-T,,TRUE,,,CPT0187930005,CPT0187930011,,CPT0187950002,CPT0187930008,,FALSE,64,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,N2,19,13,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,158,72,28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,levotyroxin,Medical Record,No,Deceased,122,122,Main malignancy,NA,132,No,Yes,No,With Tumor,Persistent Disease,,Yes,179,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,179,189,1,122,1,10,NA,64,Low,60-70
C3N-03840,PDA,C3N-03840-T,C3N-03840-N,TRUE,,CPT0236800004,CPT0236780005,CPT0236780011,,CPT0236840002,CPT0236780008,CPT0236800010,FALSE,59,Female,Unknown,Unknown,East_Asian,China,No,Body,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN1,27,1,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage II,EGFR（+），Ki-67（+15％），P53（few+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（+），MUC1（-），MUC2（-），MUC5AC（+），P16（-），C-Myc（weak+）,,IHC staining not done,158,62,24.84,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,696,NA,,702,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,696,0,6,NA,59,High or alive at last follow-up,50-60
C3L-00928,PDA,C3L-00928-T,C3L-00928-N,TRUE,,CPT0063580003,CPT0063570003,['CPT0063570006'],,CPT0065280002,CPT0063570009,CPT0063580006,FALSE,58,Female,White,Not Hispanic or Latino,European,United States,No,Other,Distal pancreas,,Unifocal,4.5,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,11,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,168,129,45.83,No,Lifelong non-drinker,Current reformed smoker within past 15 years,31,Exposure to secondhand smoke history not available,,,,,,,desvenlafaxine|escitalopram|furosemide|humalog|invanz|pantoprazole|seroquel|singulair chewables|sucralfate|synthroid|trihexyphenidyl,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,755,761,Main malignancy,NA,761,Yes,Yes,No,With Tumor,Unknown,,Yes,683,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,683,683,1,761,1,0,NA,58,High or alive at last follow-up,50-60
C3N-00517,PDA,C3N-00517-T,C3N-00517-N,TRUE,,CPT0093880003,CPT0093860003,CPT0093860006,CPT0093880009,CPT0093920002,CPT0093860009,CPT0093880006,FALSE,69,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,10,2,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,,,IHC staining not done,170,65,22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,18,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1142,1142,Main malignancy,NA,1147,No,Yes,No,With Tumor,Not Applicable,,Yes,351,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,351,356,1,1142,1,5,NA,69,High or alive at last follow-up,60-70
C3L-02112,PDA,C3L-02112-T,,TRUE,,,CPT0124410004,CPT0124410010,CPT0124430008,CPT0124440002,CPT0124410007,CPT0124430011,FALSE,66,Male,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,9,5,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,Stage II,,,IHC staining not done,174,66,21.67,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,37.6,Exposure to secondhand smoke history not available,,,,Non-Hodgkins Lymphoma,Chemotherapy,Yes,Metformin|Gliclazide|Rosuvastatin|Telmisartan|ASA,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1338,NA,,1357,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Response,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1338,0,19,NA,66,High or alive at last follow-up,60-70
C3L-00598,PDA,C3L-00598-T,,TRUE,,,CPT0019410004,['CPT0019410007'],,CPT0019480002,['CPT0019410010'],,FALSE,61,Female,Unknown,Unknown,European,Other: Canada,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,32,13,cM0,No pathologic evidence of distant metastasis,not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,163,42,16,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,4.2,Exposure to secondhand smoke history not available,,,Unknown,,,,Etidrocal|Multivitamin|Calcium with vitamin D|Vitamin C|Melatonin|Ferrous Sulfate|Ibuprofen,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Deceased,422,422,Main malignancy,NA,425,No,Yes,No,With Tumor,Complete Remission,,Yes,348,Distant Metastasis,Non-Regional Lymph Nodes / Distant Lymph Nodes,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,348,351,1,422,1,3,NA,61,Low,60-70
C3N-02585,PDA,C3N-02585-T,C3N-02585-N,TRUE,,CPT0183770004,CPT0183750005,CPT0183750011,,CPT0183810002,CPT0183750008,CPT0183770007,FALSE,65,Male,Unknown,Unknown,East_Asian,China,No,Body,,,Unifocal,2,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN0,4,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,"EGFR（+），Ki-67（+, 40％），P53（+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（-／+），MUC1（weak+），MUC2（-），MUC5AC（+），P16（focal +），C-Myc（+）",,IHC staining not done,160,48,18.75,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,melbine (DMBG),Medical Record,No,Living,1051,NA,,1054,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1051,0,3,NA,65,High or alive at last follow-up,60-70
C3N-03426,PDA,C3N-03426-T,C3N-03426-N,TRUE,,CPT0226610004,CPT0226600004,CPT0226600010,,CPT0226640002,CPT0226600007,,FALSE,68,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Cannot be assessed,Eighth Edition (2017),no resection,1,1,1,1,1,liver,R2:  Macroscopic residual tumor,Staging is not applicable or unknown,,,IHC staining not done,155,67,27.89,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Bisocard,Self Report,No,Deceased,31,123,Main malignancy,NA,128,No,Yes,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,123,1,5,NA,68,Low,60-70
C3N-01714,PDA,C3N-01714-T,,TRUE,,,CPT0124360003,CPT0124360009,,CPT0124390002,CPT0124360006,,FALSE,63,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,36,16,cM0,No pathologic evidence of distant metastasis,no,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,168,70,24,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Bisocard,Self Report,No,Deceased,448,435,Main malignancy,NA,446,No,Yes,No,With Tumor,Patient Deceased,,Yes,386,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,386,397,1,435,1,11,NA,63,Low,60-70
C3N-03039,PDA,C3N-03039-T,,TRUE,,,CPT0235230004,CPT0235230010,,CPT0235410002,CPT0235230007,CPT0235260007,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,,,,,NA,Ductal adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,73,,>70
C3N-01165,PDA,C3N-01165-T,,TRUE,,,CPT0093930004,CPT0093930007,,CPT0093970002,['CPT0093930010'],,FALSE,63,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,25,4,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,,,IHC staining not done,164,64,23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,241,241,Main malignancy,NA,246,No,Yes,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,241,1,5,NA,63,Low,60-70
C3N-01502,PDA,C3N-01502-T,,TRUE,,,CPT0065570003,['CPT0065570006'],,CPT0070700002,['CPT0065570009'],,FALSE,75,Male,White,Not Hispanic or Latino,European,United States,No,Tail,,,Unifocal,4.6,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,16,3,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,170,69,23.82,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",6,Exposure to secondhand smoke history not available,,,,,,,acetaminophen|alum Hydroxide-MAg Carbonate|asorbic acid|aspirin|vitamin D|coenzyme Q10|dicyclomine|diphenhydramine|fluticasone|omeprazole|prednisone|simvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1695,NA,,1695,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Response,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1695,0,0,NA,75,High or alive at last follow-up,>70
C3N-01380,PDA,C3N-01380-T,,TRUE,,,CPT0088260004,CPT0088260007,,CPT0088300002,['CPT0088260010'],,FALSE,65,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT3,pN1,16,4,cM0,pM1,metastasis to the duodenum,RX:  Presence of residual tumor cannot be assessed,Stage IV,"p40+, Synaptophysin +, CD 56 +",,1,176,80,25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",67.5,Exposure to secondhand smoke history not available,,,,,,,sectral|Tialorid|Apo-Doxan|Xarelto,Self Report|Self Report|Self Report|Self Report,No,Deceased,426,400,Main malignancy,NA,416,Yes,No,Yes,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,400,1,16,NA,65,Low,60-70
C3L-02604,PDA,C3L-02604-T,,TRUE,,,CPT0161770004,CPT0161770010,,CPT0162550002,CPT0161770007,,FALSE,84,Female,White,Not Hispanic or Latino,European,United States,No,Tail,,,Unifocal,2.5,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,9,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage II,,,IHC staining not done,160,62,24.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",29,Exposure to secondhand smoke history not available,,,,,,,celebrex|cozaar|Aldactone|prilosec|synthroid|Flonase|zofran-odt,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,110,118,Main malignancy,NA,118,Yes,Yes,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,118,1,0,NA,84,Low,>70
C3N-02944,PDA,C3N-02944-T,C3N-02944-N,TRUE,,CPT0208710004,CPT0208690004,CPT0208690010,,CPT0208750002,CPT0208690013,CPT0208710007,FALSE,61,Female,Unknown,Unknown,East_Asian,China,No,Tail,,,Unifocal,3.2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,27,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,"EGFR（+），Ki-67（+, 80％），P53（+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（weak+），SMAD4（+），MUC2（-），MUC5AC（-），P16（+），C-Myc（+）",,IHC staining not done,158,53,21.23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,609,NA,,612,NA,No,Yes,No,With Tumor,Complete Remission,,Yes,391,Distant Metastasis,Other : uterus,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,391,394,1,609,0,3,NA,61,High or alive at last follow-up,60-70
C3N-04119,PDA,C3N-04119-T,C3N-04119-N,TRUE,,CPT0237920004,CPT0237910004,CPT0237910010,,CPT0237960002,CPT0237910007,CPT0237920007,FALSE,54,Male,Unknown,Unknown,East_Asian,China,No,Tail,,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,19,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage II,EGFR（+），Ki-67（+20％），P53（-），HER2（-），E-Cad（+），hMLH1（partly+），hMSH2（+），SMAD4（-），hMSH6（+），PMS2（+），P16（partly+），C-Myc（cytoplasm+）,,IHC staining not done,172,70,23.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Telmisartan,Medical Record,No,Deceased,270,305,Main malignancy,NA,305,No,Yes,No,With Tumor,Persistent Disease,,Yes,179,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,179,179,1,305,1,0,NA,54,Low,50-60
C3N-02592,PDA,C3N-02592-T,C3N-02592-N,TRUE,,CPT0162780004,CPT0162760003,CPT0162760009,,CPT0162820002,CPT0162760006,,FALSE,63,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,N1,33,1,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,154,79,33,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,294,294,Main malignancy,NA,299,No,Yes,No,With Tumor,Persistent Disease,,Yes,129,Locoregional Recurrence,Unknown,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,283,NA,129,134,1,294,1,5,NA,63,Low,60-70
C3L-04853,PDA,C3L-04853-T,C3L-04853-N,TRUE,,CPT0248620003,CPT0248590004,CPT0248590014,,CPT0248630002,CPT0248590007,,FALSE,85,Female,Unknown,Unknown,European,Canada,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,3,0,cM0,pM0,Not applicable,R0:  No residual tumor,Stage II,,,IHC staining not done,162,52,19.89,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,"Breast cancer, left|Breast cancer, right",Surgery|Surgery,Yes|Yes,Losartan|Amlodipine|Merformin|Atorvastatin|Eliquis|Metoprolol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,251,279,Main malignancy,NA,260,No,No,No,With Tumor,Persistent Disease,,Yes,185,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,185,166,1,279,1,-19,NA,85,Low,>70
C3N-03007,PDA,C3N-03007-T,,TRUE,,,CPT0226570004,CPT0226570010,,CPT0226590002,CPT0226570013,,FALSE,59,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,2,47,12,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,167,63,22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,biosotal|amlessa,Self Report|Self Report,No,Deceased,58,58,Unknown,NA,36,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,58,1,-22,NA,59,Low,50-60
C3N-04284,PDA,C3N-04284-T,,TRUE,,,CPT0247090003,CPT0247090013,,CPT0247130002,CPT0247090006,,FALSE,80,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,2,8,8,IIB,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,"CK19+, Ki67 80%",,IHC staining not done,154,56,23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,metoprolol|digoxinum|cliazapril|ryworoksaban,Medical Record|Medical Record|Medical Record|Self Report,No,Deceased,8,8,Other reasons,NA,11,No,No,No,Tumor Free,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,8,1,3,NA,80,Low,>70
C3L-03639,PDA,C3L-03639-T,C3L-03639-N,TRUE,,CPT0238640004,CPT0238610009,CPT0238610015,,CPT0238650002,CPT0238610012,,FALSE,76,Male,Unknown,Unknown,East_Asian,Other: TSS did not collect,No,Head,,,Unifocal,3.9,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,13,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,"cytokeratin 19+, synaptophysin-",,IHC staining not done,159,66,26.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,hydromorphone epidural|hydromorphone inj|ondansetron|Pantoprazole|tamsulosin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,246,246,Main malignancy,NA,246,No,Yes,No,With Tumor,Complete Remission,,Yes,169,Distant Metastasis,Other : Retroperitoneal lymph nodes,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,169,169,1,246,1,0,NA,76,Low,>70
C3L-00640,PDA,C3L-00640-T,C3L-00640-N,TRUE,,CPT0064570003,CPT0064520004,['CPT0064520007'],CPT0064570006,CPT0066660002,CPT0064520010,CPT0064570009,FALSE,59,Female,White,Not Hispanic or Latino,European,United States,No,Body,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,23,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,163,52,19.68,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,1.5,Exposure to secondhand smoke history not available,,,,,,,Zoloft|Topomax|Percoset|Ativan|Zofran|Synthroid|Flonase,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Living,594,NA,,594,NA,Yes,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,585,Locoregional Recurrence,Other : Omentum and Mesentery and Vascular and Colonic,,Biopsy with Histologic Confirmation,No,,,No,No,No,NA,NA,585,585,1,594,0,0,NA,59,High or alive at last follow-up,50-60
C3N-01719,PDA,C3N-01719-T,,TRUE,,,CPT0161990005,CPT0161990011,CPT0125160010,CPT0125200002,CPT0161990008,CPT0125160007,FALSE,63,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pNX,0,0,cM0,No pathologic evidence of distant metastasis,no,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,158,50,20,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,547,547,Main malignancy,NA,547,No,Yes,No,With Tumor,Persistent Disease,Progressive Disease,Yes,42,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,42,42,1,547,1,0,NA,63,High or alive at last follow-up,60-70
C3N-00514,PDA,C3N-00514-T,C3N-00514-N,TRUE,,CPT0077950003,CPT0077930004,['CPT0077930010'],,CPT0077990002,CPT0077930007,CPT0077950006,FALSE,60,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,20,5,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage II,,,IHC staining not done,161,83,32,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,55,Yes,Yes,Yes,,,,,,,No,Deceased,795,795,Main malignancy,NA,809,No,Yes,No,With Tumor,Complete Remission,,Yes,621,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,621,635,1,795,1,14,NA,60,High or alive at last follow-up,50-60
C3L-00017,PDA,C3L-00017-T,,TRUE,,,CPT0000250017,['CPT0000250008'],CPT0000270006,CPT0000580002,CPT0000250005,CPT0000270008,FALSE,69,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,42,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,172,84,28.36,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,NA,Yes,,Yes,,,,,NaCl 0.9%|Cefuroxime|Chlorhexidine Gluconate|Atenolol|Omeprazole|Docusate|Lovastatin|Hydrochlorothiazide|Lisinopril|Metformin|Acetaminophen-Oxycodone|Gabapentin|Aspirin|TNF Medication,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Living,426,NA,,426,NA,No,Yes,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,426,0,0,NA,69,High or alive at last follow-up,60-70
C3N-03670,PDA,C3N-03670-T,,TRUE,,,CPT0246840003,CPT0246840013,,CPT0246880002,CPT0246840006,CPT0246850006,FALSE,60,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),2,2,33,7,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,176,76,24,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,lymphoma ,Unknown,No,,,No,Living,1113,NA,,1126,NA,No,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,785,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),Yes,,R0: No Residual Tumor,Unknown,Yes,Unknown,807,NA,785,798,1,1113,0,13,NA,60,High or alive at last follow-up,50-60
C3L-01328,PDA,C3L-01328-T,,TRUE,,,CPT0083270003,['CPT0083270009'],CPT0083290009,CPT0081770002,CPT0083270006,CPT0083290006,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,3.4,Ductal adenocarcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,IHC staining not done,174,81,26.85,Yes,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,Unknown,Prostate Cancer,Unknown,Yes,Tamsulosin|Lorazepam|Trihexyphenidyl|Aspirin|Clopidogrel|Furosemide|Atenolol|Lisinopril|Ezetimibe|Atorvastatin|Carbidopa-levodopa|glipizide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,271,NA,,271,NA,No,Yes,No,With Tumor,Unknown,,Yes,250,Distant Metastasis,Liver,,Biopsy with Histologic Confirmation,No,,,Unknown,Unknown,Unknown,NA,NA,250,250,1,271,0,0,NA,71,High or alive at last follow-up,>70
C3N-02295,PDA,C3N-02295-T,C3N-02295-N,TRUE,,CPT0187540004,CPT0187550004,CPT0187550010,,CPT0187580002,CPT0187550007,CPT0187540007,FALSE,56,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,1,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,Stage III,,,IHC staining not done,156,70,28,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,5.3,No or minimal exposure to secondhand smoke,,,,,,,amlopin|euthyrox,Self-reported and Medical Record|Self-reported and Medical Record,No,Deceased,383,371,Main malignancy,NA,372,Unknown,Unknown,Unknown,With Tumor,Not Applicable,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,371,1,1,NA,56,Low,50-60
C3N-02573,PDA,C3N-02573-T,C3N-02573-N,TRUE,,C3N-02573-03,CPT0183450005,CPT0183450011,,CPT0183510002,CPT0183450008,,FALSE,41,Female,Unknown,Unknown,East_Asian,China,No,Other,body and tail,,Unifocal,6,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,13,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage III,EGFR（+），Ki-67（+10％），P53（+），HER2（-），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（-／+），MUC1（+），MUC2（-），MUC5AC（+），P16（-），C-Myc（+）,,IHC staining not done,160,53,20.7,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,479,NA,,483,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,479,0,4,NA,41,High or alive at last follow-up,<50
C3L-01052,PDA,C3L-01052-T,C3L-01052-N,TRUE,,CPT0123770003,CPT0123750003,CPT0123750009,,CPT0124880002,CPT0123750006,CPT0123770006,FALSE,64,Female,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,2,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,19,0,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,Stage II,,,IHC staining not done,165,57,20.94,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Yes,Yes,,,,,,,,No,Deceased,725,743,Main malignancy,NA,716,No,Yes,No,With Tumor,Complete Remission,,Yes,565,Distant Metastasis,Tumor Bed,,Positive Biomarker(s),No,,,No,No,No,NA,NA,565,538,1,743,1,-27,NA,64,High or alive at last follow-up,60-70
C3L-00622,PDA,C3L-00622-T,,TRUE,,,CPT0081360004,['CPT0081360010'],CPT0081390006,CPT0081400002,CPT0081360007,,FALSE,72,Male,Unknown,Unknown,European,Other: Canada,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,22,1,cM0,No pathologic evidence of distant metastasis,pMx,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,174,86,28.74,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Synthroid|Candesartan|Atorvastatin|Omeprazole|Tylenol|Centrum Multi-vitamin|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1041,1041,Main malignancy,NA,1047,No,Yes,No,With Tumor,Persistent Disease,,Yes,172,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,NA,NA,172,178,1,1041,1,6,NA,72,High or alive at last follow-up,>70
C3N-00709,PDA,C3N-00709-T,C3N-00709-N,TRUE,,C3N-00709-06,CPT0203850004,CPT0203850010,,CPT0203890002,CPT0203850007,,FALSE,81,Male,White,Not Hispanic or Latino,European,United States,No,,,,,NA,Ductal adenocarcinoma,G2 Moderately differentiated,,,,,,,,,,,,Staging is not applicable or unknown,,,,NA,NA,NA,,,,NA,,,,,,,,,,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,81,,>70
C3L-04027,PDA,C3L-04027-T,,TRUE,,,CPT0254680003,CPT0254680009,CPT0254740009,CPT0254840002,CPT0254680006,CPT0254740006,FALSE,69,Male,Unknown,Unknown,European,Other: Serbia,No,Head,,,Unifocal,2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN0,10,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,,,IHC staining not done,180,75,23.15,No,"Consumed alcohol in the past, but currently a non-drinker",Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,Unknown,,,,ramipril,Self-reported and Medical Record,No,Living,240,NA,,254,NA,No,Yes,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,240,0,14,NA,69,High or alive at last follow-up,60-70
C3L-02701,PDA,C3L-02701-T,,TRUE,,,CPT0227930004,CPT0227930010,,CPT0228080006,CPT0227930007,,FALSE,72,Male,Unknown,Unknown,European,Bulgaria,No,Other,Body and tail,,Unifocal,3,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,Unknown value,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,172,83,28.06,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Telmisartan,Self Report,No,Deceased,304,243,Unknown,NA,227,Yes,No,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,243,1,-16,NA,72,Low,>70
C3L-01031,PDA,C3L-01031-T,C3L-01031-N,TRUE,,CPT0127290003,CPT0127270003,CPT0127270009,,CPT0128520002,CPT0127270006,CPT0127290006,FALSE,64,Female,Unknown,Unknown,European,Russia,No,Other,Body and Tail,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,10,0,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,Stage II,,,IHC staining not done,168,79,27.99,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Living,369,NA,,376,NA,No,Yes,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,369,0,7,NA,64,High or alive at last follow-up,60-70
C3L-01053,PDA,C3L-01053-T,C3L-01053-N,TRUE,,CPT0123890003,CPT0123860003,CPT0123860006,,CPT0124900002,CPT0123860009,CPT0123890006,FALSE,76,Female,Unknown,Unknown,European,Russia,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,1,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,Stage II,,,IHC staining not done,162,85,32.39,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,20,191,Main malignancy,NA,171,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,191,1,-20,NA,76,Low,>70
C3N-03190,PDA,C3N-03190-T,,TRUE,,,CPT0236560004,CPT0236560010,,CPT0236610002,CPT0236560007,,FALSE,31,Male,Unknown,Unknown,East_Asian,China,No,Body,,,Unifocal,3,Ductal adenocarcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,10,1,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage II,"EGFR（+）,Ki-67（+,30％）,P53（+）,HER2（-）,E-Cad（+），hMLH1（+）,hMSH2（+）, SMAD4（-）,MUC1（weak+），MUC2（-），MUC5AC（+），P16（-），C-Myc（partly+）",,IHC staining not done,167,54,19.36,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,286,398,Unknown,NA,402,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,398,1,4,NA,31,Low,<50
C3N-01715,PDA,C3N-01715-T,,TRUE,,,CPT0125090003,CPT0125090009,,CPT0125120002,CPT0125090006,,FALSE,61,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,7,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,0,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,Stage III,"cK7(+), cK19 (+), CK5/6 (-), synaptophysin (-),chromogranin (-), KI67  80%,CK20(-)",,IHC staining not done,170,80,27,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,insulin ,Self Report,No,Deceased,283,109,Main malignancy,NA,109,No,No,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,109,1,0,NA,61,Low,60-70
C3N-01012,PDA,C3N-01012-T,,TRUE,,,CPT0241320005,CPT0241320011,,CPT0241740002,CPT0241320008,,FALSE,71,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,N0,27,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,IHC staining not done,175,84,27.43,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,37.5,Exposure to secondhand smoke history not available,,,Unknown,,,,aspirin|fluticasone-salmeterol|heparin injection|montelukast,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1352,NA,,1352,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Response,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1352,0,0,NA,71,High or alive at last follow-up,>70
C3N-01167,PDA,C3N-01167-T,,TRUE,,,CPT0087890004,CPT0087890007,,CPT0087930002,['CPT0087890010'],,FALSE,77,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,21,1,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,163,70,26.35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,NEBIVOLOL|AMLODYPIN,Self Report|Self Report,No,Deceased,754,754,Main malignancy,NA,754,Yes,Yes,No,With Tumor,Persistent Disease,Not Applicable,Yes,306,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,306,306,1,754,1,0,NA,77,High or alive at last follow-up,>70
C3L-00401,PDA,C3L-00401-T,C3L-00401-N,TRUE,,C3L-00401-04,CPT0019300004,['CPT0019300007'],,CPT0019380002,CPT0019300010,,FALSE,62,Female,Unknown,Unknown,European,Other: Canada,No,Body,,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,40,3,cM0,No pathologic evidence of distant metastasis,pMx,R0:  No residual tumor,Stage II,,,IHC staining not done,164,60,22.42,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Multivitamin|Calcium citrate + vitamin D|Omega fish oils|Aspirin|Ibuprofen,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Deceased,1262,1262,Main malignancy,NA,1270,No,Yes,No,With Tumor,Complete Remission,,Yes,532,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,532,540,1,1262,1,8,NA,62,High or alive at last follow-up,60-70
C3N-01011,PDA,C3N-01011-T,C3N-01011-N,TRUE,,CPT0066020003,CPT0065640003,['CPT0065640006'],CPT0066020009,CPT0070720002,CPT0065640009,CPT0066020006,FALSE,77,Female,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,31,7,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,CDX2: positive; MUC1: positive; MUC5: Positive,,IHC staining not done,158,68,27.41,Yes,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,3,Exposure to secondhand smoke history not available,,,,Uterine Cancer,Surgery,Yes,Baby Aspirin|metformin|Naproxen|simvastatin|lisinopril|hydrochlorothiazide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1068,NA,,1037,NA,No,Yes,No,With Tumor,Complete Remission,Progressive Disease,Yes,623,Locoregional Recurrence,Other : Retroperitoneal lymph node,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,623,592,1,1068,0,-31,NA,77,High or alive at last follow-up,>70
C3N-03839,PDA,C3N-03839-T,C3N-03839-N,TRUE,,CPT0236710004,CPT0236700005,CPT0236700011,,CPT0236770002,CPT0236700008,,FALSE,54,Female,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,4,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN1,29,1,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage II,EGFR（weak+），Ki-67（+，60％），P53（-），HER2（partly+），E-Cad（+），hMLH1（+），hMSH2（+），SMAD4（+），MUC1（+），MUC2（-），MUC5AC（+），P16（+），C-Myc（+）,,IHC staining not done,168,66,23.38,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,irbesartan|glimepiride|diformin tablet,Medical Record|Medical Record|Medical Record,No,Living,696,NA,,702,NA,No,Yes,No,With Tumor,Complete Remission,,Yes,430,Locoregional Recurrence,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,No,No,NA,NA,430,436,1,696,0,6,NA,54,High or alive at last follow-up,50-60
C3N-01375,PDA,C3N-01375-T,,TRUE,,,CPT0088180004,CPT0088180007,,CPT0088220002,CPT0088180010,,FALSE,70,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,43,2,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,152,53,22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Euthyrox N|Alvesco|Nebilet ,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,Deceased,396,143,Unknown,NA,144,No,Yes,No,Unknown Tumor Status,Patient Deceased,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,143,1,1,NA,70,Low,60-70
C3N-01381,PDA,C3N-01381-T,,TRUE,,,CPT0094130004,CPT0094130007,,CPT0094170002,CPT0094130010,,FALSE,43,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,2,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,2,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,,,IHC staining not done,174,64,21.14,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,18,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,297,455,Main malignancy,NA,457,Unknown,Yes,Unknown,With Tumor,Persistent Disease,,Yes,157,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Yes,Unknown,NA,NA,157,159,1,455,1,2,NA,43,High or alive at last follow-up,<50
C3L-03350,PDA,,C3L-03350-N,FALSE,,CPT0198340004,,CPT0198310011,,CPT0198350002,CPT0198310008,,FALSE,63,Male,Unknown,Unknown,,Canada,No,Head,,,Unifocal,7.4,Colloid carcinoma (Mucinous noncystic carcinoma),G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,12,5,cM0,No pathologic evidence of distant metastasis,Not applicable,R1:  Microscopic residual tumor,Stage III,,,IHC staining not done,167,64,22.95,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Valsartan,Medical Record,No,Deceased,588,613,Main malignancy,NA,618,No,Yes,No,With Tumor,Complete Remission,,Yes,301,Locoregional Recurrence,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,NA,NA,301,306,1,613,1,5,NA,63,High or alive at last follow-up,60-70
C3L-02118,PDA,C3L-02118-T,,TRUE,,,CPT0109300004,CPT0109300007,,CPT0109340002,CPT0109300010,,FALSE,67,Female,Unknown,Unknown,East_Asian,China,No,Head,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,N0,11,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,,,IHC staining not done,146,56,26.45,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Breast,"Radiation,Surgery,Chemotherapy",Yes,Irbesartan|Janumet|ACT Etidrocal|Tiazac XC|Hydralazine|Caltrate|Vitamin D,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,631,632,Unknown,NA,638,No,Yes,No,With Tumor,Complete Remission,,Yes,517,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,517,523,1,632,1,6,NA,67,High or alive at last follow-up,60-70
C3N-00511,PDA,C3N-00511-T,,TRUE,,,CPT0078250003,['CPT0078250009'],,CPT0078310002,['CPT0078250006'],,FALSE,45,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,9,2,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,165,70,25,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,991,991,Main malignancy,NA,1001,No,Yes,No,With Tumor,Persistent Disease,,Yes,621,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,621,631,1,991,1,10,NA,45,High or alive at last follow-up,<50
C3L-02613,PDA,C3L-02613-T,,TRUE,,,CPT0124610004,CPT0124610010,CPT0124630009,CPT0124640002,CPT0124610007,CPT0124630006,FALSE,52,Female,Unknown,Unknown,East_Asian,Canada,No,Head,,,Unifocal,6,Ductal adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),T3,N1,13,2,M0,No pathologic evidence of distant metastasis,No distant metastasis,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,158,67,26.84,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Candesartan|Hydrochlorothiazide|Echinacea|Vitamin C|Alvesco Inhaler,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,211,211,Unknown,NA,215,No,Yes,No,With Tumor,Persistent Disease,,Yes,54,Distant Metastasis,Non-Regional Lymph Nodes / Distant Lymph Nodes,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,NA,NA,54,58,1,211,1,4,NA,52,Low,50-60
C3N-03069,PDA,C3N-03069-T,C3N-03069-N,TRUE,,CPT0236360004,CPT0236340004,CPT0236340010,CPT0236360010,CPT0236400002,CPT0236340006,CPT0236360007,FALSE,50,Female,Unknown,Unknown,East_Asian,China,No,Body,,,Unifocal,6.5,Ductal adenocarcinoma,G2 Moderately differentiated,Present,Cannot be assessed,Eighth Edition (2017),pT3,pN2,31,6,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,"EGFR（+）,Ki-67（+,60％）,P53（weak+）,HER2（-）,E-Cad（+），hMLH1（+）,hMSH2（+）, SMAD4（-）,MUC1（+），MUC2（-），MUC5AC（+），P16（-），C-Myc（weak+）",,IHC staining not done,158,43,17.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,10,20,Unknown,NA,24,No,No,No,Tumor Free,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,20,1,4,NA,50,Low,<50
C3N-00512,PDA,C3N-00512-T,C3N-00512-N,TRUE,,CPT0078180003,CPT0078160004,['CPT0078160010'],,CPT0078220002,CPT0078160007,CPT0078180006,FALSE,42,Male,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.8,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,26,10,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,Stage II,,,IHC staining not done,184,95,28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,24,No or minimal exposure to secondhand smoke,,,,,,,,,No,Deceased,1006,1006,Main malignancy,NA,1021,No,Yes,No,With Tumor,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1006,1,15,NA,42,High or alive at last follow-up,<50
C3L-02899,PDA,C3L-02899-T,C3L-02899-N,TRUE,,CPT0197440004,CPT0197420004,CPT0197420010,CPT0197440010,CPT0199150002,CPT0197420007,CPT0197440007,FALSE,73,Male,White,Not Hispanic or Latino,European,United States,No,Head,,,Unifocal,7,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,16,11,Staging Incomplete,pM1,aortocaval lymph node,RX:  Presence of residual tumor cannot be assessed,Stage IV,,,IHC staining not done,190,70,19.25,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Skin Cancer,Unknown,Unknown,Lipitor|Aspirin|Atenolol|Glucosamine-Chondroitin ,Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,44,91,Main malignancy,NA,91,No,Yes,No,With Tumor,Patient Deceased,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,91,1,0,NA,73,Low,>70
C3N-03006,PDA,C3N-03006-T,,TRUE,,,CPT0226530004,CPT0226530014,,CPT0226560002,CPT0226530007,,FALSE,64,Female,Unknown,Unknown,European,Poland,No,Head,,,Unifocal,3.3,Ductal adenocarcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,1,18,3,0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,"synaptophysin (+),chromogranin A (+), KI67  <3%",,IHC staining not done,153,43,18,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,betaloc|doreta,Self Report|Self Report,No,Living,708,NA,,726,NA,No,Yes,No,With Tumor,Persistent Disease,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,708,0,18,NA,64,High or alive at last follow-up,60-70
C3L-03513,PDA,,C3L-03513-N,FALSE,,CPT0355180003,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-03514,PDA,,C3L-03514-N,FALSE,,CPT0355200003,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-03515,PDA,,C3L-03515-N,FALSE,,CPT0355190003,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-07032,PDA,,C3L-07032-N,FALSE,,CPT0347760002,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-07033,PDA,,C3L-07033-N,FALSE,,CPT0347790002,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-07034,PDA,,C3L-07034-N,FALSE,,CPT0347820002,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-07035,PDA,,C3L-07035-N,FALSE,,CPT0347850002,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-07036,PDA,,C3L-07036-N,FALSE,,CPT0347880002,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3N-01001,UCEC,,,TRUE,withdrawn,,,['CPT0078880006'],,CPT0078920002,CPT0078880009,,FALSE,72,Female,Unknown,Unknown,European,Poland,Yes,Posterior endometrium,,,Unifocal,9.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,0,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage II,,,0,154,105,44.27,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Colon cancer|Breast Cancer,"Surgery|Surgery,Chemotherapy",No|No,Citabax|Lerivon|Salmex|Atrodil|Polocard|Metformin|Betaloc|Co-Amlessa|Ridlip|Fragmin|Perfalgan|Morfinum|Citrofleet,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,588,NA,,601,NA,Yes,No,No,With Tumor,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,588,0,13,NA,72,High or alive at last follow-up,>70
C3L-00084,UCEC,,,TRUE,withdrawn,,,['CPT0000820008'],,CPT0003880002,CPT0000820005,,FALSE,74,Female,White,Not Hispanic or Latino,European,United States,Yes,Posterior endometrium,,,Unifocal,4.5,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,25,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,162,130,49.23,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",5,Exposure to secondhand smoke history not available,,,,,,,Coreg|Prilosec|Dyazide|Prinicil|Norvasc|Cholecalciperol|Fish oil|Multiple Vitamins|Tylenol|glucosamine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,335,NA,,335,NA,No,Yes,No,Tumor Free,Unknown,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,335,0,0,NA,74,High or alive at last follow-up,>70
C3L-01284,UCEC,,,TRUE,withdrawn,,,['CPT0079570006'],,CPT0080140002,CPT0079570009,,FALSE,49,Female,Asian,Not Hispanic or Latino,East_Asian,United States,Yes,Other,Both anterior and posterior,,Unifocal,7,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,16,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:  No residual tumor,Stage I,,,,155,51,21.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Calcium - Vitamin D PO|Multi Vitamin,Medical Record|Medical Record,No,Living,357,NA,,357,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,357,0,0,NA,49,High or alive at last follow-up,<50
C3N-01825R,UCEC,,,FALSE,withdrawn,,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3N-00858,UCEC,C3N-00858-T,C3N-00858-N,TRUE,,CPT0078360001,CPT0078320004,['CPT0078320007'],CPT0078360006,CPT0078420002,CPT0078320010,CPT0078360009,FALSE,65,Female,Unknown,Unknown,European,Poland,No,Anterior endometrium,,,Multifocal,11,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b (FIGO IIIB),pN0,2,0,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,Stage III,,,0,158,92,36,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,colon cancer,Surgery,No,Molsydamina|Bisoprolol|Enalapril|Aspirin|Concor|Axtil|Fragmin|Fortrans,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,736,NA,,749,NA,Yes,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,736,0,13,NA,65,High or alive at last follow-up,60-70
C3L-01252,UCEC,C3L-01252-T,C3L-01252-N,TRUE,,CPT0080620001,CPT0080610003,['CPT0080610006'],,CPT0080660002,CPT0080610009,,FALSE,76,Female,White,Unknown,European,United States,No,Posterior endometrium,,,Unifocal,0.9,Endometrioid carcinoma,G1 Well differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,157,95,38.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Insulin (Novolog) |cloNIDine HCl (CATAPRES|metoprolol tartrate (LOPRESSOR,Medical Record|Medical Record|Medical Record,No,Living,1581,NA,,1552,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1581,0,-29,NA,76,High or alive at last follow-up,>70
C3L-00947,UCEC,C3L-00947-T,C3L-00947-N,TRUE,,CPT0027430001,CPT0027420003,['CPT0027420006'],,CPT0027480002,CPT0027420009,,FALSE,71,Female,White,Unknown,European,United States,No,Posterior endometrium,,,Multifocal,1.8,Endometrioid carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,22,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,,155,88,36.84,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Lisinopril|Hydrochlorothiazide |Humulin,Medical Record|Medical Record|Medical Record,No,Living,1426,NA,,1393,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1426,0,-33,NA,71,High or alive at last follow-up,>70
C3N-00734,UCEC,C3N-00734-T,,TRUE,,,CPT0026030004,['CPT0026030007'],,CPT0028500002,CPT0026030010,,FALSE,53,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Unifocal,4,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,28,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,,168,110,38.97,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,atenolol|ciprofloxacin|hydrochlorothiazide|lamotrigine|lorazepam|lurasidone|potassium chloride|pravastatin|sertraline|valsartan,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1094,NA,,1094,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1094,0,0,NA,53,High or alive at last follow-up,50-60
C3L-01248,UCEC,C3L-01248-T,,TRUE,,,CPT0080300003,['CPT0080300009'],,CPT0080340001,CPT0080300006,,FALSE,42,Female,White,Unknown,European,United States,No,Posterior endometrium,,,Unifocal,6.3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,150,134,59.78,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,798,NA,,764,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,798,0,-34,NA,42,High or alive at last follow-up,<50
C3N-00850,UCEC,C3N-00850-T,,TRUE,,,CPT0027810003,['CPT0027810006'],,CPT0027890002,CPT0027810009,,FALSE,65,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Multifocal,1,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,158,72,28.84,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,682,NA,,628,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,682,0,-54,NA,65,High or alive at last follow-up,60-70
C3L-00361,UCEC,C3L-00361-T,C3L-00361-N,TRUE,,CPT0002450001,CPT0002430011,['CPT0002430005'],CPT0002450006,CPT0004400002,['CPT0002430008'],CPT0002450009,FALSE,64,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Unifocal,2.7,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage I,,,,165,117,42.98,Yes,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Melanoma,Surgery,Yes,Simvastatin|Valsartan|Pioglitazone|Glyburide|Fluticasone|Loratadine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1707,NA,,1707,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1707,0,0,NA,64,High or alive at last follow-up,60-70
C3L-01249,UCEC,C3L-01249-T,C3L-01249-N,TRUE,,CPT0080890001,CPT0080880003,['CPT0080880006'],,CPT0080920002,CPT0080880009,,FALSE,65,Female,White,Unknown,European,United States,No,Other,Tumor occupies 75% of endometrial surface,,Unifocal,6.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pN0,24,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,168,109,38.89,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1517,NA,,1465,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1517,0,-52,NA,65,High or alive at last follow-up,60-70
C3N-00383,UCEC,C3N-00383-T,C3N-00383-N,TRUE,,CPT0022850001,CPT0022830003,['CPT0022830009'],CPT0022850006,CPT0020790002,CPT0022830006,CPT0022850009,FALSE,61,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Unifocal,4,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,157,114,46,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,790,NA,,679,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,790,0,-111,NA,61,High or alive at last follow-up,60-70
C3L-00949,UCEC,C3L-00949-T,,TRUE,,,CPT0016370003,['CPT0016370009'],,CPT0016440002,CPT0016370006,,FALSE,64,Female,White,Unknown,European,United States,No,Other,along anterior and posterior surface,,Unifocal,2.5,Endometrioid carcinoma,G1 Well differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,152,88,37.69,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Atenolol|Glipizide|Metformin (GLUCOPHAGE)|Naproxen,Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1522,NA,,1490,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1522,0,-32,NA,64,High or alive at last follow-up,60-70
C3L-00032,UCEC,C3L-00032-T,,TRUE,,,CPT0001420009,CPT0001420164,,CPT0000110163,CPT0001420005,,FALSE,50,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior endometrium,,Unifocal,4.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,18,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,163,136,51.19,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",3,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1710,NA,,1710,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1710,0,0,NA,50,High or alive at last follow-up,<50
C3L-01744,UCEC,C3L-01744-T,C3L-01744-N,TRUE,,CPT0093290000,CPT0093280003,CPT0093280006,,CPT0093320002,CPT0093280009,,FALSE,62,Female,White,Unknown,European,United States,No,Anterior endometrium,,,Unifocal,2.2,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,150,104,46.45,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,oxybutynin (DITROPAN-XL,Medical Record,No,Living,953,NA,,936,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,953,0,-17,NA,62,High or alive at last follow-up,60-70
C3L-01311,UCEC,C3L-01311-T,C3L-01311-N,TRUE,,CPT0077780001,CPT0077770003,['CPT0077770006'],CPT0077780006,CPT0080090002,['CPT0077770013'],CPT0077780009,FALSE,55,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Unifocal,3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,,160,95,37.11,Yes,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Basal cell carcinoma,Unknown,Yes,Calcium|Vitamin D-3|Aygestin|Lopressor|Paxil|Hyzaar|Ferrous Sulfate|Arava,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1785,NA,,1785,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1785,0,0,NA,55,High or alive at last follow-up,50-60
C3L-01256,UCEC,C3L-01256-T,C3L-01256-N,TRUE,,CPT0073460001,CPT0073450003,['CPT0073450006'],,CPT0073470002,CPT0073450009,,FALSE,75,Female,White,Unknown,European,United States,No,Anterior endometrium,,,Unifocal,4.3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pN0,14,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,152,80,34.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,losartan-hydrochlorothiazide (HYZAAR) ,Medical Record,No,Living,1435,NA,,1371,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1435,0,-64,NA,75,High or alive at last follow-up,>70
C3L-00358,UCEC,C3L-00358-T,,TRUE,,,CPT0002210011,['CPT0002210005'],,CPT0004360002,CPT0002210008,,FALSE,>=90,Female,White,Not Hispanic or Latino,European,United States,No,Other,Both anterior and posterior endometrium,,Unifocal,4.5,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage I,,,,168,74,26.22,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,Unknown,,,,multivitamin |cholecalciferol|vitamin E |levothyroxine |Lotrel|Vitamin C |Osteo Bi-Flex Triple Strength|Probiotic|calcium (as carbonate)-vitamin D,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,164,NA,,164,NA,No,No,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,164,0,0,NA,90,High or alive at last follow-up,>70
C3L-00942,UCEC,C3L-00942-T,,TRUE,,,CPT0016830003,['CPT0016830009'],,CPT0016970001,CPT0016830006,,FALSE,64,Female,White,Unknown,European,United States,No,Anterior endometrium,,,Unifocal,4.5,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,,,,163,83,31.58,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Allopurinol |Atenolol,Medical Record|Medical Record,No,Living,1382,NA,,1323,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1382,0,-59,NA,64,High or alive at last follow-up,60-70
C3N-00389,UCEC,C3N-00389-T,,TRUE,,,CPT0026270003,['CPT0026270006'],,CPT0026370002,['CPT0026270009'],,FALSE,62,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Multifocal,1.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,9,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,164,48,17.85,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,671,NA,,665,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,671,0,-6,NA,62,High or alive at last follow-up,60-70
C3L-01307,UCEC,C3L-01307-T,C3L-01307-N,TRUE,,CPT0064320001,CPT0064290004,['CPT0064290010'],CPT0064320006,CPT0065410002,CPT0064290007,CPT0064320009,FALSE,74,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior,,Unifocal,3.5,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM1,pM1,omentum,RX:  Presence of residual tumor cannot be assessed,Stage IV,,,,162,83,31.63,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,xarelto|glucophage XR|vitamin E,Medical Record|Medical Record|Medical Record,No,Deceased,181,205,Main malignancy,NA,205,No,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,205,1,0,NA,74,Low,>70
C3L-01282,UCEC,C3L-01282-T,C3L-01282-N,TRUE,,CPT0077660001,CPT0077650003,['CPT0077650009'],CPT0077660006,CPT0080070001,CPT0077650006,CPT0077660009,FALSE,64,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Unifocal,3,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,,176,99,31.96,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,red yease rice 600mg|triamcinolone 0.1% cream |Fish oil|Vitamin B12|Vitamin B6,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1784,NA,,1784,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1784,0,0,NA,64,High or alive at last follow-up,60-70
C3L-01304,UCEC,C3L-01304-T,C3L-01304-N,TRUE,,CPT0064240001,CPT0064210003,['CPT0064210009'],CPT0064240006,CPT0065400002,CPT0064210006,CPT0064240009,FALSE,68,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior,,Unifocal,3.7,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,,149,92,41.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,ProAir HFA|HCTZ|Quinapril HCI|Levothyroxine Sodium|Sertraline HCI|MetFORMIN HCI|Crestor|Fenofibrate|Advair HFA|Evista|RaNITidine HCI|Calcium 600 +D|Mult for HER 50+|CPAP machine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1862,NA,,1862,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1862,0,0,NA,68,High or alive at last follow-up,60-70
C3L-00946,UCEC,C3L-00946-T,,TRUE,,,CPT0027520003,['CPT0027520006'],,CPT0027580002,CPT0027520009,,FALSE,64,Female,White,Unknown,European,United States,No,Posterior endometrium,,,Multifocal,3.9,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,7,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,,,,159,44,17.64,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45,Exposure to secondhand smoke history not available,,,1,,,,,,No,Living,995,NA,,971,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,995,0,-24,NA,64,High or alive at last follow-up,60-70
C3N-00322,UCEC,C3N-00322-T,,TRUE,,,CPT0010430003,['CPT0010430009'],,CPT0077050001,CPT0010430006,,FALSE,70,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire Uterine Cavity,,Multifocal,2.6,Serous carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,147,68,31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,694,NA,,668,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,694,0,-26,NA,70,High or alive at last follow-up,60-70
C3N-00337,UCEC,C3N-00337-T,,TRUE,,,CPT0018960003,['CPT0018960013'],,CPT0019100002,CPT0018960006,,FALSE,67,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire Uterine Cavity,,Multifocal,1.3,Serous carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,172,86,29.07,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,701,NA,,668,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,701,0,-33,NA,67,High or alive at last follow-up,60-70
C3N-00333,UCEC,C3N-00333-T,C3N-00333-N,TRUE,,CPT0011020003,CPT0011000003,['CPT0011000009'],CPT0011020005,CPT0011100002,CPT0011000006,,FALSE,65,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire Uterine Cavity,,Multifocal,1,Serous carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,158,78,31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,674,NA,,654,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,674,0,-20,NA,65,High or alive at last follow-up,60-70
C3L-00006,UCEC,C3L-00006-T,C3L-00006-N,TRUE,,CPT0001470001,CPT0001460012,CPT0001460164,CPT0001470006,CPT0000120163,CPT0001460007,CPT0001470009,FALSE,64,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Unifocal,2.9,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,31,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,152,90,38.88,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",5,Exposure to secondhand smoke history not available,,,,,,,proventil|coreg|lasix|micro-K|prilosec|ditropan|ventolin inhaler|singulair|lipitor|diovan|Fluticasone-Salmeterol|Atrovent HFA|Levothroxine Sodium|Calcium 500 |ASA 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,737,NA,,737,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,737,0,0,NA,64,High or alive at last follow-up,60-70
C3L-00769,UCEC,C3L-00769-T,C3L-00769-N,TRUE,,CPT0026540001,CPT0026530003,['CPT0026530006'],,CPT0026590002,CPT0026530009,,FALSE,56,Female,White,Unknown,European,United States,No,Anterior endometrium,,,Multifocal,4.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,15,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,,168,131,46.64,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,4,Exposure to secondhand smoke history not available,,,,,,,Amlodipine|Losartan,Medical Record|Medical Record,No,Living,1507,NA,,1450,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1507,0,-57,NA,56,High or alive at last follow-up,50-60
C3L-00362,UCEC,C3L-00362-T,,TRUE,,,CPT0002500011,['CPT0002500005'],,CPT0002850002,CPT0002500008,,FALSE,38,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior endometrium,,Unifocal,13.5,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,6,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,178,177,55.86,No,Lifelong non-drinker,Current reformed smoker within past 15 years,20,Exposure to secondhand smoke history not available,,,,,,,Protonix|Lipitor|Glucophage XR|Lexapro|Lantus Solostar|Mobic|Topamax|Thiamine|Novolog|actos|Zantac|Vitamin D|losartan-hydrochlorothiazide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1745,NA,,1745,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1745,0,0,NA,38,High or alive at last follow-up,<50
C3L-01312,UCEC,C3L-01312-T,,TRUE,,,CPT0063670003,['CPT0063670009'],,CPT0065300002,CPT0063670006,,FALSE,56,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior,,Unifocal,4,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,,,,165,87,31.96,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Progesterone Micronized |Armour thyroid,Medical Record|Medical Record,No,Living,1784,NA,,1784,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1784,0,0,NA,56,High or alive at last follow-up,50-60
C3L-00449,UCEC,C3L-00449-T,,TRUE,,,CPT0007100003,['CPT0007100006'],,CPT0002770002,CPT0007100009,,FALSE,59,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior endometrium,,Unifocal,7,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,15,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,162,73,27.82,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,38,Exposure to secondhand smoke history not available,,,,,,,Valium|Norco|Motrin|Keflex|colace,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1749,NA,,1749,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1749,0,0,NA,59,High or alive at last follow-up,50-60
C3L-00601,UCEC,C3L-00601-T,C3L-00601-N,TRUE,,CPT0007660001,CPT0007600003,['CPT0007600006'],CPT0007660006,CPT0002900002,CPT0007600009,CPT0007660009,FALSE,57,Female,White,Not Hispanic or Latino,European,United States,No,Other,Both anterior and posterior,,Unifocal,3.5,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage I,,,,157,62,25.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Multivitamin ,Medical Record,No,Living,1722,NA,,1722,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1722,0,0,NA,57,High or alive at last follow-up,50-60
C3N-00729,UCEC,C3N-00729-T,C3N-00729-N,TRUE,,CPT0064950001,CPT0064930004,['CPT0064930007'],,CPT0070650002,CPT0064930010,,FALSE,86,Female,White,Not Hispanic or Latino,European,United States,No,Other,both anterior and posterior,,Multifocal,4,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1b,pN0,4,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,165,81,29.62,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,amlodipine (norvasc)|aspirin (ecotrin)|clopidogrel (plavix)|ezetimibe (zetia)|fenofibrate (Tricor)|fluticasone|furosemide (lasix)|levothyroxine|loratadine (claritin)|metoprolol (toprol xl)|Niacin Antihyperlipidemic (niaspan)|nitroglycerin (nitrostat)|polyethyl glycol-propyl gycol|ranitidine HCI (Zantac)|rosuvastatin calcium (crestor)|tramadol (ultram),Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,873,NA,,848,NA,Yes,No,No,With Tumor,Persistent Disease,,Yes,347,Locoregional Recurrence,Other: vaginal vault,,,No,,,No,No,No,NA,NA,347,322,1,873,0,-25,NA,86,High or alive at last follow-up,>70
C3L-00586,UCEC,C3L-00586-T,C3L-00586-N,TRUE,,CPT0023640001,CPT0023630003,['CPT0023630009'],CPT0023640006,CPT0024590002,CPT0023630006,CPT0023640009,FALSE,50,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and posterior endometrium,,Unifocal,6,Endometrioid carcinoma,G1 Well differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN2 (FIGO IIIC2),18,4,cM0,Staging Incomplete,Not applicable,RX:  Presence of residual tumor cannot be assessed,Stage III,,,,170,62,21.45,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,1,,,,Paxil|vitamin D-3|Leci-Sitosteral-Nia-Betn-Chit,Medical Record|Medical Record|Medical Record,No,Living,1801,NA,,1801,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1801,0,0,NA,50,High or alive at last follow-up,<50
C3N-01212,UCEC,C3N-01212-T,,TRUE,,,CPT0075380003,['CPT0075380006'],,CPT0075440002,CPT0075380009,,FALSE,63,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Unifocal,1.5,Endometrioid carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage III,,,,161,79,30.48,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,680,NA,,666,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,680,0,-14,NA,63,High or alive at last follow-up,60-70
C3N-00836,UCEC,C3N-00836-T,,TRUE,,,CPT0023810003,['CPT0023810006'],,CPT0023910002,CPT0023810009,,FALSE,75,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Multifocal,1,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,160,78,30.47,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,665,NA,,642,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,665,0,-23,NA,75,High or alive at last follow-up,>70
C3N-00339,UCEC,C3N-00339-T,,TRUE,,,CPT0020530003,['CPT0020530006'],,CPT0020600002,CPT0020530009,,FALSE,45,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,1.3,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,10,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,163,58,21.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,701,NA,,701,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,701,0,0,NA,45,High or alive at last follow-up,<50
C3L-01246,UCEC,C3L-01246-T,C3L-01246-N,TRUE,,CPT0080990001,CPT0080980003,CPT0080980006,,CPT0081030002,CPT0080980009,,FALSE,62,Female,White,Unknown,European,United States,No,Posterior endometrium,,,Unifocal,2.3,Clear cell carcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,160,100,39.14,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",18,Exposure to secondhand smoke history not available,,,,,,,lisinopril-hydrochlorothiazide (PRINZIDE) ,Medical Record,No,Living,1538,NA,,1524,NA,Yes,Yes,No,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1538,0,-14,NA,62,High or alive at last follow-up,60-70
C3L-01257,UCEC,C3L-01257-T,C3L-01257-N,TRUE,,CPT0073530001,CPT0073520003,['CPT0073520013'],,CPT0073580002,CPT0073520009,,FALSE,71,Female,White,Unknown,European,United States,No,Other,Tumor involves 75% of endometrial cavity per diagnostic pathology report,,Unifocal,8,Endometrioid carcinoma,G1 Well differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pN0,15,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,,,,168,48,17.11,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,rosuvastatin,Medical Record,No,Living,603,NA,,580,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,603,0,-23,NA,71,High or alive at last follow-up,>70
C3L-00780,UCEC,C3L-00780-T,,TRUE,,,CPT0070330004,['CPT0070330007'],,CPT0071010002,CPT0070330010,,FALSE,69,Female,White,Hispanic or Latino,European,United States,No,Other,Posterior and Anterior Endometrium,,Unifocal,1.7,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1a,pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,160,119,46.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,furosemide|amlodipine|losartan|levothyroxine|atenolol|ibuprofen|NPH 58/58|Insulin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1053,NA,,1033,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1053,0,-20,NA,69,High or alive at last follow-up,60-70
C3L-00930,UCEC,,C3L-00930-N,TRUE,,CPT0027020001,,['CPT0027010006'],,CPT0027070002,CPT0027010009,,FALSE,72,Female,White,Not Hispanic or Latino,European,United States,Yes,Anterior endometrium,,,Multifocal,4.5,Mixed cell adenocarcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,11,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,0,165,69,25.29,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,24,Exposure to secondhand smoke history not available,,,,,,,levothyroxine,Medical Record,No,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,0,NA,NA,NA,NA,72,,>70
C3N-01217,UCEC,C3N-01217-T,,TRUE,,,CPT0076500003,['CPT0076500009'],,CPT0076580002,CPT0076500006,,FALSE,58,Female,Unknown,Unknown,European,Ukraine,No,Other,Endometrium,,Multifocal,0.8,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,162,95,36.2,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,715,NA,,682,NA,Yes,No,No,With Tumor,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,715,0,-33,NA,58,High or alive at last follow-up,50-60
C3N-00323,UCEC,C3N-00323-T,,TRUE,,,CPT0010610003,['CPT0010610009'],,CPT0010760002,CPT0010610006,,FALSE,78,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,4,Serous carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,168,78,27,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,1195,NA,,1130,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1195,0,-65,NA,78,High or alive at last follow-up,>70
C3L-00918,UCEC,C3L-00918-T,,TRUE,,,CPT0063790003,['CPT0063790009'],,CPT0065320002,CPT0063790006,,FALSE,68,Female,White,Not Hispanic or Latino,European,United States,No,Other,Both anterior and posterior endometrium,,Unifocal,3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:  No residual tumor,Stage I,,,,163,114,43,No,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",22,Exposure to secondhand smoke history not available,,,Unknown,,,,Synthroid|Gabapentin|Lantus Solostar Pen|Zocor|Zoloft|Aspirin Enteric Coated|Calcium Carbonate|Norvasc|Nystatin|Atorvastatin|Tramadol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1176,1192,Main malignancy,NA,1192,No,No,No,With Tumor,Not Applicable,Patient Deceased,Yes,1042,New Primary Tumor,Other: ear acoustic neuroma tumor non cancerous,,,No,,,Yes,No,No,NA,NA,1042,1042,1,1192,1,0,NA,68,High or alive at last follow-up,60-70
C3N-00866,UCEC,C3N-00866-T,C3N-00866-N,TRUE,,CPT0063110001,CPT0063090003,['CPT0063090006'],CPT0063110004,CPT0063210002,CPT0063090009,,FALSE,77,Female,White,Not Hispanic or Latino,European,United States,No,Other,"Anterior, posterior and fundus",,Multifocal,3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Unknown,R0:  No residual tumor,Stage I,,,,165,65,23.88,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,13.5,Exposure to secondhand smoke history not available,,,,Clear cell Renal Carcinoma,Surgery,Yes,atenolol|lisinopril|metformin|simvastatin (ZOCOR) 20 MG tablet|warfarin (COUMADIN) 5 MG tablet,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,511,NA,,524,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,511,0,13,NA,77,High or alive at last follow-up,>70
C3L-00932,UCEC,C3L-00932-T,C3L-00932-N,TRUE,,CPT0027130001,CPT0027120003,['CPT0027120006'],CPT0027130006,CPT0027180002,CPT0027120009,CPT0027130009,FALSE,67,Female,White,Not Hispanic or Latino,European,United States,No,Other,left cornu,,Unifocal,1,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,14,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,,160,122,47.82,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Lisinopril,Medical Record,No,Living,1502,NA,,1475,NA,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1502,0,-27,NA,67,High or alive at last follow-up,60-70
C3L-00963,UCEC,C3L-00963-T,C3L-00963-N,TRUE,,CPT0016530001,CPT0016490003,['CPT0016490009'],,CPT0016580002,CPT0016490006,,FALSE,59,Female,White,Unknown,European,United States,No,Other,Tumor occupies 70% of the anterior endometrium and 50% of the posterior endometrium per the pathology report,,Unifocal,2.6,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,22,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,,,,160,89,34.89,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",6.3,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,810,NA,,750,NA,Yes,Yes,No,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,810,0,-60,NA,59,High or alive at last follow-up,50-60
C3N-00335,UCEC,C3N-00335-T,,TRUE,,,CPT0018790003,['CPT0018790009'],,CPT0018910002,['CPT0018790006'],,FALSE,57,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,2.5,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,154,70,29.52,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,686,NA,,667,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,686,0,-19,NA,57,High or alive at last follow-up,50-60
C3N-00326,UCEC,C3N-00326-T,,TRUE,,,CPT0022530003,['CPT0022530009'],,CPT0019690002,['CPT0022530006'],,FALSE,45,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,1.3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,175,109,35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,682,NA,,644,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,682,0,-38,NA,45,High or alive at last follow-up,<50
C3L-00961,UCEC,C3L-00961-T,,TRUE,,,CPT0027320003,['CPT0027320006'],,CPT0027380002,CPT0027320009,,FALSE,59,Female,White,Unknown,European,United States,No,Anterior endometrium,,,Multifocal,4.5,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,9,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,,170,83,28.5,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,9.5,Exposure to secondhand smoke history not available,,,2,,,,,,No,Deceased,1289,1290,Other reasons,NA,1277,No,No,No,Tumor Free,Complete Remission,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1290,1,-13,NA,59,High or alive at last follow-up,50-60
C3L-00770,UCEC,C3L-00770-T,C3L-00770-N,TRUE,,CPT0026660001,CPT0026650003,['CPT0026650006'],,CPT0026710002,CPT0026650009,,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Multifocal,2.7,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,,163,121,45.83,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,Renal Clear cell carcinoma ,Surgery,Yes,Glimipiride|Lisinopril|Simvastatin,Medical Record|Medical Record|Medical Record,No,Living,1547,NA,,1476,NA,No,No,No,Tumor Free,Not Applicable,Not Applicable,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1547,0,-71,NA,73,High or alive at last follow-up,>70
C3N-00200,UCEC,C3N-00200-T,C3N-00200-N,TRUE,,CPT0017930001,CPT0017870003,['CPT0017870009'],,CPT0028400002,CPT0017870006,,FALSE,72,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Other,anterior and posterior endometrial cavity,,Multifocal,9,Mixed cell adenocarcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN1 (FIGO IIIC1),10,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,,168,132,46.85,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",8.3,Exposure to secondhand smoke history not available,,,,,,,atorvastatin|chlordiazepoxide|docusate|enalapril|hydrochlorothiazide|insulin |verapamil,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,732,732,Main malignancy,NA,593,No,No,No,With Tumor,Complete Remission,,Yes,722,Locoregional Recurrence,Other: peritoneum and mesentery,,,No,,,No,No,No,NA,NA,722,583,1,732,1,-139,NA,72,High or alive at last follow-up,>70
C3N-00379,UCEC,C3N-00379-T,,TRUE,,,CPT0015520003,['CPT0015520006'],,CPT0015740002,CPT0015520009,,FALSE,41,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity.,,Multifocal,2.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,164,99,36.81,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,658,NA,,642,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,658,0,-16,NA,41,High or alive at last follow-up,<50
C3L-01275,UCEC,C3L-01275-T,,TRUE,,,CPT0073730003,['CPT0073730006'],,CPT0073760002,CPT0073730009,,FALSE,65,Female,Unknown,Unknown,European,United States,No,Other,100 PERCENT OF ENDOMETRIAL SURFACE INVOLVED,,Unifocal,5,Endometrioid carcinoma,G2 Moderately differentiated,Present,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pN0,26,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,160,82,32.06,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,levothyroxine (Levothroid),Medical Record,No,Living,1485,NA,,1450,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,Yes,657,Locoregional Recurrence,Other: vaginal bleeding,,,No,,,No,Yes,No,NA,NA,657,622,1,1485,0,-35,NA,65,High or alive at last follow-up,60-70
C3N-01003,UCEC,C3N-01003-T,,TRUE,,,CPT0078610003,['CPT0078610006'],CPT0078620004,CPT0078650002,CPT0078610009,,FALSE,73,Female,Unknown,Unknown,European,Poland,No,Anterior endometrium,,,Multifocal,3,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3b (FIGO IIIB),0,6,0,cM1,pM1,omentum,R0:  No residual tumor,Stage IV,,,0,164,86,31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Fraxiparine|Metocard|Siofor|Glibetic|Omeprazol|Digoxin|Phlebodia|Acenocumarol|Fortrans,Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self Report|Self Report|Self Report|Self Report|Medical Record,No,Deceased,606,759,Main malignancy,NA,772,No,Yes,No,With Tumor,Complete Remission,,Yes,440,Distant Metastasis,Other: peritoneal carcinomatosis,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,440,453,1,759,1,13,NA,73,High or alive at last follow-up,>70
C3N-00386,UCEC,C3N-00386-T,,TRUE,,,CPT0016220003,['CPT0016220006'],,CPT0016770002,CPT0016220009,,FALSE,44,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity.,,Multifocal,2.3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,169,78,27.31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,673,NA,,664,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,673,0,-9,NA,44,High or alive at last follow-up,<50
C3L-00145,UCEC,C3L-00145-T,,TRUE,,,CPT0002630003,['CPT0002630006'],,CPT0007990002,CPT0002630009,,FALSE,59,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior endometrium,,Unifocal,4.7,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,Stage I,,,,167,102,36.57,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",5,Exposure to secondhand smoke history not available,,,,,,,Benadryl|Adderall|Cymbalta|Toprol-XL|Toujeo Solostar|Victoza|Glucophage|Lipitor|Flonase|Vitamin D|Asa 81mg|Iron,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1799,NA,,1799,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1799,0,0,NA,59,High or alive at last follow-up,50-60
C3N-01211,UCEC,C3N-01211-T,C3N-01211-N,TRUE,,CPT0075940001,CPT0075900003,['CPT0075900006'],,CPT0076020002,CPT0075900009,,FALSE,59,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Multifocal,1.4,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,8,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage II,,,,180,127,39.2,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,740,NA,,670,NA,Yes,Yes,No,With Tumor,Complete Remission,,Yes,637,Distant Metastasis,Liver,,,No,,,No,Yes,No,NA,NA,637,567,1,740,0,-70,NA,59,High or alive at last follow-up,50-60
C3L-01247,UCEC,C3L-01247-T,,TRUE,,,CPT0080700003,['CPT0080700006'],,CPT0080800002,CPT0080700009,,FALSE,63,Female,White,Unknown,European,United States,No,Other,"If Other, specify: Tumor occupies 100% of endometrial surface",,Unifocal,11,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN1 (FIGO IIIC1),13,2,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage III,,,,160,98,38.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,1464,NA,,1464,NA,Yes,Yes,No,With Tumor,Complete Remission,Persistent Disease,Yes,1310,Locoregional Recurrence,Other: endometrium,,,No,,,No,Yes,No,NA,NA,1310,1310,1,1464,0,0,NA,63,High or alive at last follow-up,60-70
C3N-00340,UCEC,C3N-00340-T,,TRUE,,,CPT0022620003,['CPT0022620009'],,CPT0020710002,['CPT0022620006'],,FALSE,60,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,3.5,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN1 (FIGO IIIC1),13,1,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage III,,,,158,69,27,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,722,NA,,700,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,722,0,-22,NA,60,High or alive at last follow-up,50-60
C3N-01825,UCEC,C3N-01825-T,,TRUE,,,CPT0097710003,"['CPT0097730009', 'CPT0097710006']",,CPT0097750002,"['CPT0097730006', 'CPT0097710009']",,FALSE,70,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Unifocal,5,Serous carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,10,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,167,95,34.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,687,NA,,661,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,687,0,-26,NA,70,High or alive at last follow-up,60-70
C3N-01267,UCEC,C3N-01267-T,,TRUE,,,CPT0027970003,['CPT0027970006'],,CPT0028110002,CPT0027970009,,FALSE,57,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Multifocal,1.2,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN1 (FIGO IIIC1),6,6,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage III,,,,159,78,30.85,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,663,NA,,646,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,663,0,-17,NA,57,High or alive at last follow-up,50-60
C3N-00321,UCEC,C3N-00321-T,,TRUE,,,CPT0010260003,['CPT0010260013'],,CPT0010380002,CPT0010260006,,FALSE,64,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,1.5,Serous carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,157,66,26,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,59,NA,,42,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,59,0,-17,NA,64,High or alive at last follow-up,60-70
C3L-00905,UCEC,C3L-00905-T,,TRUE,,,CPT0063380003,['CPT0063380006'],,CPT0065250002,CPT0063380009,,FALSE,64,Female,White,Not Hispanic or Latino,European,United States,No,Other,anterior and posterior,,Unifocal,4.5,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN1 (FIGO IIIC1),2,2,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,,,2,165,122,44.81,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,meloxicam|Amlodipine |Benazepril|mulivitamin |simvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1749,NA,,1756,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1749,0,7,NA,64,High or alive at last follow-up,60-70
C3L-01253,UCEC,C3L-01253-T,,TRUE,,,CPT0080400003,['CPT0080400006'],,CPT0080440002,CPT0080400009,,FALSE,77,Female,White,Unknown,European,United States,No,Other,Both anterior and posterior endometrium are remarkable for tumor,,Unifocal,5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,11,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,152,74,31.83,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Metoprolol|liraglutide (VICTOZA 2-PAK,Medical Record|Medical Record,No,Living,1532,NA,,1512,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1532,0,-20,NA,77,High or alive at last follow-up,>70
C3L-00771,UCEC,C3L-00771-T,C3L-00771-N,TRUE,,CPT0026780001,CPT0026770003,['CPT0026770006'],,CPT0026830002,CPT0026770009,,FALSE,86,Female,White,Not Hispanic or Latino,European,United States,No,Posterior endometrium,,,Multifocal,6,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,4,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage III,,,,157,57,22.86,No,Alcohol consumption history not available,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,Metoprolol|levothyroxine|Atorvastatin,Medical Record|Medical Record|Medical Record,No,Deceased,134,134,Unknown,NA,13,No,No,No,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,134,1,-121,NA,86,Low,>70
C3L-00563,UCEC,C3L-00563-T,C3L-00563-N,TRUE,,CPT0063260001,CPT0063250003,['CPT0063250006'],,CPT0065230002,CPT0063250009,,FALSE,62,Female,Asian,Not Hispanic or Latino,South_Asian,United States,No,Other,Both anterior and posterior,,Unifocal,3,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,,168,98,34.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Glyburide|Atorvastatin|Metoprolol tartrate|Levothyroxine|Pioglitazone|Aspirin|Ferrous sulfate|Metformin|Vitamin D PO,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1785,NA,,1785,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1785,0,0,NA,62,High or alive at last follow-up,60-70
C3L-00356,UCEC,C3L-00356-T,,TRUE,,,CPT0002130003,['CPT0002130006'],,CPT0004350002,CPT0002130009,,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,Other,Both anterior and posterior endometrium,,Unifocal,3.9,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,27,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage I,,,0,162,67,25.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Levothyroxine|Amlodipine|Losartan-hydrochlorothiazide|Magnesium,Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,1351,1351,Main malignancy,NA,1351,Yes,Yes,No,With Tumor,Complete Remission,,Yes,934,Locoregional Recurrence,Other: right pelvic lymphadenopathy,,,No,,,No,Yes,Yes,NA,NA,934,934,1,1351,1,0,NA,73,High or alive at last follow-up,>70
C3L-00139,UCEC,C3L-00139-T,,TRUE,,,CPT0001850012,['CPT0001850008'],,CPT0003950002,CPT0001850005,,FALSE,83,Female,White,Not Hispanic or Latino,European,United States,No,Other,Both anterior and posterior,,Unifocal,4,Serous carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pNX,0,,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage III,,,,163,57,21.57,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Calcium|Multi Vitamin |Esomeprazole,Medical Report|Medical Report|Medical Report,No,Deceased,422,422,Main malignancy,NA,422,Yes,Yes,No,With Tumor,Persistent Disease,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,422,1,0,NA,83,Low,>70
C3N-00324,UCEC,C3N-00324-T,,TRUE,,,CPT0010820003,['CPT0010820009'],,CPT0010950002,CPT0010820006,,FALSE,66,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,2.3,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,10,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage II,,,,160,90,35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,710,NA,,645,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,710,0,-65,NA,66,High or alive at last follow-up,60-70
C3L-00605,UCEC,C3L-00605-T,C3L-00605-N,TRUE,,CPT0063900001,CPT0063890003,['CPT0063890009'],,CPT0065340002,CPT0063890006,,FALSE,73,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior,,Unifocal,2.7,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,,157,95,38.54,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,ibuprofen|tylenol 325|Aspirin 81mg|Lipitor|lisinopril |Nexium|Synthroid|Calcium 6000 +D|mult. vitamin  with minerals,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1795,NA,,1795,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1795,0,0,NA,73,High or alive at last follow-up,>70
C3N-00743,UCEC,C3N-00743-T,,TRUE,,,CPT0062940003,['CPT0062940006'],,CPT0063060002,CPT0062940009,,FALSE,53,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Other,"Involves fundus, anterior and posterior walls",,Multifocal,3.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,24,0,cM0,No pathologic evidence of distant metastasis,Unknown,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,159,122,48.46,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,19.5,Exposure to secondhand smoke history not available,,,,,,,Albuterol|Ferrous Gluconate,Medical Record|Medical Record,No,Living,584,NA,,590,NA,No,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,584,0,6,NA,53,High or alive at last follow-up,50-60
C3N-01219,UCEC,C3N-01219-T,,TRUE,,,CPT0076160003,['CPT0076160009'],,CPT0076220002,CPT0076160006,,FALSE,58,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Unifocal,5,Endometrioid carcinoma,G3 Poorly differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,4,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage III,,,,154,62,26.14,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,738,NA,,683,NA,No,No,No,With Tumor,Complete Remission,,Yes,591,Locoregional Recurrence,Other: Locoregional recurrence,,,No,,,No,Yes,No,NA,NA,591,536,1,738,0,-55,NA,58,High or alive at last follow-up,50-60
C3N-01520,UCEC,C3N-01520-T,,TRUE,,,CPT0076860003,['CPT0076860006'],,CPT0076940002,CPT0076860009,,FALSE,69,Female,Unknown,Unknown,European,Ukraine,No,Other,Endometrium,,Multifocal,1,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,164,79,29.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Deceased,287,287,Other reasons,NA,278,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,287,1,-9,NA,69,Low,60-70
C3L-00090,UCEC,C3L-00090-T,,TRUE,,,CPT0001140003,CPT0001140164,,CPT0000040163,CPT0001140005,,FALSE,75,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior endometrium,,Unifocal,3.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage I,,,,165,89,32.69,Yes,Alcohol consumption history not available,Current reformed smoker within past 15 years,7.5,Exposure to secondhand smoke history not available,,,,"Skin Cancer , Unspecified ",Unknown,No,synthroid|Tylenol Extra Strength,Medical Record|Medical Record,No,Deceased,1279,1281,Other reasons,NA,1287,Yes,Yes,No,With Tumor,Persistent Disease,,Yes,50,New Primary Tumor,Lung,,,No,,,Yes,Yes,No,NA,NA,50,56,1,1281,1,6,NA,75,High or alive at last follow-up,>70
C3N-00880,UCEC,C3N-00880-T,,TRUE,,,CPT0078710004,['CPT0078710007'],,CPT0078790002,CPT0078710010,,FALSE,61,Female,Unknown,Unknown,European,Poland,No,Anterior endometrium,,,Unifocal,3.2,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,,,0,170,80,27,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Triplixam|Beto  ZK 25|Atrox 20|Cardilopin 5|Fragmin|Fortrans,Medical Record|Medical Record|Self Report|Medical Record|Medical Record|Medical Record,No,Living,1757,NA,,1769,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1757,0,12,NA,61,High or alive at last follow-up,60-70
C3N-00328,UCEC,C3N-00328-T,,TRUE,,,CPT0019840003,['CPT0019840006'],,CPT0020410002,CPT0019840009,,FALSE,62,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,3,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,165,85,31.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,697,NA,,644,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,697,0,-53,NA,62,High or alive at last follow-up,60-70
C3L-00767,UCEC,C3L-00767-T,,TRUE,,,CPT0026430003,['CPT0026430006'],,CPT0026490002,CPT0026430009,,FALSE,56,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Multifocal,2.3,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,,160,168,65.71,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,,,,Hydrochlorothiazide |Lisinopril,Medical Record|Medical Record,No,Living,419,NA,,273,NA,No,No,No,Tumor Free,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,419,0,-146,NA,56,High or alive at last follow-up,50-60
C3N-01346,UCEC,C3N-01346-T,C3N-01346-N,TRUE,,CPT0116570003,CPT0116550004,CPT0116550010,CPT0116570009,CPT0116610002,CPT0116550007,CPT0116570006,FALSE,63,Female,Unknown,Unknown,European,Poland,No,Anterior endometrium,,,Unifocal,5.5,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN2 (FIGO IIIC2),25,4,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage III,,,,162,90,34,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,NA,Yes,Yes,,,,,,Eltroxin|Torvacard|Essentix|Zaldiar|Ketonal|Paracetamol|cyclonamine|Exacyl|Poltram|Clexane|fortrans|Potassium Chloride,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1348,NA,,1366,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1348,0,18,NA,63,High or alive at last follow-up,60-70
NX1,UCEC,,NX1-N,TRUE,,NX1,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX2,UCEC,,NX2-N,TRUE,,NX2,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3N-00388,UCEC,C3N-00388-T,,TRUE,,,CPT0016940003,['CPT0016940006'],,CPT0017290002,CPT0016940008,,FALSE,59,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity.,,Multifocal,4,Serous carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,10,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,168,58,20.55,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,645,NA,,650,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,645,0,5,NA,59,High or alive at last follow-up,50-60
C3N-01537,UCEC,C3N-01537-T,,TRUE,,,CPT0097010003,CPT0097010006,,CPT0097050002,CPT0097010009,,FALSE,74,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Unifocal,1.5,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,7,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage II,,,,154,84,35.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,698,NA,,671,NA,No,No,No,Tumor Free,Complete Remission,,Yes,58,Locoregional Recurrence,Other: Vagina,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,62,NA,58,31,1,698,0,-27,NA,74,High or alive at last follow-up,>70
C3L-00413,UCEC,C3L-00413-T,,TRUE,,,CPT0009980003,['CPT0009980009'],,CPT0019850002,CPT0009980006,,FALSE,60,Female,White,Not Hispanic or Latino,European,United States,No,Other,Both anterior and posterior,,Unifocal,3.2,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,33,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage II,,,,160,108,42.19,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",NA,Exposure to secondhand smoke history not available,,,,,,,Hydrocodone-acetaminophen|Venlafaxine|Levothyroxine Sodium|Meloxicam|Alprazolam|Amlodipine|Triamterene-hydrochlorothiazide|Amlodipine-atorvastatatin |IRON PO|Multivitamin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1767,NA,,1767,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1767,0,0,NA,60,High or alive at last follow-up,50-60
C3L-00157,UCEC,C3L-00157-T,,TRUE,,,CPT0002560003,['CPT0002560006'],,CPT0008040002,CPT0002560009,,FALSE,60,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Anterior endometrium,,,Unifocal,4.2,Serous carcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT3a (FIGO IIIA),pN2 (FIGO IIIC2),45,17,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage III,,,,162,92,34.84,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Tramadol|Omeprazole|Proctofoam HC,Medical Record|Medical Record|Medical Record,No,Deceased,1396,1396,Main malignancy,NA,1396,Yes,Yes,No,With Tumor,Complete Remission,Patient Deceased,Yes,1337,Distant Metastasis,Other: peritoneal,,,No,,,No,No,No,NA,NA,1337,1337,1,1396,1,0,NA,60,High or alive at last follow-up,50-60
C3L-00161,UCEC,C3L-00161-T,,TRUE,,,CPT0070380004,['CPT0070380010'],,CPT0070970002,CPT0070380007,,FALSE,46,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Other,Anterior and Posterior Endometrium,,Unifocal,7,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pN0,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,155,164,68.39,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Provera|Tramadol|Colace|Remeron|Coumadin|Lovanox|Pepcid|Prilosec,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1775,NA,,1775,NA,Yes,Yes,No,With Tumor,Complete Remission,Persistent Disease,Yes,1369,Locoregional Recurrence,Other: lymph nodes,,,No,,,No,Yes,No,NA,NA,1369,1369,1,1775,0,0,NA,46,High or alive at last follow-up,<50
C3N-01349,UCEC,C3N-01349-T,,TRUE,,,CPT0116630003,CPT0116630009,,CPT0116700002,CPT0116630006,,FALSE,77,Female,Unknown,Unknown,European,Poland,No,Anterior endometrium,,,Multifocal,5,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,6,6,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage I,,,,165,86,31,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,No or minimal exposure to secondhand smoke,,,,sarcoma of the left leg,Surgery,No,acenokumarol|Clexane|Betaloc|metformax|diaprel|lisiprol|dironorm|fortrans,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Deceased,850,555,Main malignancy,NA,570,Unknown,Unknown,Unknown,With Tumor,Unknown,,Yes,405,Distant Metastasis,Other: lymph nodes,,,Unknown,,,Unknown,Unknown,Unknown,NA,NA,405,420,1,555,1,15,NA,77,High or alive at last follow-up,>70
NX3,UCEC,,NX3-N,TRUE,,NX3,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX4,UCEC,,NX4-N,TRUE,,NX4,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3N-01521,UCEC,C3N-01521-T,,TRUE,,,CPT0076680003,['CPT0076680006'],,CPT0076760002,CPT0076680009,,FALSE,75,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Unifocal,4.2,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,167,82,29.4,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,728,NA,,681,NA,Yes,No,No,With Tumor,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,728,0,-47,NA,75,High or alive at last follow-up,>70
C3L-00098,UCEC,C3L-00098-T,,TRUE,,,CPT0000980012,['CPT0000980008'],,CPT0003930002,CPT0000980005,,FALSE,63,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior  and Posterior endometrium,,Unifocal,6,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,157,50,20.28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,claritin|Ultram|adderall|prilosec|norco|lasix|potassium|citracal |Vitamin D ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1748,NA,,1748,NA,No,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1748,0,0,NA,63,High or alive at last follow-up,60-70
C3N-00334,UCEC,C3N-00334-T,,TRUE,,,CPT0018570003,['CPT0018570009'],,CPT0018720002,['CPT0018570006'],,FALSE,68,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,1.4,Serous carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,Stage I,,,,159,83,32.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,674,NA,,659,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,674,0,-15,NA,68,High or alive at last follow-up,60-70
C3N-00377,UCEC,C3N-00377-T,,TRUE,,,CPT0021650003,['CPT0021650006'],,CPT0021710002,CPT0021650009,,FALSE,64,Female,Unknown,Unknown,European,Ukraine,No,Other,Uterine cavity,,Multifocal,1,Endometrioid carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,153,80,34,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,707,NA,,670,NA,Yes,No,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,707,0,-37,NA,64,High or alive at last follow-up,60-70
C3L-00143,UCEC,C3L-00143-T,,TRUE,,,CPT0001910016,['CPT0001910008'],,CPT0003970002,CPT0001910012,,FALSE,69,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior endometrium,,Unifocal,5.2,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1 (FIGO I),pN0,19,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,Stage I,,,,170,99,34.26,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",1,Exposure to secondhand smoke history not available,,,,,,,synthroid|cozaar|lipitor|glucophage|aygestin|hygroten|glucosamine|probiotic|vitamin D|vitamin C|fish oil,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,Living,1708,NA,,1708,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1708,0,0,NA,69,High or alive at last follow-up,60-70
C3N-01510,UCEC,C3N-01510-T,,TRUE,,,CPT0079650003,['CPT0079650006'],,CPT0080750002,CPT0079650009,,FALSE,53,Female,White,Not Hispanic or Latino,European,United States,No,Other,Bulky tumor involving both anterior and posterior walls,,Multifocal,8.5,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT2 (FIGO II),pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,,158,101,40.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,acetaminophen|albuterol|atorvastatin|cholecalciferol|fenofibrate|glipizide|ibuprofen|indapamide|levothroxine|losartan|metformin|sertraline,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1100,NA,,1044,NA,Yes,No,No,Unknown Tumor Status,Complete Remission,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,1100,0,-56,NA,53,High or alive at last follow-up,50-60
C3L-01925,UCEC,C3L-01925-T,,TRUE,,,CPT0113690003,CPT0113690006,,CPT0114410002,CPT0113690009,,FALSE,65,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and posterior endometrium,,Unifocal,4.5,Serous carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b (FIGO IIIB),pN1 (FIGO IIIC1),3,2,Staging Incomplete,pM1,Omentum,R0:  No residual tumor,Stage IV,,,0,165,75,27.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Acetaminophen|ascorbic acid|Vitamin D3|coQ10|Green Tea Leaf Extract|melatonin|Multivitamin|Prasterone (DHEA)|Bone Restore/Triple cruciferous vegetable extract/mushroom extract/Biocuncumin/NK Cell Activator|Quercetin Dihydrate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1351,NA,,1338,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1351,0,-13,NA,65,High or alive at last follow-up,60-70
NX5,UCEC,,NX5-N,TRUE,,NX5,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX6,UCEC,,NX6-N,TRUE,,NX6,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-00921,UCEC,C3L-00921-T,,TRUE,,,CPT0064150004,['CPT0064150010'],,CPT0065390002,CPT0064150007,,FALSE,66,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior,,Unifocal,4,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,6,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,Stage II,,,,165,88,32.32,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",16,Exposure to secondhand smoke history not available,,,,,,,nystatin|Stool softner|Advil,Medical Record|Medical Record|Medical Record,No,Living,1776,NA,,1776,NA,Yes,No,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1776,0,0,NA,66,High or alive at last follow-up,60-70
C3L-00156,UCEC,C3L-00156-T,,TRUE,,,CPT0002080011,['CPT0002080005'],,CPT0004340002,CPT0002080008,,FALSE,56,Female,White,Not Hispanic or Latino,European,United States,No,Anterior endometrium,,,Unifocal,2.2,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage I,,,,173,83,27.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Naproxen Sodium|Ibuprofen|Hydrochlorothiazide|Amlodipine|Multi Vitamin |Insulin Lispro,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,Living,1776,NA,,1776,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1776,0,0,NA,56,High or alive at last follow-up,50-60
C3L-00938,UCEC,C3L-00938-T,,TRUE,,,CPT0016260003,['CPT0016260009'],,CPT0016330002,CPT0016260006,,FALSE,53,Female,White,Unknown,European,United States,No,Other,both anterior and posterior,,Unifocal,5.5,Endometrioid carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage I,,,,155,109,45.53,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Atenolol|levothyroxine,Medical Record|Medical Record,No,Living,1561,NA,,1529,NA,Yes,Unknown,Unknown,Tumor Free,Unknown,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1561,0,-32,NA,53,High or alive at last follow-up,50-60
C3L-00137,UCEC,C3L-00137-T,,TRUE,,,CPT0002010011,['CPT0002010005'],,CPT0003870002,CPT0002010008,,FALSE,60,Female,White,Not Hispanic or Latino,European,United States,No,Other,Both anterior and posterior,,Unifocal,5,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,Stage I,,,,165,70,25.68,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Doxycycline|Cetirizine,Medical Record|Medical Record,No,Living,823,NA,,823,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,823,0,0,NA,60,High or alive at last follow-up,50-60
C3N-00848,UCEC,C3N-00848-T,,TRUE,,,CPT0024130003,['CPT0024130006'],,CPT0024210002,CPT0024130009,,FALSE,66,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Multifocal,3,Endometrioid carcinoma,G2 Moderately differentiated,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage I,,,,158,84,33.65,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,658,NA,,636,NA,Yes,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,658,0,-22,NA,66,High or alive at last follow-up,60-70
NX7,UCEC,,NX7-N,TRUE,,NX7,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3L-00781,UCEC,C3L-00781-T,,TRUE,,,CPT0070260003,['CPT0070260006'],,CPT0071030002,CPT0070260009,,FALSE,48,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Other,Anterior and Posterior Endometrium,,Unifocal,5.5,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Cannot be assessed,Seventh Edition (2010),pT2 (FIGO II),pN0,13,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,Stage II,,,0,160,83,32.59,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Dexamethasone|Morphine,Medical Record|Medical Record,No,Living,1519,NA,,1519,NA,Yes,Yes,No,Tumor Free,Complete Remission,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1519,0,0,NA,48,High or alive at last follow-up,<50
NX8,UCEC,,NX8-N,TRUE,,NX8,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX9,UCEC,,NX9-N,TRUE,,NX9,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
C3N-01802,UCEC,C3N-01802-T,,TRUE,,,CPT0080030003,['CPT0080030006'],,CPT0080810002,CPT0080030009,,FALSE,85,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Other,entire uterine cavity,,Unifocal,3.8,Serous carcinoma,G3 Poorly differentiated,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,5,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,Stage II,,,,163,64,24.32,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,ferrous sulfate|lisinopril|vitamin D3,Medical Record|Medical Record|Medical Record,No,Living,775,NA,,740,NA,Yes,No,No,With Tumor,Complete Remission,,Yes,598,Locoregional Recurrence,Other: left lower abdomen,,,No,,,No,No,No,NA,NA,598,563,1,775,0,-35,NA,85,High or alive at last follow-up,>70
C3N-00151,UCEC,C3N-00151-T,,TRUE,,,CPT0066620003,['CPT0066620009'],,CPT0071660002,CPT0066620006,,FALSE,60,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Unifocal,0,Endometrioid carcinoma,G3 Poorly differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,8,0,cM0,No pathologic evidence of distant metastasis,Not known,R0:  No residual tumor,Stage I,,,,163,72,27.1,No,Lifelong non-drinker,Smoking history not available,NA,Exposure to secondhand smoke history not available,,,,,,,,,No,Living,0,NA,,NA,NA,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,,Unknown,NA,,,,,,,,,,,NA,NA,NA,NA,0,0,0,NA,NA,60,High or alive at last follow-up,50-60
C3L-00136,UCEC,C3L-00136-T,,TRUE,,,CPT0000730011,['CPT0000730005'],,CPT0003860002,CPT0000730008,,FALSE,50,Female,White,Not Hispanic or Latino,European,United States,No,Other,Anterior and Posterior endometrium,,Unifocal,4.5,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,162,147,55.67,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,Ibuprofen|Alprazolam|aspirin 81mg|Oxycodone|tylenol ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,1794,NA,,1794,NA,No,No,No,Tumor Free,Not Applicable,Complete Remission,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,1794,0,0,NA,50,High or alive at last follow-up,<50
C3L-00008,UCEC,C3L-00008-T,,TRUE,,,CPT0001300009,CPT0001300164,,CPT0000080163,CPT0001300005,,FALSE,58,Female,White,Not Hispanic or Latino,European,United States,No,Posterior endometrium,,,Unifocal,3.5,Endometrioid carcinoma,G1 Well differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,Stage I,,,,162,105,39.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",19,Exposure to secondhand smoke history not available,,,,,,,Synthroid|celexa|nizoral|Microzide|vitamin D|vitamin B|flaxseed,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,Living,898,NA,,898,NA,No,No,No,Tumor Free,Not Applicable,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,898,0,0,NA,58,High or alive at last follow-up,50-60
C3N-00847,UCEC,C3N-00847-T,,TRUE,,,CPT0027650003,['CPT0027650006'],,CPT0027740002,CPT0027650009,,FALSE,65,Female,Unknown,Unknown,European,Ukraine,No,Other,Entire uterine cavity,,Multifocal,4.3,Endometrioid carcinoma,G2 Moderately differentiated,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,4,0,cM0,Staging Incomplete,No,R0:  No residual tumor,Stage III,,,,165,94,34.53,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,Exposure to secondhand smoke history not available,,,,,,,,,Yes,Living,682,NA,,628,NA,No,Yes,No,Tumor Free,Complete Remission,,No,NA,,,,,,,,,,,NA,NA,NA,NA,0,682,0,-54,NA,65,High or alive at last follow-up,60-70
NX12,UCEC,,NX12-N,TRUE,,NX12,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX17,UCEC,,NX17-N,TRUE,,NX17,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX13,UCEC,,NX13-N,TRUE,,NX13,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX14,UCEC,,NX14-N,TRUE,,NX14,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX10,UCEC,,NX10-N,TRUE,,NX10,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX16,UCEC,,NX16-N,TRUE,,NX16,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX18,UCEC,,NX18-N,TRUE,,NX18,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX11,UCEC,,NX11-N,TRUE,,NX11,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,
NX15,UCEC,,NX15-N,TRUE,,NX15,,,,,,,FALSE,,,,,,,,,,,,NA,,,,,,,,,,,,,,,,,,NA,NA,NA,,,,NA,,,,,,,,,,,,NA,NA,,NA,NA,,,,,,,,NA,,,,,,,,,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,